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Abstract 
 
In 2002 a new family of 14-membered resorcylic macrolides, the aigialomycins, were 
isolated from the mangrove fungus Aigialus parvus BCC 5311. Subsequent biological 
testing of these new natural products found aigialomycin D (Am D) to be the most 
biologically active member of the family, exhibiting moderate activity against malaria 
(Plasmodium falciparum K1, IC50 19.7 μM) and modest cytotoxicity towards certain 
cancer cells (KB cells: IC50 9.0 μM and BC-1 cells: 53.8 μM). More recently, Am D has 
been shown to inhibit the kinases CDK1/5 and GSK at low μM concentrations. 
 
At the onset of this research project, with only one total synthesis of Am D reported in 
the literature, there remained a need for an efficient synthesis of Am D that would be 
amenable to the synthesis of a range of analogues. This thesis reports two synthetic 
approaches to Am D that differ primarily in the chemistry utilised to install the (E)-
olefins at C1′–C2′ and C7′–C8′: a Horner-Wadsworth-Emmons (HWE) strategy and a 
Ramberg-Bäcklund (RB) strategy. The Ramberg-Bäcklund strategy ultimately proved to 
be successful, providing Am D in 16 steps with 9% overall yield. A retrosynthetic 
analysis of Am D disconnects the molecule into three major fragments: an aromatic 
fragment, a C2′–C7′ carbohydrate-derived fragment and a C8′–C11′ alcohol fragment. 
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The synthesis of the three fragments for each strategy is described and the attempts 
made to couple the fragments together, first with HWE methodology and then 
successfully with ring-closing metathesis (RCM) and RB reactions, are discussed. The 
synthesis of several Am D analogues and their preliminary biological testing is also 
described.  
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Chapter One: 
Introduction 
 
1.1 Synthesis of Natural Products 
 
Friedrich Wöhler’s synthesis of urea from ammonium cyanate in 18281 was not only the 
birth of organic chemistry; it also marked the dawn of natural product synthesis. This 
landmark event once-and-for-all closed the debate over whether the synthesis of natural 
products was constrained to the realm of nature. These days, the discipline of natural 
product synthesis is an important investigative field whose returns range from drug 
discovery to process development.2,3 Natural product synthesis provides an ideal stage 
to demonstrate the power of organic synthesis and illustrate the scope and limitations of 
synthetic prowess at a given point in time. The challenge of synthesising natural 
products requires the development of the new synthetic tools needed to push towards 
higher molecular complexity, diversity and efficiency.4 
  
Not only does natural product synthesis give opportunities for the discovery and 
development of new synthetic techniques and methodology with application stretching 
far beyond the discipline, it also provides an alternative source of natural products with 
promising biological activity. Normatively, natural products of interest are present at 
very low concentrations in the natural source, such that an exhaustive amount of the 
organism needs to be harvested and extracted to provide enough material for further 
extensive biological testing and/or medical application. Thus total synthesis is often 
necessary to provide enough material to be of use. Additionally, natural products can 
provide a structural platform which can be elaborated upon or simplified to achieve 
enhanced potency, improved selectivity, reduced toxicity, or other desirable physical 
and chemical properties.5 Synthesis of such analogues enables study of the relationship 
between the structure of the natural compound and its activity (the structure activity 
relationship, SAR). Finally, the chemical synthesis of a natural product still provides the 
absolute proof of the configuration and connectivity assigned to its structure.6 
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1.2 Resorcylic Acid Lactones (RALs) 
 
One subclass of natural products that exhibits promising biologically activity is the 
resorcylic acid lactones (RALs) (Figure 1–1).7 RALs are macrocyclic lactones that 
contain a β-resorcylic acid unit (shown in blue) and feature an array of chemical 
functionality across both the β-resorcylic acid unit and the macrocyclic ring. The term 
RAL is used to denote the 14-membered β-resorcylic acid macrolactones in particular. 
 
 
Figure 1–1. General structure of RALs. 
 
One member of the RAL family is the fungal metabolite aigialomycin D (Am D, 1) 
(Figure 1–2). This natural product was isolated in 2002 from the mangrove fungus 
Aigialus parvus BCC 5311. The relative stereochemistry and absolute configuration of 
Am D was proposed to be 1′E,5′S,6′R,7′E,10′S based on extensive NMR analysis and 
comparisons with related metabolites of known X-ray structure.8 This macrolactone was 
initially observed to exhibit modest cytotoxicity against certain cancer cell lines and 
moderate antimalarial activity.8 Several years later, Am D was shown to inhibit three 
protein kinases.9 
OH
HO
O
O
OH
OH
Aigialomycin D (Am D)
1  
Figure 1–2. Structure of the fungal metabolite aigialomycin D (1). 
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1.2.1  Biosynthesis of RALs 
 
Resorcylic acid lactones (RALs) are mycotoxins produced by a variety of different 
fungal strains via polyketide biosynthesis. The fungal polyketide synthases (PKSs) 
involved in RAL biosynthesis are large multidomain enzymes that iteratively catalyse 
the condensation of nine units of thioacetates or malonates (Figure 1–3).7 Different 
modules in the enzyme complex can further process the product of each condensation 
by reduction or dehydration of the resulting β-diketone. The only RAL whose 
biosynthesis has been studied in detail is zearalenone.10,11 This biosynthesis is proposed 
to involve two PKSs, the first of which is responsible for the coupling of the first six 
acetate units, with further processing to arrive at the final oxidation state at each carbon. 
The second PKS performs the remaining three rounds of condensation without any 
carbonyl reduction. The unreduced ketones are highly reactive and spontaneously 
cyclise and aromatize, mediated by the enolisation of the ketone groups via a 
nonenzymatic process. After cyclisation, the macrolactone is subsequently released 
from the second PKS.10 The diversity of functionality present in RAL macrocycles can 
be accounted for by the different combinatorial arrangements of the various β-keto 
processing modules involved in the first five condensations. 
 
 
 
Figure 1–3. Top: Generalised biosynthesis of resorcylic acid lactones. The red bonds 
represent the two-carbon units that are added in each of the nine iterative condensations. 
Bottom: Representation of the two multidomained polyketide synthases involved in the 
biosynthesis of zearalenone.11 
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1.2.2  The Family of 14-Membered RALs. 
 
The first RAL to be isolated was monorden (2, Figure 1–4), extracted in 1953 from the 
fungus Monosporium nordinii.12 This same metabolite was independently isolated 10 
years later from Nectria radicicola and renamed radicicol.13 The structural 
configuration originally proposed for monorden was found to be incorrect and hence the 
name radicicol has prevailed. Initially reported to have mild sedative and moderate 
antibiotic properties,13 the potent and selective inhibition of heat shock protein 90 
(Hsp90) by this compound remained undiscovered until 1998.14,15 The molecular 
chaperone Hsp90 mediates the stabilisation and folding of various client oncogenic 
proteins such as Raf1 and Her2.16 Inhibition of the chaperoning activity of Hsp90 
results in the degradation of its client proteins by the proteasome. This ultimately results 
in antitumor activity. The structurally related pochonin D (3) has also been shown to be 
a nanomolar inhibitor of Hsp90.17 
 
 
Figure 1–4. Structures, targets and inhibitory concentrations (IC50)24 of Hsp90 
inhibitors radicicol (2)14,15 and pochonin D (3).17 
 
Several RALs that have the cis-enone functionality incorporated into the macrocycle 
have been reported to be protein kinase inhibitors. Protein kinases are enzymes that 
chemically alter their protein substrates by attaching phosphate groups to them. This 
process, phosphorylation, usually results in functional changes to the target protein and 
altered enzyme activity, cellular location, or association with other proteins. The kinase 
reversibly transfers a phosphate group from adenosine triphosphate (ATP) to serine, 
threonine or tyrosine residues on their target that can be removed by protein 
phosphatases in a dephosphorylation step (Figure 1–5).18 These two reactions play a 
crucial role in the regulation of a large number of cellular processes, including the 
transmission of signals within the cell along the many signal transduction pathways. 
                                                 
24 The IC50, or inhibitory concentration for 50% inhibition, is the concentration at which growth or 
activity is inhibited by 50%. It is often used as a measure of the cytotoxicity of a compound. 
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Figure 1–5. Phosphorylation and dephosphorylation mediated by kinases and 
phosphatases.19 
 
The profound effects that protein kinases can have on cells require their strict 
regulation. Research over the past 40 years has shown that deregulation of kinase 
activity, resulting in defective signalling, is a frequent cause of cancer and many other 
human diseases such as diabetes, inflammation disorders and cardiovascular diseases.20 
Specific kinase inhibitors are a promising new class of therapeutics. This class includes 
drugs such as the tyrosine kinase inhibitors Imatinib and Gefitinib. The vast majority of 
these compounds compete with ATP, inhibiting the kinase at the ATP-binding site.  
 
Kinases belonging to the MAP (mitogen-activated protein) pathway are important in 
regulating the cellular response to environmental stimuli by translating these cues into 
gene expression, cell growth or apoptosis. Consequently, MAP kinases have become 
primary targets in drug discovery. 
 
cis-Enones hypothemycin (4), LL-Z1640-2 (5), radicicol A (6), and LL-783,277 (7) 
have all been reported to be inhibitors of various kinases (Figure 1–6). These RALs 
exemplify the observation that small structural differences in this family of compounds 
are able to change their mode of action and presumably the target of inhibition. 
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Figure 1–6. Structures, targets and IC50’s of hypothemycin (4), LL-Z1640-2 (5), 
radicicol A (6), and LL-783,277 (7).21-24 
 
The first RAL reported to inhibit a kinase was radicicol A (6, Figure 1–6). Radicicol A 
was isolated in 1987 from a strain of fungus F/87-2509.04 while screening for 
interleukin 1 beta (IL1β) inhibition, an important mediator of inflammation.23 Several 
years later, Traber and co-workers showed that radicicol A (6) also inhibited tumour 
necrosis factor alpha (TNF-α) secretion, another major mediator of inflammation.21 
Discovered in 1980,25 hypothemycin (4) was shown by researchers at Merck in 1999 to 
inhibit MEK25 with an IC50 of 15 nM, slightly less active than LL-783,277 (7) which 
exhibited an IC50 of 4 nM.24 LL-783,277 was shown to express inhibition of MEK1 
through competing with ATP binding. First isolated in 1978,26 LL-Z1640-2 (5) was 
shown in 2003 by Matsumoto et al. to irreversibly inhibit the kinase activity of TAK126 
(IC50 of 8.1 nM) at the ATP-binding site.22 
 
In addition to the macrolactones already mentioned, several other RALs have been 
characterised in the literature. Zearalenone (8, Figure 1–7), first isolated from 
Gibberella zea in 1962,27 generated much interest in the organic chemistry community 
due to its estrogenic agonistic properties. These properties were shown to arise from the 
metabolite’s ability to adopt a conformation that mimics that of the native steroid 17-
estradiol.28 
                                                 
25 MEK (MAP kinase kinase) is a dual-specificity kinase that phosphorylates tyrosine and threonine 
residues and is involved in the MAP (mitogen activated protein) kinase cascade. The MAP kinases relay, 
amplify and integrate signals from a variety of extracellular stimuli thereby regulating the cell’s response 
to the environment. 
26 TAK1 is MAPKKK (MAP kinase kinase kinase) involved in the p38 signalling cascade for 
proinflammation signals (e.g. cytokines)  
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Figure 1–7. The structures of zearalenone (8) and 17-estradiol whose conformation is 
mimicked by 8. 
 
More recently isolated RALs include queenslandon (9, Figure 1–8), which was isolated 
from the fungal strain Chrysosporium queenslandicum IFM51121 in 2002.29 This 
macrolide showed distinct anti-fungal activity but lacked antibacterial activity. 
 
In 2003, a new family of RALs, the pochonins, were reportedly isolated from Pochonia 
chlamydosporia var. catenulata alongside the known metabolite, radicicol.30 The family 
was identified in a Herpes Simplex Virus 1 (HSV1) replication assay. All pochonins 
except for pochonin D (3) exhibited low micromolar range activity against HSV1, for 
example pochonin C (10) exhibited an IC50 of 6 μM (Figure 1–8). 
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anti-fungal activity  
Figure 1–8. Structures and targets of queenslandon (9)29 and a representative of the 
pochonin family, pochonin C (10).30 
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1.3 Aigialomycin D 
 
1.3.1  Discovery and Isolation of Aigialomycin D 
 
In 2002, a new family of 14-membered resorcylic macrolides, the aigialomycins (Am) 
A–E (Figure 1–9, 11–13, 1, 14), was isolated from the mangrove fungus Aigialus 
parvus BCC 5311 (Figure 1–10).8 They were present alongside the already known 
metabolite hypothemycin (4). Their isolation was achieved through activity guided 
fractionation and chromatographic separation. The structures of the natural products, 
including absolute configuration, were elucidated by using a variety of spectroscopic 
methods, chemical conversions and x-ray analyses. 
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Figure 1–9. Structures of aigialomycins A–E (11–13, 1, 14) and hypothemycin (4) 
isolated from Aigialus parvus BCC 5311. 
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Figure 1–10. Aigialus parvus, a mangrove fungus.  
 
Like other members of the RAL family, compounds 1 and 11 to 14 are characterised by 
the presence of a resorcylic aromatic ring fused to a 14-membered macrocycle 
containing a benzoate lactone functionality and a high degree of oxygenation and/or 
unsaturation. Am D (1) was found to have a second (E)-olefin at C1′–C2′ instead of the 
epoxide functionality found on compounds 11–13 and two free phenolic hydroxyl 
groups. A NOESY NMR experiment on the acetonide derivative of 1 confirmed that the 
two hydroxyls at C5′ and C6′ are in a cis relationship.8 The structure of Am E (14) 
differs from Am D only by having a (Z)-configuration at C1′–C2′.  
 
Two other metabolites, the acetal aigialone (15) and the spiroacetal aigialospirol (16) 
(Figure 1–11), were isolated from the same fungus in 2004.31 Aigialospirol is 
structurally related to the aigialomycins and hypothemycin in having a resorcylic 
portion with a polyketide chain. It differs, however, in the presence of spiroketal system 
instead of the 14-membered macrocycle found in the aigialomycins and hypothemycin.  
 
 
Figure 1–11. Structures of Aigialone (15) and aigialospirol (16), metabolites isolated 
from Aigialus parvus BCC 5311. 
 
© copyright National Institute of Oceanography, Dona Paula, 403 004, Goa, India 2000 
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1.3.2  Biological Testing of Aigialomycin D 
  
The natural products 1, 4 and 11–14 isolated from Aigialus parvus BCC 5311 were all 
screened for antimalarial activity and cytotoxicity (Table 1–1).8 Compounds 15 and 16 
were inactive in all the biological assays they were subjected to.31 
 
Table 1–1. Antimalarial Activity and Cytotoxicity of Macrolides 11–13, 1, 14 and 4 
Cytotoxicity (IC50, μM)b Compound 
Plasmodium 
falciparum K1 
(IC50, μM) KB BC-1 Vero 
aigialomycin A (11) > 50 > 50 29 11 
aigialomycin B (12) > 50 > 50 > 50 > 50 
aigialomycin C (13) > 50 > 50 > 50 > 50 
aigialomycin D (1) 20 9.0 54 5.4 
aigialomycin E (14) > 50 > 50 40 > 50 
hypothemycin (4) 5.8 45 16 17 
chloroquine 
diphosphatea 0.3 31 39 39 
ellipticineb – 1.9 2.4 4.1 
 
a standard antimalarial drug. b standard anticancer drug. 
  
Am D (1) and hypothemycin (4) were the only members of this series of compounds 
that displayed antimalarial activity. Compounds 1 and 4 also exhibited modest 
cytotoxicity towards skin and breast cancer cells (KB and BC-1 cells), and Vero cells 
(African green monkey kidney fibroblasts). Neither of these compounds would be 
practical in the treatment of malaria as their average cytotoxicity is similar in magnitude 
to their antimalarial activity, leaving no usable therapeutic window.  
 
Initially it was reported that Am D bound to Hsp90, albeit to a significantly lower 
degree than the structurally related macrolide radicicol.32 Further investigation, 
however, found that Am D did not lead to degradation of Her2, one of the most 
sensitive client proteins of this chaperone, even at 10 μM, and it is therefore not likely 
to be an inhibitor of Hsp90.33 
 
New information regarding the biological activity of Am D was reported by Winssinger 
and co-workers in late 2006.9 Their tests found that Am D inhibited the kinases 
CDK1/cyclin B, CDK5/p25 and GSK-3 with IC50’s of 5.7 μM, 5.8 μM and 14 μm 
respectively, suggesting that Am D’s mode of cytotoxicity in human cells could be due 
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to the inhibition of these kinases. Interestingly, Am D was not found to inhibit the 
Plasmodium homologue of GSK-3, PfGSK-3 (IC50>100 μM), suggesting Am D’s 
antimalarial activity cannot be attributed to the inhibition of this kinase. Although the 
exact binding sites of Am D are yet to be determined, it is probable that Am D binds at 
their ATP sites as has been observed in many RAL inhibitions. 
 
Due to its interesting biological profile, the focus of this research project was to 
complete the total synthesis of Am D. Before details of the synthetic methodology are 
discussed, a review of previous syntheses of Am D is presented. 
 
1.3.3  Previous Total Syntheses of Aigialomycin D 
 
To date there have been five successful total syntheses9,32,34-36 and two partial 
syntheses37,38 of Am D published in the literature. The first total synthesis, reported by 
Danishefsky and co-workers in 2004,32 was the sole synthesis published when the 
research described in this thesis was commenced.  
 
1.3.3.1 Danishefsky’s synthesis 
 
The first total synthesis of Am D was reported by Danishefsky et al. in 2004. Their 
predominantly linear synthesis was accomplished in 18 steps with an overall yield of 
8%.32 
 
Syntheses of RALs generally utilise an aromatic starting material.7 Danishefsky and co-
workers, however, disconnected through the aromatic ring of Am D. They chose to 
install the aromatic ring using a cycloaddition reaction, to take place after 
macrocyclisation (Figure 1–12). The macrocyclic dienophile 18 was disconnected at the 
olefin, which would be formed through the use of a ring-closing metathesis (RCM) 
reaction. Acyclic precursor 19 was further disconnected at the ester linkage and the 
homopropargylic alcohol to give the synthon 20, alkyne 21, and chiral alcohol 22. 
Carbohydrate-derived 20 was built up sequentially from D-2-deoxy-D-ribose (23), an 
inexpensive, readily available starting material.  
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Figure 1–12. Retrosynthetic analysis of Am D conducted by Danishefsky et al.32 
 
Synthesis of Am D began with a carbon chain extension of 2-deoxy-D-ribose (23) 
through a Wittig olefination reaction (Scheme 1–1). The resulting primary alcohol was 
protected as its pivaloyl derivative prior to hydroboration and oxidation to give alcohol 
24. Parikh-Doering oxidation39 of alcohol 24 afforded an aldehyde before further 
extension of the carbon chain through nucleophilic propargylation to give a mixture of 
stereoisomers. These were subsequently protected as their t-butyldimethylsilyl (TBS) 
ethers before cleavage of the pivaloate group to yield alcohol 25. A second Parikh-
Doering oxidation was followed by a Wittig reaction to install the first of the vinyl 
groups required for the RCM reaction. After carboxylation of the alkyne 26, 
esterification with the (R)-alcohol 22 under Mitsunobu conditions40 gave the (S)-ester 
19 as a mixture of epimers at the C2′ position.  
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Scheme 1–1. The synthetic strategy employed by Danishefsky in the synthesis of a 
diene precursor of Am D. 
 
Reagents and conditions: a) 2-methoxypropene, p-TsOH, 62%; b) KHMDS, Ph3P+CH3I-, 68%; c) PivCl, 
Et3N, DMAP, 90%; d) 9-BBN, then NaOH, H2O2, 88%; e) SO3-Pyr, DMSO, Et3N; f) propargyl bromide, 
zinc; g) TBSOTf, 2,6-lutidine, 89% (3 steps); h) NaOMe, 88%; i) SO3-Pyr, DMSO, Et3N, then KHMDS, 
Ph3P+CH3I-, 86% for two steps; j) n-BuLi, CO2 (s); k) 22, DIAD, PPh3, 85% for two steps. 
 
Several attempts were made to cyclise diene 19 to macrolactone 18 using Grubbs’ 
second generation catalyst 2841,42 (Scheme 1–2). However, only starting material was 
recovered from the RCM reaction. Interestingly, there was no indication in the report 
that any cross-metathesis product was isolated. Danishefsky postulated that the alkyne 
functionality in the molecule might be the cause of the failed attempts at olefin 
metathesis for two reasons. Firstly, the alkyne group could unproductively coordinate to 
the catalyst, thus reducing the amount of free catalyst to carry out metathesis. The 
second important factor considered was the additional conformational rigidity of the 
alkyne group compared to an alkene group. It is likely that the linear geometry of the 
alkyne does not allow the terminal alkene groups to be close enough in space for 
metathesis to occur. 
 
 
Scheme 1–2. Danishefsky’s attempted RCM reaction on diene 19.  
 
Reagents and conditions: a) 28 (25 mol%), Δ, CH2Cl2.  
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Previous work done by Danishefsky’s group had shown that similar RCM precursors 
required further modification before ring-closing metathesis could occur.33 Thus the 
alkyne group was ‘protected’ as its dicobalt hexacarbonyl complex (30) (related to 
intermediates formed in a Pauson-Khand reaction),43 preventing coordination of the 
catalyst to the alkyne group (Scheme 1–3). Furthermore, this complexation likely causes 
distortion of the alkyne bond from the normal 180° to approximately 140° 44 allowing 
the two olefins to be in closer proximity. With this modification, metathesis occurred in 
excellent yield to provide compound 31 as a mixture of epimers. 1H NMR spectroscopy 
indicated a ratio of 1:1.2 for the two isomers but their stereochemistries were not 
rigorously assigned, as this chiral centre would be transformed into a sp2-hybridised 
carbon atom in the final steps of the synthesis. They did, however, note that for each 
diastereomer, only the (E)-alkene was generated in the RCM reaction (JHH ≅ 15.2 Hz).  
 
 
Scheme 1–3. Danishefsky’s synthesis of macrolactone 31. 
 
Reagents and conditions: a) Co2(CO)8, 94%; b) 28 (25 mol%), 80%. 
 
Macrolactone 31 was then decomplexed through treatment with ceric ammonium nitrate 
(CAN) (Scheme 1–4). The subsequent cycloaddition reaction between alkyne 18 and 
disiloxydiene 17, provided the adduct 32 in high yield (79%). This transformation 
involves a cycloaddition followed by a cycloreversion as the newly formed ring 
aromatises, extruding gaseous isobutylene (Scheme 1–5).  
 
 15
 
Scheme 1–4. Final steps in Danishefsky’s total synthesis of Am D. 
 
Reagents and conditions: a) CAN, 95%; b) 17, Δ, 79%; c) MOMCl, DIPEA, 80%; d) HF-py, 83%; e) 
[PhC(CF3)2O]2SPh2, 87%; f) 0.5 M HCl, 69%. 
 
 
 
Scheme 1–5. Installation of the aromatic ring through a cycloaddition/cycloreversion 
reaction sequence. 
 
The cycloaddition product underwent aromatic desilylation during the course of 
purification by silica gel chromatography. The two phenol groups were orthogonally 
protected as their methoxymethyl (MOM) derivatives, before the secondary alcohol was 
selectively deprotected, yielding 34. Installation of the (E)-olefin at C1′–C2′ was 
accomplished through dehydration of alcohol 34 using Martin’s sulfurane reagent.45 
Both epimers of 34 led to the same product, 35, which underwent global acidic 
deprotection, completing the first total synthesis of Am D. The final product was 
established as Am D through the very close correspondence of the 1H NMR, 13C NMR, 
mass spectral and IR data of the synthetically derived material with the data previously 
reported for the natural product.8  
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1.3.3.2 Pan’s synthesis 
 
The second total synthesis of Am D was published by Pan et al. in 2006.34 Despite this 
synthesis being more convergent than that undertaken by Danishefsky et al., 18 steps 
were still required to deliver Am D in an overall yield of 2.5%.  
 
Like the approach of Danishefsky, Pan and co-workers disconnected Am D at the two 
olefins (Figure 1–13). However, rather than disconnecting through the aromatic ring, 
their third disconnection at the lactone gave an intact resorcylic unit (36) and two 
benzothiazol-2-yl sulfone units (37 and 38). Pan envisioned that the olefins could be 
installed with two Juliá-Kocienski olefinations before formation of the macrocycle 
through a Yamaguchi macrolactonisation.  
 
Figure 1–13. Retrosynthetic analysis of Am D conducted by Pan et al. 
 
Synthesis of the first fragment began with commercially available propargyl alcohol 
(Scheme 1–6). Alkylation of 39 with 1-benzyloxy-3-iodopropane followed by reduction 
with lithium aluminum hydride (LAH) afforded an (E)-allylic alcohol. This underwent 
asymmetric epoxidation under Sharpless conditions46,47 to give epoxide 40. 
Regioselective opening of the epoxy alcohol with benzoic acid was mediated by Ti(i-
PrO)4,48 which after manipulation of protecting groups gave alcohol 41. Compound 41 
was readily converted to sulfone 38 through a Mitsunobu reaction and oxidation of the 
resulting thioether in 81% yield over two steps. The benzylic olefin was installed 
through a Juliá-Kocienski49,50 reaction by addition of aldehyde 36 to the preformed 
potassium salt of sulfone 38, furnishing the (E)-olefin with good stereoselectivity (E/Z = 
95:5). After reductive cleavage of the pivaloate and oxidation of the resulting hydroxyl 
group under Dess-Martin conditions,51 the second Juliá-Kocienski reaction proceeded 
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with moderate stereoselectivity, affording TBS ether 43 with an E/Z ratio of 83:17. 
After cleavage of the TBS group and carboxylation with n-butyllithium and carbon 
dioxide, the macrocyclic lactone 35 was formed using a Yamaguchi 
macrolactonisation.52 The macrocycle was then globally deprotected under acidic 
conditions to afford the target compound with identical physical and spectroscopic data 
to those reported for Am D.8,32 
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Scheme 1–6. Pan’s synthesis of Am D. 
 
Reagents and conditions: a) BnOCH2CH2CH2I, n-BuLi, 70%; b) LiAlH4, 96%; c) Ti(O-iPr)4, TBHP, (–)-
DIPT, cat. CaH2, 89%; d) Ti(O-iPr)4, PhCO2H, 75%; e) EtMgBr, 95%; f) PivCl, Et3N, DMAP, 88%; g) 2-
methoxypropene, PPTS, 95%; h) 10% Pd/C, H2, 4 h, 95%; i) 1-phenyl-1H-tetrazole-5-thiol, DIAD, PPh3; 
j) m-CPBA, NaHCO3, 81% for two steps; k) KHMDS, 36, 68%; l) DIBAL-H, 96%; m) Dess–Martin 
periodinane, 85%; n) KHDMS, 37, 58%; o) TBAF, 95%; p) n-BuLi, CO2, 83%; q) 2,4,6-
trichlorobenzoylchloride, Et3N, then DMAP, 51%; r) 0.5M HCl, 70%. 
 
Despite Pan’s synthesis having the identical number of steps in the longest linear 
sequence as the synthesis of Danishefsky and co-workers, their yield is significantly 
lower. The three coupling reactions are the lowest yielding steps (51-68%), greatly 
diminishing the overall yield at such late stages in the synthesis.  
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1.3.3.3 Winssinger’s Synthesis 
 
A third total synthesis of Am D was published shortly after that of Pan. Winssinger and 
co-worker’s efficient and highly convergent synthesis was completed in a mere 10 steps 
with a 21% overall yield.9 They also developed a polymer supported synthesis of Am D. 
 
Like Pan, Winssinger disconnected Am D at the lactone and two olefins yielding three 
main fragments (Figure 1–14). A key part of their strategy was the use of a benzylic 
thio- or selenoether which facilitated alkylation chemistry and provided a site for 
attachment to a polymer support. The macrocycle would be formed through a ring-
closing metathesis, installing the (E)-olefin between C7′–C8′. Winssinger et al. followed 
a similar approach to that of Pan et al., generating the cis-diol through a stereoselective 
opening of the epoxide 46. The benzylic olefin could finally be accessed through 
oxidation of thio- or selenoether and elimination of the resulting sulfoxide or 
selenoxide. 
 
 
Figure 1–14. Retrosynthetic analysis of Am D conducted by Winssinger et al. 
 
The key intermediate 46 was obtained in four steps from commercially available 
starting materials (Scheme 1–7). Thus, cross-metathesis of 5-bromopentene with (Z)-
1,4-but-2-enediol, catalysed by Hoveyda–Grubbs’ second generation catalyst (50),53 
gave alcohol 48 in excellent yield and E/Z ratio (>25:1). Sharpless asymmetric 
epoxidation of allylic alcohol 48, followed by oxidation and Wittig olefination, lead to 
epoxide 46 in 62% overall yield. Sc(OTf)3 mediated opening of epoxide 46 gave the 
desired diol, which was subsequently protected as the isopropylidene 49.  
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Scheme 1–7. Synthesis of key intermediates 46 and 49.  
 
Reagents and conditions: a) 10% Hoveyda–Grubbs II catalyst (50), 97%; b) Sharpless asymmetric 
epoxidation, 85%; c) SO3·py, DMSO; d) Ph3P=CH2, 70% over two steps; e) Sc(OTf)3, 100%; f) 
2,2-dimethoxypropane, p-TsOH·H2O, 70%.   
 
The aromatic fragment was obtained in three steps from the benzoic acid 45 (Scheme 1–
8). The unprotected benzoic acid 45 was esterified through a Mitsunobu reaction with 
(R)-4-penten-2-ol (22). The use of tri(meta-chlorophenyl)phosphine in the Mitsunobu 
reaction was crucial in preventing the undesired coupling of aromatic units through the 
para-hydroxyl group.54 Polymer supported diethyl azodicarboxylate (PS-DEAD) 
allowed for easy purification of the product. After protection of both phenolic hydroxyl 
groups, the selenide was introduced through deprotonation at the benzylic position 
followed by the addition of diphenyldiselenide, providing compound 51 in 59% yield. 
Selenide 51 was alkylated with bromide 49 to give the metathesis precursor 52 in good 
yield. Treatment of diene 52 with second generation Grubbs’ catalyst (28) under 
equilibrating conditions55 (80 °C for 12 h) gave the macrocycle 53 with a good E/Z ratio 
of 10:1. Treatment of macrocycle 53 with hydrogen peroxide led to oxidation and 
elimination of the selenide to give protected Am D. Global deprotection of the 
isopropylidene and ethoxymethyl (EOM) groups was achieved in quantitative yield by 
treatment with polymer supported sulfonic acid, affording Am D with identical spectral 
properties to that of the isolated natural product. This method of deprotection improved 
on the ~70% yields achieved by Danishefsky and Pan using their methanolic hydrogen 
chloride conditions.  
 
 20
 
Scheme 1–8. Synthesis of Am D by Winssinger. 
 
Reagents and conditions: a) PS-DEAD, (R)-4-penten-2-ol (22), (m-ClC6H4)3P, 83%; b) iPr2EtN, EOMCl, 
TBAI (cat.), 95%; c) LDA then (PhSe)2, 75%; d) LDA, 49, 75%; e) 5% Grubbs II catalyst (28), 92%; f) 
H2O2, 82%; g) PS–SO3H, quant. 
 
The order of the oxidation/elimination and metathesis reactions was found to be very 
important. If the oxidation/elimination step was carried out first, a significant amount of 
undesired styrene derivative 55 and six-membered ring product 56 were formed in the 
RCM reaction through cyclisation of the C7′ alkene with the benzylic olefin (Scheme 1–
9).   
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Scheme 1–9. Alternative order in oxidation/elimination and RCM of advanced 
intermediate 52. 
 
Winssinger also investigated carrying forward epoxide 57 as a masked diol (Scheme 1–
10). The alkylation, metathesis and oxidation/elimination steps all proceeded efficiently, 
however, when it came to the Lewis acid mediated opening of epoxide 57 they observed 
no 1,2-cis-diol product. Instead, the nucleophile carried out an SN2′ opening, affording a 
 21
1,4-diol (58a). This divergent reaction pathway was taken advantage of to synthesise 
aigialomycin analogues (59a–f) through the use of nucleophiles such as sodium azide or 
postassium cyanide or simultaneous epoxide opening/deprotection with different 
alcohols (methanol, ethanol, isopropanol), all in the presence of sulfonic acid resin.  
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Scheme 1–10. Access to Am D analogues through SN2′ attack of various nucleophiles.  
 
Reagents and conditions: a) LDA, 46, 74%; b) 5% Grubbs’ II catalyst (28), 90%;  c) H2O2, 85%; d) 
THF/H2O, PS-SO3H, quant.; or NaN3, PS-SO3H, 83%; or KCN, PS-SO3H, 89% (for R = OH, N3, CN); e) 
PS-SO3H, >90% (for R = OH, N3, CN); f) PS-SO3H, ROH, quant. (for R = MeO, EtO, i-PrO) 
 
After a successful solution-phase synthesis of Am D, Winssinger et al. investigated the 
utility of solid-supported synthesis for Am D and analogues. To this end, the phenyl 
selenide was replaced with a polymer-bound thioether. Gratifyingly, the chemistry to 
Am D proved to be as efficient on solid phase as in solution. 
 
Once coupled to the thiophenol resin and the phenol groups protected, the polymer-
bound substrate was alkylated the benzylic position with a variety of alkyl bromides 
yielding a raft of metathesis precursors (62a–e) (Scheme 1–11). The RCM conditions 
developed for the selenide based synthesis failed to deliver any macrocyclic product. 
However, excellent yields of the macrocycles (63a–e) were achieved when microwave 
(MW) irradiation was used to heat the CH2Cl2 solution to 120 °C for 75 min. The 
lifetime of the second-generation Grubbs’ catalyst 28 is short under such conditions, 
requiring the addition of the catalyst in three portions of 6 mol%. The macrocycles were 
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released from the resin by oxidation/elimination (H2O2/HFIP) or by free-radical 
cleavage (Bu3SnH, AIBN), which, followed by global deprotection with sulfonic acid 
resin, led to aigialomycin D (1) and analogues thereof (64a,c–e), including a series of 
dihydro-aigialomycin analogues (65a-d).  
 
 
Scheme 1–11. Diversity-oriented synthesis of aigialomycin D and analogues by 
Winssinger and co-workers.  
 
Reagents and conditions: a) PS-SH, i-Pr2EtN, 82% (by mass gain assuming 0.8 mmol g-1 for PS-SH); b) 
DBU, EOMCl, TBAI (cat.), ~96% (by mass gain assuming 0.8 mmol g-1 for PS-SH); 80% over two steps 
(by radical cleavage: AIBN (cat), nBu3SnH, MW); c) LDA, R1Br, ~quant. (by radical cleavage; and by 
oxidation/elimination: H2O2 then Δ); d) 3 x 6% Grubbs’ II catalyst (28), MW, 100% (by radical 
cleavage); e) H2O2, Δ, >90%; f) PS-SO3H, >90%; g) AIBN (cat), Bu3SnH, MW, >98%.  
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To increase understanding about the biological activity of Am D, Winssinger screened 
the natural product and several analogues (1-acetonide, 59a and 59b) against a panel of 
kinases.56 Whilst Am D was found to inhibit kinases CDK1/cyclin B, CDK5/p25 and 
GSK-3 at micromolar levels, the isopropylidene-protected aigialomycin D and 
analogues with different relative arrangements of the hydroxyl groups (59a and 59b) 
showed no notable activity. 
 
1.3.3.4 Chen’s Synthesis 
 
Chen and co-workers completed the fourth total synthesis of Am D in 2007 with a 
longest linear sequence of 11 steps and in 19% overall yield.35 Chen et al. also 
disconnected Am D at the lactone and two olefins giving three fragments (Figure 1–15), 
and envisioned assembling Am D through a Mitsunobu reaction, alkylation/elimination 
and RCM reaction. 
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Figure 1–15. Retrosynthetic analysis of Am D conducted by Chen et al. 
 
Methyl orsellinate (74) was MOM-protected, saponified and exposed to Mitsunobu 
conditions to provide aromatic segment 75 in excellent overall yield (85%) (Scheme 1–
12). To investigate the proposed benzylic lithiation–addition coupling of ester 75 to 
aldehyde 70, the 1′-lithiated derivative of 75 was reacted with model aldehyde butanal 
(76). Disappointingly, the product from this reaction was found to be δ-lactone 77, 
proposed to have been formed by cyclisation of the hydroxy ester. Therefore, Chen et 
al. turned to acylation methodology to carry out the coupling with an appropriate 
Weinreb amide (71).   
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Scheme 1–12. Undesired formation of δ-lactone 77 from the 1′-lithiated derivative of 
75. 
 
Reagents and conditions: a) MOMCl, NaH, quant.; b) KOH then HOAc, pH 6, 99%; c) DIAD, Ph3P, (R)-
4-penten-2-ol (22), 86%; d) LDA, 76. 
 
To secure the cis-diol functionality in Am D, Chen and co-workers initiated their 
synthesis with the commercially available chiral building block D-(-)-erythronolactone 
acetonide, 73, from which Weinreb amide 71 was accessed in six steps (Scheme 1–13). 
To extend the carbon chain of the fragment, Wittig methodology was used twice. The 
sequence of hydrogenation and Wittig olefination reactions avoided any difficulties in 
the selective reduction of the α,β-unsaturated olefin in the presence of the terminal 
olefin. 
 
 
Scheme 1–13. Chen’s synthesis of Weinreb amide 71. 
 
Reagents and conditions: a) DIBAL-H, 92%; b) Ph3P=CHCO2Et, PhCO2H (0.2 mol%), E/Z = 1:2, 73%; 
c) H2, 10% Pd/C (cat.), 97%; d) PCC, NaOAc, 4Å mol. sieves, 80%; e) Ph3P+CH3Br–, n-BuLi, 71%; f) 
MeONHMe·HCl, i-PrMgCl, 96%. 
 
Acylation of 75 at the benzylic position with Weinreb amide 71 afforded the desired 
ketone 66 in 82% yield (Scheme 1–14). As might be expected from the model reaction 
in Scheme 1–12, reduction of the ketone with sodium borohydride did not give the 
desired alcohol 67 but instead gave the δ-lactone 79 following an intramolecular 
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lactonisation of the 2′-alkoxide with the ester. Chen and co-workers hypothesised that if 
the macrocycle was formed prior to the reduction, the structural rigidity of the molecule 
should keep the 2′-alkoxide far enough away from the ester to avoid this attack.  
 
 
Scheme 1–14. Formation of undesired δ-lactone 79. 
 
Reagents and conditions: a) LDA, then 71, 82%; b) NaBH4. 
  
The macrocyclisation of diene 66 under the RCM conditions employed by Danishefsky 
and co-workers afforded an inseparable mixture of E/Z stereoisomers of 80 in 86% yield 
with an E/Z ratio of only 5.7:1, as evident from the 1H NMR spectrum. Chen and co-
workers sought alternative conditions to both improve the yield and increase the (E)-
selectivity of the product. MW-irradiation of RCM reactions has been reported to both 
improve the yield and reaction efficiency.57-59 It was proposed that the RCM of 66 under 
MW irradiation at elevated temperatures should favour the thermodynamically more 
stable (E)-isomer. Satisfyingly, cyclisation of 66 with Grubbs’ second generation 
catalyst (28) at high dilution (0.005 M in CH2Cl2) under MW irradiation (100 °C for 30 
minutes) afforded the cyclised product 80 in 98% yield with complete (E)-selectivity 
(Scheme 1–15). Only one set of olefinic peaks was observed in the 1H NMR spectrum 
with a coupling constant of 15.0 Hz. 
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Scheme 1–15. MW-assisted RCM reaction of diene 66 by Chen. 
 
Reagents and conditions: a) CH2Cl2 (0.005 M), Grubbs’ II catalyst (28) (10 mol%), MW irradiation, 100 
°C, 30 min, 98%, (E) only. 
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Reduction of macrocyclic ketone 80 with sodium borohydride under standard 
conditions did indeed give desired alcohol 67 without any δ-lactone product being 
observed (Scheme 1–16). With the formal total synthesis of Am D complete, Chen set 
about to replicate the last steps of Danishefsky’s synthesis. Installation of the benzylic 
olefin through treatment of alcohol 67 with Martin’s sulfurane dehydrating agent led to 
the formation of the desired product 35 mixed with decomposed sulfurane reagent, 
which could not be separated from the product. However, elimination of mesylate 81 
with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) under reflux was found to cleanly give 
the diene 35 in 74% yield and with complete regio- and (E)-selectivity. Global 
deprotection under acidic conditions afforded Am D in 91% yield.  
 
 
Scheme 1–16. Final steps in Chen’s synthesis of Am D. 
 
Reagents and conditions: a) NaBH4, quant.; b) (i) MsCl, Et3N, DMAP (10 mol%); (ii) DBU, 74% over 
two steps; c) 1M HCl/MeOH (1:1), 91%. 
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1.3.3.5 Montgomery’s Synthesis  
 
The fifth total synthesis of Am D was reported by Montgomery et al. in 2008.36 
Montgomery and co-workers envisioned that chemistry developed in their laboratory 
for the catalytic macrocyclisation of ynals60 and intermolecular diastereoselective 
coupling of alkynyl silanes and α-silyloxy aldehydes61 could be employed for the 
cyclisation of 82 (Figure 1–16). Alkynyl silane 82 could be further disconnected to give 
three key fragments: aryl iodide 83, alcohol 84 and diol 85. These three building blocks 
could be assembled through a Mitsunobu reaction and Suzuki coupling reaction. 
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Figure 1–16. Retrosynthetic analysis of Am D by Montgomery et al. 
 
Aryl iodide 83 was protected as the bis-MOM derivative before ester hydrolysis and 
subsequent Mitsunobu esterification with alcohol 84 which afforded ester 86 in 52% 
yield (Scheme 1–17). Alkenyl boronic acid 87 was prepared from the known diol 85 by 
bis-silyl protection prior to treatment with catecholborane and catalytic 9-BBN. The 
carbon skeleton was completed through the palladium-catalysed cross-coupling of the 
boronic acid 87 with aryl iodide 86 providing 88 in excellent yield. Intermediate 88 was 
either selectively monodeprotected and oxidised to aldehyde 89 or silanated prior to 
selective monodeprotection and oxidation giving aldehyde 82.  
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Scheme 1–17. Montgomery’s synthesis of key fragments and assembly of the 
cyclisation precursors 82 and 89. 
 
Reagents and conditions: a) MOMCl, i-PrNEt2, 87%; b) NaOTMS, 86%; c) DEAD, PPh3, then 84, 70%; 
d) TBSCl, Im, 97%; e) catecholborane, 9-BBN (8 mol%), then NaOH, 65%; f) 86, TlOET, Pd(PPh3)4 (35 
mol%), 90%; g) HF.py, 66%; h) Dess-Martin, 81%; i) LDA, TMSCl, 49%; j) HF.py; k) Dess-Martin, 
56% (two steps). 
 
Montgomery and co-workers first investigated the macrocyclisation of the precursor 82 
with Et3SiH (5.0 equiv.), Ni(COD)2 (25 mol%), IMes·HCl (25 mol%), and t-BuOK (25 
mol%) (Scheme 1–18). Rather than forming the expected macrocycle, a new product 
that retained the alkynyl silane but had lost the aldehyde was isolated as the major 
product. Evaluation of the COSY, HMQC and NOE data led to the structural 
assignment of 91. 
 
Scheme 1–18. Attempted macrocyclisation of alkynyl silane 82. 
 
Reagents and conditions: a) Et3SiH, Ni(COD)2 (25 mol%), IMes·HCl (25 mol%), t-BuOK (25 mol%), 
50%. 
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With the failure of the alkynyl silane 82 to cyclise to the desired macrocycle, 
Montgomery and co-workers turned to the cyclisation of alkyne 89 (Scheme 1–19). 
Prior studies carried out in their laboratory had shown that terminal alkynes undergo 
intermolecular couplings with α-silyloxy aldehydes albeit with a considerably lower 
diastereoselection than alkynyl silanes. Under these same cyclisation conditions desired 
macrocyle 92 was obtained in 61% yield as a 1:1 mixture of diastereoisomers. Global 
deprotection under acidic conditions afforded aigialomycin D (1) in 46% yield and the 
6′-epimer of Am D (6′-epi-1) in 44% yield after preparative HPLC separation. Thus, 
Montgomery completed the synthesis of Am D in a total of 8 steps from known starting 
materials with a 7% overall yield. 
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Scheme 1–19. Montgomery’s synthesis of Am D.  
 
Reagents and conditions: a) Et3SiH, Ni(COD)2, IMes·HCl, t-BuOK (25 mol% each), 61%; b) 0.5M 
HCl/MeOH, then HPLC separation, 46%. 
 
 
1.3.3.6 Zhang’s Synthesis of the C2′–C7′ Segment of Am D 
 
Synthesis of the C2′–C7′ segment of Am D was published by Zhang and Chen in 2007 
(Figure 1–17).37 They reported the synthesis of this segment in six steps from D-ribose 
(93) with 37% overall yield.  
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Figure 1–17. Retrosynthetic analysis of Am D by Zhang and Chen. 
 
After acetonide protection of the cis-diol of D-ribose (93), the carbon chain was 
extended through a Wittig olefination (Scheme 1–20). Alkene 95 was hydrogenated 
prior to oxidative cleavage of the unprotected diol to give aldehyde 96. A second Wittig 
reaction was used to install the terminal olefin of the desired fragment. Finally, selective 
reduction of ethyl ester 97 afforded aldehyde 70, the desired C2′–C7′ segment of Am D.  
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Scheme 1–20. Zhang and Chen’s synthesis of the C2′–C7′ segment.  
 
Reagents and conditions: a) acetone, H2SO4 (cat.), 93.5%; b). CH2Cl2, PPh3=CHCO2Et, PhCO2H (cat.), 
97%; c). MeOH, H2 (101.3 kPa), 5% Pd/C (cat.), 94%; d). MeOH/H2O (1:1), NaIO4, 78%; e). THF, 
Ph3P+CH3Br-, n-BuLi, 80%; f). THF, DIBAL-H, -78 °C, 70%. 
 
Zhang and Chen are likely to strike difficulties incorporating aldehyde 70 into a total 
synthesis of Am D, as Chen and co-workers35 have shown that δ-lactone formation 
results from an alkylation of an aldehyde such as 70 with a suitable aromatic fragment. 
Futhermore, olefination through a Wittig, HWE or Juliá-Kocienski reaction will likely 
result in the formation of the undesired six-membered cycle upon subsequent RCM, as 
shown by Winssinger.9 
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1.3.3.7 Jennings’ Synthesis of 6′-epi-Am D 
 
Jennings and Bajwa reported an attempt to synthesise Am D that led to the synthesis of 
6′-epi-aigialomycin D and deoxy-aigialomycin C.38 Jennings and Bajwa utilised the 
common disconnections at the lactone and C1′–C2′ alkene, and a disconnection at C6′ –
C7′ (Figure 1–18). A key feature of Jennings and Bajwa’s approach was the utility of an 
alkynyl addition to obtain the diol functionality. Other important features were the 
esterification of the diol fragment to form the metathesis precursor and the attempted 
use of a RCM reaction to form the macrocyle of Am D via installation of the benzylic 
olefin.  
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Figure 1–18. Retrosynthetic analysis of Am D by Jennings and Bajwa. 
 
Synthesis of the diol fragment started with the treatment of known epoxide 10362 with 
allyl magnesium bromide to give alcohol 104. Protection of the free hydroxyl group as 
the MOM ether before selective deprotection and oxidation of the resulting primary 
alcohol afforded aldehyde 102 in 57% yield over 4 steps. Addition of alkyne 101 to 
aldehyde 102 yielded the entire carbon skeleton of the C2′–C11′ fragment, 105, in 71% 
yield. The addition of 101 to 102 gave rise to alcohol 105 with a 2:1 diastereoselective 
ratio (dr) favouring the desired Cram product63 (Scheme 1–21), contrary to expectations 
of modest selectivity for the anti-Cram product due to the ability of the MOM group to 
provide chelation-control in such additions. Stereoselective reduction of alkyne 105 was 
achieved through chelated hydroalumination with Red-Al, affording olefin 106 with an 
E/Z ratio ≥ 15:1, whilst retaining the 2:1 dr at the C6′ hydroxyl group.  
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To set the required stereochemistry at C6′, alcohol 106 was oxidised with TPAP-NMO, 
and reduced by chelation control to afford cis-diol 107. Both lithium and sodium 
borohydrides failed to give any selectivity in this reduction. LAH reduction provided 
the diol in high yield but with a selectivity that replicated the dr from the addition 
reaction. However, reduction with Red-Al provided the desired alcohol 107 with an 
acceptable dr of 6:1 (by 1H NMR of crude product) in a good yield of 84%. 
Deprotection of alcohol 107 under acidic conditions was followed by reprotection of the 
cis-diol as isopropylidene 100 in 62% yield over two steps.  
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Scheme 1–21. Jennings and Bajwa’s synthesis of diol intermediate 100.  
 
Reagents and conditions: a) Li2CuCl4 (2 mol%), allylMgBr; b) MOMCl, DIPEA, 93%; c) TBAF, 96%; d) 
TPAP (10 mol%), NMO, 74%; e) n-BuLi , 101, 71%; f) Red-Al, 72%; g) TPAP (10 mol%), NMO, 92%; 
h) Red-Al, 84%; i) HCl (two drops concd), MeOH, 100%; j) DMP, PPTS (2 mol%), 62%. 
 
The aromatic fragment was prepared from known aryl triflate 99 (Scheme 1–22).64 
Suzuki-Miyaura coupling of aryl triflate 99 with potassium vinyl trifluoroborate and 
Pd(dppf)Cl2 provided styrene derivative 98 in 77% yield.65  Treatment of 98 with the 
alkoxide anion of 100 afforded an inseparable mixture of esters 108a and 108b in a 6:1 
diastereoisomeric ratio, the same as that for starting material 100. Jennings and Bajwa 
relied on a chemoselective RCM reaction to provide the desired macrocycle. However, 
as Winssinger had earlier discovered,9 carrying out the RCM reaction in the presence of 
an internal alkene resulted in the undesired formation of the six-membered ring 56. 
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Thus, when the mixture of dienes 108a and 108b were submitted to RCM with second-
generation Grubbs’ catalyst 28 in refluxing CH2Cl2 (0.0002 M), macrocycle 110 and 
acyclic diene 109 were isolated in 14% and 84% yields (1:6), respectively. Thus it 
appears that the stereochemistry present at C6′ influences the result of the RCM reaction 
giving resolution of the two diastereoisomers. In the mechanism of the RCM reaction, 
the initial formation of the carbene must occur at the more accessible isolated alkene 
group followed by either 6- or 14-membered ring formation via RCM. Formation of the 
cis-isopropylidene protected cyclohexene diol (56) appeared to be favoured over 
macrocyclisation. Formation of the trans-isomer of 56 would be unfavourable due to the 
energy barrier in forming such a strained bicyclic system. Indeed, RCM 
macrocyclisation of epimer 108b gave macrocycle 110 exclusively. Global deprotection 
of macrocycle 110 with boron tribromide afforded 6′-epi Am D (6′-epi-1) in a 
respectable yield of 74%.  
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Scheme 1–22. Jennings and Bajwa’s synthesis of 6′-epi-aigialomycin D.  
 
Reagents and conditions: (a) potassium vinyl trifluoroborate, Et3N, Pd(dppf)Cl2 (10 mol%), 77%; b). 
NaH, 100, 78% (6:1); c) Grubbs’ 2nd gen. (5 mol%), 13% of 110 and 84% of 109; d) BBr3, 74%. 
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1′,2′-deoxy-Aigialomycin C was prepared by taking advantage of this diastereoselective 
RCM reaction (Scheme 1–23). Esterification of the methyl protected styrene derivative 
112 with alcohol 100 (2:1 ratio at C6′) provided ester 113 in good yield. The subsequent 
RCM of diene 113 afforded macrocycle 114 in quantitative yield with respect to the 
trans-diol diastereomer of 113. Deprotection of the isopropylidene moiety with HCl 
yielded 1′,2′-deoxy-aigialomycin C (116) in 17% yield over the 3 steps. 
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Scheme 1–23. Jennings and Bajwa’ synthesis of 1′,2′-deoxy-aigialomycin C via a 
diastereoselective RCM reaction.  
 
Reagents and conditions: (a) NaH, 100, 78%. (b) Grubbs’ 2nd gen. (5 mol%), 31%. (c) HCl (two drops 
conc.), MeOH, 69%. 
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1.3.3.8 Summary of Total and Partial Syntheses of Am D and 
Analogues  
 
The partial and total syntheses discussed above can be summarised by considering 
Figure 1–19, which depicts all the disconnections made by these researchers. The most 
common disconnections of Am D were made at the two olefins and lactone 
functionality. Four of the seven routes used or envisioned use of an RCM reaction for 
macrocyclisation at C7′–C8′. Danishefsky, Chen, and Zhang accessed the cis-diol 
moiety from a chiral starting material, whilst Winssinger and Pan obtained this 
functionality through a stereoselective epoxide formation followed by ring opening. 
Montgomery and Jennings set the stereochemistry of the hydroxyl at C6′ through 
alkynyl additions with limited success.  
 
 
Figure 1–19. Summary of the retrosynthetic disconnects for all total and partial 
syntheses of Am D. 
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1.4 Research Objectives 
 
Aigialomycin D (Am D) belongs to a family of important bioactive natural products 
whose small structural differences lead to wide ranging biological activities (from 
anabolic to antitumour activities) in the micromolar to nanomolar range (refer to 
Section 1.2.2). At the onset of this research project (2005), Danishefsky’s synthesis of 
Am D was the only synthesis published in the literature. Therefore, there remained a 
need for a more efficient synthesis of Am D and analogues thereof. The aim of this 
research was to develop an efficient and convergent synthesis of Am D that would be 
amenable to the preparation of a variety of interesting analogues. With these analogues 
the hope was to either amplify the compound’s activity into the nanomolar range or 
create a therapeutic window by skewing its bioactivity towards either antimalarial or 
cytotoxic activity whilst exploring the structure activity relationship (SAR) inherent in 
Am D. Thus, the following proposed routes to Am D were investigated. It became 
apparent during the course of the research project that a number of other research 
groups had devised similar synthetic strategies to those detailed below. Pan’s synthesis, 
in particular, used similar Wittig and macrolactonisation chemistry to that which was 
proposed in the original synthetic approach to Am D presented here. 
 
 
1.4.1  Total Synthesis of Am D and Analogues 
 
In the two main approaches to Am D presented in this thesis, it was decided to make 
retrosynthetic disconnections between the lactone and the olefins at C1′ to C2′ and C7′ 
to C8′ (Figure 1–20). Subsequent publications revealed that these were to be commonly 
selected disconnections during Am D synthesis.9,34,35,37 In all, five related strategies 
were designed. Three were part of the original plan, providing different options should 
key reactions fail. Two further options were later devised following experience from our 
own studies and that of recently published literature. The first strategy proposes the use 
of the Horner-Wadsworth-Emmons (HWE) variation of the Wittig reaction66,67 to install 
the two (E)-olefins of Am D. The lactone functionality could be installed either before 
the C7′–C8′ alkene is incorporated or in a late-stage macrolactonisation. The second 
proposed strategy utilises a RCM reaction to connect the macrocycle at the C7′–C8′ 
olefin and the Ramberg-Bäcklund (RB) reaction to install the benzylic olefin. In this 
strategy, the ester linkage would be installed before the RCM reaction. 
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Figure 1–20. Proposed retrosynthetic disconnects for the HWE and RBR/RCM 
strategies to Am D. 
 
1.4.2  HWE-Based Retrosynthetic Analysis of Am D 
 
The HWE reaction is a well documented method for the installation of (E)-alkenes in 
the total synthesis of natural products.68 Hence, HWE methodology seemed to be an 
ideal choice for the installation of the C1′–C2′ alkene, with the potential to couple 
arylphosphonate 121 with a carbohydrate-derived 2,3-dihydroxyaldehyde (e.g. 122 or 
123). The benzyl bromide 120 69 and glucal-derived aldehydes 122 70 and 123 71 have 
been described previously in the literature. Similarly, the C7′–C8′ alkene could be 
installed through the HWE coupling of aldehyde 119 with hydroxyphosphonate 118. 
 
 
 
Figure 1–21. Proposed retrosynthetic analysis of Am D: the HWE route. 
 
1.4.2.1 HWE-Based Synthetic Route 
 
In this route, the aromatic segment, and the C2′–C7′ and C8′–C11′ segments would be 
prepared separately prior to their assembly. The aromatic segment could then be 
coupled with the C2′–C7′ chain before linking this extended moiety with the C8′–C11′ 
segment. Macrolactonisation would thus afford a protected derivative of Am D. 
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1.4.2.2 Proposed Synthetic Approaches to the Aromatic Segment 
 
The ethyl analogue of arylmethyl bromide 126 (Scheme 1–24) has been previously 
prepared by a reaction of ethyl bromoacetoacetate (124) with diketene (125), albeit in 
low yield (8%).69   
 
Scheme 1–24. Preparation of benzylic bromide 126.69  
 
Reagents and conditions: (a) NaH, 8%. 
 
Alternatively, the non-brominated analogue 74 has been prepared in significantly better 
yield (46-78%) by self-condensation of methyl acetoacetate (127) (Scheme 1–25).72 The 
resultant benzoate 74 (or a protected variant) could be brominated at the benzylic 
position. Another potential route to methyl orsellinate (74) is by formylation of 3,5-
dihydroxytoluene (128) with DMF/POCl3 to aldehyde 129. This is then oxidised to the 
desired carboxylic acid (45) with sodium chlorite73 prior to a Fisher esterification to 
compound 74 (Scheme 1–25). 
 
 
Scheme 1–25. Previous syntheses of methyl orsellinate (74).72,73 
 
Reagents and conditions: a) NaH, n-BuLi, 46-78%;72 b) DMF, POCl3, then 10% NaOH; then 10% HCl; 
c) NaClO2, NaH2PO4, 97% (two steps);73 d) MeOH, H2SO4.  
 
Franck and co-workers found that bromination of the 2,4-dimethoxy analogue 13074 
with N-bromosuccinimide (NBS) without a radical initiator led to electrophilic aromatic 
substitution of a bromine atom (131)75 (Scheme 1–26). However, benzylic bromination 
has been successfully achieved when the 4-hydoxyl group is methylated (132).76 The 
efficient dibromination of 137, with the 2-hydroxyl group acetylated, has also been 
claimed in a patent.77 Unfortunately, the use of methyl ethers as protecting groups for 
phenolic hydroxyl groups has been shown to be problematic in later synthetic steps, as 
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deprotection requires harsh conditions that can cause decomposition of other parts of 
the molecule.74 Eicher and co-workers successfully brominated diacetate 139 under UV-
Vis irradiation in good yield (76%).78 As a suitable UV-Vis irradiator was unavailable 
to us, Eicher’s procedure required adaptation. Hence, bromination of 134 with NBS and 
benzoyl peroxide in carbon tetrachloride was expected to afford the desired bromide 
135. Acetate protection of the phenolic hydroxyl groups would also avoid the necessity 
for harsh deprotection conditions. 
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Scheme 1–26. Bromination of protected analogues of benzoate 74 and its ethyl 
homologue.27 75-78 
 
Reagents and conditions: (a) K2CO3, Me2SO4, 98%;74 (b) NBS, CCl4;75 (c) MeI, K2CO3, 87%;76 (d) Br2, 
CCl4, hv, 59%;76 (e) Ac2O, pyridine, 100%; (f) NBS, AIBN, CCl4, 99%;77 (g) Ac2O, NEt3; (h) Br2, CCl4, 
hv, 76%; 78(i) NBS, benzoyl peroxide, CCl4. 
 
                                                 
27 Solid arrows represent reactions described in the literature, whereas dotted arrows represent reactions 
that have not been reported. 
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With the arylmethyl bromide (135) in hand, the next step would be an Arbuzov 
reaction79 with triethylphosphite to provide desired phosphonate 142 (Scheme 1–27). 
 
 
Scheme 1–27. Proposed synthesis of phosphonate 142. 
 
Reagents and conditions: (a) P(OEt)3, 120 °C. 
 
1.4.2.3 Proposed Synthetic Approaches to the C8′–C11′ Segment 
 
The formation of compound 118 could be achieved via the reduction of diethyl 
3-oxybutylphosphonate (144). The ketophosphonate 144 would be prepared from 
ketoamine 143,80 which itself could be obtained from a Mannich reaction81 of diethyl 
amine hydrochloride, acetone and paraformaldehyde (Scheme 1–28). Amine 143 would 
then undergo an Arbuzov-like reaction with triethylphosphite upon activation with 
methyl iodide.82 Diethyl 3-hydroxybutylphosphonate (118) has been prepared in 
racemic form by reduction of ketone 144.83 Despite successful kinetic resolution of 
lower homologues, treatment of this particular substrate with an acylating lipase did not 
lead to formation of the corresponding acetate in adequate optical purity.83 Nonetheless, 
there are a number of chemical methods for stereoselective reduction of ketones,84 so 
enantiopure 118 should be attainable. The hydroxyl group of the target synthon 118 
may need protection prior to the HWE reaction. The TBS silyl ether (146) should be a 
suitable protecting group.  
 
 
Scheme 1–28. Proposed preparation of phosphonate 118. 
 
Reagents and conditions: a) HNEt2·HCl, CH2O, 59%;80 b) MeI, P(OEt)3, 72%;82 c) reduction; d) Candida 
antarctica lipase B (CALB), vinyl acetate;83 e) (R)-2-methyl-CBS-oxazaborolidine, (S,S)-
dimethylborolane or RuCl2(S-BINAP); f) TBSCl, Im. 
 41
1.4.2.4  Proposed Synthetic Approaches to the C2′–C7′ Segment 
 
The 2,3-dideoxyhexose derivatives 122, 152 and 153 could serve as substrates for 
Wittig chemistry. Synthesis of these intermediates could be achieved via the Ferrier 
rearrangement85 of tri-O-acetyl-D-glucal (147) with benzyl alcohol (Scheme 1–29).86 
Hydrogenation of this product (148) should remove the anomeric benzyl protecting 
group and reduce the double bond concurrently.71 If the acetate protecting groups were 
to be not robust enough for the basic conditions of the HWE olefination, diacetate 148 
could be converted to isopropylidene 152. Deprotection of diacetate 148 would give 
diol 149, which could then be protected as an isopropylidene acetal and undergo 
hydrogenation to hemiacetal 152. Alternatively, if the acetal was found to be unsuitable 
for the hydrogenation conditions, 149 could be protected as silyl ether 15186 and then 
subsequently hydrogenated to give hemiacetal 153.   
 
Scheme 1–29. Preparation of carbohydrate-derived C2′–C7′ segments.  
 
Reagents and conditions: a) BnOH, FeCl3, 93%;86 b) H2, Pd/C; c) Na, MeOH, 95%;86 d) 2,2-dimethoxy 
propane, p-TsOH; e) TBSCl, Im., 92%.86 
 
 
1.4.2.5  Proposed Assembly of the Three Segments 
 
The HWE reaction between the anion of phosphonate 142 and the open-chain form of 
hemiacetal 122 should afford alkene 140 (Scheme 1–30). As the base-labile acetate 
groups of 122 and 142 are likely to be cleaved in the HWE reaction, reprotection may 
be required before carrying out further chemistry. Selective protection of the primary 
hydroxyl as a TBS ether could be followed by formation of an isopropylidene acetal to 
protect the cis-diol moiety (157). Alternatively, silyl ether 153 could be suitable for use 
in the first HWE reaction, followed by protection of the cis-diol of 156 as 
isopropylidene 157. If the lability of the acetate and silyl protecting groups on 122 and 
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153 prove to be problematic, the acetonide-protected hemiacetal 152 could alternatively 
be used as the HWE substrate. After deprotection of 154, triol 155 could be transformed 
to isopropylidene 157 in three steps. 
 
Removal of the silyl group and oxidation of resulting primary alcohol on 158 would 
provide aldehyde 159. The HWE reaction between aldehyde 159 and phosphonate 118 
should afford diene 160, thus completing the carbon framework of Am D. 
Saponification of the methyl ester and then esterification, using either a carbodiimide 
protocol87 or Yamaguchi macrolactonisation,52 could provide the desired macrocycle 
161. Finally, the acetal could be hydrolysed under mildly acidic conditions, to complete 
the synthesis of aigialomycin D (1).   
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Scheme 1–30. Proposed final steps in the synthesis of Am D (1).  
 
Reagents and conditions:  a) base; b) 1M HCl; c) TBSCl, Im; d) 2,2-dimethoxypropane, p-TsOH; e) 
HF.py;  f) oxidation; g) 118, base; h) LiOH, THF/MeOH/H2O then EDCI, HOBt, DMAP or 2,4,6-
trichlorobenzoylchloride, Et3N, then DMAP; i) 1M HCl.  
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1.4.3  RB-Based Retrosynthetic Analysis of Am D  
 
An alternative approach to Am D was envisioned that utilises a combination of ring-
closing metathesis (RCM) and the Ramberg-Bäcklund (RB) reaction88 as the key steps 
for the generation of alkenes C7′–C8′ and C1′–C2′ respectively (Figure 1–22). 
Disconnections at the lactone and two alkenes give three fragments that are 
constitutionally related to those required for the HWE route. This approach enables 
coupling of the aromatic and C2′–C7′ prior to the RCM. The benzylic olefin is 
‘masked’, initially as a thioether and later as a sulfone, with the olefin only revealed 
after the successful macrocyclisation. Intermediate thioether 167 could be obtained by 
either coupling iodide 168 with thiol 170 or by coupling thiol 169 with bromide 135.  
 
Figure 1–22. Proposed retrosythetic analysis of Am D: the RB route. 
 
 
1.4.3.1 Proposed Synthetic Approaches to the Aromatic Segment 
 
The two potential aromatic fragments required for the RB route are bromide 135 and 
thiol 170. The proposed synthesis of bromide 135 was discussed earlier in Section 
1.4.2.2. Thioacetate 171 could be prepared through the nucleophilic substitution of 
bromide 135 with potassium thioacetate (Scheme 1–31). Global deacetylation should be 
attainable by treatment with sodium methoxide in methanol to give thiol 170.  
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Scheme 1–31. Proposed synthesis of thiol 170. 
 
Reagents and conditions: a) KSAc; b) NaOMe. 
 
1.4.3.2. Proposed Synthetic Approaches to the C8′–C11′ Segment 
 
The homoallylic alcohol segment, (R)-4-penten-2-ol (22), is commercially available 
from Sigma-Aldrich™ but could also be prepared via a boron-mediated asymmetric 
allylation of acetaldehyde (Scheme 1–32).89,90 Utilisation of this methodology should 
provide sufficient quantities of alcohol 22.  
 
Scheme 1–32. The boron-mediated asymmetric allylation of acetaldehyde. 
 
Alternatively, Banwell and Loong have described the enzymatic resolution of (±)-4-
penten-2-ol [(±)-22] using Candida antarctica lipase B (CALB), leading to the isolation 
of homoallylic alcohols on a multigram scale with an ee > 99.9% (Scheme 1–33).91  
 
 
Scheme 1–33. Banwell’s enzymatic resolution of alcohol 22.  
 
Reagents and conditions: a) vinyl acetate, CALB; b) pH 7.3 aq. phosphate buffer, CALB. 
 
1.4.3.3 Proposed Synthetic Approaches to the C2′–C7′ Segment 
 
In the proposed RB route to Am D, the diol segment of Am D could either be 
functionalised as an iodide (168) or thiol (169) depending on the functional group 
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present at the benzylic position of the aromatic segment (135 or 170). Iodide 168 could 
be prepared from tri-O-acetyl-D-glucal (147) (Scheme 1–34).  
 
The synthesis of aldehyde 177 and subsequent conversion to olefin 178 has been 
previously reported by Nakata92 and Saski93, respectively. A Ferrier reaction of glucal 
147 with methanol, followed by hydrogenation would give methyl glycoside 173. 
Deprotection of diacetate 173, reprotection as bis-TBS ether 175 and selective 
deprotection of the primary TBS ether would give access to alcohol 176. Oxidation to 
aldehyde 177 would provide the substrate for a Wittig olefination to give alkene 178. 
Hydrolysis of the methyl glycoside should lead to hemi-acetal 179. Sodium 
borohydride94 or lithium aluminium hydride (LAH) reduction95 of the open-chain form 
of 179 should reveal a primary alcohol that could be selectively converted to iodide 
168.96,97  
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Scheme 1–34. Proposed preparation of C2′–C7′ segment 168.  
 
Reagents and conditions: a) MeOH, montmorillonite K-10; b) H2, Pd/C; c) K2CO3, MeOH, 95% (three 
steps);92 d) TBSCl, Im, 100%;92 e) CSA, 97%;92 f) SO3·pyridine,93 or (COCl)2, DMSO, i-Pr2NEt;92 g) 
Ph3P+CH3Br-, base, 95%;93 h) AcOH/H2O; i) NaBH4 or LAH, j) PPh3, I2.  
 
Alternatively, thiol 169 could be accessed from D-ribose (93) via the known ω-enal 185 
(Scheme 1–35).98 It has been shown that D-ribose can be rapidly transformed to iodide 
184, via the nucleophilic displacement of tosylate 183 with potassium iodide.98 Iodide 
184 is the required substrate for a Vasella reaction99 that should yield aldehyde 185.100-
103 A two-carbon chain elongation of crude aldehyde 185 with methyl 
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triphenylphosphoranylidene acetate should give α,β-unsaturated ketone 186. This 
Vasella/Wittig reaction system was used by van Boom in the synthesis of a variety of 
highly functionalised carbocycles.104 These two steps might be able to be carried out in 
one pot, avoiding the isolation of the reactive aldehyde 185. Selective reduction of the 
conjugated double bond in the presence of the terminal alkene should be achievable 
using a metal-catalysed conjugate reduction system: e.g. Mg metal/MeOH;105 
NiCl2.6H2O/NaBH4;106 CuCl2/NaBH4;107 or CuCl/NaBH4.108 Subsequent reduction of 
the methyl ester with LAH should give alcohol 187. In fact, it is possible that LAH 
might be a suitable reagent to carry out reduction of the conjugated alkene prior to 
reduction of the ester, thus affording saturated alcohol 187 in one step.109 However, 
LAH reductions of such α,β-unsaturated systems have been shown in some cases to give 
a mixture of the unsaturated and saturated alcohols.110 Activation of alcohol 187 by 
mesylation followed by nucleophilic displacement with potassium thioacetate should 
give thioacetate 189. Deprotection of thioacetate 189 would afford desired thiol 169. If 
the oxidation of thiol 169 to disulfide 190 is a concern, it could be generated in situ 
during the subsequent coupling reaction.  
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Scheme 1–35. Proposed synthesis of thiol 154 from D-ribose. 
 
Reagents and conditions: a) Me2CO, MeOH, HCl; b) TsCl, py., 54% (two steps);98 c) NaI, 94%;98 d) Zn, 
cat. AcOH; e) Ph3P=CHCO2Me; f) stepwise reduction; g) MsCl, NEt3; h) KSAc; i) NaOMe. 
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1.4.3.4 Proposed Assembly of the Three Segments 
 
It was proposed that the coupling of the aromatic and carbohydate-derived C2′-C7′ 
segments would involve a nucleophilic displacement of the alkyl or benzylic halide with 
a thiol, which would be prepared in situ or prior to the coupling reaction (Scheme 1–
36). The basic conditions used in the coupling reaction should also cleave the two 
phenolic acetates, giving two other potential nucleophiles. However, when the “hard 
and soft acids and bases” (HSAB) theory111-113 is considered, the soft organohalide 
should favour nucleophilic attack of the soft thiolate ion leading to the desired product 
191. The free phenolic hydroxyl groups could be protected as MOM ethers either before 
or after saponification of the methyl ester. Homoallylic alcohol 22 could be coupled to 
carboxylic acid 193 through a Mitsunobu esterification thus completing the carbon 
framework of Am D. 
 
The RB reaction requires thioether 167 to be oxidised to a sulfone. Thioethers are 
typically oxidised with meta-chloroperbenzoic acid (m-CPBA),114-116 NaBO3/AcOH,117 
Oxone™ ,118 or H2O2/AcOH;119 reagents which also have the potential to epoxidise 
double bonds. The fact that terminal alkenes are generally less reactive towards 
epoxidation than internal alkenes120 suggests that it would be prudent to oxidise the 
thioether prior to RCM. Indeed, Yao has demonstrated the chemoselective oxidation of 
thioethers to sulfones with m-CPBA in the presence of terminal alkenes.116 Formation of 
the sulfone at this early stage also avoids the potential difficulties associated with RCM 
reactions of compounds containing low oxidation state sulfur.121 The presence of the 
acid sensitive acetonide in thioether 167 suggests that m-CPBA and Oxone™ would be 
more suitable oxidising agents than the systems requiring acetic acid.  
 
Following sulfone formation, the macrolactone will be formed by a RCM reaction.  
MW-assisted RCM reactions of macrocyclic systems similar to RCM precusor 195 have 
displayed improved yield and stereoselectivity for (E)-alkenes than the RCM reactions 
attempted under standard thermal condition.35 Hence, treatment of diene 195 with 
Grubb’s second generation catalyst (28) under MW-irridiation should provide the 
desired macrolactone 196. 
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Scheme 1–36. Proposed coupling of the segments for the RB route. 
 
Reagents and Conditions: (a) base; (b) MOMCl, NEt3; (c) NaOH, MeOH/H2O, Δ; (d) 22, PPh3, DIAD, 
THF; (e) m-CPBA; (f) 28, MW 
 
1.4.3.5 Ramberg-Bäcklund (RB) Reaction  
 
At this stage, the benzylic olefin in Am D remains to be installed via a RB reaction. The 
RB reaction converts an α-halo sulfone into an alkene in the presence of a strong base, 
with the extrusion of sulfur dioxide (Scheme 1–37). The α-protons of a sulfone are of 
sufficient acidity that they can be abstracted by a strong base such as potassium tert-
butoxide. The carbanion formed can nucleophilically displace the halide in the α′-
position creating a short-lived episulfone. The unstable strained intermediate undergoes 
a cheletropic rearrangement, providing the desired alkene.  
 
 
Scheme 1–37. Mechanism for the Ramberg-Bäcklund reaction.122 
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Two modifications of the RB reactions are commonly used; namely the Meyers123 and 
Chan124 modifications. The Meyers’ modification of the RB reaction allows the direct 
conversion of unhalogenated sulfones to their corresponding alkenes via an in situ 
chlorination (Scheme 1–38). Meyers’ protocol involves the treatment of a suitable 
sulfone with pulverised KOH suspended in a mixture of t-BuOH and CCl4. Meyers’ 
variant of the RB reaction further extended the synthetic utility of this olefination 
reaction and has been used extensively.125,126 
 
 
Scheme 1–38. Mechanism for Meyers’ modification of the RB reaction.127 
 
Whilst Meyers’ protocol gives quantitative yields for the preparation of stilbenes from 
dibenzyl sulfones123 and 1,1-diarylalkenes from benzhydryl sulfones,128 sulfones of 
other structural types give rise to different byproducts: bis(primary alkyl) sulfones face 
α, α- and/or α, α′-dichlorination before the 1,3 elimination to afford predominantly the 
potassium salts of alkenesulfonates;129 benzyl primary-alkyl sulfones suffer similar 
problems to give mixtures of the desired β-alkylstyrenes, α-chloro-β-alkylstyrenes, and 
potassium alkenesulfonates;124 bis(sec-alkyl) sulfones give rise to largely tetraalkyl 
gem-dichlorocyclopropanes emerging from the subsequent attack of the tetrasubstituted 
alkenes by dichlorocarbene which is the by-product resulting from the initial 
chlorination (Scheme 1–39).123 
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Scheme 1–39. Formation of the dichlorocyclopropanes and potassium alkenesulfonates 
under Meyers’ protocol above.125  
 
Chan and co-workers addressed these limitations by investigating alternative halogen 
sources for the RB reaction.124 Chan found CF2Br2 to be the best substitute for CCl4. 
The treatment of dicyclopentyl sulfone with pulverised KOH–CF2Br2–t-BuOH gave 
bicyclopentylidene as the only isolable product in 90% yield, whereas Meyers’ protocol 
gave a mixture of products consisting of bicyclopentylidene (15%) and its 
dichlorocarbene adduct (25%) (Scheme 1–40).123 Chan also found that exchanging 
pulverised KOH for alumina-supported KOH (KOH–Al2O3) subdued the dihalogenation 
prior to 1,3-elimination that plagued RB reactions with bis(primary alkyl) sulfones 
(Scheme 1–40). This change allowed to conversion to alkenes in good yields. Moreover, 
KOH–Al2O3 proved to be a superior base for all types of sulfones trialled.124 The 
efficacy of the alumina-supported KOH was proposed to be a consequence of the 
greater surface area of the base and was perhaps also due to the activating effects of the 
alumina surface.130 
 
 
Scheme 1–40. Comparison of the RB reactions of dicyclopentyl sulfone with CF2Br2 
and CCl4 as the halogen sources127 and the successful RB reaction of dioctyl sulfone 
with Chan’s protocol.124 
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The superiority of the Chan modification of the RB reaction over Meyers’ modification 
was exemplified in Taylor’s synthesis of exo-gycals (Scheme 1–41).118 Despite Meyers’ 
conditions delivering exo-glycal 198 in reasonable yield (56%), Chan’s conditions gave 
exceptional conversion to the glycal 198 in 94% yield. In both cases the Z-product 
predominated.  
 
 
Scheme 1–41. Synthesis of exo-glycal 198 via Meyers’ and Chan’s modifications of the 
RB reaction.118 
 
There are a few examples in the literature of the RB reaction being used in the 
construction of macrocycles. MaGee and Beck attempted to use the RB reaction to 
install an (Z)-olefin in an 11-membered macrocycle (Table 1–2).115 To their surprise, 
treatment of α-chlorosulfone 199 with t-BuOK afforded (E)-olefin 200 in excellent yield 
and stereoselectivity (97%, 98:2 E/Z) despite the expectation that the (Z)-isomer of 200 
would dominate. Attempts to reverse the stereoselectivity of the reaction through 
changing the base failed to provide stereochemically pure (Z)-olefin. Although the 
levels of (Z)-olefin did improve, it was at the expense of the overall yield. MaGee’s 
results support our expectation that the RBR on sulfone 196 will give the desired (E)-
olefin 35.  
N
CO2tBu
S Cl
O O
N
CO2tBu
conditions
199
200
 
Table 1–2. RB reactions of sulfone 189 reported by MaGee and Beck.115 
 
Reaction conditions Yield (%) % (E) % (Z) 
t-BuOK, DMSO, rt, 10 min 97 98 2 
aq. KOH, H2O, 100 °C, 1 h  57 61 39 
DBU, toluene, 110 °C, 1 h 56 57 43 
NEt3, toluene, 110 °C, 1 h NR   
Urea, H2O, 100 °C, 1 h NR   
NBu3, toluene, 110 °C, 1 h NR   
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Chan et al. utilised the RB reaction to form a 17-membered macrocycle in the synthesis 
of [14][14] metaparacyclophane (Scheme 1–42).131 The 1H NMR spectrum of diene 201 
showed a doubling of olefinic signals which indicated the presence of a mixture of 
stereoisomers. No ratio of these isomers was reported as this isomeric mixture was 
vanquished in the subsequent hydrogenation of the material. 
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Scheme 1–42. Chan’s synthesis of [14][14] metaparacyclophane. 
 
Reagents and Conditions: (a) CF2Br2, KOH–Al2O3, t-BuOH/CH2Cl2; (b) H2, Pd/C, 28% (two steps). 
 
Both Meyers’ and Chan’s protocols were explored during the course of this research to 
find the optimal conditions for the RB reaction of substrate 196. A successful RB 
reaction would yield macrocycle 35 and thus complete the formal total synthesis of Am 
D (Scheme 1–43). Global deprotection of 35 would be achieved by treatment in acidic 
conditions, affording the natural product 1.33,35 
 
 
Scheme 1–43. Use of RB reaction to complete the synthesis of Am D, 1. 
 
Reagents and conditions: (a) CCl4, t-BuOH, KOH, or CF2Br2, t-BuOH, KOH/Al2O3; (b) HCl. 
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1.5 Plans for Analogue Synthesis 
 
Our devised synthetic route should be adaptable to analogue synthesis by making 
functional group or stereochemical changes to one or more of the three major fragments 
of Am D. These functional modifications could be included prior to assembly or a 
variation could potentially also be introduced at a later stage. For example, one could 
invert the stereochemistry of the hydroxyl at C5′, creating a trans-diol (202), simply by 
using D-galactose instead of D-glucose as the starting material for the carbohydrate 
fragment (Figure 1–23). Likewise, the stereochemistry of the C10′ methyl (203) could 
be inverted by either reducing the ketophosphonate to the (S)-alcohol, by esterifying 
118 under Mitsunobu conditions or by coupling homoallylic alcohol 22 via a 
carbodiimide protocol (Figure 1–23). The 2,4-dideoxy Am D analogue 204 could be 
accessed from methyl 2-methylbenzoate derivates 205. This simplified aryl analogue 
should additionally be an excellent model system on which to investigate the key 
reactions proposed for our strategies towards Am D. 
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Figure 1–23. Potential analogues of Am D with different stereochemistries or aryl 
functionalisation. 
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Other simple modifications include alkyl substitution of one or both of the phenol 
groups (206) (Figure 1–24). An aryl substituent could be introduced at C5 (207), in a 
similar manner to the chlorine atom that is present in radicicol and some of the 
pochonins. Regioselective chlorination has been achieved with such resorcylic 
compounds using thionyl chloride.33 However, this product is usually accompanied with 
its isomeric chlorinated product (~70:30, desired aryl chloride to isomer). Blagg used 
calcium hypochlorite to accomplish this transformation on a similar system in good 
yield (88%), without reporting isolation of the C3-isomer.132 
 
An epoxide or cyclopropyl group could potentially be introduced at a late stage in the 
synthesis (208) (Figure 1–24). The epoxide of pochonin A has previously been 
introduced after formation of the macrolactone using methyl(trifluoromethyl)-dioxirane 
giving a 3:1 diastereomeric mixture.133 Introduction of a cyclopropyl group at a similar 
stage using (R,R)- or (S,S)-dioxaborolane, diethyl zinc and diiodomethane could also be 
attempted.134 Hydrogenation of Am D (209) would yield a C5′ hydroxy analogue of β-
zearalanol,135 which might exhibit some interesting anabolic properties. 
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Figure 1–24. Potential analogues of Am D containing alkylation, substitution, 
epoxidation, cyclopropanation or hydrogenation. 
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1.6 Summary of Synthetic Routes 
 
The above two sections have described several potential routes to the natural product 
aigialomycin D (1) and analogues thereof, which rely on HWE or RCM and RB 
methodology to install the two (E)-alkenes. These two main convergent strategies are 
amenable to the synthesis of a wide range of analogues that will enable exploration of 
the structure activity relationship inherent in Am D. Flexibility has also been built into 
the design such that, as is inevitably needed, the protecting groups may be altered and 
the order of the final steps may be changed. The successful development of our 
proposed synthetic strategies are discussed in the following chapters.  
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Chapter Two: 
Synthesis of the Aromatic Segment 
 
 
The aromatic portion of Am D comprises a benzoic acid derivative with an ortho 
methyl group and phenolic groups ortho and para to the ester functionality. It was 
envisaged that this portion could be accessed from methyl 2,4-dihydroxy-6-
methylbenzoate (methyl orsellinate, 74) (Figure 2–1). In a Horner-Wadsworth-Emmons 
(HWE) strategy, a protected phosphonate derivative of 74 could be prepared from the 
related bromide. Alternatively, a Ramberg-Bäcklund (RB) strategy would require the 
preparation of a protected bromide derivative of 74 or the related thiol derivative.  
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Figure 2–1. Two proposed retrosynthetic analyses of Am D with focus on the aromatic 
fragment. 
 
2.1 Model Aromatic Fragment 
 
In order to investigate the utility of the proposed HWE strategy, synthesis of the 
simplified 2,4-deoxy analogue of Am D (204) was undertaken (Figure 2–2). The 
absence of the two phenolic hydroxyl groups in the analogue removes their potentially 
problematic reactivity and the additional protection/deprotection steps required for 
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synthesis of the natural product. Disconnection of analogue 204 at the benzylic alkene 
and lactone gives benzylic phosphonates 210 or 211 as the model aromatic fragment. 
Thus, phosphonates 210 and 211 were prepared as model compounds to investigate the 
utility of the HWE reaction for installation of the benzylic (E)-alkene of Am D. 
Phosphonate 211 was synthesised to provide a model with a slightly bulkier ester group 
than the methyl ester of 210. 
 
 
Figure 2–2. Retrosynthetic analysis for the aromatic segment of 2,4-deoxy model 
analogue of Am D: the HWE route. 
 
Methyl 2-methyl benzoate 212 was purchased from Sigma-Aldrich and commercially 
available 2-methylbenzoic acid was subjected to a Fischer esterification136 with ethanol 
to afford ethyl 2-methylbenzoate 213. The methylbenzoates 212 and 213 were then 
rapidly and efficiently brominated with N-bromosuccinimide (NBS) in refluxing 
CH2Cl2 (Scheme 2–1). Trace amounts of the α,α-dibromide were visible in the 1H NMR 
spectra of the crude reaction mixtures. Bromide 214 was initially purified by flash 
column chromatography, providing the pure compound in 90% yield. However, the 
dibromide contaminants were found to be unreactive towards triethyl phosphite in the 
subsequent Arbuzov reaction, and the crude reaction mixtures were thus used without 
further purification. The resulting phosphonates 210 and 211 were purified by a 
distillation followed by column chromatography to provide both phosphonates in 
excellent yield.137  
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Scheme 2–1. Synthesis of model phosphonates 210 and 211.  
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2.2 Synthesis of Methyl Orsellinate (74)   
 
Methyl orsellinate (74) is a naturally occurring compound that was first isolated in 1940 
from the lichen Parmelia latissima138 and more recently from lichens Lobaria linita139 
and Peltigera leucophlebia.140 Methyl orsellinate was used as the aromatic starting 
material in Chen et al.’s synthesis of Am D35 and has been a key component in the 
synthesis of a range of natural products.141-146  
 
A one-pot synthesis of orsellinate 74 was developed by Barrett et al.72 inspired by the 
work of Harris et al.147 Barrett’s protocol72 involved the base-promoted self-
condensation of methyl acetoacetate (127) in the presence of sodium hydride and n-
butyllithium (Scheme 2–2). Upon acidification, the self-condensation produced methyl 
3,5,7-trioxo-octanoate (216). After treatment of triketo-ester 216 with a pH 9.2 buffer 
solution for 12 hours and re-acidification, methyl orsellinate 74 was extracted and 
recrystallised to give a white solid in excellent overall yield (78%).  
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CO2Me
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HO
1. NaH (1.5 eq.), THF, rt, 12 h
2. n-BuLi (0.95 eq.), -78 °C to
reflux, 72 h, then 10% HCl
3. pH 9.2 buffer soln, 12 h
MeO
O O O O
216
78%
127 74
 
Scheme 2–2. Barrett’s synthesis methyl orsellinate (74). 
 
Joullié and Chiarello subsequently reported a simplified version of Barrett’s protocol, 
refluxing the reaction for only 24 hours before acidifying the solution to pH 1.5 – 2.0 
for 12 hours.141 When the synthesis of 74 via Joullié’s modified protocol was attempted, 
it proved to be more challenging than anticipated. Initial attempts to self-condense 
methyl acetoacetate (127) only returned starting material (Table 2–1).  
 
As indicated in Table 2–1, different reaction solvents and reaction temperatures were 
investigated for the reaction. Previous studies by Hu148,149 had found that the optimal 
reaction conditions for the condensation required the slow addition of n-butyllithium 
over a period of two hours, followed by reflux for 40 hours. These conditions were 
implemented but failed to improve the result. 
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Table 2–1. Conditions used in attempts to prepare methyl orsellinate (74) via the self-
condensation of methyl acetoacetate.a 
 
Solvent 
Temperature 
at addition of 
n-BuLi (°C)b 
Time for n-
BuLi addition 
(min)c 
Temperature 
after n-BuLi 
additiond 
Time of 
heating (h)e 
Yield of 74 
(%) 
-78 20 reflux 24 0 
-78 120 rt 24 0 
-78 120 rt 40 0 
-40 120 reflux 40 0 
0 120 reflux 40 0 
 
 
THF 
 
 
-78 120 reflux 40 40 
-78 20 rt 24 0 Et2O -78 20 reflux 24 0 
-40 20 rt 24 0 
Hexanes -40 120 reflux 40 0 
 
a The first step of the reaction was carried out by addition of 127 to a NaH suspension in the solvent 
stated at 0 °C. The reaction was stirred for 1.5 h, warming to room temperature. b,c In the second step of 
the reaction, n-BuLi was added to the cooled reaction mixture over a set period of time. d,e The reaction 
was warmed to room temperature or heated at reflux for 24 or 40 h. The reaction was then cooled to room 
temperature and acidified with 10% HCl to pH 1 before being stirred at room temperature overnight and 
worked up.   
 
Correspondence with Dr Y. Gimbert150 revealed that Gimbert and co-workers had also 
experienced the same difficulty with this reaction,151 occasionally only getting starting 
material returned. They found that the source of the sodium hydride was crucial to the 
success of the reaction. Macdonald et al.152 noted that commercially available potassium 
hydride (KH) is often contaminated with impurities that can greatly influence the 
efficiency of chemical processes. Macdonald and co-workers found a great deal of 
variability in the quality of the KH between batches, which lead to yields ranging from 
0 to 76% in studies of an anionic oxy-Cope rearrangement. Macdonald postulated that 
the contaminants present in the commercial reagent could be unreacted elemental 
potassium or its subsequent oxidation product, potassium superoxide. We proposed the 
same problem was occurring with the NaH used for this reaction. Thus, upon changing 
the source of sodium hydride used for the reaction and following the optimised 
conditions of Hu,149 74 was observed in the crude reaction mixture and obtained in a 
modest yield of 40%.  
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The mechanism for the base-promoted self-condensation of methyl acetoacetate (127) 
has been proposed in the literature (Scheme 2–3)153-155 Thus, 127 is deprotonated with 
sodium hydride (1.5 eq) to give monoanion 217. The majority of monoanion 217 is 
deprotonated again by n-butyllithium (0.95 eq.) to form the strongly nucleophilic 
dianion 218. It is believed that the dianion undergoes a Claisen condensation reaction 
with the remaining monoanion, forming triketo-ester 219 with the loss of methoxide. 
This triketo-ester can be further deprotonated by dianion 218, producing trianion 220 
and reforming monoanion 217 which can then react with another molecule of dianion 
218. Quenching the reaction with 1N HCl protonates the triketo-ester and induces an 
intramolecular aldol condensation between the terminal ketone and an enol tautomer of 
the methyl ester 216 forming a 6-membered ring. Subsequent elimination of water and 
tautomerisation leads to aromatisation, providing ester 74.  
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Scheme 2–3. Proposed mechanism for the self-condensation of methyl acetoacetate. 
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2.3 Strategies for the Protection of Orsellinate 74 
 
The HWE strategy for synthesis of Am D requires phenolic protecting groups that are 
base stable. To this end, the two phenolic groups were initially protected as their methyl 
ethers. The 4-hydroxyl group is more reactive than the 2-hydoxyl group, which is 
presumably involved in a strong hydrogen bond with the neighbouring ester carbonyl 
group. This led to the isolation of methyl orsellinate derivatives predominately 
protected only at the 4-hydroxyl when standard methylating conditions [K2CO3 and 
(MeO)2SO2] were employed (Scheme 2–4). Under these conditions, mono-methylated 
compound 132 was formed in 80% yield. Methylation with methyl iodide and sodium 
hydroxide in THF at room temperature was found to be the optimal conditions for the 
protection of both phenolic groups. Thus, dimethylated 130 was obtained in 62% yield.  
  
OH
HO
OMe
O OH
MeO
OMe
O
Me2SO4, K2CO3,
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2
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2
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132
130
2
4
2
4
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Scheme 2–4. Protection of 74 with methyl ethers.  
 
Methyl ethers are renowned for being challenging to remove, especially in the presence 
of sensitive functional groups.74 Therefore, methoxymethyl (MOM) ethers were 
investigated as an alternative base-stable protecting group for methyl orsellinate. The 
phenolic groups were first deprotonated with sodium hydride before the addition of 
MOM-Cl (Scheme 2–5). Small amounts of both possible mono-protected esters (222 
and 223) were often isolated alongside the desired di-protected 221.  
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Scheme 2–5. Protection of 74 as bis(methoxymethyl) ether 221.  
 
The propensity of orsellinate 74 and its derivatives to undergo electrophilic aromatic 
substitutions at C3 156,157 and C5 74,132,156 has been well documented in the literature. 
The ability of the methyl and MOM ethers to stabilise the positive charge created during 
the electrophilic substitution by resonance may activate the aromatic ring to the 
undesired substitution (Scheme 2–6). 
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Scheme 2–6. Electrophilic aromatic substitution of 130 at C5. 
 
In contrast, acetate protecting groups should deactivate the aromatic ring towards 
electrophilic substitution by withdrawing electron density. However, they undergo 
facile cleavage by nucleophilic bases, such as methoxide, which may be required for the 
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HWE reaction. Despite this disadvantage, diacetate 134 was also prepared with plans to 
reprotect the phenolic groups at a later stage in the synthesis, if necessary. Protection of 
the phenolic hydroxyl groups of 74 with acetyl groups did not suffer the difficulties 
associated with methylation, affording at room temperature the diacetate in near 
quantitative yields (Scheme 2–7).  
 
 
Scheme 2–7. Protection of 74 as diacetate 134. 
 
 
2.4 Benzylic Derivatisation of Aromatic Segment 
2.4.1  Synthesis of Phosphonate 142 
 
Attempts to brominate the benzylic position of 130 and 132 using the same conditions 
used for the successful bromination of model compound 214 (see Section 2.1), led to 
competing electrophilic aromatic substitution of the aromatic ring (Scheme 2–8). The 
bromide was assumed to be substituted at C5 as has been reported previously in the 
literature.75 
 
 
Scheme 2–8. Bromination of methyl ethers 130 and 132. 
 
It has been found, however, that replacement of at least one of the methyl groups by an 
acetate group deactivates the aromatic ring enough to favour bromination at the benzylic 
position.78,158,159 Following a reported procedure159 bromide 135 was prepared in 71% 
yield from diacetate 134 (Scheme 2–9). N-Bromosuccinimide (NBS) and the radical 
initiator benzoyl peroxide were added in portions to a solution of 134 in carbon 
tetrachloride (CCl4) in an attempt to reduce the amount of dibromide 226 formed in the 
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reaction. The progress of the bromination reaction was monitored via 1H NMR 
spectroscopy. At the end of the reaction, the crude residue contained a mixture of 
starting material and mono- and di-bromo products. Fortunately, the desired 
monobromomethylbenzoate 135 could be isolated through careful column 
chromatography. Although the Rf vaules of these three components were almost 
identical in the eluent (CH2Cl2), they all stained a different colour when the TLC plates 
of the eluted fractions were developed in anisaldehyde dip: black for dibromo-, brown 
for monobromo- and red for starting material. This colour difference allowed the 
identification of the fractions that contained pure monobromomethylaryl 135. 
 
The benzylic bromide was converted into the arylmethylphosphonate through an 
Arbuzov reaction79 with triethyl phosphate (Scheme 2–9). The first step of this reaction 
involves nucleophilic attack by the phosphorus on the arylmethyl bromide, followed by 
the bromide ion dealkylation of the resulting trialkoxyphosphonium salt, providing 
phosphonate 142 and bromoethane as the by-product. The excess reagent was removed 
by distillation to give the required aromatic fragment 142 as a pale yellow oil.  
 
 
Scheme 2–9. Synthesis of the aromatic segment (142) for the HWE route.  
 
Several attempts were also made to prepare the Wittig salt of the aromatic bromide 135 
(Scheme 2–10). The product from the reaction of bromide 135 with triphenylphosphine 
would not crystallise out of solution despite trying a wide range of solvent mixtures. 
The 1H NMR spectrum of the crude product in CDCl3 was too complex to determine 
whether the reaction was indeed successful. This route was thus abandoned and focus 
returned to the phosphonate 142, which should favour the formation of the desired (E)-
olefin in an HWE reaction.  
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Scheme 2–10. Attempted Wittig salt preparation.  
 
As previously discussed, the acetate protecting groups are susceptible to the 
nucleophilic bases that might be used in the HWE reactions. Therefore conversion of 
the acetate groups of the aromatic segment to TBS ethers was undertaken (Scheme 2–
11). The acetates of phosphonate 142 were easily removed by treatment with sodium 
methoxide in methanol and reprotected with TBSCl, providing phosphonate 228 in 
good yield.  
 
 
Scheme 2–11. Preparation of the TBS-ether protected aromatic phosphonate.  
 
 
2.4.2  Attempted Synthesis of Thiol 170 
 
Thioether 191 was required as an intermediate in the Ramberg-Bäcklund (RB) route to 
Am D (Scheme 2–12). One approach to compound 191 would involve the preparation 
of thiol 170 or thioacetate 171 to react with alkyl halide 229.  
 
 
Scheme 2–12. Proposed synthesis of intermediate 191. 
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Thioacetate 171 was prepared through the nucleophilic displacement of bromide 135 
with potassium thioacetate (Scheme 2–13). Attempts were made to obtain the free thiol 
by deprotecting 171 with sodium methoxide. However, a mixture of compounds was 
formed in this reaction, including the major products thioacetate 230 and thiolactone 
231. The latter presumably arises via the attack of the methyl ester by the sulfide formed 
by methanolysis of 230, forming a stable thiolactone. This reactivity has been exploited 
in the literature for the synthesis of thiolactones.160 
 
 
Scheme 2–13. Synthesis of thioacetate 171 and its subsequent methanolysis products 
thioacetate 230 and thiolactone 231.   
 
To avoid the formation of thiolactone 231, an alternative strategy, involving 
displacement of benzylic bromide 135 by a carbohydrate-derived thiol 169, was instead 
investigated (Scheme 2–14). This strategy was ultimately successful in the total 
synthesis of Am D and is discussed in Section 5.2. 
Scheme 2–14. Alternative strategy to thioether 191. 
 
 
2.5 Summary of Chapter Two 
 
In summary, bromide 214 was obtained in 90% yield from methyl 2-methylbenzoate. 
The simplified model aromatic phosphonates 210 and 211 were prepared in two steps 
from commercially available methyl benzoates 212 and 213 in 88% and 89% yield 
respectively.  
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Three aromatic fragments relevant to the synthetic strategies for Am D have been 
prepared for the HWE and RB routes. Bromide 135 was synthesised in two steps from 
methyl orsellinate in 70% overall yield. Phosphonate 142 and thioacetate 171 were 
prepared in three steps from methyl orsellinate in 64% and 63% overall yield, 
respectively. Phosphonate 228 was obtained in five steps from methyl orsellinate in 
43% overall yield 
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Chapter Three: 
Synthesis of the C2′–C7′ Segment 
 
In both retrosynthetic analyses under consideration, disconnections at the olefins of Am 
D would lead to terminally functionalised six-carbon synthons containing the required 
diol moiety. It was envisaged that this unit could be derived from carbohydrate chiral 
pool reagents with the appropriate cis-stereochemistry at adjacent centres.  
 
3.1 The Horner-Wadsworth-Emmons (HWE) route  
 
The proposed HWE strategy to Am D involves disconnections at olefins C1′–C2′ and 
C7′–C8′ giving, inter alia, a dialdehyde synthon (Figure 3–1). D-Glucose (232) would 
be a suitable carbohydrate precursor for various protected derivatives of the dialdehyde 
synthon, in which the diol at C5′ and C6′ would be retained in the product, while the C2′ 
and C7′ termini would be differentially functionalised as aldehydes or masked 
aldehydes and oxygens at C3′ and C4′ would be removed. 
 
 
Figure 3–1. Retrosynthetic analysis of Am D with focus on the C2′–C7′ fragment. 
 
Over a series of transformations, D-glucose could be converted to a protected 
hemiacetal (Scheme 3–1), with the open-chain form able to react with an appropriate 
phosphonate to afford the required benzylic (E)-alkene. Deprotection and oxidation of 
the primary hydroxyl of the resulting conjugate would provide the aldehyde required for 
the second HWE olefination, thus completing the full carbon backbone of Am D.  
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Scheme 3–1. Conversion of D-glucose to protected hemiacetals and their proposed use 
in HWE reactions to install the benzylic (E)-alkene. The numbering of the 
carbohydrate-derived segments corresponds to their numbering in Am D.  
 
 
3.1.1  Synthesis of Hemiacetal Fragments 
 
Three carbohydrate substrates were prepared for use in this strategy (Figure 3–2): the 
diacetate 122, acetonide 152 and silyl ether 153. These three targets differ in the extent, 
type and stability of protecting groups, thus the likelihood of finding a suitable substrate 
for the HWE was increased. 
 
 
Figure 3–2. The three proposed hemiacetals (122, 152 and 153) targeted for use as 
substrates in the HWE reaction.  
 
 
 
3.1.1.1 Synthesis of Diacetate 122 
 
The synthesis of all three protected carbohydrate derivatives began with the efficient 
conversion of D-glucose to tri-O-acetyl-D-glucal on a multigram scale (Scheme 3–2). 
Thus, global acetylation of D-glucose with acetic anhydride and catalytic perchloric acid 
was performed prior to treatment with hydrogen bromide affording bromide 233. These 
somewhat harsh acidic conditions led to the formation of the α-bromo anomer, which, 
upon elimination with zinc in 1:1 solution of acetic acid/water, gave tri-O-acetyl-D-
glucal, 147, in 91% yield (over 3 steps).161,162  
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Scheme 3–2. Preparation of tri-O-acetyl-D-glucal (147). 
 
 
Tri-O-acetyl-D-glucal readily underwent a Ferrier rearrangement85 with benzyl alcohol 
catalysed by the Lewis acid iron(III) chloride (FeCl3) (Scheme 3–3).163 Benzyl 
glycoside 148 was afforded as an inseparable mixture of anomers with an α:β ratio of 
9:1 as determined by 1H NMR spectroscopy. Presumably, the α-anomer was favoured 
due to the anomeric effect. The mechanism involves complexation of FeCl3 to the 
carbonyl oxygen of the allylic acetate, thereby activating it as a leaving group. A lone 
pair of electrons on the ring oxygen provides stabilisation of the resulting allylic cation 
through formation of an oxonium intermediate 234. The short-lived oxonium ion is 
attacked at C2′ by a nucleophile (in this case benzyl alcohol) restoring the lone pair of 
electrons to the pyranose oxygen, giving benzyl glycoside 148.  
 
 
Scheme 3–3. The Ferrier rearrangement of tri-O-acetyl-D-glucal with benzyl alcohol. 
 
It was envisaged that catalytic hydrogenation of the anomeric mixture of benzyl 
glycoside 148 would simultaneously reduce the olefin and remove the benzyl protecting 
group (Scheme 3–4). Initial investigations found that catalytic palladium on carbon 
(Pd/C) was suitable for the hydrogenation of the double bond but was ineffective in 
catalysing the hydrogenolysis of the benzyl group. Reaction in the presence of catalytic 
platinum oxide on carbon (PtO2/C) hydrogenated the olefin and the aromatic ring of the 
benzyl group giving cyclohexylmethyl glycoside 236. Finally, the catalyst palladium(II) 
hydroxide on carbon [Pd(OH)2/C] was found to be reactive enough to hydrogenate the 
double bond and remove the benzyl protecting group in good yield. 
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Scheme 3–4. Catalytic hydrogenation of benzyl glycoside 148.  
 
Alongside desired hemiacetal 122, two other products from the hydrogenation reaction 
were frequently observed as minor by-products, namely ethyl glycoside 237 and 
tetrahydropyran 238 (Scheme 3–5). In fact, on several occasions, ethyl glycoside 237 
was isolated as the major product (70–80%). There seemed to be no consistent factors 
that differentiated these instances from those giving the expected outcome.  
 
 
Scheme 3–5. Products from the hydrogenation reaction of benzyl glycoside 148.  
 
 
Toshima and co-workers reported the formation of related side products when 
attempting the hydrogenation of acetate 239 (Scheme 3–6).164 The isolation of 
tetrahydropyran 242 as the major product suggested that the allylic acetate has a 
tendency to eliminate hydrogenolytically via a π-allyl palladium complex (245) under 
the given hydrogenation conditions. Anomeric acetate 240 was found to be unreactive 
when exposed to the same hydrogenation conditions. This suggested that the double 
bond at C2–C3 is indeed required for cleavage of the anomeric acetate and thus 
supported the hypothesis of a π-allyl palladium complex as an intermediate. 
Hydrogenation of methyl glycoside 243 gave saturated methyl glycoside 244 as the sole 
product, which suggested that the reduction to tetrahydropyran 242 requires an 
appropriate leaving group as the anomeric substituent.  
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Scheme 3–6. Products from the hydrogenation of acetates 239 and 243 by Toshima.164 
 
This tendency of allylic acetates to eliminate hydrogenolytically was previously shown 
by Baldwin and co-workers when allylic acetate 246 was reduced to tetrahydropyran 
247 upon treatment with Raney-Nickel (Ra-Ni) (Scheme 3–7).165 Haukaas and 
O’Doherty extended this observation to allylic anomeric pivaloates having obtained a 
1:1 ratio of pivaloate 249 and tetrahydropyran 250 in excellent yield from the 
palladium-catalysed hydrogenation of allylic pivaloate 248.166  
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Scheme 3–7. Formation of tetrahydropyrans from the hydrogenolysis of anomeric 
acetates165 and pivaloates.166 
 
A mechanism proposed for the formation of hemiacetal 122, ethyl glycoside 237 and 
tetrahydropyran 238 is presented in Scheme 3–8. Upon co-ordination of the palladium 
catalyst (Pd) to the olefin, complex 251 could follow the hydrogenation pathway 
(shown in orange) to give saturated 235 and ultimately hemiacetal 122. Complexation 
could also lead to formation of a π-allyl Pd complex of type 252 via elimination of the 
benzyl group.164 This π-allyl intermediate could then proceed along one of two 
pathways: it might be trapped by a molecule of ethanol (shown in blue) and 
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subsequently hydrogenated to give ethyl glycoside 237; or a Pd-complexed hydride 
could attack at the anomeric centre (shown in red). Tetrahydropyran 238 could 
ultimately be obtained through this latter pathway, after addition of hydrogen to Pd and 
subsequent hydrogenation. Alternatively, ethyl glycoside 237 and π-allyl Pd complex 
252 could be formed via conjugated oxonium ion 234. This pathway requires the 
activation of benzyl glycoside 148 by either acid or Pd(OH)2/C acting as a Lewis 
acid.164,167 Oxonium ion 234 could then either be trapped as ethyl glycoside 237 by 
reacting with the solvent (ethanol) prior to alkene hydrogenation (shown in green), or it 
could co-ordinate to Pd to give π-allyl Pd complex 252. These mechanistic pathways 
would be in competition with each other, with the formation of hemiacetal 122 being 
the favoured process under the conditions used (10% Pd(OH)2/C, H2, EtOH).  
 
When the reaction solvent was changed from ethanol to chloroform, tetrahydropyran 
238 was obtained as the major product (Scheme 3–9) with only trace amounts of 
compounds 122 and 235 being observed in the 1H NMR spectrum of the reaction 
mixture (≥5% combined). Under palladium-catalysed hydrogenation conditions, 
chloroform is known to produce small quantities of hydrogen chloride.168 The presence 
of hydrogen chloride could promote the formation of oxonium ion 234 over Pd complex 
251. In the absence of a bountiful nucleophilic source (e.g. ethanol solvent), the 
formation of tetrahydropyran 238 via π-allyl Pd complex 252 would be the end result. 
Furthermore, we propose that the incidental formation of hydrogen chloride from 
chloroform could enhance the rate of formation of tetrahydropyran 238 over the desired 
product 122, indicating that π-allyl Pd complex 252 might be formed from oxonium ion 
234, thus bypassing π-complex 251. Hydrogenation of 148 in deuterated chloroform 
confirmed that the hydrogen atom from chloroform was not being incorporated into the 
product, as the 1H NMR spectra of the products from both the deuterated and non-
deuterated solvents were identical. Therefore it appears that tetrahydropyran 238 derives 
from a mechanism related to that shown in Scheme 3–8. 
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Scheme 3–8. Proposed mechanisms for the formation of hemiacetal 122, ethyl 
glycoside 237 and tetrahydropyran 238 in the hydrogenation reactions of benzyl 
glycoside 148. 
 
 
Scheme 3–9. Product from hydrogenation of benzyl glycoside 148 in CHCl3. 
 
 
Despite the aforementioned formation of by-products 237 and 238, the desired HWE 
substrate, hemiacetal 122, was successfully generated over 5 steps from D-glucose in an 
excellent yield of 55%. 
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3.1.1.2 Synthesis of Silyl Ether 153 
 
Silyl ether 153, the second desired carbohydrate substrate, was targeted to provide a 
substrate with superior protecting group stability to that of diacetate 122 in the basic 
conditions of the HWE reaction (Scheme 3–10). Diacetate 148 was deprotected with a 
catalytic amount of methoxide (prepared in situ from methanol and K2CO3) giving diol 
149 as a white solid. The primary hydroxyl group of diol 149 was selectively protected 
as its TBS ether in excellent yield (95%). However, hydrogenation/hydrogenolysis of 
the benzyl glycoside 151 with catalytic Pd(OH)2/C in EtOH did not afford hemiacetal 
153. The absence of aromatic and olefinic peaks in the 1H NMR spectrum of the crude 
product confirmed that the hydrogenation and hydrogenolysis reactions were successful. 
However, the characteristic TBS signals were missing from the spectrum, indicating 
that the silyl ether had also been cleaved in the reaction. Toshima and co-workers have 
previously reported the susceptibility of TBS ethers to undergo cleavage when exposed 
to Pd(OH)2/C catalysed hydrogenation conditions.167 The product was assumed to be 
the corresponding triol 253. Thus, the route was abandoned as the additional protection 
group manipulations required to prepare a suitable HWE substrate from 253 rendered it 
inefficient. 
 
 
Scheme 3–10. Attempted synthesis of desired hemiacetal 153. 
 
 
3.1.1.3    Elimination/Rearrangement of Benzyl Glycosides 149 and 151 
Whilst characterising samples of silyl ether 151 in CDCl3 via NMR spectroscopy, it was 
observed that, over the course of 12 hours, the signals corresponding to the benzyl 
group were disappearing and a new proton signal at 7.40 ppm was concurrently 
appearing (Scheme 3–11). Diol 149 was found to also undergo the same transformation 
but at much slower rate. An NMR sample of the unprotected diol would typically be 
fully converted to this new compound over a period of 4 days. Diacetate 148 was, 
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however, found to be inert to CDCl3 over a period of two weeks. This result suggested 
that the C5′ hydroxyl group is involved in this transformation.  
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Scheme 3–11. Rearrangement of benzyl glycosides 149 and 151 in CDCl3.  
 
Detailed NMR analysis of the acetylated product from the degradation of diol 149 led to 
elucidation of its structure. The 1H NMR spectrum of the acetylated degradation product 
(256) contains seven signals representing a total of 12 protons (Figure 3–4). The 13C 
NMR contains ten carbon signals, four of which are in the characteristic unsaturated 
region (~110–150 ppm).169 The HSQC spectrum indicates that the methylene signals at 
4.43 and 4.47 ppm belong to the protons on C7′, while the gCOSY spectrum exhibits a 
correlation between the methylene protons and the signal at 6.10 ppm (Figure 3–3). 
Thus the 6.10 ppm signal belongs to the proton on C6′. A weak correlation between the 
methyl group of the acetate at 2.10 ppm and the C6′ methine in the HMBC spectrum 
indicates that the hydroxyl on C6′ is acetylated (Figure 3–5). Hence, C6′ is no longer 
part of the ring system. The chemical shift of the C6′ methine is shifted up field from a 
typical –CH(OAc)– resonance,170 indicating that there is further deshielding from a 
neighbouring group. The HMBC spectrum shows that the methine at C6′ is also 
adjacent to a quaternary carbon at 149.4 ppm (C5′). Carbon C5′ in turn, exhibits 
correlation with the methines at 6.36, 6.40 and 7.40 ppm and thus forms part of the ring. 
The chemical shifts of the protons (6.36, 6.40 and 7.40 ppm) and their adjoining 
carbons (110.4, 109.6 and 143.0 ppm) are typical of the furans.171 Thus it became clear 
that the products from these transformations are substituted furans. 
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Figure 3–3. Assignment of chemical shift and the 
gCOSY and HMBC couplings exhibited by furan 
256. 
 
 
 
 
Figure 3–4. 1H NMR spectrum of diacetyl furan 256. 
 
Carbon  C (ppm) H (ppm) 
2' 143.0 7.40 
3' 110.6 6.36 
4' 109.3 6.40 
5' 149.2 - 
6' 66.2 6.11 
7' 63.3 4.47, 4.43 
Ac C=O 170.6 - 
Ac Me 20.9 2.09 
Ac1 C=O 170.0 - 
Ac1 Me 20.7 2.06 
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Figure 3–5. HMBC spectrum of diacetyl furan 256. 
 
Having noted that a free C5′ hydroxyl was required for the transformation to occur, a 
mechanism related to the alternative mechanism for the formation of ethyl glycoside 
237 (Scheme 3–8) was proposed (Scheme 3–12). Activation and elimination of the 
benzyl group would generate oxonium ion 257. Trace amounts of water could then 
attack at the anomeric centre to give hemi-acetal 258a. The free C5′ hydroxyl could 
attack the carbonyl of the open-chain form hemi-acetal 258a to give hemi-acetal 258b. 
Protonation of the anomeric hydroxyl would activate hemi-acetal 258b toward 
elimanition, giving the highly stable furan.  
 
Scheme 3–12. A proposed mechanism for the benzyl glycoside transformation to furans 
254 and 255. 
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This proposed mechanism is supported by an investigation into the potential role of acid 
in this rearrangement. A catalytic amount of para-toluenesulfonic acid (p-TsOH) was 
added to a solution of benzyl glycoside 149 in MeOH. The benzyl group was found to 
be labile under these conditions, being completely exchanged with MeOH within ten 
minutes, as judged by TLC and 1H NMR spectroscopy (Scheme 3–13). Over the next 
four hours, furan 255 gradually accumulated to become the major product. 
Mechanistically, the benzyl oxygen is protonated, activating it as a leaving group. The 
resulting oxonium intermediate is common to both pathways. This can be intercepted by 
the solvent methanol, the leaving group (benzyl alcohol), or by water. While the excess 
of solvent molecules ensures that the methyl glycoside is the kinetic product, the 
thermodynamic preference for furan 255 leads ultimately to this material.  
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Scheme 3–13. Proposed mechanisms for the transformation of 149 in acidic methanol.  
 
This experiment seemed to imply that the earlier instability of diol 149 and silyl ether 
151 in deuterated chloroform was due to activation of the benzyl group through 
deuteration. These transformations did not, however, occur in non-deuterated CHCl3, 
even when the substrates were left in the solvent for a period of several days. Lab grade 
CHCl3 usually contains ethanol or amylenes as stabilisers, which could retard the 
acidity of the solvent. However, quenching the stabiliser by washing CHCl3 with 10% 
HCl prior to its reaction with silyl ether 151 also did not lead to furan 255. 
Theoretically, CDCl3 should be less acidic than CHCl3 since C–D bonds are stronger 
than C–H bonds (C–H 349.2 kJ mol-1, C–D 374.5 kJ mol-1 for CHCl3 and CDCl3 
respectively).172 On the other hand, D+ might be more stable than H+ due to having a 
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larger nucleus that could better accommodate the positive charge and therefore 
dissociate more easily. A clear explanation for the difference in reactivity between 
CDCl3 and CHCl3 has not yet been found. 
 
A similar rearrangement of D-glucal in the presence of acid and catalytic mercuric 
sulfate was observed by Perlin et al. (Scheme 3–14).173 The reaction is thought to 
proceed via initial oxymercuration of the 1,2 π-bond. The product 259 is in equilibrium 
with its furanose form 260. Elimination of the mercuric ion followed by a second 
elimination leads to the highly stable furan 255. 
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Scheme 3–14. Mechanism proposed by Perlin for the conversion of D-glucal to furan 
255. 
 
Since this first report there have been a number of examples of furan synthesis from 
D-glucal catalysed by a variety of Lewis acids including: Sm(OTf)2,174 InCl3,175 HClO4–
SiO2,176 KSF Montmorillonite177 and FeCl3·6H2O.178 
 
3.1.1.4 Synthesis of Acetonide 152 
The third proposed substrate for the HWE reaction was synthesised by protecting the 
C5′ and C7′ hydroxyl groups of benzyl glycoside 149 as an isopropylidene acetal prior 
to hydrogenation/hydrogenolysis (Scheme 3–15). Isopropylidene acetals are stable to 
base treatment and additionally may favour the open form of hemiacetal 152. 
 
 
Scheme 3–15. Conversion of benzyl glycoside 149 to isopropylidene acetal 152. 
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Initial attempts to install the isopropylidene group by heating a solution of diol 149, 
2,2-dimethoxypropane and 0.3 equivalents of p-TsOH in DMF at 60 ˚C failed to give 
the desired product. Instead, a significant proportion of starting material was returned 
alongside a side product resulting from the acid catalysed elimination/rearrangement, 
isopropylidene protected 261 (Scheme 3–16).  
 
 
Scheme 3–16. Acid catalysed rearrangement/elimination. 
 
The acetonide synthesis was repeated and eventually proved successful by warming a 
solution of 2,2-dimethoxypropane and catalytic p-TsOH in DMF at 50 ˚C for 12 hours 
in the presence of 4Å molecular sieves (4Å MS) (Scheme 3–17). A catalyst loading of 2 
mol% was found to be the ideal acid concentration to avoid side-product formation. 
Benzyl glycoside 150 was found to be relatively acid sensitive, with loss of the 
acetonide group occurring whilst sitting overnight in CDCl3. To buffer 
hydrogenation/hydrogenolysis reactions, triethylamine has been used as a co-solvent 
with EtOH.179 When triethylamine was added to the Pd(OH)2/C catalysed reaction, the 
reaction did not proceed past olefin hydrogenation, leaving the benzyl group intact. The 
catalyst poisoning property of triethylamine is known and has been exploited to 
selectively hydrogenate an olefin whilst preventing hydrogenolysis of O-benzyl 
groups.180,181 The successful hydrogenolysis of O-benzyl anomeric groups by López et 
al. might be explained by the high pressures of hydrogen gas (25 psi) that were used in 
their work.179 
In the event, hydrogenation of 150 in ethanol without triethylamine proceeded with little 
loss of the isopropylidene group. After this discovery, a range of other solvents were 
investigated to improve the yield. Ethyl acetate was found to be the optimal solvent, 
giving the highest yields without any detectable decomposition occurring.  
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Scheme 3–17. Preparation of hemiacetal 152 from benzyl glycoside 149.   
 
The 1H NMR spectrum of hemiacetal 152 exhibits a small signal at ~9.77 ppm 
characteristic of aldehyde protons, which suggested that about 10% of this material 
exists in the open-chain aldehyde form 262 in solution. Hemiacetal 152 was the second 
HWE substrate successfully prepared from D-glucose, in a total of six steps and an 
overall yield of 48%. 
 
 
3.2. The Ramberg-Bäcklund (RB) route 
 
In the proposed Ramberg-Bäcklund (RB) route to Am D two approaches to the 
intermediate thioether 263 were considered (Figure 3–6): either bromide 135 could be 
coupled with thiol 169, or thioacetate 171 could be coupled with iodide 168. Thiol 169 
and iodide 168 could ultimately be derived from D-ribose and D-glucose respectively.   
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Figure 3–6. Retrosynthetic analysis for the RB route with focus on the C2′ to C7′ 
segment.    
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3.2.1  Attempted Synthesis of Iodide 168 
 
The RB approach to Am D was initially focused on coupling thioacetate 171 with 
iodide 168. Synthesis of iodide 168 began from tri-O-acetyl-D-glucal, 147 (Scheme 3–
18). Nakata’s procedure was followed to afford alcohol 176 in 65% yield over 5 steps.92 
Here a Ferrier reaction with methanol gave methyl glycoside 172 in good yield (85%). 
Hydrogenation proceeded quantitatively without the formation of undesired side 
products, consistent with Toshima’s observations.164 After removal of the acetate 
groups, the resulting hydroxyl groups were reprotected as TBS ethers. Upon treatment 
with (±)-camphorsulfonic acid (CSA), the primary TBS ether was selectively cleaved 
affording primary alcohol 176.  
 
 
Scheme 3–18. Synthesis of alcohol 176 following Nakata’s procedure.92 
 
A mild method for oxidation of primary alcohol 176 to the corresponding aldehyde was 
sought. The N-oxoammoium salt based oxidation developed by Piancatelli and co-
workers182 involves the use of a catalytic amount of 2,2,6,6-tetramethyl-1-
piperidinyloxy free radical (TEMPO), which gives an oxoammonium salt and a 
hydroxylamine moiety by disproportionation, in the presence of 
bis(acetoxy)iodobenzene (BAIB) that regenerates TEMPO by oxidation of the 
hydroxylamine (Scheme 3–19).  
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Scheme 3–19. The catalytic cycle for the TEMPO/BAIB oxidation system.182 
 
This TEMPO/BAIB oxidation system has been used to oxidise the C6–OH of 
carbohydrate substrates similar to alcohol 176 to their corresponding aldehydes.183 
However, when this system was used on alcohol 176, the reaction did not go to 
completion, returning a 1:1 mixture of starting material and desired aldehyde 177. In 
contrast, Swern oxidation184 of alcohol 176 provided the desired aldehyde in a better 
yield and purity (Scheme 3–20). With concerns about its stability, aldehyde 177 was 
immediately reacted in a Wittig olefination without purification. Alkene 178 was 
isolated in 49% yield from alcohol 176.  
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Scheme 3–20. Oxidation and olefination of alcohol 176.  
 
Hydrolysis of methyl glycoside 178 was attempted several times but did not provide 
hemiacetal 179 (Table 3–1). It is likely that the TBS ether was unstable in the acidic 
reaction conditions required, presumably providing deprotected 264 as the major 
product. Attempted purification of the reaction mixture did not lead to the isolation of 
any recognisable compounds.  
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Table 3–1. Attempted hydrolysis of methyl glycoside 178 under various conditions.
   
Nevertheless, the crude mixture from the 50% AcOH hydrolysis reaction was carried 
forward in an attempted reduction with sodium borohydride. This resulted in an even 
more complex mixture of compounds. Due to the lack of success with the hydrolysis 
and reduction reactions, this approach to thioether 263 was abandoned in favour of a 
route to thiol 169 starting from D-ribose as described below. 
 
 
3.2.2  Synthesis of Thioacetate 189 
In the alternative route for the RB approach, D-ribose was converted to thiol derivative 
189 over 8 steps (Scheme 3–21). 
 
 
Scheme 3–21. Transformation of D-ribose to thioacetate 189.  
 
D-Ribose was transformed into the acetonide-protected β-methyl glycoside (182) in a 
one-pot reaction (Scheme 3–22).98 The crude product was easily isolated from the 
starting material with a solvent extraction before activation as the tosylate 183, which 
was purified by recrystallisation.  
Tosylate 183 underwent nucleophilic substitution with sodium iodide to give iodide 
184.98 The iodide had the same Rf as the starting material on silica and was UV active, 
requiring 1H NMR analysis of the crude reaction mixture to determine if reacton was 
complete. No impurities were detected in the 1H NMR spectrum of the crude product, 
so it was carried through without further purification.  
Reagents Solvent Temp Yield of 179 
6% HCl THF RT n.d.a 
10% HCl dioxane reflux n.d. 
10% HCl dioxane 50 °C n.d. 
50% AcOH dioxane 50 °C n.d. 
a n.d. = not detected 
OTBSO
OMe
OTBSO
OH
OHO
OH
178 179
264
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Scheme 3–22. Synthesis of iodide 184 from D-ribose.98 
 
The key step in the synthesis of thiol derivative 189 was the one-pot Vasella-Wittig 
reaction sequence (Scheme 3–23). This sequence involves opening the sugar ring and 
extending the carbon chain by the two units required for Am D. The Vasella reaction (or 
Bernet-Vasella reaction) is a zinc-induced reductive ring opening of 6-deoxy-6-
halopyranoside or 5-deoxy-5-halofuranoside derivatives.99,185-187 This reaction produces 
a ω-enal, which could react in situ with a stabilised ylide such as 265. Thus, after zinc 
insertion into the C–I bond of 184, elimination of zinc iodide and loss of methoxide 
leads to the formation of aldehyde 185 (Scheme 3–23). The addition of acetic acid 
activates the zinc towards oxidative insertion in the C–I bond. Vasella has proposed that 
the reductive fragmentation of β-anomers is concerted since all the bonds that are 
breaking can become anti-periplanar (Scheme 3–23).187 Following completion of the 
reaction, the excess zinc and zinc salts were removed by filtration through a wud of 
silica before the addition of Wittig reagent 265. Ester 186 was isolated in a good 74% 
yield with an E/Z ratio of 1:4.5. Although the E and Z stereoisomers could be separated 
by careful silica column chromatography, methyl ester 186 could be carried forward as 
a mixture of stereoisomers, as the conjugated olefin was to be saturated in the 
subsequent reaction. 
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Scheme 3–23. One-pot Vasella-Wittig reaction leading to α,β-unsaturated ester 186. 
 
The use of a HWE reaction to obtain the ethyl analogue of methyl ester 186 was also 
investigated (Scheme 3–24). Sequential addition of triethyl phosphonoacetate and 
sodium ethoxide to the filtered solution of aldehyde 185 provided ethyl ester 266 in 
superior stereoselectivity but lower overall yield than when the Wittig reagent was used. 
Hence, the chain extension of aldehyde 185 with Wittig reagent 265 was continued.  
 
 
Scheme 3–24. One-pot Vasella-HWE reaction leading to α,β-unsaturated ester 266. 
 
With the α,β-unsaturated ester in hand, methodology was sought for the selective 
reduction of the α,β-unsaturated ester to a saturated primary alcohol in either a single 
step or over two consecutive steps (Scheme 3–25). This selective reduction proved to be 
quite a challenge. 
 
 
Scheme 3–25. Stepwise or one-pot reduction of α,β-unsaturated ester 186 to alcohol 
187. 
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An attempted reduction with magnesium metal in methanol105 led to reductive cleavage 
of the γ-hydroxyl group to give allylic alcohol 269 (Scheme 3–26). The reaction 
mechanism is proposed to occur via stepwise single electron transfers (SETs) from the 
metal to the substrate.188 The carbanion (268) formed in the first SET undergoes the 
cleavage of the dioxolanyl group which, followed with the second SET and subsequent 
protonation, gives allylic alcohol 269. 
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Scheme 3–26. Proposed mechanism for the reductive cleavage of α,β-unsaturated ester 
186, with magnesium in methanol.188 
 
Reduction of α,β-unsaturated ester 186 with lithium aluminium hydride (LAH)109,110,189 
afforded three products: the allylic alcohol 270 as the major product, along with ester 
267 and desired saturated alcohol 187 as minor components (Scheme 3–27). Since 187 
and 270 were chromatographically inseparable and selective hydrogenation of the major 
unsaturated alcohol 270 would be difficult, an alternative reduction system was sought. 
 
 
Scheme 3–27. Reduction of the α,β-unsaturated olefin with LAH. 
 
A variety of simple transition metal catalysts were trialled for the sodium borohydride 
reduction of the α,β-unsaturated olefin (Table 3–2). Such reduction systems have been 
reported to reduce the olefin of an α,β-unsaturated ester group whilst leaving the ester 
intact.106-108,190 In general, when α,β-unsaturated ester 186 was subjected to these 
published reduction systems, the reactions rarely went to completion and the undesired 
reduction of the terminal olefin was difficult to prevent.  
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Table 3–2. Reduction of the α,β-unsaturated olefin with NaBH4 and metal catalysts. 
 
Typical procedure: To a cooled solution of the olefin 186 in MeOH and metal catalyst was added NaBH4 
over several minutes. The reaction was kept cool for 1 h before warming to rt. Entry 5 involved addition 
of the metal catalyst to a solution of olefin 186 already charged with NaBH4. 
a when mixtures of 267 and 271 were obtained their yields were estimated from the 1H NMR spectra. 
 
As a control, α,β-unsaturated olefin 186 was treated with sodium borohydride in the 
absence of a transition metal catalyst (entry 1), returning starting material after 3 h at 
0 °C. The first metal catalyst trialled was nickel(II) chloride hexahydrate (NiCl2.6H2O) 
(entry 2).106,191-193 Although the α,β-unsaturated olefin was successfully reduced, the 
terminal olefin was also hydrogenated in the process. Reduction catalysed by cobalt(II) 
chloride hexahydrate (CoCl2.6H2O)190 similarly led to the sole isolation of saturated 271 
(entry 3).  
Focus turned to the use of catalytic anhydrous copper(II) chloride (CuCl2), as this 
reduction system has been used to selectively reduce an α,β-unsaturated olefin in the 
presence of a terminal alkene (entries 4–7).107 Conjugate reduction catalysed by CuCl2 
afforded some desired product but unfortunately it was chromatographically inseparable 
from hydrogenated 271 (entry 4). The CuCl2 catalysed reductions failed to go to 
completion, returning significant amounts of starting material. Lactone 272 and allylic 
  Yields   Entry Metal Amount (equiv.) Temp. Additive 186 267a 271a 272 273 
1 none  0 °C  100%     
2 NiCl2.6H2O 0.5 0 °C    84%   
3 CoCl2 0.2 rt    67%   
4 CuCl2 0.75 0 °C  18% 32% 15% 17%  
5 CuCl2 0.75 0 °C  24% 45% 8% 10% 3% 
6 CuCl2 0.75 0 °C THF (1 mL) 37% 47% 9%   
7 CuCl2 0.75 -78 °C  24% 24% 5% 10% 10% 
8 CuCl 0.75 0 °C  47% 33% 5%   
9 
CuCl 0.75 -78 °C 
cyclohexene 
(4 eq.),  
NaOMe 
(0.75 eq.) 
13% 71% 6%   
10 CuCl 0.75 -78 °C cyclohexene (4 eq.)  96%    
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alcohol 273 were also frequently isolated as minor products from the copper(II) 
catalysed reductions. Changing the order of addition of reagents (entry 5) improved the 
yield of desired product 267 but still returned a noteworthy amount of starting material. 
Use of THF as co-solvent gave a similar yield of desired product to entry 5, but without 
the side products 272 and 273 (entry 6).194 Lowering the temperature improved the yield 
of desired product with respect to saturated 271 but not with respect to side products 
272 and 273 (entry 7). When the copper catalyst was changed from copper(II) chloride 
to copper(I) chloride (CuCl) similar conversions were initially obtained (entry 8).108  
The four products from the reduction reactions all have the α,β-unsaturated olefin of 
186 reduced, suggesting that this more reactive olefin was the first to react. If the 
reactivity of the reduction system could be lowered it might be possible to prevent the 
reduction of the terminal olefin. It was proposed that over-reduction could be prevented 
by the addition of an unsaturated compound that could compete with the terminal alkene 
in 187 for the undesired hydrogenation. Cyclohexene was chosen as the unsaturated 
additive since it contains a reactive olefin due to ring strain and because both 
cyclohexene and cyclohexane can be easily removed under reduced pressure at the 
completion of the reaction. Sodium methoxide was initially also included to counteract 
the Lewis acidity of the copper catalyst which presumably leads to lactone 272 and 
allylic alcohol 273 (Scheme 3–28). Indeed, use of these two additives afforded the 
highest yield of desired product yet, with a greatly reduced amount of starting material 
returned (entry 9). When sodium methoxide was excluded, the desired product 267 was 
the sole product and isolated in an excellent yield (entry 10). 
Formation of allylic alcohol 273 and lactone 272 is likely to arise after the reduction of 
the α,β-unsaturated olefin since their conjugated equivalents 274 and 275 were not 
observed (Scheme 3–28). It is proposed that a hydride attacks the terminal olefin with 
the π-electrons flowing to eliminate acetone giving allylic alcohol 273, which can then 
cyclise to give the lactone 272. Evidence for these products can be seen in their 1H 
NMR spectra with new methyl doublets being observed at 1.70 and 1.75 ppm 
respectively and the presence of only two signals characteristic of olefinic protons. 
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Scheme 3–28. A proposed mechanism for the synthesis of the isolated side products 
272 and 273. 
 
After selective reduction of the α,β-unsaturated olefin using catalytic copper(I) chloride 
and sodium borohydride, ester 267 was reduced with LAH to give alcohol 187 in 
excellent yield (Scheme 3–29). 
 
 
Scheme 3–29. Stepwise reduction of conjugated ester 186 to alcohol 187. 
 
Alcohol 187 was activated to nucleophilic attack by conversion to mesylate 188 
(Scheme 3–30). Nucleophilic substitution of the mesylate with potassium thioacetate in 
dimethylformamide proceeded to give thioacetate 189 in 93% yield over the two steps. 
 
 
Scheme 3–30. Synthesis of thioacetate 189. 
 
Attempts were made to deprotect thioacetate 189 to the free thiol moiety (Scheme 3–
31). These attempts resulted in the synthesis of a product less polar than thioacetate 189, 
with a 1H NMR spectrum that was almost identical to that of the starting material but 
with loss of the characteristic acetate methyl peaks. This compound was confirmed to be 
the symmetrical disulfide 190 by HRMS. Thiol 169 was likely oxidised to disulfide 190 
on work up. 
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Scheme 3–31. Attempted preparation of thiol 169 that led to disulfide product 190. 
 
The couplings of benzylic halides and thiols formed by in situ deprotection of the 
corresponding thioacetate have been previously reported. In one such procedure, Yelm 
preformed the sulphide with pyrrolidine in acetonitrile prior to addition of a benzylic 
bromide and triethylamine to the reaction.195 Han and Balakumar more simply reported 
that the addition of K2CO3 to a solution of thioacetic acid and benzyl bromide in MeOH 
led to an efficient coupling of the two units.196 Therefore, thioacetate 189 was 
stockpiled as the masked form of the thiol 169 to be the key fragment to couple with the 
aromatic fragment 135. 
 
 
3.4  Summary of Chapter Three 
 
Two substrates for the HWE reaction were successfully prepared from D-glucose. 
Diacetate 122 and acetonide 152 were obtained in 55% (5 steps) and 48% (7 steps) 
yields respectively. A mechanism for the formation of hydrogenation by-products 237 
and 238 was proposed. A similar mechanism was invoked for the formation of furans 
254 and 255. The RB substrate, thioacetate 189, was prepared from D-ribose in 39% 
yield over seven steps. With both aromatic and C2′–C7′ segments in hand, access to the 
remaining segment, the C8′–C11′ portion, was sought (Chapter 4). 
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Chapter Four: 
Synthesis of the C8′–C11′ Segment 
 
Preparation of the C8′–C11′ segments for both synthetic strategies centred around 
establishing the appropriate stereochemistry at C10′ using asymmetric methodology. 
The HWE strategy involved the preparation of phosphonate 118 via an asymmetric 
reduction of the corresponding ketone, whilst the RB strategy involved the preparation 
of alcohol 22 via an asymmetric allylboration of acetaldehyde (Figure 4–1). 
  
 
Figure 4–1. Desired C8′–C11′ segments for the HWE and RB routes, respectively.  
 
 
4.1  Route to Hydroxyphosphonate 118 
 
Our initial approach to Am D utilised a HWE reaction to install the olefin at C7′ and C8′ 
(Figure 4–2). This approach required the synthesis of phosphonate (S)-118 or its 
enantiomer (R)-118, depending on the method of ester formation chosen. Compound 
118 and its enantiomer comprise the C8′–C11′ fragment of Am D.  
 
 
Figure 4–2. Retrosynthetic analysis of the C8′–C11′ fragment of Am D: the HWE 
route. 
 
In the first instance, it was decided to synthesis racemic 118. Following the procedure 
published by Wilds and Shunk,80 the four-carbon chain of this fragment was synthesised 
in the form of amine 143, using a Mannich reaction81 between acetone, formaldehyde 
and diethylamine hydrochloride (Scheme 4–1). The addition of methyl iodide to amine 
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143 provided a quaternary ammonium salt, activating the adjacent carbon to 
nucleophilic attack by triethyl phosphite in an Arbuzov-like reaction, affording 
phosphonate 144.82 The sodium borohydride reduction of keto-phosphonate 144 
provided the racemic form of desired hydroxyphosphonate (±)-118 in moderate overall 
yield (41%).  
 
 
 
Scheme 4–1. Synthesis of phosphonate (±)-118.  
 
The first avenue considered for obtaining hydroxyphosphonate (R)- or (S)-118 was the 
non-stereoselective reduction of ketone 144 followed by enzymatic resolution. A 
published investigation of the kinetic resolution of hydroxyalkanephosphonates 
catalysed by Candida antarctica lipase B83 found that one enantiomer of diethyl 2-
hydroxypropanephosphonate [(±)-277] was a good substrate for the enzyme, giving 
excellent resolution on acetylation of one enantiomer (Scheme 4–2). The acetate 278 
and free alcohol 277 were both found to have enantiomeric excesses (ee) of > 95%. 
However, diethyl 3-hydroxybutanephosphonate [(±)-118] was not resolved under the 
same conditions, with both enantiomers being equally acetylated by the enzyme.83 It 
was postulated that this was due to the enzyme–substrate binding of the enantiomers 
differing less in the transition states than that of the diethyl 2-
hydroxypropanephosphonate isomers.83 
 
 
Scheme 4–2. Kinetic resolution of hydroxyalkanephosphonates with Candida 
antarctica lipase B (CALB). 
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With enzymatic resolution of phosphonate (±)-118 ruled out, attention was focussed 
instead on the use of asymmetric reduction of ketone 144 to prepare the 
enantiomerically pure alcohol (S)-118. A number of methods exist in the literature for 
such an asymmetric reduction.84 Corey and co-workers have developed a family of 
compounds called the oxazaborolidines for the enantioselective reduction of ketones 
(Figure 4–3).84,197,198  
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Figure 4–3. Oxazaborolidine catalysts for the asymmetric reduction of ketones 
developed by Corey et al.  
 
In these Corey-Bakshi-Shibata (CBS) reductions, the oxazaborolidine catalyst behaves 
like an enzyme in the sense that it binds both the ketone (substrate) and borane 
(reducing agent), activating them both to reaction (Scheme 4–3). After the reaction is 
complete, the product is released, freeing the oxazaborolidine catalyst to react again. 
The mechanism of the CBS reduction proposed by Corey is based on early 
spectroscopic studies.197 Upon addition of the borane reagent to the oxazaborolidine 
catalyst, coordination and activation of borane by the nitrogen gives species 279. This 
activates the borane as a reducing agent. The carbonyl oxygen of the ketone substrate 
coordinates to the oxazaborolidine ring boron with the larger carbonyl appendage (RL) 
pointing away from the boron substituent (R) and the phenyl rings on the catalyst. 
Hydrogen transfer from the activated borane takes place via a six-membered transition 
state, 280. The enantiomerically pure alcohol is finally released as boron ether 281, 
which provides the alcohol upon aqueous workup.  
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Scheme 4–3. Corey’s proposed mechanism for the catalytic reduction of ketones by 
oxazaborolidine catalysts. 
 
When ketophosphonate 144 is the substrate for the CBS reduction, the methyl and 
alkylphosphonate groups correspond to the small and large carbonyl appendages 
respectively (Scheme 4–4).  
 
≡ 
≡ 
 
Scheme 4–4. Expected hydroxyphosphonate products from CBS-catalysed reductions.  
 
Either alcohol (R)-118 or (S)-118 could be used in the total synthesis of Am D, 
depending on the esterification methodology to be employed. As the formation of the 
macrocycle by Yamaguchi macrolactonisation52 was initially planned (Section 1.4.2.5, 
Scheme 1–29), (S)-118 was required. Thus a solution of (R)-2-methyl-CBS-
oxazaborolidine [(R)-Me-CBS] in toluene was used to catalyse the reduction of 
ketophosphonate 144 (Scheme 4–5). 
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Scheme 4–5. (R)-Me-CBS catalysed reduction of ketophosphonate 144 to alcohol 
(S)-118.  
 
The reduction was rather low yielding (60%) compared with the yields reported with 
other substrates (85–99%).84 It was, however, comparable to the yield for the non-
stereoselective reduction of ketophosphonate 144 with sodium borohydride (62%). To 
assess the stereoselectivity of the reaction, the (S)- and (R)-Mosher esters of alcohol (S)-
118 were prepared and analysed using 1H NMR spectroscopy.199,200 (R)- and (S)-α-
methoxy-α-(trifluoromethyl)phenylacetyl chloride (MTPA-Cl) are chiral derivatising 
agents that are useful for determining the ee of chiral alcohol substrates and for 
identifying the stereochemistry of their chiral centre(s). Upon separate reaction with 
(R)- and (S)-MTPA-Cl the substrate in question should yield diastereomers with non-
equivalent chemical shifts in their 1H and 19F spectra. When (R)- and (S)-MTPA-Cl 
were individually reacted with phosphonate 118, the corresponding (S)- and (R)-Mosher 
esters were isolated in only 56% and 42% yields, respectively (Scheme 4–6). It is likely 
that the acid chlorides 280 and 281 had slowly hydrolysed whilst in storage, forming 
their carboxylic acids, which were unreactive towards the alcohols under the reaction 
conditions used. For accurate measurement of the ee, near quantitative yields of the 
Mosher esters are required so as to negate any kinetic resolution due to differential 
reaction rates of the substrate enantiomers.201 Thus, it is plausible that some kinetic 
resolution could have occurred in this reaction. Analysis of the non-equivalent –OCH3 
peaks in each 1H NMR spectrum suggested diastereoisomeric excesses (de’s) of 47% 
and 73%, for the (S)- and (R)-Mosher esters respectively. The difference in these values 
suggests that kinetic resolution of the mixture of enantiomers may have been occurring 
during its reactions with the chiral acid chlorides.  
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Scheme 4–6. Synthesis of Mosher esters of hydroxyphosphonate 118. 
 
The quartet expected for the –OCH3 peak at 3.56 ppm appears to be quintet in the 1H 
NMR spectrum of (S)-Mosher-118 (Figure 4–4). This multiplet could potentially arise 
from the overlap of the –OCH3 quartet from (S)-Mosher-118 and the –OCH3 quartet 
from (R)-MTPA-OH.202 However, the persistence of (R)-MTPA-OH after washing the 
reaction mixture with 1M sodium hydroxide solution is improbable. Further analysis of 
the 1H NMR spectrum reveals the presence of a small quartet of doublets at 4.39 ppm 
(JHH = 7.1, 0.8 Hz) that is characteristic of ethyl Mosher esters.203 Furthermore the –
OCH3 peak for ethyl (±)-Mosher ester is reported to be observed as a singlet at 3.56 
ppm.203 The small quartet of doublets at 4.39 ppm is also present in the 1H NMR 
spectrum of (R)-Mosher-118. However, it is impossible to detect the singlet at 3.56 ppm 
under the large quartet present. The contribution of this singlet to the integration of the 
–OCH3 peaks at 3.56 ppm would have the effect of both reducing the de of (S)-Mosher-
118 and enhancing the de of (R)-Mosher-118. Hence, any conclusions drawn from the 
calculated de’s (e.g. apparent kinetic resolution) can only be made tentatively. The 
formation of these ethyl esters could result from the hydrolysis of diethyl phosphonate 
118. This could additionally explain the why no starting material was observed in the 1H 
NMR spectra despite the low yields of the reactions (confirmed by absence of the 
CH3CH(OH)-R methine at 3.82 ppm).  
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Figure 4–4. Sections from 1H NMR spectra of (S)-Mosher-118 (above) and (R)-
Mosher-118 (below). 
 
Unfortunately, before the CBS reduction of ketophosphonate 144 could be repeated, the 
CBS catalyst degraded, precipitating out of solution. At this point in time, the HWE 
(S)-Mosher-118 
(R)-Mosher-118 
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route was being re-evaluated due to difficulties with the HWE reaction required to 
install the olefin at C1′ and C2′. As a result, this route to the C8′–C11′ fragment of Am 
D was abandoned in favour of a route utilising an asymmetric allylation reaction as 
described in the following section. 
  
 
4.2  Route to (R)-4-Penten-2-ol (22) 
 
In the Ramberg-Bäcklund (RB) route to Am D, the C8′–C11′ fragment is obtained from 
the homoallylic alcohol (R)-4-penten-2-ol (22) (Figure 4–5). Past syntheses of Am D 
have shown the Mitsunobu reaction to be an effective method for coupling the aromatic 
moiety with alcohol 22.9,32,35  
 
Figure 4–5. Retrosynthetic analysis of the C8′–C11′ fragment of Am D: the RB route. 
 
Brown and co-workers have developed a route to enantiomerically-pure homoallylic 
alcohols through the asymmetric allylboration of aldehydes.89,204 Preparation of (R)-4-
penten-2-ol (22) via Brown’s methodology began with synthesis of (-)-B-
allyldiisopinocampheylborane by treatment of (+)-α-pinene with borane-dimethyl 
sulphide complex (Scheme 4–7). The hydroboration reaction is left for several days, to 
allow for equilibration, which results in a reagent with a 98.9% ee, from (+)-α-pinene 
with a 91.3% ee.89 Methanolysis of borane 284 was directly followed by treatment with 
allylmagnesium bromide to give the allylating agent (-)-B-
allyldiisopinocampheylborane, 285. It has been shown that removal of the magnesium 
salts from this reagent leads to shorter reaction times and can improve the enantiomeric 
excess.205 However, the increase in ee is outweighed by the time-consuming filtration 
required and hence the reagent 285 was used directly by cooling to -78 °C before the 
addition of acetaldehyde. After warming to room temperature the reaction mixture was 
worked up with either the addition of alkaline hydrogen peroxide, water or silica to give 
the desired alcohol 22.  
  
 101
 
Scheme 4–7. Asymmetric allylboration of acetaldehyde. 
 
The 1H NMR spectrum of the crude residue exhibited the characteristic signals 
associated with (R)-4-penten-2-ol alongside those of (+)-α-pinene and its derivatives.204 
All attempts to isolate the alcohol, however, failed. Following reported procedures for 
purification by distillation89,90 and column chromatography,89 pure (R)-4-penten-2-ol 
was never isolated beyond trace quantities. Despite having a reported atmospheric 
boiling point of 115–116 °C, alcohol 22 seemed too volatile to be concentrated under 
reduced pressure (~20 mmHg). It was also found to form an azeotrope with diethyl 
ether at atmospheric pressure. Additionally, the distilled alcohol was often contaminated 
with an isopinocampheol by-product from the allylation reaction. Though separable by 
flash column chromatography from by-products, alcohol 22 co-evaporated with the 
eluant (1:4, diethyl ether–pentanes). Thus a commercial source of alcohol (R)-22 was 
obtained. 
 
4.3 Summary of Chapter Four 
 
The racemate of alcohol 118 was successfully prepared in three steps from acetone with 
41% overall yield. The asymmetric reduction of ketophosphonate 144 catalysed by (R)-
methyl-CBS-oxazaborolidine provided alcohol (S)-118 with an estimated ee of between 
47 – 73%, based on Mosher’s ester analysis. After re-evaluation of the HWE route, the 
synthesis of alcohol (S)-118 was abandoned in favour of (R)-4-penten-2-ol (22). 
After much experimentation, the synthesis of (R)-4-penten-2-ol (22) was also 
abandoned in favour of purchasing it from Sigma-Aldrich. The racemate of alcohol 22 
was also purchased from Merck and used whilst waiting for delivery of alcohol (R)-22. 
Thus, the C8′–C11′ segment of Am D was obtained from a commercially available 
reagent with known enantiomeric purity (95%). 
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Chapter Five: 
Piecing Together Aigialomycin D 
 
5.1 Investigation of a HWE Reaction for Installation 
of the C1′-C2′ Bond 
 
The first proposed route to Am D relied on the use of the Horner-Wadsworth-Emmons 
(HWE) reaction for the installation of the two (E)-olefins present in Am D (Scheme 5–
1). The reaction of phosphonate 142 with protected hemiacetal 287 could provide the 
conjugated C1′–C2′ olefin of Am D. In like manner, derived aldehyde 288 could be 
reacted with phosphonate 118 to install the C7′–C8′ olefin. Macrolactonisation and 
global deprotection would ultimately deliver the natural product. It is noteworthy that 
Pan and co-workers34 successfully installed the two (E)-alkenes utilising another variant 
of the Wittig reaction, the Juliá-Kocienski olefination (Section 1.3.3.2).  
 
 
Scheme 5–1. Proposed HWE olefinations for the installation of the (E)-alkenes of Am 
D. 
 
Phosphonate 142 contains an ester group in the δ-position (Scheme 5–2). Once 
deprotonated, the electron density from the carbanion could flow through the aromatic 
system to the ester, contributing an additional resonance structure for the phosphonate 
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carbanion. This conjugation should help stabilise the phosphonate carbanion, increasing 
the acidity of benzylic hydrogens. 
 
 
Scheme 5–2. Generic HWE reaction of δ-keto phosphonate 142 with an aldehyde.  
 
Similar HWE methodology was employed by Taylor and co-workers in the synthesis of 
the epoxide-containing macrolactone nucleus of oximidine I (Scheme 5–3).137 In this 
synthesis, the aryl phosphonate involved in the HWE reaction was a derived ortho-
toluenic acid.  
 
 
 
Scheme 5–3. Utility of the HWE reaction in the synthesis of an oximidine I analogue by 
Taylor. 
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5.1.1      HWE Reactions With Simplified Model Phosphonates 
 
Initial investigations into the utility of the HWE reaction for the installation of the 
conjugated alkene of Am D focused on the reaction between the model phosphonates 
210 and 211 and the straight-chain aldehydes butanal (76) and octanal (289) (Scheme 5-
3, Table 5–1). A solution (THF, Et2O or toluene) of the phosphonate at a set 
temperature (-78 °C, 0 °C or rt) was first treated with a base (t-BuOK, NaH, LiHMDS, 
or K2CO3). After addition of the base, the solution typically turned bright orange, 
suggesting that deprotonation had occurred. The addition of the freshly distilled 
aldehyde to this solution caused fading of the colour, although a pale yellow colour 
would typically persist even after quenching with saturated ammonium chloride 
solution (sat. NH4Cl (aq)). These reactions produced very little of the desired substituted 
styrenes 290a/b and 291a/b (0 – 30%). The major products of the reactions (21 – 69%) 
were very polar compounds, which were found in the aqueous layer after washing the 
crude reaction mixture with 2M sodium hydroxide solution.  
 
 
Table 5–1. HWE reactions of phosphonates 210 and 211 with butanal (76) and octanal 
(289). 
Yield 
Phosphonate Aldehyde Solvent Base 
Reaction 
Temp.   
(° C)a SM 290a/b 291a/b 292 293
210 octanal THF LiHMDS (1 eq) 0 15 - 30 - 28 
210 octanal ether LiHMDS (1 eq) -78  - 7 - 55 
210 octanal THF LiHMDS (1 eq) -78  -  - 69 
210 octanal toluene LiHMDS (1 eq) -78 22 - 9 - 33 
210 octanal THF K2CO3 (2 eq) rt 100 -  -  
210 butanal ether LiHMDS (1.1 eq) -78 14  - 29 - 
210 butanal toluene LiHMDS (1.2 eq) -78 18 20 - 21 - 
211 butanal THF NaH (1 eq) -78  20 -  - 
211 butanal neat MeONa (2 eq) 0 100  -  - 
294 butanal THF LiHMDS (2.2 eq) -78 100  -  - 
a The reactions were allowed to warm to room temperature (rt) after two hours stirring at the stated 
reaction temperature.  
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A signal characteristic of an olefinic proton was visible at ~6.7 ppm in the 1H NMR 
spectrum of these polar compounds (Figure 5–2). This one-proton doublet of triplets 
(JHX = 23.1, 7.3 Hz) did not exhibit coupling to any peaks in the characteristic 
unsaturated region (4.5–7.5 ppm)206 suggesting that the benzylic carbon has two non-
hydrogen substituents. Indeed, the large coupling constant (JHP = 23.1 Hz) is typical of 
the proton–phosphorus coupling (1H–31P coupling) between diethyl phosphonates in a 
cis-relationship with a hydrogen across a double bond.207,208 Kobayashi and William 
utilised the characteristic coupling constants between vicinal hydrogen and phosphorous 
atoms to assign the stereochemistry of a series of α-arylalkenylphosphonates they had 
synthesised (Figure 5–1).209 Thus it is highly probable that the by-products also contain 
a phosphonate group trans to the aliphatic chain from the aldehyde. The protons 
coupling to the peak at ~6.7 ppm in the gCOSY spectrum are complex signals in the 
aliphatic region (1.99 – 1.82 ppm). The ethyl signals from the phosphonate esters are 
still visible but the methyl ester peak is no longer present in the spectrum (Figure 5–2). 
Further detailed analysis of the NMR spectral data supported the assignment of the 
structures as alkenylphosphonates 292 and 293 (Figure 5–2). Assignment of this 
structure was further supported by the high resolution mass spectrum (HRMS) of 
compound 292, which contained a peak corresponding to the sodium ion of this 
structure. 
 
 
Figure 5–1. Diagnostic 31P–1H coupling in diethyl (E)-1-phenyl-1-
heptenylphosphonate, diethyl (Z)-1-phenyl-1-heptenylphosphonate209 and 
alkenylphosphonates 292 and 293. 
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Figure 5–2. The 1H and gCOSY NMR spectra of alkenylphosphonate 293. 
 
The proposed mechanism for the formation of alkenylphosphonates 292 and 293 is 
shown in Scheme 5–4.  The deprotonated phosphonate attacks the carbonyl of the 
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aldehyde as in the usual HWE mechanism. The reaction then deviates from the desired 
mechanism with the resulting alkoxide 295 attacking the methyl ester that resides in 
close proximity. This forms a δ-lactone (296) rather than the standard oxaphosphetane 
intermediate. The released methoxide likely causes the elimination that forms the ring-
opened carboxylate, which would be protonated upon quenching with sat. NH4Cl (aq).  
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Scheme 5–4. Proposed mechanism for the unexpected formation of 
alkenylphosphonates 292 and 293. 
 
When aldehydes 76 and 289 were exchanged for pivaldehyde, the HWE reaction 
proceeded to give benzylic (E)-alkene (297) in excellent yield (Scheme 5–5). It is 
postulated that the extra steric bulk of the tert-butyl group does not allow the alkoxide 
to adopt the conformation required to form the lactone and the usual HWE product is 
formed. The added steric bulk might also enhance the rate of the irreversible elimination 
of the usual HWE mechanism to alleviate the unfavoured steric interactions.  
 
 
Scheme 5–5. HWE reaction between phosphonate 210 and pivaldehyde. 
 
Eicher et al. have reported the successful HWE olefination between the phosphonate 
298 and benzaldehyde.78 However, our adaptation of Eicher’s reaction conditions to the 
reaction between phosphonate 210 and benzaldehyde failed to replicate their success 
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(Scheme 5–6). Unreacted phosponate and benzaldehyde were returned from the reaction 
mixture. 
 
 
Scheme 5–6. Attempted synthesis of stilbene 299. 
 
Several attempts were made to couple hemiacetal 122 and phosphonate 210 utilising the 
HWE reaction (Table 5–2). The expected product of the HWE reaction would be alkene 
300, which could also undergo attack by the free hydroxyl to give tetrahydropyran 301. 
However, neither of these products were observed or isolated from the reaction 
mixtures. Phosphonate 210 was recovered, while hemiacetal 122 was not. Hemiacetal 
122 may have been lost in the aqueous workup after base induced deacetylation to a 
water-soluble triol. 
 
Table 5–2. Attempted HWE reactions between model phosphonate 210 and hemiacetal 
122. 
 
Despite the limited success of HWE reactions of the simplified phosphonates 210 and 
211 with a range of aldehydes and hemiacetals, our investigation turned to HWE 
reactions involving phosphonates with various protection on the phenol groups at C2 
and C4 in order to determine whether these would provide more favourable results. 
Phosphonate Aldehyde Solvent Base Temperature (°C) Results 
210 122 THF t-BuOK (1.2 eq) 0 recovered 210 
210 122 THF t-BuOK (1.2 eq), 18Crown6 (1.2 eq) 0 recovered 210 
210 122 THF NaH (2 eq) 0 recovered 210 
210 122 THF LiHMDS (1 eq) 0 recovered 210 
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5.1.2  HWE Reactions with Phosphonate 142 
 
The HWE reaction of phosphonate 142 with butanal gave four partially or fully 
deacetylated compounds (Scheme 5–7). Alkene 304 and phosphonate 303 both retained 
an acetate group, as evidenced by three-proton singlets at 2.26 ppm in their 1H NMR 
spectra. Alkene 304 was isolated alongside alkene 302 giving a combined yield of 38% 
for the (E)-alkenes. Interestingly, no product analogous to alkenylphosphonates 292 or 
293 was isolated from this reaction. The oxygens in the real system may increase the 
electron density on the aromatic ring sufficiently to decrease the rate of lactonisation 
(viz. Scheme 5–4), thus circumventing the production of unwanted alkenylphophonates 
and promoting the usual HWE mechanism. 
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Scheme 5–7. HWE reaction between phosphonate 142 and butanal (76).  
 
The HWE reactions between phosphonates 142 and 228 and hemiacetals 122 and 152 
were explored over a range of reaction conditions (Table 5–3). However, no conditions 
were found to provide the desired conjugated alkene 305 or its ring-closed product 306. 
Deprotection of the phenolic groups of phosphonates 142 and 228 was observed and 
deprotection of hemiacetals 122 and 152 was inferred from the poor recovery of these 
starting materials after aqueous work-up.  
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Table 5–3. Summary of HWE reactions between phosphonates 142 and 228 and 
hemiacetals 122 and 152. 
 
Phosphonate Hemiacetal Base Solvent Reaction Temperature Results 
142 122 LiHMDS (2 eq) THF 0 °C No product 
142 152 NaOMe (3 eq) MeOH rt No product 
142 152 t-BuOK (2 eq) THF 0 °C to rt No product 
142 152 NaOMe  (3 eq) DMF 0 °C to 80 °C No product 
228 152 LDA (1.2 eq) THF -78 °C to rt No product 
228 152 NaOMe (3 eq) Toluene rt No product 
228 152 NEt3, LiBr (1.1 eq) THF rt No product 
228 152 NaOMe (2 eq) DMF 0 °C to rt No product 
 
 
The failure of hemiacetal 122 to participate in an HWE reaction might be due to the 
lability of the acetate protecting groups. Base-induced cleavage of the two acetate 
protecting groups would give a triol which is likely to have poor solubility in most of 
the solvents examined. Acetonide 152, however, should not suffer concomitant 
deprotection under the basic reaction conditions. Indeed, when acetonide 152 was 
reacted with triethyl phosphonoacetate, the homologated product 307 was isolated 
(Scheme 5–8). Pyran 307 presumably forms by the internal conjugate addition of the 
alkoxide upon the newly formed double bond. The successful coupling of hemiacetal 
152 in this HWE reaction suggested that, in the above reactions, the 
arylmethylphosphonates 142 and 228 were the problematic substrates. Stabilisation of 
the deprotonated derivatives phosphonates 142 and 228 by conjugation through to the 
ester group (Scheme 5–2) is therefore likely to be less significant than originally 
postulated.  
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Scheme 5–8. HWE reaction between hemiacetal 152 and triethyl phosphonoacetate.  
 
After many failed attempts to utilise the aforementioned aromatic phosphonates in 
HWE reactions and the predominance of by-product formation, this route was 
abandoned in favour of the Ramberg-Bäcklund (RB) approach to Am D. Fortuitously, 
some of the intermediates synthesised for the HWE approach were useful for the RB 
route.  
 
 
5.2 Investigation of RB Reaction for Connecting the 
C1′-C2′ Bond 
 
As was discussed earlier (Chapter 3, Section 3.2), the RB route was to involve the same 
disconnections as the HWE route; that is through the C1′-C2′ and the C7′-C8′ olefins 
and the lactone. Thus, Am D would be synthesised from key intermediate 263, to which 
there were two possible paths (Figure 5–3). However, as described in Section 3.2.1, 
synthesis of iodide 168 was abandoned due to the problematic hydrolysis of the methyl 
glycoside, leaving the coupling between benzylic bromide 135 with thiol source 189 as 
the method of choice. Having observed the undesired formation of disulfide 190 when 
thioacetate 189 was deprotected (Section 3.2.2), focus turned to the in situ deprotection 
of thioacetate 189 for the coupling reaction with benzylic bromide 135. 
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Figure 5–3. Retrosynthetic analysis of Am D with focus on the RB reaction precursors.  
 
 
5.2.1  Preparation of RB Precursor 196 
 
Whilst developing mild and efficient routes to benzylic thiols from benzylic bromides, 
Han and Balakumar found that the treatment of 1.0 equivalent of benzyl bromide and 
1.2 equivalent of thioacetic acid with 2.2 equivalent of potassium carbonate in methanol 
afforded dibenzylsulfide as the major product (87%) (Scheme 5–9).196 Dibenzylsulfide 
was presumably formed via intermediate benzyl thioacetate.   
 
 
Scheme 5–9. The formation of dibenzylsulfide observed by Han and Balakumar.196 
 
Adaptation of Han’s method to the coupling of bromide 135 with thioacetate 189 
produced thioether 191 in excellent yield (86%) (Scheme 5–10). Although, concomitant 
deprotection of the phenolic acetates did occur in the reaction, no undesired 
etherification between aromatic units was observed. It is probable that the phenolic 
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groups have a low nucleophilicity towards the benzylic bromide due to the ester group 
withdrawing electron density. Disulfide 190 was also isolated as a minor by-product 
from the reaction.  
 
 
Scheme 5–10. Coupling of the aromatic and carbohydrate-derived fragments. 
 
Thioether 191 was successfully oxidised to sulfone 309 with meta-chloroperbenzoic 
acid (m-CPBA) without any epoxidation of the terminal alkene being observed (310) 
(Scheme 5–11). Thin layer chromatographic (TLC) analysis suggests that the oxidation 
proceeds sequentially, with oxidation to sulfoxide 308 before the second oxidation to 
sulfone 309. Interestingly, the sulfoxide 308 (Rf = 0.07, 2:1 hexanes/EtOAc) is more 
polar than the desired sulfone 309 (Rf = 0.26, 2:1 hexanes/EtOAc). This marked 
difference in polarity initially caused some confusion when following the reaction by 
TLC, resulting in the premature quenching of the reaction when the sulfoxide spot was 
assumed to be that of epoxide 310.  
Saponification of ester moiety 309 with KOH in methanol unfortunately led to 
decomposition of the material. The presence of the sulfone introduces acidic protons at 
the α and α′ positions. It is likely that basic conditions of the saponification could lead 
to deprotonation at these positions, and ultimately a variety of decomposition products.   
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Scheme 5–11. Oxidation and saponification of thioether 191. 
 
To avoid the undesirable reactivity associated with the sulfone group, the approach was 
modified and saponification was attempted prior to oxidation of the thioether. 
Treatment of thioether 191 with a hydroxide base in aqueous methanol or aqueous THF 
unexpectedly yielded a product with a Rf higher than the starting material (Rf = 0.21 vs. 
0.09, 2:1 hexanes/EtOAc) (Table 5–4, entries 1–3). The methyl ester signal in the 1H 
NMR spectrum of the product was notably absent. The aromatic signals had also 
changed to a two proton doublet and one proton triplet at 6.37 and 6.23 ppm 
respectively. The presence of three aromatic protons in the 1H NMR spectrum and 
absence of a carbonyl signal in the 13C NMR implied that thioether 191 had undergone a 
decarboxylative saponification to form compound 311. Different conditions were thus 
sought. Ester hydrolysis with ethanthiolate returned starting material when used with n-
butyllithium (entry 4) and a mixture of starting material and decarboxylated product 
when the base was sodium hydride (entry 5). Decarboxylation in the latter case might 
result from the traces of sodium hydroxide often present in sodium hydride. Attempted 
saponification of methyl ester 191 with ethanolic barium hydroxide resulted in the 
decomposition of the starting material (enty 6). 
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Table 5–4. Summary of attempted hydrolyses of methyl ester 191.  
Yield Entry Reagent Solvent Reaction temperature
Reaction 
time (h) SM 194 311 
1 LiOH (4 eq) 1:1 THF/H2O 50 °C 12 5 a 0 23 a 
2 LiOH (4 eq) 2:1 MeOH/H2O 50 °C 6 64 b 0 36 b 
3 NaOH (4 eq) 2:1 MeOH/H2O 50 °C 6 37 b 0 63 b 
4 EtSH (5 eq), n-BuLi (4.5 eq) THF -10 °C to rt 2 100
 b 0 0 b 
5 EtSH (5 eq), NaH (4.5 eq) DMF -10 °C to rt 12 20
 b 0 80 b 
6 Ba(OH)2 (3 eq) EtOH rt 18 decomposed 
 
a Isolated yield. b Relative yields are based on ratios in the 1H NMR spectrum of the crude product 
mixture. 
 
Aromatic esters with phenol groups located in positions ortho to the ester are known to 
undergo decarboxylation upon saponification.73,210,211 Pettigrew and Wilson exploited 
this property of alkyl ortho-hydroxybenzoates in their synthesis of xyloketal B 
analogues (Scheme 5–12).212 
 
 
Scheme 5–12. An example of decarboxylative saponification utilised in the synthesis of 
analogues of xyloketal B by Pettigrew and Wilson.212 
 
To avoid the unproductive expending of valuable intermediate 191 in the quest for 
suitable ester hydrolysis conditions, the ester hydrolysis of methyl orsellinate (74) was 
studied. Not unexpectedly, orsellinate 74 was found to also undergo decarboxylative 
saponification when treated with a hydroxide base in aqueous methanol (Table 5–5, 
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entries 1 and 2). The literature was then further examined for saponification procedures 
suitable for benzoic esters with ortho phenolic groups. Despite implementing the 
saponification and hydrolysis conditions that have been used successfully in the 
cleavage of other aromatic esters ortho to a phenol group, no conditions were found to 
be suitable for this particular system. All procedures returned varied ratios of starting 
material and the decarboxylated product, orcinol (312) (Table 5–5). Coutts and co-
workers described the mild ester hydrolysis benzoic esters with ortho amine and 
hydroxyl groups with pyridine hydrochloride (py.HCl) in refluxing pyridine.213 
Refluxing methyl benzoate 74 in either neat pyridine or pyridine hydrochloride in 
pyridine both returned mixtures of the starting material 74 and orcinol (312) (entry 7).   
 
 
Table 5–5. Summary of attempts to hydrolyse methyl orsellinate, 74.  
Yield (%) 
Entry Reagent Solvent Temperature
Reaction 
time SM 312 313 
1 KOH (5 eq) 1:1 MeOH/H2O reflux 12 h 0 a 82 a 0 a 
2 KOH (11 eq) 2:1 MeOH/H2O rt 4 days 68 b 32 b 0 b 
3 KOH (7 eq) 3:1 DMSO/H2O 80 °C 12 h decomposed 
4 NaOH (6 eq)214 1:1 dioxane/H2O rt 12 h 100
 b 0 b 0 b 
5 t-BuOK (6 eq)215 THF rt 6 days 74
 b 26 b 0 b 
6  pyridine (py)213 reflux 18 h 68 b 32 b 0 b 
7 py.HCl213 py reflux 12 h 43 b 57 b 0 b 
8  5:1 10% H2SO4(aq)/THF 
50 °C 4 h 100 b 0 b 0 b 
 
a Isolated yield; b relative yield based on 1H NMR spectrum of crude product mixture. 
 
The proposed mechanism for this decomposition is shown in Scheme 5–13. The 
deprotonated orsellinate 74a is attacked by a hydroxide ion, forming a carboxylic acid. 
The other tautomer of carboxylic acid 45 is diene 313a. Upon rotation of the carboxylic 
acid moiety, the compound would readily lose carbon dioxide and re-aromatise to give 
orcinol.This mechanism is supported by the fact that this type of decarboxylative 
saponification has only been observed in benzoates with ortho amine or hydroxyl 
groups.  
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Scheme 5–13. Proposed mechanism for the decarboxylative saponification of methyl 
orsellinate, 74.  
 
Chen and co-workers have shown that MOM protection of the phenolic hydroxyl 
groups on benzoate 74 (Scheme 1–11, Section 1.3.3.4) allows for the facile 
saponification of the methyl ester, providing the desired benzoic acid in quantitative 
yields.35 Consequently, ester 191 was protected as the bis-MOM ether 192 in good yield 
(Scheme 5–14). Subjection of this compound to saponification with potassium 
hydroxide in 1:1 MeOH/H2O, gratifyingly afforded desired benzoic acid 193 in near 
quantitative yield. The workup procedure for this reaction involved acidifying the 
reaction mixture to pH 6 with 50% AcOH(aq) prior to extraction with EtOAc. Washing 
the crude organic extract with enough water to remove excess AcOH was found to be 
extremely important. If AcOH remained in organic phase when the solvent was 
concentrated, the acid cleaved the MOM-groups from 193.  
 
 
Scheme 5–14. Preparation of benzoic acid 193. 
 
The sequence of reactions that are described below were all first carried out with 
racemic alcohol (±)-22 whilst waiting for delivery of (R)-22 from the supplier. To avoid 
redundancy, only discussion of the enantiopure synthesis of Am D is included below. 
The procedure that Chen and co-workers used for the Mitsunobu reaction in their 
synthesis of Am D involved the addition of diisopropyl azodicarboxylate (DIAD) to a 
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THF solution of the benzoic acid, (R)-4-penten-2-ol (22) and triphenylphosphine at 0 
°C.35 Adaption of Chen’s procedure to the coupling of the benzoic acid derivative 193 
and alcohol (R)-22 provided diene 167, albeit in a low 34% yield. However, when a 
THF solution of acid 193 was added to a premixed solution of triphenylphosphine, 
DIAD and alcohol (R)-22, the reaction proceeded to give the desired diene 167 in 94% 
yield (Scheme 5–15). Diene 167 contains the complete carbon framework of Am D, 
requiring a ring-closing metathesis (RCM) cyclisation and RB reaction to produce the 
14-membered ring of Am D. Oxidation of the thioether in 167 proceeded selectively 
without observable production of any epoxide by-product, affording the metathesis 
precursor, sulfone 195, in excellent yield.  
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Scheme 5–15. Synthesis of sulfone 195. 
 
Following recent reports on the utility of microwave-assisted (MW-assisted) RCM 
reactions to obtain products with high yield57-59 and stereoselectivity,35 a 0.005 M 
solution of diene 195 and 10 mol% of catalyst 28 in CH2Cl2 was subjected to MW 
irradiation, heating the solution to 75 °C for 30 minutes (Scheme 5–16). The (E)-alkene 
of macrocycle 196 was the sole product in 86% yield, as evidenced by the 15 Hz 
coupling constant present in the two olefinic signals at 5.71 ppm and 5.55 ppm 
respectively. In an attempt to compare the MW-assisted RCM reaction with standard 
thermal RCM reactions, 0.005 M solutions of diene 195 in CH2Cl2 or toluene with 10 
mol% of catalyst 28 were heated to reflux and 80 °C respectively, for 12 hours. 
Surprisingly, no product was observed for either reaction. The RCM reaction in toluene 
was expected to yield macrocycle 196 as this procedure has been successfully used by 
 119
Chen35 and Winssinger9 in their syntheses of Am D. However, since the MW-assisted 
RCM procedure was working well, the thermal RCM reactions were not repeated.   
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Scheme 5–16. The MW-assisted RCM reaction of diene 195, yielding RB reaction 
precursor 196.  
 
The macrocycle of Am D was now complete, and work could begin on the RB reaction 
to produce the C1′–C2′ olefin. 
 
5.2.2      Preliminary Trials of the RB Reaction  
 
To identify suitable RB reaction conditions for the installation of the C1′–C2′ (E)-olefin 
in Am D, sulfone 316 was studied as a simplified model of sulfone 196. Sulfone 316 
was prepared from benzyl mercaptan (314) in two steps with excellent yield (Scheme 5–
18). Thus, thioether 315, itself obtained from the coupling of 1-bromopetane and benzyl 
mercaptan, was oxidised to sulfone 316 by treatment with sodium perborate in acetic 
acid.117  
 
 
Scheme 5–17. Preparation of model sulfone 316. 
 
There are two general approaches reported in the literature to utilising the RB reaction 
in synthesis (see Section 1.4.3.5). In one approach, the α-halogenated sulfone 
intermediate can be isolated and subsequently treated with a base to form the desired 
alkene over two discrete steps using classical methodology.115 Alternatively one-pot 
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methods have been developed that involve in situ α-halogenation immediately prior to 
the RB reaction. The two common examples of such one-pot systems are the Meyers123 
and Chan124 modifications of the RB reaction (Scheme 5–18).  
 
 
Scheme 5–18. The two common one-pot modifications of the RB reaction.   
 
In the first instance, the classical two-step methodology was employed. Attempts to 
prepare and isolate α-chloro or α-bromo derivatives of sulfone 316 using succinimide 
reagents were unsuccessful (Table 5–6, entries 1 and 2). Starting material was returned 
in both instances. Focus therefore turned to the one-pot systems. Chan’s modification of 
the RB reaction replaced carbon tetrachloride (CCl4), which was used as the halogen 
source for the in situ halogenation in Meyers’ modification, for 
dibromodifluoromethane (CF2Br2), as the latter was shown to avoid formation of by-
products commonly produced in Meyers’ method.124 Unfortunately, the import of 
CF2Br2 into New Zealand is banned due to its potential as an ozone depleter. Chan’s 
other modification to Meyers’ method was changing the form of the base from 
powdered potassium hydroxide (KOH) to alumina-loaded KOH (KOH–Al2O3). This 
was suggested to improve the reaction by increasing the surface area of the base.124 
KOH–Al2O3 was easily prepared and substituted as the base in Meyers’ modification of 
the RB reaction (entries 3 and 4). This modification to Meyers’ method gave a 51% 
conversion of the sulfone (entry 3). Unfortunately alkene 318 was inseparable from 
other by-products. The yields could be estimated by analysis of the integration of the 
olefinic protons in the 1H NMR spectra. Alkene 318 could be differentiated from the 
other products in the 1H NMR spectra as it was the only compound that contained two 
olefinic protons. Thus, alkene 318 was produced in 20% yield (estimated by 1H NMR) 
along with a mix of the other unidentified by-products. Increasing the temperature of the 
reaction failed to improve the conversion of the starting material, although the relative 
yield of alkene 318 improved (entry 4). An attempt was next made to use the more 
environmentally friendly NBS as the halogen source (entry 5). However, the conversion 
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was significantly lower, returning 78% starting sulfone. Completely changing the 
system to the use of an organic base (DBU) in DMF resulted in no reaction (entry 6). 
Meyers’ original method, in fact, gave the best result, with a 75% conversion, including 
45% yield of the desired alkene 318 (entry 7).  
 
Table 5–6. Investigation into the RB reactions of sulfone 316.a 
Yieldb 
Entry Reagent(s) Solvent(s) 318 319, 321 320, 322 SM 
1 NCS CCl4   100 
2 NBS CH2Cl2   100 
3 CCl4, KOH–Al2O3 t-BuOH 20 31 49 
4c CCl4, KOH–Al2O3 t-BuOH 30 20 49 
5 NBS, KOH–Al2O3 t-BuOH/CH2Cl2 16 6 78 
6 NBS, DBU DMF   100 
7 CCl4, KOH, H2O t-BuOH 45 30 25 
 
a reactions were stirred at rt for 2 h unless otherwise noted. b estimated from 1H NMR of crude products.  
c reaction heated to 40 °C.  
 
 
5.2.3  Use of RB Reaction in the Synthesis of Am D. 
 
Although the problems with incomplete conversion and side reactions were not fully 
overcome, Meyers’ method was implemented in the RB reaction of macrocyclic sulfone 
196. The constrained cyclic structure of sulfone 196 is likely to influence the reactivity 
in ways unexamined in the simple straight-chain model, 316. 
Sulfone 196 was found to be only sparingly soluble in tert-butanol (t-BuOH) and 
required the addition of dichloromethane to dissolve the material (Scheme 5–19). 
Addition of freshly powdered KOH resulted in the formation of a pale yellow solution. 
The immediate addition of CCl4 to the suspension was followed with visible evolution 
of sulfur dioxide. The reaction was warmed to 35 °C and was deemed complete by TLC 
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analysis after 30 minutes. The 1H NMR spectrum provided evidence that only one 
stereoisomer was formed in this reaction, with the two sets of olefinic signals present in 
the spectrum all containing coupling constants of ~15 Hz. Gratifyingly, the 1H NMR 
spectrum was found to be identical to those reported by Danishefsky33 and Chen.35 
 
 
Scheme 5–19. The use of Meyers’ modification of the Ramberg-Bäcklund reaction in 
the preparation of protected Am D 35.  
 
The stereoselectivity of the RB reaction in cyclic systems can be justified by an 
investigation by MaGee and Beck who carried out RB reactions and recorded the 
stereoselectivities on a series of sulfonated azacycles. The RB reaction under Chan’s 
conditions (i., Table 5–7) gave the cis-7 and 8-membered rings as the sole products (i. 
entries 1 and 2). However, as the ring size increased, the formation of the trans-cycles 
predominated with a Z/E ratio ranging from 40:60 for the 10-membered azacycle (i. 
entry 4) to 15:85 for the 12-membered azacycle (i. entry 6). The trans-stereoselectivity 
in the larger rings is much more pronounced in the classical RB reactions of the 
corresponding pre-formed α-chlorosulfones (ii., Table 5–7). As with Chan’s 
modification, cis-7 and 8-membered rings were the sole products of the reaction 
between t-BuOK and the corresponding α-chlorosulfones (ii. entries 1 and 2). Beyond 
these first two cases, the RB reaction produced the azacycles with Z/E ratios of at least 
6:94 for ring sizes of 9 to 13 members (ii. entries 3 – 7). Cyclic systems were thus found 
to behave differently to comparable acyclic systems for which the cis-olefin 
predominates in most cases.122,125,126 In attempt to explain this observed 
stereoselectivity, MaGee suggested that significantly greater transannular interactions 
are encountered when α-chlorosulfones attempt to adopt the conformation required for 
the formation of cis-episulfones than those experienced in the formation of trans-
episulfones. The enhanced Z/E selectivity observed in the classic RB versus Chan’s 
modification is also likely to be influenced by the differences in reactivity between α-
chloro and α-bromo sulfones. The stereoselective formation of the C1′–C2′ olefin of bis-
MOM 35 is consistent with MaGee’s findings. 
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Table 5–7. Use of the RB reaction in the stereoselective synthesis of Boc-protected 
azacycles by MaGee and Beck.216  
 
Z:E (Yield) 
Entry m n i. a ii. 
1 2 2 100:0 (63) 100:0 (66) 
2 3 2 100:0 (33) 100:0 (41) 
3 3 3 35:65 (59) 6:94 (100) 
4 4 3 40:60 (67) 5:95 (54) 
5 4 4 27:73 (68) 2:98 (97) 
6 5 4 15:85 (62) 1:99 (76) 
7 5 5 39:61 (53) 6:94 (93) 
a over 2 steps from the sulfide 
 
The formal total synthesis of Am D was thus complete. Global deprotection of bis-
MOM 35 was achieved by stirring in methanolic hydrochloric acid for 3 days, providing 
the natural product in good yield (Scheme 5–20). The total synthesis of Am D was 
completed in 16 steps from D-ribose in 9% overall yield. The 1H and 13C NMR data of 
this synthetic Am D matched those of the natural product (Table 5–8, 5–9).8,9,33,35 
 
 
Scheme 5–20. The acidic global deprotection of protected 35 to reveal the natural 
product Am D (1).  
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Table 5–8. 1H NMR Data of Aigialomycin D. 
Position Isolated Am D Danishefsky's Synthetic Am D RB-route 
3 6.27 (d, 2.4) 6.28 (d, 2.3) 6.28 (d, 2.0) 
5 6.52 (d, 2.4) 6.53 (d, 2.3) 6.53 (d, 2.0) 
1' 7.14 (d, 15.9) 7.16 (d, 15.9) 7.15 (d, 15.9) 
2' 6.09 (ddd, 15.9, 5.6, 5.4) 6.10 (ddd, 15.9, 5.7, 5.5) 6.09 (ddd, 15.9, 5.7, 5.5) 
3' 2.31-2.34 (m) 2.32-2.36 (m) 2.32-2.36 (m) 
 2.31-2.34 (m) 2.32-2.36 (m) 2.32-2.36 (m) 
4' 2.14 (m) 2.14 (m) 2.14 (m) 
 1.58 (m) 1.58-1.61 (m) 1.59 (m) 
5' 3.62 (m) 3.64 (m) 3.63 (m) 
6' 4.35 (brd 4.3) 4.35 (brd 4.1) 4.35 (brd, 4.1) 
7' 5.68 (dd, 15.7, 5.0) 5.69 (dd, 15.6, 5.1) 5.69 (ddt, 15.6, 5.2, 1.2) 
8' 5.87 (tdd, 15.7, 7.3, 1.2) 5.87 (tdd, 15.6, 7.4, 1.4) 5.88 (tdd, 15.6, 7.4, 1.6) 
9' 2.55 (ddd, 14.6, 7.5, 3.2) 2.55 (ddd, 14.5, 7.3, 3.1) 2.57 (ddd, 14.6, 7.4, 3.1) 
 2.42 (m) 2.43-2.46 (m) 2.43 (m) 
10' 5.42 (m) 5.41-5.47 (m) 5.44 (m) 
10'-CH3 1.38 (d, 6.4) 1.39 (d, 6.4) 1.37 (d, 6.4) 
2-OH 11.65 (s) 11.7 (s) 11.66 (s) 
4-OH 9.5 (brs) 9.1 (brs) 9.25 (brs) 
5'-OH not detected 3.56 (brs) 3.20 (brs) 
6'-OH not detected 3.76 (brs) 3.82 (brs) 
 
Table 5–9. 13C NMR Data of Aigialomycin D. 
Position Isolated Am D Danishefsky's synthetic Am D RB-route 
1 104.3 104.3 104.4 
2 165.5 166.0 165.8 
3 102.4 102.6 102.5 
4 163.1 163.2 163.1 
5 107.7 107.9 107.8 
6 144.2 144.5 144.3 
1' 130.6 130.8 130.6 
2' 133.6 133.8 133.6 
3' 27.9 28.1 28.0 
4' 28.5 28.8 28.5 
5' 73.1 73.1 73.0 
6' 76.4 76.7 76.5 
7' 135.6 135.9 135.7 
8' 125.4 125.6 125.4 
9' 37.9 38.1 37.9 
10' 72.9 73.1 73.0 
-COO- 172.1 172.3 172.2 
10'-CH3 19.1 19.2 19.1 
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5.3 Summary of Chapter Five 
 
Aigialomycin D was successfully synthesised from D-ribose in 16 steps with 9% overall 
yield. Our route proved to be more efficient than the original total synthesis by 
Danishefsky (18 steps, 8% yield), Pan’s synthesis (18 steps, 2.5% yield), and 
Montgomery’s synthesis (8 steps, 7% yield). 
Many unsuccessful attempts were made to couple the various aromatic phosphonate and 
carbohydrate-derived hemiacetal substrates utilising the HWE reaction. Success in 
coupling phosphonates and simple aldehydes was limited, affording the benzylic olefins 
in low yields (0–38%). The HWE reaction between simplified phosphonate 210 and 
pivaldehyde was the sole exception, giving the desired product in 88% yield. 
The aromatic and C2′–C7′ segments were readily coupled via a thioether linkage. 
Saponification of the unprotected thioether 191 resulted in undesired decarboxylation. 
Protecting the phenolic hydroxyls as MOM ethers allowed the saponifcation to proceed 
with near quantitative yields. The Mitsunobu reaction of acid 193 with alcohol (R)-22 
completed the carbon backbone of Am D. Oxidation to sulfone 195 prior to the 
stereoselective MW-assisted RCM of the diene precursor facilitated the successful 
installation of the C7′–C8′ (E)-olefin present in Am D. The Ramberg-Bäcklund reaction 
provided the bis-MOM protected 35 in excellent yield and stereoselectivity. Global 
deprotection under acidic conditions provided the natural product from D-ribose in 16 
steps and 9% overall yield. 
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Chapter Six: 
Synthesis of Am D Analogues and Biological Evaluation 
 
6.1 Synthesis of Am D Analogues 
 
After the successful synthesis of Am D via the Ramberg-Bäcklund route (Chapter 5, 
Section 5.2), focus turned to the synthesis of Am D analogues. Analogues of bioactive 
compounds are commonly used to help probe the molecular source of the observed 
biological activity through examination of their structure-activity relationships. 
Modification of functional groups that results in a significant change of the particular 
activity of interest highlights the biologically important regions or groups. Likewise, 
changes that result in no observable change in activity highlight areas that are most 
likely not involved in eliciting the biological response. Analogues that simplify the 
required synthetic chemistry whilst retaining or improving the natural product’s level of 
bioactivity are the prized end goals of analogue synthesis. 
 
Three considerations guided the design of Am D analogues that would be synthesised in 
this project. Firstly, the proposed analogues should explore modifications to the key 
functional groups of Am D, i.e. the (E)-alkenes, cis-diol, aromatic ring and phenolic 
groups. These groups are the parts of the molecule that are most likely to be interacting 
with the biological target. Modifications that generate products which interpolate 
between Am D and other resorcylic acid lactones are also of interest. Such 
modifications include the epoxidation of the (E)-alkene(s), methylation of the 4-
hydroxyl group, oxidation of the C6′-hydroxyl group, and inversion of the C11′ methyl 
group. Finally, the ability to access analogues from existing synthetic intermediates is 
desirable, avoiding the arduous task of engineering new routes. 
 
Thus, to investigate the importance of the two (E)-alkenes in Am D, tetrahydro-
aigialomycin D (209) was prepared in two steps from the protected form of Am D 35 
(Scheme 6-1). Palladium-catalysed hydrogenation reduced the olefins to give the 
saturated macrocycle 324. Global deprotection under acidic conditions afforded 
saturated diol 209 in 89% yield over two steps. Saturation of the two alkene bonds 
should greatly increase the conformational freedom of the macrocycle, which in turn 
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may impart a different mode of biological activity than that exhibited by the natural 
product. Tetrahydro-aigialomycin D (209) is a C5′ hydroxy analogue of the fungal 
metabolite β-zearalanol135 and therefore might exhibit similar anabolic properties. 
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Scheme 6–1. Synthesis of the saturated analogue 209 of Am D. 
 
The potent Hsp90 inhibitors radicicol and pochonin D both contain a chlorine atom 
substituted at C5 on their aromatic rings. An attempt was made to chlorinate the C5 
position of protected Am D 35 (Scheme 6–2) following the procedure Blagg and co-
workers developed for the chlorination of related compounds.132 However, no reaction 
occurred and the starting material was recovered.   
 
 
Scheme 6–2. Attempted synthesis of the 5-chloro analogue of Am D. 
 
The sulfone-containing 15-membered macrolactone 325 (Scheme 6–3), derived from 
the RB precursor 196, is an interesting analogue of Am D, containing the C7′–C8′ olefin 
present in Am D but with a sulfone moiety instead of the C1′–C2′ olefin. Sulfone 325 
was readily prepared by deprotecting the RB precursor 196 under acidic conditions. It 
too may have a different mode of activity to Am D, due to the larger ring size enabling 
the compound to adopt different conformations than those of the natural product.  
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Scheme 6–3. Synthesis of the sulfone 15-membered macrolactone 325 analogue of Am 
D. 
 
Significant progress was made towards the synthesis of the C10′-epimer of Am D (203) 
(Scheme 6–4). To access the non-natural C10′ configuration in compound 167, an 
esterification protocol with N,N'-dicyclohexylcarbodiimide (DCC) and 4-
dimethylaminopyridine (DMAP) was used to couple acid 193 and alcohol (R)-22. Ester 
10'-epi-167 was obtained in relatively low yield (32%) compared to the esterification 
achieved under the Mitsunobu conditions utilised in the synthesis of the natural product 
(90 – 94%). The subsequent oxidation and RCM steps proceeded efficiently to give RB 
precursor 10'-epi-196. The RB reaction provided protected 10'-epi-35 alongside small 
amounts of impurities. Initial attempts to purify the product by flash column 
chromatography failed to afford pure 10'-epi-35. Due to time constraints the synthesis of 
10'-epi-Am D (203) was not completed. Once purified, the deprotection of protected 
10'-epi-35 should pose few difficulties.  
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Scheme 6–4. Progress towards the synthesis of 10'-epi-Am D (203). 
 
The 2,4-dideoxy analogue of Am D, 204, was synthesised in order to investigate the 
importance of the phenolic hydroxyl groups to the activity of Am D. These groups are 
likely to be involved in important hydrogen bonds to amino acid residues inside the 
binding site of Am D’s molecular target.132 Macrocycle 204 was readily prepared 
following the chemistry previously developed for the synthesis of Am D as discussed in 
the previous chapter (Scheme 6–5). Thus, bromide 210 was synthesised as described in 
Section 2.1. This was reacted with thioacetate 189 to produce thioether 326. Complete 
separation of thioether 326 from the by-product disulfide 190 with flash column 
chromatography was not easily achieved. However, this by-product was easily removed 
after saponification by extraction with Et2O prior to acidification. The remaining steps 
proceeded with similar yields to those obtained for the natural product, affording the 
2,4-dideoxy analogue 204 in 7 steps from bromide 210 with an overall yield of 33%. 
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Scheme 6–5. Synthesis of the 2,4-dideoxy analogue 204 of Am D. 
 
 
 
6.2 Biological Testing of Am D (1), Tetrahydro-Am D 209 and 
Sulfone 325  
 
Am D (1) and analogues 209 and 325 were tested for cytotoxicity against the cell line 
HL-60 (Human promyelocytic leukemia cells) with 48 hour MTT assays217 at the Centre 
for Biodiscovery laboratories in the School of Biological Sciences by Reem Hanna 
(Figure 6–1). Unfortunately, 2,4-dideoxy analogue 204 had degraded to a complex 
mixture of unidentified compounds before samples were submitted for biological 
testing. Am D was the most active compound, exhibiting an IC50 of 12.5 µM. Thus, the 
cytotoxicity of Am D for HL-60 cells was the same order of magnitude to that reported 
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for KB and Vero cells. Sulfone 325 and tetrahydro-aigialomycin D (209) exhibited 
similar magnitudes of activity, with an IC50 of 14.3 and 19.7 μM respectively. Sulfone 
325 and tetrahydro-Am D 209 are likely to exist in a wider range of conformations than 
Am D due to the removal of sp2 centres that reduce the flexibility of compounds. The 
fact that these three compounds have similar levels of cytotoxicity suggests that either 
they are able to exist in the same conformation as target-bound Am D or that these 
compounds are interacting with different targets to give their observed activity.  
 
Am D (1)                                                   Tetrahydro-aigialomycin D (209) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Sulfone 325 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6–1. Graphs showing inhibition of cell growth as a function of concentration of 
Am D (1), tetrahydro-Am D (209) and sulfone analogue (325). 
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6.2 Summary of Chapter Six 
 
Three analogues of Am D have been synthesised to investigate the importance of the 
double bonds and phenolic hydroxyl groups in the activity of Am D. Both sulfone 325 
and tetrahydro-Am D (209) exhibited a similar degree of cytotoxicity towards HL-60 
cells to that of Am D (12.5 μM), with IC50’s 14.3 and 19.7 μM. Unfortunately, the 2,4-
dideoxy analogue 204 had decomposed before a sample was submitted for biological 
testing. Attempts were made to prepare the 5-chloro analogue of Am D and 10′-epi-Am 
D, but due to time constraints these syntheses were not completed. 
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Chapter Seven: 
Future Work and Conclusions 
 
7.1  Future Work 
 
One goal of this research project was to synthesise a range of Am D analogues to gain 
further insight into the structure activity relationship inherent to Am D. While the 
synthesis of three analogues was described in this work, there is plenty of scope to 
develop other interesting analogues. These may include analogues with epoxide 
functionality in place of one or both of the alkenes, as present in radicicol (2)13 and 
some members of the pochonin family,30 such as epoxide 332 (Figure 7–1). Selective 
oxidation of the allylic alcohol at C6′ would introduce enone functionality that is 
present in several other resorcylic acid lactones (RALs), for example hypothemycin (4) 
(Figure 7–1). These RALs contain C8′ to C6′ cis-enones whereas Am D analogue 333 
would contain a trans-enone. 
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Figure 7–1. Proposed Am D analogues 332 and 333 that contain functional groups 
present in radicicol and hypothemycin. 
 
The complete set of stereochemical arrangements possible for the diol at C5′ and C6′ 
could be accessed by starting with different sugars as such D-xylose, D-arabinose or D-
lyxose (Figure 7–2). Montgomery36 and Jennings38 have both synthesised the 6′-epimer 
of Am D, which could also be prepared from D-xylose using the methodology described 
in this work. However, the 5′- and 5′,6′-epimers of Am D are yet to be synthesised. 
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Figure 7–2. The range of stereochemistries accessible for the C5′–C6′ diol of Am D 
when starting from D-ribose, D-arabinose, D-xylose or D-lyxose. 
 
Finishing the synthesis of 10′-epi-Am D 203 should be rather straightforward. 10′-epi-
Am D 203 should also be amenable to the late stage modifications that have been 
undertaken or proposed on Am D, such as hydrogenation and epoxidation.  
 
Figure 7–3. Structure of 10′-epi-Am D 203. 
 
After expanding the library of Am D analogues, these compounds will need to be tested 
alongside Am D in a variety of biological assays, similar to those reported in Chapter 6. 
The data collected from this testing will help to determine the parts of the molecule that 
are required to elicit the desired activity. These studies would also determine whether 
any of the modifications to Am D have tuned the bioactivity towards one particular 
activity, e.g. anti-cancer vs. anti-malarial activity, or even altered the biochemical 
target. 
 
Furthermore, a chemical genetics study218 could be undertaken to confirm whether the 
inhibition of kinases identified by Winssinger9 is the cause of the Am D’s cytotoxicty, 
and to identify other potential molecular targets of Am D. This study will be undertaken 
at the School of Biological Sciences at Victoria University of Wellington.  
 
 135
7.2  Concluding Remarks 
 
The isolation and identification of aigialomycin D and its promising biology have 
resulted in a flurry of synthetic activity,7 culminating so far in several reported total 
syntheses of this intriguing target7,9,33-36 and a number of synthetic analogues.9,36,38  
 
Two synthetic strategies to Am D were investigated in this research project: a HWE 
strategy and a RB strategy. The three major segments were successfully synthesised for 
both approaches. However, the coupling between the aromatic and C2′–C7′ fragments 
through HWE reactions proved to be more challenging than anticipated. All attempts to 
couple arylmethyl phosphonates with protected hemiacetals failed to provide any olefin 
product. Studies of the HWE reactions between model aromatic phosphonates and 
simple aldehydes found that the model alkenes could be synthesised, albeit in low 
yields, but often accompanied by formation of alkenylphosphonate by-products.  
 
In contrast, the RB approach, which involved a combination of Mitsunobu, RCM and 
RB reactions allowed the assembly of the natural product with high yield and 
stereoselectivity. The RB reaction proved to be an excellent approach to ‘masking’ the 
benzylic olefin until late in the synthesis, thus avoiding any complications with the 
RCM reaction. Aigialomycin D was successfully synthesised from D-ribose in 16 steps 
with 9% overall yield. Our route proved to be more efficient than the original total 
synthesis by Danishefsky (18 steps, 8% yield), and the subsequent syntheses by Pan (18 
steps, 2.5% yield) and Montgomery (8 steps, 7% yield). This RB route was also shown 
to be flexible towards the synthesis of several new Am D analogues.  
 
The analogues sulfone 325 and tetrahydro-Am D 209 were successfully prepared from 
late-stage Am D intermediates. The RB route was shown to be flexible, resulting in the 
syntheses of 2,4-dideoxy analogue 204 and 10′-epi-35, the penultimate intermediate en 
route to analogue10′-epi-Am D 203. Preliminary biological testing revealed that sulfone 
325 and tetrahydro-Am D (209) exhibited a similar magnitude of cytotoxicity towards 
HL-60 cells with IC50’s of 14.3 and 19.7 μM, compared to that of Am D (12.5 μM). 
 
Thus, the major goals of this research project have been met. The RB route led to the 
successful total synthesis of natural product Am D and proved adaptable to synthesis of 
several new analogues. This project has laid the groundwork for the synthesis of many 
new Am D analogues.  
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Chapter Eight: 
Experimental 
 
8.1 General 
 
Unless otherwise stated, the following conditions apply. All reactions were performed 
under argon in oven-dried or flame-dried glassware using dry solvents and standard 
syringe techniques. Diethyl ether (Et2O) and tetrahydrofuran (THF) were distilled from 
the sodium benzophenone ketyl radical ion. Dichloromethane (CH2Cl2), triethylamine 
(NEt3), and acetonitrile (MeCN) were distilled from calcium hydride. Toluene, hexanes 
and methanol (MeOH) were distilled from sodium. Diisopropylethylamine (iPr2NEt) 
and pyridine were distilled from sodium hydroxide. Acetone was distilled from 
potassium carbonate. Anhydrous dimethylformamide (DMF) and dimethylsulfoxide 
(DMSO) were purchased from Aldrich Chemical Company and were used without 
further purification. Sodium hydride (NaH) was obtained as a 60% suspension in 
mineral oil, washed three times with dry hexanes and dried under vacuum immediately 
prior to use. All other reagents were of commercial quality and distilled prior to use if 
necessary. 
 
Reaction progress was monitored using aluminium backed thin layer chromatography 
(TLC) plates pre-coated with silica UV254 and visualised by either UV radiation 
(254 nm), anisaldehyde dip. Retention factors (Rf) are reported for development of TLC 
plates in 2:1 heanes/EtOAc unless stated otherwise. Purification of products via flash 
chromatography was conducted using a column filled with silica gel 60 (220-240 mesh) 
with solvent systems as indicated. MW-assisted reactions were carried out in a 
Milestone Microsynth reactor, monitored by a fibre optic temperature and pressure 
probe. 1H and 13C NMR spectra were recorded on either a Varian Unity Inova 300 (300 
MHz for 1 H and 75 MHz for 13C), or a Varian Unity Inova 500 (500 MHz for 1H and 
125 MHz for 13C) spectrometer. All chemical shifts (δ) were referenced to solvent peaks 
(CDCl3: 1H - 7.26 ppm, 13C - 77.0 ppm; d6-acetone: 1H - 2.05 ppm, 13C - 29.84 ppm; d4-
MeOH: 1H - 3.31 ppm, 13C - 49.00 ppm). Optical rotation was measured on a Perkin-
Elmer Polarimeter (sodium lamp). Infrared spectra were obtained on either a Biorad 
FTS-7 spectrometer or a Bruker Tensor 27 FTIR spectrometer. High-resolution mass 
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spectrometry (HRMS) was recorded on a Mariner 5158 time of flight spectrometer or a 
Waters Q-TOF Premier™ Tandem Mass Spectrometer. The structure of each compound 
is presented with its method of preparation.  
 
8.2 Experimental for Chapter Two 
 
Methyl 2-(bromomethyl)benzoate (214) 
A solution of methyl 2-methylbenzoate (212) (1.0 g, 6.67 mmol) and 
NBS (1.31 g, 7.35 mmol) in CH2Cl2 (20 mL) was heated to reflux with a 
heat lamp (200 W) for 30 min. The reaction mixture was cooled and 
filtered to remove the solid succinimide before concentrating under reduced pressure to 
give a pale yellow oil. The crude residue was purified by flash column chromatography 
(silica, 20:1 hexanes/EtOAc) to give a colourless oil (1.37 g, 90%). 1H NMR (300 MHz, 
CDCl3) δ 7.97 (d, J = 7.4 Hz, 1H), 7.52 – 7.45 (m, 2H), 7.37 (m, 1H), 4.96 (s, 2H), 3.95 
(s, 3H). Spectral data matched those reported in the literature.219 
 
Methyl 2-[(diethoxyphosphoryl)methyl]benzoate (210) 
A solution of methyl 2-methylbenzoate (212) (2.0 g, 13.3 mmol) and 
NBS (2.61g, 14.7 mmol) in CH2Cl2 (20 mL) was heated to reflux with 
a heat lamp (200 W) for 30 min. The reaction mixture was cooled and 
filtered to remove the solid succinimide before concentrating under 
reduced pressure to give a pale yellow oil (~3.05 g, ~13.3 mmol). To the crude 
bromomethyl 2-methylbenzoate (214) was added triethyl phosphite (6.91 mL, 39.7 
mmol) and the reaction mixture was heated to 150 °C for 12 h. The unreacted triethyl 
phosphite was distilled from the product to yield a yellow oil. The crude product was 
purified by flash column chromatography (silica, gradient elution 2:1 hexanes/EtOAc to 
EtOAc), yielding a pale yellow oil (3.38 g, 89%). 1H NMR (300 MHz, CDCl3) δ 7.91 
(d, J = 7.8 Hz, 1H), 7.44 (dd, J = 8.5, 15.3 Hz, 1H), 7.39 (d, J = 8.2 Hz, 1H), 7.31 (t, J = 
7.5 Hz, 1H), 3.99 (p, J = 7.2 Hz, 4H), 3.91 (s, 3H), 3.80 (d, J = 22.8 Hz, 2H), 1.21 (t, J 
= 7.1 Hz, 6H).  
 
2-[(Diethoxyphosphoryl)methyl]benzoic acid (294) 
To a solution of phosphonate 210 (250 mg, 0.87 mmol) in EtOH (3 mL) 
was added KOH (147 mg, 2.62 mmol). The solution was stirred for 8 h 
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at rt before heating to reflux for 12 h. The cooled solution was acidified to pH 1 with 
10% HCl and extracted with EtOAc (3 x 15 mL). The combined organic fractions were 
dried over MgSO4, filtered and reduced to give a white solid (194 mg, 82%).  1H NMR 
(300 MHz, CDCl3) δ 7.97 (d, J = 7.7 Hz, 1H), 7.45 (t, J = 7.6 Hz, 1H), 7.33 (td, J = 7.5, 
2.0 Hz, 2H), 4.12 – 4.01 (m, 4H), 3.81 (d, J = 22.7 Hz, 2H), 1.25 (t, J = 7.0 Hz, 6H).  
 
Ethyl 2-methylbenzoate (213)  
To a solution of 2-methylbenzoic acid (2.03 g, 14.9 mmol) in EtOH (25 
mL) was added H2SO4 (0.95 mL) dropwise. The reaction mixture was 
heated to reflux for 12 h. The solvent was removed from the cooled reaction mixture 
and the crude oil was dissolved in Et2O before being washed with 1M NaOH(aq) (2 x 50 
mL). The organic layer was dried over MgSO4, filtered and reduced to give a colourless 
oil (2.27 g, 93%). 1H NMR (300 MHz, cdcl3) δ 7.91 (d, J = 8.2 Hz, 1H), 7.39 (t, J = 7.5 
Hz, 1H), 7.28 – 7.20 (m, 2H), 4.36 (q, J = 7.1 Hz, 2H), 2.60 (s, 3H), 1.39 (t, J = 7.1 Hz, 
3H). Spectral data matched those reported in the literature.220  
 
Ethyl 2-[(diethoxyphosphoryl)methyl]benzoate (211) 
A solution of methyl 2-methylbenzoate (213) (2.27 g, 13.8 mmol) and 
NBS (2.71 g, 15.2 mmol) in CH2Cl2 (25 mL) was heated to reflux with a 
heat lamp (200 W) for 30 min. The reaction mixture was cooled and 
filtered to remove the solid succinimide before concentrating under 
reduced pressure to give a pale yellow oil. A solution of the crude bromomethyl 2-
methylbenzoate (3.31 g, 13.6 mmol) in triethyl phosphite (5.9 mL, 34.1 mmol) was 
heated at 150 oC for 12 h. The unreacted triethyl phosphite was removed by distillation 
to yield the product as a yellow oil. The crude product was purified with flash column 
chromatography (silica, gradient elution 2:1 hexanes/EtOAc to EtOAc), affording a pale 
yellow oil (3.66 g, 88%). 1H NMR (300 MHz, CDCl3) δ 7.91 (d, J = 7.8 Hz, 1H), 7.44 – 
7.37 (m, 2H), 7.30 (t, J = 7.8 Hz, 1H), 4.37 (q, J = 7.2 Hz, 2H), 3.99 (q, J = 7.8 Hz, 4H), 
3.81 (d, J = 22.9 Hz, 2H), 1.40 (t, J = 7.0 Hz, 3H), 1.21 (t, J = 7.0 Hz, 6H). Spectral 
data matched those reported in the literature.221 
 
 
Methyl 2,4-dihydroxy-6-methylbenzoate (methyl orsellinate, 74)141 
To a suspension of 60% NaH (2.56 g, 64 mmol, washed three 
times with dry hexanes) in THF (100 mL) at 0 °C was added 
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methyl acetoacetate (5.0 g, 43 mmol) dropwise. The mixture was stirred for 1 h, 
warming to rt. The reaction was cooled down to -78 °C and a 1.6 M solution of n-
butyllithium in hexanes (25.6 mL, 41 mmol) was added dropwise over 2 h. The reaction 
was then stirred at rt for 12 h. The reaction mixture was then refluxed for a further 24 h. 
The cooled orange solution was acidified with 10% HCl to pH 1 and stirred at rt for 12 
h. The organic layer was separated and the aqueous layer was extracted with EtOAc (3 x 
75 mL), dried with MgSO4, filtered and concentrated under reduced pressure. The 
product was purified using flash column chromatography (silica, gradient elution 5:1 to 
3:1 hexanes/EtOAc) to provide methyl orsellinate 74 as a white solid (1.56 g, 40%). Rf 
(silica, 2:1) = 0.44. mp 141 – 142 °C. [lit.222 mp 139 – 140 °C] 1H NMR (300 MHz, 
CDCl3) δ 11.78 (s, 1H), 6.28 (d, J = 2.5 Hz, 1H), 6.23 (d, J = 2.5 Hz, 1H), 5.52 (s, 1H), 
3.92 (s, 3H), 2.48 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 172.2, 165.2, 160.3, 144.0, 
111.4, 105.6, 101.2, 51.9, 24.3.  Spectral data matched those reported in the literature.141 
 
Methyl 2-hydroxy,4-methoxy-6-methylbenzoate (132) 
To a solution of orsellinate 74 (50 mg, 0.27 mmol) and K2CO3 
(152 mg, 1.10 mmol) in acetone (2 mL) was added Me2SO4 (105 
μL, 1.10 mmol) dropwise. The reaction was heated to 50 °C for 48 h. The reaction 
mixture was filtered and reduced to dryness. The crude product was purified using flash 
column chromatography (silica, gradient elution 10:1 to 3:1 hexanes/EtOAc) giving a 
white solid (43 mg, 80%). mp 68 – 69 °C. [lit.223 mp 70 – 71 °C]. 1H NMR (300 MHz, 
CDCl3) δ 11.80 (s, 1H), 6.32 (d, J = 2.4 Hz, 1H), 6.27 (d, J = 2.4 Hz, 1H), 3.91 (s, 3H), 
3.79 (s, 3H), 2.48 (s, 3H). Spectral data matched those reported in the literature.223 
 
Methyl 4,6-dimethoxy-2-methylbenzoate (130)  
A suspension of KOH (38 mg, 0.95 mmol) and orsellinate 74 (52 
mg, 0.286 mmol) in THF (2 mL) was stirred at rt for 20 min over 
which time a white precipitate (ppt) formed. To the reaction was added MeI (100 μL, 
0.309 mmol) and it was stirred for 12 h at rt. The reaction was quenched with 10% HCl 
(5 mL) and extracted with EtOAc (3 x 5 mL), dried over MgSO4, filtered and reduced to 
give a white solid. The crude product was purified using flash column chromatography 
(silica, gradient elution 5:1 to 3:1 hexanes/EtOAc) giving a white solid (38 mg, 62%). 
mp 42 – 44 °C. [lit.224 mp 42 – 44 °C]. 1H NMR (300 MHz, CDCl3) δ 6.31 (s, 2H), 3.88 
(s, 3H), 3.79 (s, 3H), 3.79 (s, 3H), 2.28 (s, 3H). Spectral data matched those reported in 
the literature.146 HRMS (ESI) calcd. for C11H15O4+ [M + H+] 211.0965, found 211.1198.  
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Methyl 2,4-bis(methoxymethoxy)-6-methylbenzoate (221) 
To solution of orsellinate 74 (100 mg, 0.55 mmol) in DMF 
cooled to 0 °C was added a 60% dispersion of NaH in mineral 
oil (44 mg, 1.10 mmol). The reaction was warmed to rt for 15 min before cooling back 
down to 0 °C. MOM-Cl was added dropwise to reaction mixture and it was left to warm 
up to rt over 12 h. The reaction mixture was diluted with Et2O (15 mL) and washed with 
H2O (20 mL). The organic phase was washed with sat. NaHCO3(aq) (3 x 10 mL), washed 
with brine (10 mL), dried with MgSO4, filtered and reduced giving a colourless oil. The 
crude product purified by flash column chromatography (silica, 5:1 hexanes/EtOAc) 
yielding bis-MOM 221 (110 mg, 74%), 4-MOM 222 (19 mg, 15%) and 2-MOM 223 
(4.5 mg, 3%). 221: 1H NMR (500 MHz, CDCl3) δ 6.66 (d, J = 2.1 Hz, 1H), 6.55 (d, J = 
2.1 Hz, 1H), 5.15 (s, 4H), 3.89 (s, 3H), 3.47 (s, 3H), 3.46 (s, 3H), 2.28 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 168.5, 158.7, 155.4, 138.0, 118.5, 110.7, 101.3, 94.8, 94.2, 
56.2, 56.1, 52.1, 19.8. Spectral data matched those reported in the literature.225 
Methyl 2-hydroxy-4-methoxymethoxy-6-methylbenzoate (222) 
1H NMR (500 MHz, CDCl3) δ 11.67 (s, 1H), 6.49 (d, J = 2.4 
Hz, 1H), 6.38 (d, J = 2.4 Hz, 1H), 5.17 (s, 2H), 3.93 (s, 3H), 
3.46 (s, 3H), 2.50 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
172.1, 165.1, 161.4, 143.3, 111.8, 106.2, 101.4, 93.8, 56.3, 51.9, 24.4. IR: 2956, 2906, 
1655, 1618, 1578, 1442, 1323, 1258, 1212, 1149, 1021, 942, 911, 735 cm-1. 
Methyl 2-methoxymethoxy-4-hydroxy -6-methylbenzoate (223) 
1H NMR (500 MHz, CDCl3) δ 6.50 (d, J = 2.2 Hz, 1H), 6.32 
(d, J = 2.2 Hz, 1H), 5.42 (brs, 1H), 5.13 (s, 2H), 3.89 (s, 3H), 
3.46 (s, 3H), 2.24 (s, 3H). 
 
Methyl 2,4-bis(acetyloxy)-6-methylbenzoate (134) 
To a solution of orsellinate 74 (1.26 g, 6.90 mmol) in CH2Cl2 
(17.5 mL) at rt was added NEt3 (5.76 mL, 41.4 mmol) and acetic 
anhydride (Ac2O) (2.56 mol, 27.6 mmol). The reaction was stirred for 12 h at rt before 
being quenched with sat. NaHCO3(aq) (30 mL). The organic layer was separated, dried 
with MgSO4, filtered and concentrated under reduced pressure. The crude oil was 
purified through a short silica column (gradient elution 5:1 to 2:1 hexanes/EtOAc) with 
a few drops of AcOH, yielding the title compound as a white solid (1.82 g, 98%). Rf 
(silica, 2:1) = 0.31. mp 53 – 54 °C. 1H NMR (300 MHz, CDCl3) δ 6.89 (d, J = 2.2 Hz, 
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1H), 6.80 (d, J = 2.2 Hz, 1H), 3.88 (s, 3H), 2.41 (s, 3H), 2.28 (s, 3H), 2.26 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ 168.9, 168.6, 166.3, 151.7, 149.3, 139.8, 121.3, 114.2, 77.2, 
52.2, 21.1, 20.8, 20.5. IR (neat): 3086, 2959, 1781, 1732, 1616, 1587, 1446, 1370, 1280, 
1174, 1137, 1098, 1054, 1018, 953, 911 cm-1. HRMS (ESI) calcd. for C13H14O6Na+ [M 
+ Na]+ 289.0683, found 289.0685.  
 
Methyl 3-bromo-4,6-dimethoxy-2-methylbenzoate (225) 
To a solution of arylmethyl 130 (35 mg, 0.17 mmol) in CH2Cl2 (2 
mL) was added NBS (30 mg, 0.17 mmol) and AIBN (10 mg) and 
the solution was heated to reflux for 30 min under irradiation with 
a heat lamp (200 W). The reaction mixture was cooled to rt, filtered and reduced to give 
a white solid (32 mg, 65%). mp 132 – 134 °C. 1H NMR (300 MHz, CDCl3) δ 6.35 (s, 
1H), 3.89 (s, 3H), 3.87 (s, 3H), 3.81 (s, 3H), 2.31 (s, 3H). Spectral data matched those 
reported in the literature.75 
  
(Methyl 3-bromo-6-hydroxy,4-methoxy-2-methylbenzoate 
(224) 
To a solution of arylmethyl 132 (15 mg, 77 μmol) in CH2Cl2 (2 
mL) was added NBS (15 mg, 77 μmol) and AIBN (10 mg) and 
the solution was heated to reflux for 30 min under irradiation with a heat lamp (200 W). 
The reaction mixture was cooled to rt, filtered and reduced to give a white solid (15 mg, 
71%). 1H NMR (300 MHz, CDCl3) δ 11.55 (s, 1H), 6.41 (s, 1H), 3.95 (s, 3H), 3.90 (s, 
3H), 2.77 (s, 3H), 2.68 (s, 3H).  
 
Methyl 2,4-bis(acetyloxy)-6-(bromomethyl)benzoate (135) 
To a solution of arylmethyl 134 (440 mg, 1.64 mmol) in CCl4 (15 
mL) were added NBS (180 mg, 1.01 mmol) and benzoyl peroxide 
(20 mg) and the reaction mixture was heated to reflux. After 3 h, 
another portion of NBS (180 mg, 1.01 mmol) and benzoyl peroxide (20 mg) was added 
to mixture and the reaction was heated to reflux for a further 3 h. After this time the 
reaction was cooled to rt and the solid succinimide filtered off and solvent removed 
under reduced pressure. The resulting orange oil was purified using careful flash 
column chromatography (silica, CH2Cl2) to yield the title compound 135 as a white 
solid (400 mg, 71%), and the corresponding dibromide 226 as white solid (81 mg, 
12%). Rf (silica, CH2Cl2) = 0.46. mp 62 – 64 °C. 1H NMR (300 MHz, CDCl3) δ 7.12 (d, 
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J = 2.2, 1H), 6.95 (d, J = 2.2, 1H), 4.63 (s, 2H), 3.92 (s, 3H), 2.29 (s, 3H), 2.27 (s, 3H). 
13C NMR (75 MHz, CDCl3) δ 168.6, 168.3, 165.2, 152.0, 149.8, 139.3, 123.0, 121.3, 
117.0, 52.7, 29.7, 21.1, 20.7. IR (KBr): 3082, 2950, 1770, 1731, 1613, 1434, 1370, 
1282, 1187, 1138, 1094, 1033, 1017, 907 cm-1. HRMS (ESI) calcd. for C13H13O6BrNa+ 
[M + Na]+ 366.9793, found 366.9798.  
Methyl 2,4-bis(acetyloxy)-6-(dibromomethyl)benzoate (226)  
1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 2.2 Hz, 1H), 7.38 (s, 
1H), 7.12 (d, J = 2.2 Hz, 1H), 4.05 (s, 3H), 2.43 (s, 3H), 2.38 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 168.4, 168.0, 164.6, 152.5, 
148.6, 142.7, 121.2, 119.2, 118.1, 52.9, 35.8, 21.0, 20.6.  
 
Methyl 2,4-bis(acetyloxy)-6-[(diethoxyphosphoryl)methyl]benzoate (142) 
Bromide 135 was heated to 120 ˚C in neat P(OEt)3 for 12 h. After 
TLC confirmed that all the starting bromide had reacted, the 
excess P(OEt)3 was distilled off under reduced pressure (20 
mmHg) yielding the phosphonate as a pale yellow liquid (264 
mg, 92%). 1H NMR (500 MHz, CDCl3) δ 7.08 (t, J = 2.5 Hz, 
1H), 6.90 (t, J = 2.2 Hz, 1H), 4.04 – 3.96 (m, 4H), 3.89 (s, 3H), 3.48 (d, J = 22.4 Hz, 
2H), 2.28 (s, 3H), 2.26 (s, 3H), 1.24 (t, J = 7.1 Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 
168.6, 168.3, 165.7, 151.9 (d, J = 3.7 Hz), 149.8 (d, J = 3.4 Hz), 134.1 (d, J = 9.4 Hz), 
123.6 (d, J = 6.5 Hz), 122.1 (d, J = 5.8 Hz), 115.6 (d, J = 3.5 Hz), 62.4 (d, J = 6.8 Hz), 
52.4, 31.3 (d, J = 137.5 Hz), 21.1, 20.8, 16.3 (d, J = 5.9 Hz). IR (neat): 2986, 1772, 
1727, 1612, 1433, 1370, 1282, 1191, 1136, 1094, 1028, 961, 911, 787, 730 cm-1. HRMS 
(ESI) calcd. for C17H23O9PNa+ [M + Na]+ 425.0972, found 425.1207. 
 
 [3,5-Bis(acetyloxy)-2-(methoxycarbonyl)benzyl](phenyl)phosphonium bromide  
A solution of bromide 135 (113 mg, 0.328 mmol) and triphenyl 
phosphine (103 mg, 0.393 mmol) was heated to reflux in toluene 
(2.5 mL) for 12 h. The solution was cooled but the phosphorane 
ylid failed to precipitate out of solution. Many attempts were 
made to crystallise the product from toluene, toluene/THF, THF/hexanes, 
EtOH/hexanes, and EtOAc/hexanes. The product persistently oiled out of solution 
rather than crystallised. 
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Methyl 2-[(diethoxyphosphoryl)methyl]-4,6-dihydroxybenzoate (121) 
To a solution of phosphonate 142 (264 mg, 0.657 mmol) in 
MeOH (5 mL) was added K2CO3 (363 mg, 2.63 mmol) and 
stirred at rt for 4 h. The reaction mixture was filtered and 
reduced. The residue was dissolved in EtOAc before acidifying to 
pH 1 with 10% HCl(aq). The organic layer was separated and the 
aqueous layer further extracted with EtOAc (2 x 20 mL). The combined organic layers 
were dried over MgSO4, filtered and reduced to give a colourless oil (172 mg, 83%). 1H 
NMR (500 MHz, CDCl3) δ 11.41 (s, 1H), 6.50 (t, J = 2.5 Hz, 1H), 6.34 (t, J = 2.5 Hz, 
1H), 4.07 – 3.93 (m, 4H), 3.92 (s, 3H), 3.68 (d, J = 23.1 Hz, 2H), 1.24 (t, J = 7.0 Hz, 
6H). 13C NMR (125 MHz, CDCl3) δ 171.4, 171.3, 165.2, 165.1, 162.5, 162.4, 134.8, 
134.8, 112.9, 112.9, 104.6, 104.6, 103.0, 103.0, 62.7, 62.7, 51.8, 34.3, 33.2, 16.3, 16.3. 
IR: 3131, 2988, 1656, 1621, 1589, 1439, 1324, 1265, 1205, 1167, 1024 cm-1.   
 
Methyl 2,4-bis(tert-butyldimethylsiloxy)-6-
[(diethoxyphosphoryl)methyl]benzoate (228) 
To a solution of phosphonate 227 (49 mg, 0.154 mmol) in DMF 
(1 mL) at 0 °C, was added TBSCl (58 mg, 0.385 mmol) and 
imidazole (42 mg, 0.616 mmol). The reaction was left to warm to rt whilst stirring for 
12 h. The reaction was diluted with EtOAc (10 mL) before being washed with H2O (10 
mL) and sat. NaHCO3(aq) (3 x 10 mL). The organic layer was dried with MgSO4, filtered 
and reduced to give a colourless oil. The product was purified with flash column 
chromatography (silica, 2:1 hexanes/EtOAc) giving a colourless oil (68 mg, 81%). 1H 
NMR (500 MHz, CDCl3) δ 6.53 (s, 1H), 6.23 (s, 1H), 4.05 – 3.95 (m, 4H), 3.84 (s, 3H), 
3.25 (d, J = 22.3 Hz, 2H), 1.24 (t, J = 7.1 Hz, 3H), 0.96 (s, 18H), 0.20 (s, 12H), 0.19 (6s, 
H). 13C NMR (125 MHz, cdcl3) δ 168.3, 157.2 (d, J = 3.5 Hz), 154.6 (d, J = 2.9 Hz), 
132.4 (d, J = 9.0 Hz), 119.9 (d, J = 7.2 Hz), 115.9 (d, J = 5.5 Hz), 110.1 (d, J = 3.2 Hz), 
62.1 (d, J = 6.8 Hz), 51.9, 31.3 (d, J = 137.5 Hz), 25.6, 25.5, 18.2, 18.1, 16.3 (d, J = 6.0 
Hz), -4.4, -4.4.  
 
Methyl 2,4-bis(acetyloxy)-6-[(acetylthio)methyl]benzoate 
(171) 
To a solution of the bromide 135 (148 mg, 0.43 mmol) at 0 °C in 
DMF (3 mL) was added KSAc (60 mg, 0.53 mmol). The reaction 
was allowed to warm to rt whilst stirring for 4 h. The reaction mix was diluted with 
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EtOAc (10 ml) and washed with sat. NaHCO3(aq) (3 x 10 mL). The organic layer was 
washed with brine (10 mL) and dried over MgSO4, filtered and reduced to give a white 
solid. The white solid was purified by flash column chromatography (silica, 5:1 
hexanes/EtOAc) giving a white solid (133 mg, 91%). mp 100 – 101 °C. 1H NMR (500 
MHz, CDCl3) δ 7.12 (d, J = 2.2 Hz, 1H), 6.90 (d, J = 2.3 Hz, 1H), 4.23 (s, 2H), 3.89 (s, 
3H), 2.32 (s, 3H), 2.28 (s, 3H), 2.26 (s, 3H). 13C NMR (125 MHz, CDCl3) 194.9, 168.7, 
168.4, 165.5, 152.1, 149.8, 149.8, 140.3, 122.6, 121.5, 116.1, 52.5, 31.4, 30.2, 21.1, 
20.8. IR (film): 2954, 1772, 1727, 1692, 1611, 1282, 1189, 1135, 1032 cm-1. HRMS 
(ESI) calcd. for C15H16O7SNa+ [M + Na]+ 363.0509, found 363.0460. 
 
Methyl 2-[(acetylthio)methyl]-4,6-dihydroxybenzoate (230) 
and 5,7-dihydroxy-2-benzothiophen-1(3H)-one (231). 
To a solution of thioacetate 171 (164 mg, 0.488 mmol) in MeOH 
(10 mL) at rt was added K2CO3 (4.5 mg, 33 μmol). The reaction 
was stirred at rt for 12 h before being filtered through a silica plug. 
The crude brown solid was purified by flash column 
chromatography (silica, gradient elution 10:1 to 5:1 
hexanes/EtOAc) giving thiolactone 231 as a white solid (37 mg, 42%) and thioacetate 
230 as a white solid (35 mg, 28%). 230: mp 200 – 202 °C (decomp.).  1H NMR (300 
MHz, CDCl3) δ 11.61 (s, 1H), 6.51 (d, J = 2.2 Hz, 1H), 6.36 (d, J = 2.2 Hz, 1H), 4.35 (s, 
2H), 3.94 (s, 3H), 2.32 (s, 3H). 231: mp 204 – 206 °C (decomp.). 1H NMR (300 MHz, 
CDCl3) δ 9.47 (brs, 1H), 6.48 (d, J = 1.9 Hz, 1H), 6.33 (d, J = 1.9 Hz, 1H), 4.36 (s, 2H). 
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8.3 Experimental for Chapter Three 
 
8.3.1  The HWE route 
 
3,4,6-Tri-O-acetyl-D-glucal (147)161,162 
To a solution of D-glucose (0.125g, 0.694 mmol) in acetic anhydride 
(75 mL, 0.795 mol) was added perchloric acid (450 μL) dropwise while the temperature 
was kept at 40 °C. To the solution was added D-glucose (18.75 g, 104 mmol) in portions 
over 30 min before cooling to rt. To the cooled solution was added 45% HBr in AcOH 
(75 mL) and the reaction mixture was stirred for 90 min at rt. The reaction mixture was 
diluted with CH2Cl2 (175 mL) and washed with ice cold water (2 x 50 mL) and cold sat. 
NaHCO3(aq) until the solution was neutral. The organic layer was separated, dried over 
MgSO4 and concentrated, giving 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
(41.9 g, 0.102 mol).  
 
Water (150 mL) was poured into a one litre three-necked round bottom flask and stirred 
with an overhead stirrer at 0 °C. Zinc powder (50 g, 0.765 mol) was added to the water 
followed by AcOH (150 mL). A solution of crude 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl bromide (41.9 g, 0.102 mol) in Et2O (250 mL) was added dropwise over 
a period of 1 h. The reaction was allowed to warm to rt and stirred overnight (~14 h). 
The reaction mixture was filtered and the zinc dust was repeatedly washed with Et2O. 
The aqueous layer was extracted with ether (6 x 50 mL). The combined organic 
fractions were washed with sat. NaHCO3 (aq) solution until evolution of CO2 ceased. The 
combined aqueous fractions were further extracted with ether (4 x 50 mL). The ether 
layers were again combined and washed with H2O (2 x 100 mL) and brine (1 x 100 
mL). These aqueous layers were extracted with ether (4 x 50 mL). Finally the ether 
solution was dried over MgSO4 and concentrated under reduced pressure to give a white 
solid. The crude product was purified by recrystallising from Et2O (25.6 g, 90%). 1H 
NMR (300 MHz, CDCl3) δ 6.45 (d, J = 7.5 Hz, 1H), 5.32 (dd, J = 5.9, 3.0 Hz, 1H), 5.21 
(dd, J = 7.5, 5.7 Hz, 1H), 4.83 (dd, J = 6.2, 3.2 Hz, 1H), 4.39 (dd, J = 11.8, 5.5 Hz, 1H), 
4.28 – 4.13 (m, 2H), 2.08 (s, 3H), 2.07 (s, 3H), 2.03 (s, 3H). Spectral data matched 
those reported in the literature.226 
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Benzyl 4,6-di-O-acetyl-2,3-deoxy-α-D-erytho-hex-2-
enopyranoside (148)86 
To a solution of 3,4,6-tri-O-acetyl-D-glucal (5.0 g, 18 mmol) and 
benzyl alcohol (1.9 mL, 18 mmol) in CH2Cl2 (100 mL) was added a 0.1 M solution of 
FeCl3 in CH2Cl2 (2 mL). The reaction mixture was stirred at rt for 1 h before being 
quenched with sat. NaHCO3(aq) (50 mL). The layers were separated and aqueous layer 
was further extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried 
over MgSO4, filtered and concentrated under reduced pressure. The crude product was 
purified using flash column chromatography (silica, 5:1 hexanes/EtOAc) giving title 
compound as a mixture of anomers (5.01 g, 85%, α/β = 9:1). [α]D22 = +77.3 (c 1.00, 
CHCl3) [lit.86 +75.3 (c 1.04, MeOH)]. 1H NMR (500 MHz, CDCl3, α-anomer) δ 7.38 – 
7.28 (m, 5H), 5.90 (d, J = 10.2 Hz, 1H), 5.85 (ddd, J = 10.2, 2.6, 1.8 Hz, 1H), 5.33 (ddd, 
J = 9.5, 3.1, 1.6 Hz, 1H), 5.14 (s, 1H), 4.81 (d, J = 11.7 Hz, 1H), 4.60 (d, J = 11.7 Hz, 
1H), 4.25 (dd, J = 11.8, 5.1 Hz, 1H), 4.18 – 4.10 (m, 2H), 2.10 (s, 3H), 2.08 (s, 3H). 13C 
NMR (125 MHz, CHCl3) δ 170.8, 170.3, 137.6, 129.3, 128.5, 128.0, 127.9, 127.7, 93.6, 
70.3, 67.1, 65.3, 62.9, 21.0, 20.8. IR (neat): 3033, 2906, 1742, 1455, 1370, 1227, 1100, 
1037, 965, 911, 731 cm-1. Spectral data matched those reported in the literature.86 
 
Benzyl 4,6-di-O-acetyl-2,3-deoxy-α-D-erythro-hexopyranoside 
(235) 
To a solution of benzyl glycoside 148 (100 mg, 0.31 mmol) in 
EtOH (4 mL) under an atmosphere of argon was added 10% Pd/C (10 mg). Into the 
reaction vessel was attached a balloon of H2(g) and the vessel briefly flushed with H2(g). 
The reaction was stirred at rt for 3 h. The solution was filtered through Celite® and 
reduced to give a colourless oil (73 mg, 73%). 1H NMR (300 MHz, CDCl3) δ 7.39 – 
7.27 (m, 5H), 4.96 (s, 1H), 4.77 (m, 1H), 4.73 (d, J = 12.0 Hz, 1H), 4.42 (d, J = 12.0 Hz, 
1H), 4.30 (dd, J = 12.0, 5.1 Hz, 1H), 4.10 (dd, J = 10.0, 2.5 Hz, 1H), 3.99 (m, 1H), 2.12 
(s, 3H), 2.06 (s, 3H), 2.01 – 1.83 (m, 3H), 1.72 (m, 1H). 
 
Cyclohexylmethyl 4,6-di-O-acetyl-2,3-deoxy-α-D-
erytho-hexopyranoside (237)  
To a solution of benzyl glycoside 148 (30 mg, 0.13 mmol) 
in EtOH (1 mL) under an atmosphere of argon was added 10% PtO2/C (3 mg). The 
reaction vessel was flushed with H2(g) before a attaching a balloon of H2(g) into the 
vessel. The reaction was stirred at rt for 3 h. The solution was filtered through Celite® 
O
OAc
AcO
OBn
O
OAc
AcO
O
O
OAc
AcO
OBn
 147
and reduced to give a colourless oil. The crude product was purified using flash column 
chromatography (silica, 2:1 hexanes/EtOAc) giving a colourless oil (18 mg, 59%) 1H 
NMR (300 MHz, CDCl3) δ 4.74 (d, J = 2.7 Hz, 1H), 3.81 (d, J = 4.1 Hz, 2H), 3.67 – 
3.52 (m, 2H), 3.43 (dd, J = 9.5, 7.1 Hz, 1H), 3.17 (dd, J = 9.3, 5.9 Hz, 1H), 1.85 – 1.55 
(m, 10H), 1.32 – 1.11 (m, 2H), 1.01 – 0.86 (m, 2H). 
 
4,6-di-O-Acetyl-2,3-deoxy-α-D-erythro-hexose (122) 
To a solution of benzyl glycoside 148 (550 mg, 1.72 mmol) in 
EtOH (10 mL) under an atmosphere of argon was added 10% 
Pd(OH)2/C (52 mg). The reaction vessel was briefly evacuated before attaching a 
balloon of H2(g) into the vessel. The reaction was stirred at rt for 3 h. The solution was 
filtered through Celite® and reduced to give a colourless oil. The crude product was 
purified using flash column chromatography (silica, gradient elution 5:1 to 3:1 
hexanes/EtOAc) giving the title compound as a white solid (284 mg, 71%), ethyl 
glycoside 237 as a colourless oil (22 mg, 5%) and tetrahydropyran 238 as a colourless 
oil (74 mg, 20%).122: mp 78 – 79 °C.  [α]D17 = +93.5 (c 1.05, CHCl3). [lit.70 +75.7 (c 
0.7, CH2Cl2)].  1H NMR (300 MHz, CDCl3, α-anomer) δ 5.32 (s, 1H), 4.80 – 4.64 (m, 
1H), 4.26 – 4.10 (m, 3H), 2.56 (br s, 1H), 2.27 – 2.18 (m, 1H), 2.09 (s, 3H), 2.06 (s, 
3H), 2.03 – 1.78 (m, 3H). 13C NMR (75 MHz, CDCl3, α-anomer) δ 171.0, 170.1, 90.6, 
68.3, 67.8, 63.2, 28.7, 23.0, 20.9, 20.7. IR (neat): 2952, 2858, 1737, 1440, 1372, 1228, 
1105, 1069, 1038, 915, 729 cm-1. HRMS (ESI) calcd. for C10H16O6Na+ [M + Na]+ 
255.0845, found 255.0840. Spectral data matched those reported in the literature.70 
 
Methyl 4,6-di-O-acetyl-2,3-deoxy-α-D-erytho-hexopyranoside 
(237) 
1H NMR (500 MHz, CDCl3) δ 4.83 (s, 1H), 4.73 (td, J = 10.1, 4.8 
Hz, 1H), 4.25 (dd, J = 12.0, 5.2 Hz, 1H), 4.08 (dd, J = 12.0, 2.2 Hz, 1H), 3.92 (ddd, J = 
10.0, 5.2, 2.2 Hz, 1H), 3.71 (dq, J = 9.8, 7.1 Hz 1H), 3.47 (dq, J = 9.8, 7.1 Hz, 1H), 2.07 
(s, 3H), 2.03 (s, 3H), 2.00 – 1.94 (m, 1H), 1.89 – 1.78 (m, 3H), 1.22 (t, J = 7.1, 3H). 13C 
NMR (125 MHz, CDCl3) δ 170.9, 170.0, 96.1, 68.5, 67.8, 63.2, 62.7, 28.8, 23.9, 21.1, 
20.8, 15.0.  
 
1-Anhydro-2,3-dideoxy-4,6-diacetate-D-erythro-hexopyranose (238) 
To a solution of benzyl glycoside 148 (105 mg, 0.33 mmol) in CHCl3 (5 
mL) under an atmosphere of argon was added 10% Pd(OH)2/C (10 mg). The reaction 
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vessel was briefly evacuated before attaching a balloon of H2(g) into the vessel. The 
reaction was stirred at rt for 2 h. The solution was filtered through Celite® and reduced 
to give a colourless oil. The crude product was purified using flash column 
chromatography (silica, gradient elution 5:1 to 2:1 hexanes/EtOAc) giving a colourless 
oil (50 mg, 86%). [α]D17 = +38.2 (c 1.0, CHCl3) [lit.227 +37.5 (c 1.7, ethanol)] 1H NMR 
(500 MHz, CDCl3) δ 4.68 (ddd, J = 10.7, 9.9, 4.8 Hz, 1H), 4.18 (dd, J = 12.0, 5.4 Hz, 
1H), 4.13 (dd, J = 12.0, 2.4 Hz, 1H), 3.97 (ddt, J = 11.4, 4.4, 1.5 Hz, 1H), 3.46 (ddd, J = 
9.7, 5.4, 2.4 Hz, 1H), 3.39 (td, J = 11.8, 2.6 Hz, 1H), 2.21 (m, 1H), 2.07 (s, 3H), 2.03 (s, 
3H), 1.76 (tdd, J = 16.8, 8.5, 4.3 Hz, 1H), 1.68 (m, 1H), 1.45 (tdd, J = 12.9, 11.0, 4.5 
Hz, 1H) 13C NMR (125 MHz, CDCl3) δ 171,0 169.9, 77.5, 68.0, 67.9, 63.5, 29.2, 24.8, 
21.1, 20.8.IR(neat): 2954, 2857, 1738, 1441, 1230, 1106, 1070, 1039 cm-1. HRMS (ESI) 
calcd. for C10H16O5Na+ [M + Na]+ 239.0895, found 239.0898.  
 
Benzyl 2,3-dideoxy-α-D-glycero-hex-2-enopyranoside (149)86   
To a solution of benzyl glycoside 148 (3.28 g, 10.3 mmol) in 
MeOH (30 mL) at rt was added Na (15 mg, 64 μmol). The reaction 
was stirred at rt for 2 h. To the solution was added AcOH dropwise until the reaction 
was neutral. The solvent was removed yielding a colourless oil. The crude product was 
purified by flash column chromatography (silica, gradient elution 2:1 to 1:2 
hexanes/EtOAc) to give a white solid (2.18 g, 90%). 1H NMR (300 MHz, CDCl3) δ 7.39 
– 7.26 (m, 5H), 5.93 (d, J = 10.2 Hz, 1H), 5.75 (dt, J = 10.2, 2.3 Hz, 1H), 5.07 (s, 1H), 
4.76 (d, J = 11.8 Hz, 1H), 4.59 (d, J = 11.8 Hz, 1H), 4.18 (d, J = 8.9 Hz, 1H), 3.78 (d, J 
= 4.0 Hz, 2H), 3.72 (dd, J = 8.9, 4.0 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 137.7, 
133.6, 128.5, 128.1, 127.9, 126.0, 93.6, 71.5, 70.3, 64.0, 62.4. Spectral data matched 
those reported in the literature.228 
 
Benzyl 6-O-(tert-butyldimethylsilyl)-2,3-dideoxy-α-D-glycero-
hex-2-enopyranoside (151)86 
To a solution of diol 149 (2.18 g, 9.24 mmol ) and imidazole (1.36 
g, 20 mmol) in dry DMF (15 mL) at 0 °C was added a solution of TBSCl (1.67 g, 11.1 
mmol) in DMF (5 mL). The reaction was warmed to rt and stirred for 12 h. The reaction 
was quenched with sat. NaHCO3(aq) (30 mL) and extracted with CH2Cl2 (3 x 20 mL). 
The organic layers were combined, dried with MgSO4 and reduced to dryness. The 
crude oil was purified using flash column chromatography (silica, gradient elution 3:1 
to 2:1 hexanes/EtOAc) to give a colourless oil (3.06 g, 95%).  1H NMR (300 MHz, 
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CDCl3) δ 7.40 – 7.26 (m, 5H), 5.95 (dt, J = 10.2, 1.4 Hz, 1H), 5.76 (ddd, J = 10.2, 2.8, 
2.3 Hz, 1H), 5.05 (dt, J = 2.6, 1.3 Hz, 1H), 4.77 (d, J = 11.9 Hz, 1H), 4.60 (d, J = 11.9 
Hz, 1H), 4.19 (m, 1H), 3.88 – 3.65 (m, 3H), 2.85 (brs, 1H), 0.91 (s, 9H), 0.11 (s, 6H). 
13C NMR (125 MHz, CDCl3) δ 138.1, 133.0, 128.4, 127.9, 127.6, 125.8, 93.5, 70.2, 
70.1, 67.0, 65.3, 25.9, 18.2, -5.5, -5.5. Spectral data matched those reported in the 
literature.228 
 
(1R)-(2-Furyl)-2-tert-butyldimethylsilanyloxyethan-1-ol (254) 
TBS ether 151 (503 mg, 1.43 mmol) was dissolved in CDCl3 (5 mL) 
and left at rt for 48 h. The solvent was removed and the crude residue 
purified by flash column chromatography (silica,  5:1 hexanes/EtOAc) returning starting 
material (140 mg) and yielding a colourless oil (226 mg, 65% [93% based on recovered 
starting material]). [α]D17 = +15.2 (c 1.0, CHCl3) [lit.229 +15.9 (c 1.37, CH2Cl2)]. 1H 
NMR (500 MHz, CDCl3) δ 7.37 (dd, J = 1.8, 0.9 Hz, 1H), 6.34 (dd, J = 3.2, 1.8 Hz, 
1H), 6.31 (dt, J = 3.2, 0.9 Hz, 1H), 4.76 (dd, J = 7.0, 4.2 Hz, 1H), 3.86 (dd, J = 10.1, 4.2 
Hz, 1H), 3.83 (dd, J = 10.1, 7.0 Hz, 1),  0.90 (s, 9), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 153.6, 142.0, 110.2, 107.0, 68.4, 65.7, 25.8, 18.3, -5.4, -5.5. 
Spectral data matched those reported in the literature.229 IR: 3436, 2929, 2858, 1256, 
1148, 1119, 1007, 838, 778, 735. HRMS (ESI) calcd. for C12H22O3SiNa+ [M + Na]+ 
255.1236, found 239.1238.  
 
 
(1R)-(2-Furyl)ethane-1,2-diol (255) 
 A. To a solution of diol 140 (195 mg, 0.823 mmol) in MeCN at 0 °C 
was added p-TsOH (1.6 mg, 82 μmol). The reaction mixture was 
warmed to rt for 3 h. The solvent was removed under reduced pressure and the crude 
residue purified by flash column chromatography (silica, 3:1 hexanes/EtOAc) yielding a 
colourless oil (70 mg, 66%). 1H NMR (500 MHz, CDCl3) δ 7.39 (dd, J = 1.8, 0.7 Hz, 
1H), 6.36 (dd, J = 3.3, 1.8 Hz, 1H), 6.33 (dt, J = 3.3, 0.7 Hz, 1H), 4.82 (t, J = 5.7 Hz, 
1H), 3.88 (d, J = 5.7 Hz, 2H). Spectral data matched those reported in the literature.229 
 
B. A solution of diol 140 (233 mg, 0.987 mmol) in CDCl3 (5 mL) was stirred at rt for 
4 days. The solvent was removed under reduced pressure and the crude residue purified 
by flash column chromatography (silica, gradient elution 3:1 to 1:3 hexanes/EtOAc) 
yielding a colourless oil (114 mg, 90%). 
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(1R)-(2-Furyl)ethane-1,2-diol diacetate (256) 
To a solution of diol 255 (40 mg, 0.31 mmol) in CH2Cl2 (2 mL) were 
added Ac2O (118 μL, 1.25 mmol) and NEt3 (261 μL, 1.88 mmol) and 
the mixture was stirred at rt for 72 h. The reaction was diluted with CH2Cl2 (5 mL) and 
washed with 10% HCl(aq) (5 mL) and sat. NaHCO3(aq) (2 x 5 mL). The organic phase 
was dried over MgSO4, filtered and evaporated under reduced pressure. The crude 
residue was purified by flash column chromatography (silica, 5:1 hexanes/EtOAc) to 
give a colourless oil (41 mg, 62%). 1H NMR (500 MHz, CDCl3) δ 7.40 (m, 1H), 6.40 
(dd, J = 3.3, 0.5 Hz, 1H), 6.36 (dd, J = 3.3, 1.8 Hz, 1H), 6.10 (dd, J = 4.5, 7.7 Hz, 1H), 
4.47 (dd, J = 11.8, 4.5 Hz, 1H), 4.43 (dd, J = 11.8, 7.7 Hz, 1H), 2.09 (s, 3H), 2.06 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 170.6, 170.0, 149.2, 143.0, 110.4, 109.6, 66.2, 
63.3, 20.9, 20.7. Spectral data matched those reported in the literature.230 
Attempted Synthesis of benzyl 2,3-dideoxy-4,6-O-(1-
methylethylidene)-α-D-erythro-hex-2-enopyranoside (150) 
To a solution of diol 149 (150 mg, 0.64 mmol) and 2,2-
dimethoxypropane (156 μL, 1.27 mmol) in DMF (3 mL) was added p-TsOH (24 mg, 
0.13 mmol). The reaction mixture was stirred at rt for 2 h before being heated to 60 °C 
for 12 h. The reaction was quenched with sat. NaHCO3(aq) and extracted with EtOAc (3 
x 10 mL). The organic phase was washed with sat. NH4Cl(aq) (15 mL) and brine (15 
mL), dried over MgSO4, filtered and reduced. The residue was purified by flash column 
chromatography (silica, gradient elution 5:1 to 1:1 hexanes/EtOAc) to return starting 
material (100 mg) and acetonide 255  (32 mg).  
255: 1H NMR (300 MHz, CDCl3) δ 7.42 (m, 1H), 6.37 – 6.33 (m, 2H), 
5.09 (dd, J = 7.4, 6.5 Hz, 1H), 4.22 (dd, J = 8.3, 6.5 Hz, 1H), 4.10 (dd, 
J = 8.1, 7.7 Hz, 1H), 1.50 (s, 3H), 1.45 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 151.6, 143.0, 110.3, 109.9, 108.4, 71.2, 67.8, 26.3, 25.9. 
 
Benzyl 2,3-dideoxy-4,6-O-(1-methylethylidene)-α-D-erythro-
hex-2-enopyranoside (150) 
To a solution of diol 149 (255 mg, 1.08 mmol) and 2,2-
dimethoxypropane (397 μL, 3.24 mmol) in DMF (3 mL) was added 4Å molecular 
sieves (1g) and a 0.158 M solution of p-TsOH in DMF (137 μL, 22 μmol). The reaction 
was heated for 12 h at 50 ˚C. The cooled reaction was quenched with water (10 mL) and 
organics were extracted with EtOAc (3 x 15 mL). The combined organic layers were 
washed with sat. NaHCO3 (aq) (3 x 10 mL) and dried over MgSO4 before filtering and 
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reducing to give a colourless oil. The crude product was purified by flash column 
chromatography (silica, 10:1 hexanes/EtOAc) yielding a white solid (258 mg, 87%). mp 
110 – 112 °C. [α]D22 = +46.8 (c 1.05, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.26 
(m, 5H), 6.00 (d, J = 10.2 Hz, 1H), 5.71 (dt, J = 10.2, 2.5 Hz, 1H), 5.06 (dt, J = 2.5, 1.3 
Hz, 1H), 4.78 (d, J = 11.9 Hz, 1H), 4.59 (d, J = 11.9 Hz, 1H), 4.20 (m, 1H), 3.84 – 3.72 
(m, 3H), 1.51 (s, 3H), 1.43 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 137.9, 131.7, 128.4, 
127.9, 127.7, 126.5, 99.9, 94.3, 70.1, 67.7, 65.1, 63.0, 29.2, 19.0. IR (neat): 2995, 2913, 
1494, 1455, 1376, 1267, 1199, 1100, 1045, 950, 862, 742, 720 cm-1. Anal. Calcd for 
C16H20O4: C, 69.54; H, 7.30. Found: C, 69.44; H, 7.21. 
  
Benzyl 2,3-dideoxy-4,6-O-(1-methylethylidene)-α-D-erythro-
hexopyranoside (264) 
To a solution of acetonide 150 (21 mg, 76 μmol) in 5% NEt3 v/v 
EtOH (1 mL) was added Pd(OH)2/C (6.5 mg) and the flask was evacuated briefly. A H2 
balloon was attached into the sealed flask and the reaction stirred at rt for 12 h. The 
reaction mixture was filtered through Celite® and reduced to give a colourless oil. The 
crude product was purified by flash column chromatography (silica, 5:1 
hexanes/EtOAc) to give a colourless oil (16 mg, 76%). 1H NMR (300 MHz, CDCl3) δ 
7.38 – 7.26 (m, 5H), 4.86 (dd, J = 3.3, 0.9 Hz, 1H), 4.71 (d, J = 11.9 Hz, 1H), 4.46 (d, J 
= 11.9 Hz, 1H), 3.85 – 3.58 (m, 4H), 1.99 – 1.71 (m, 4H), 1.52 (s, 3H), 1.42 (s, 3H). 13C 
(125 MHz, CDCl3) δ 137.8, 128.4, 127.8, 127.7, 99.4, 95.9, 70.5, 68.7, 66.1, 62.9, 29.6, 
29.3, 24.4, 19.2. IR (neat): 2995, 2933, 1456, 1382, 1201, 1093, 1045, 909, 732 cm-1. 
 
2,3-Dideoxy-4,6-O-(1-methylethylidene)-D-erythro-hexose (152) 
To a solution of acetonide 150 (128 mg, 0.46 mmol) in EtOAc 
(7.5 mL) was added Pd(OH)2/C (14 mg) and the flask was 
evacuated briefly. A H2 balloon was attached into the sealed flask and the reaction 
stirred at rt with monitoring by TLC. The reaction was completed after 12 h and was 
filtered through Celite® before reducing to give a pale brown solid. The crude product 
was purified by flash column chromatography (silica, gradient elution 5:1 to 2:1 
hexanes/EtOAc) to give a white solid (69 mg, 79%). [α]D22 = +55.0 (c 0.20, CHCl3). 1H 
NMR (500 MHz, CDCl3) δ 9.77 (d, J = 2.6 Hz, 0.1H), 5.22 (s, 1Hα), 4.84 (d, J = 4.0 
Hz, 1Hβ), 3.87 (dd, J = 10.0, 5.1 Hz, 1H), 3.83 (dd, J = 11.7, 5.3 Hz, 1H), 3.79 – 3.73 
(m, 3H), 3.68 (t, J = 10.6 Hz, 1H), 3.60 – 3.55 (m, 2H), 3.28 (td, J = 9.8, 5.3 Hz, 1H), 
3.17 (s, 1H), 2.03 (m, 1H), 1.97 – 1.76 (m, 4H), 1.72 (m, 1H), 1.62 – 1.54  (m, 2H), 
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1.50 (s, 3H), 1.49 (s, 3H), 1.40 (s, 3H), 1.39 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
99.5, 99.5, 96.0, 91.3, 71.7, 70.6, 69.6, 65.9, 62.9, 62.5, 32.1, 29.6, 29.2, 29.2, 27.8, 
23.6, 19.1, 19.1. IR: 3422, 2949, 2878, 1378, 1270, 1085, 1044, 970, 874 cm-1. HRMS 
(ESI) calcd. for C9H16O4Na+ [M + Na]+ 211.0946, found 211.0947. 
 
8.3.2  The RB route 
 
Methyl 4,6-di-O-acetyl-2,3-deoxy-α-D-erythro-hex-2-
enopyranoside (172)231 
To a solution of glucal 147 (2.00 g, 7.38 mmol) in CH2Cl2 (40 
mL) and MeOH (0.360 mL, 8.86 mmol) at rt was added a 0.1 M solution FeCl3 in 
CH2Cl2 (0.738 mL, 73.8 μmol) and the reaction stirred for 1 h. The reaction was 
quenched with the addition of sat. NaHCO3 (aq) (40 mL) and stirred for 30 min at rt. The 
organic layer was separated and aqueous layer extracted with CH2Cl2 (3 x 50 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced to give a pale 
brown oil. The crude product was purified via flash column chromatography (silica, 
gradient elution 5:1 to 3:1 hexanes/EtOAc), yielding a colourless oil (1.51 g, 84%) 1H 
NMR (300 MHz, CDCl3) δ 5.89 (d, J = 10.4 Hz, 1H), 5.86 – 5.79 (m, 1H), 5.32 (dd, J = 
9.7, 1.3 Hz, 1H), 4.93 (s, 1H), 4.26 (dd, J = 12.1, 5.3 Hz, 1H), 4.18 (dd, J = 12.1, 2.4 
Hz, 1H), 4.08 (ddd, J = 9.6, 5.3, 2.4 Hz, 1H), 3.45 (s, 3H), 2.11 (s, 3H), 2.08 (s, 3H). 
Spectral data matched those reported in the literature.231 HRMS (ESI) calcd. for 
C11H20NO6+ [M + NH4+] 262.12851, found 262.12650. 
 
Methyl 4,6-di-O-acetyl-2,3-deoxy-α-D-erythro-hexopyranoside 
(173)92 
To a solution of methyl glycoside 172 (1.51 g, 6.19 mmol) in 
EtOAc (40 mL) was added 10% Pd/C (150 mg). The flask was briefly evacuated before 
creation of a H2(g) atmosphere with the attachment of a balloon full of H2(g). The reaction 
was left stirring under the H2(g) atmosphere for 12 h. The mixture was filtered through 
Celite® and reduced giving a colourless oil (1.51 g, 99%) that was determined to be pure 
by the 1H NMR spectroscopy. 1H NMR (300 MHz, CDCl3) δ 4.78 – 4.67 (m, 2H), 4.26 
(dd, J = 12.0, 5.3 Hz, 1H), 4.11 (dd, J = 12.0, 1.8 Hz, 1H), 3.90 (ddd, J = 9.5, 4.9, 1.8 
Hz, 1H), 3.37 (s, 3H), 2.09 (s, 3H), 2.04 (s, 3H), 2.02 – 1.70 (m, 4H). Spectral data 
matched those reported in the literature.232 
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Methyl 2,3-deoxy-α-D-erythro-hexopyranoside (174)92 
To a solution of diacetate 173 (6.17g, 25.1 mmol) in MeOH (125 
mL) was added K2CO3 (231 mg, 1.67 mmol). The reaction was left 
to stir at rt for 3 h, after which it was filtered and reduced to dryness. The crude white 
solid was dissolved in 1:1 hexanes/EtOAc (20 mL) with 10 drops of AcOH and MeOH 
and purified by flash column chromatography (silica, gradient elution 1:1 
hexanes/EtOAc to EtOAc) yielding a white solid (3.78, 93%) 1H NMR (300 MHz, 
CDCl3) δ 4.67 (s, 1H), 3.83 (d, J = 3.9 Hz, 2H), 3.67-3.49 (m, 2H), 3.35 (s, 3H), 1.92-
1.70 (m, 4H). Spectral data matched those reported in the literature.233 
 
Methyl 4,6-di-O-bis(tert-butyldimethylsilyl)-2,3-deoxy-α-D-
erythro-hexopyranoside (175)92 
To a solution of diol 174 (3.78, 23.3 mmol) in DMF (45 mL) 
were added TBSCl (8.45 g, 55.9 mmol) and imidazole (3.17 g, 46.6) at 0 ˚C. The 
reaction was allowed to warm to rt as it stirred for 12 h. The reaction was diluted with 
EtOAc (100 mL), washed with water (100 mL), sat. NaHCO3(aq) (5 x 50 mL) and brine 
(50 mL) before drying over MgSO4 and reducing to dryness. The crude oil was loaded 
neat on a silica column and eluted with 10:1 hexanes/EtOAc to afford a colourless oil 
(7.92 g, 87%). Rf  = 0.79. 1H NMR (500 MHz, CDCl3) δ 4.66 (d, J = 3.3 Hz, 1H), 3.88 
(d, J = 10.9 Hz, 1H), 3.65 (dd, J = 11.3, 5.7 Hz, 1H), 3.55 – 3.43 (m, 2H), 3.35 (s, 3H), 
1.84 – 1.72 (m, 3H), 1.72 – 1.65 (m, 1H), 0.90 (s, 9H), 0.87 (s, 9H), 0.06 (s, 6H), 0.05 
(s, 6H). 13C NMR (125 MHz, CDCl3) δ 97.0, 74.5, 67.0, 63.3, 54.1, 29.1, 28.0, 26.0, 
25.7, 18.4, 17.9, -4.1, -4.9, -5.1, -5.3. Spectral data matched those reported in the 
literature.234 
 
Methyl 4-O-(tert-butyldimethylsilyl)-2,3-deoxy-α-D-erythro-
hexopyranoside (176)92 
To a solution of bis-TBS ether 175 (7.92 g, 20.2 mmol) in 1:1 
MeOH/CH2Cl2 (200 ml) at 0 ˚C was added (±)-CSA (469 mg, 2.02 mmol). The reaction 
was stirred at 0 ˚C for 2.5 h. The reaction was quenched with the addition of NEt3 (280 
μL, 2.02 mmol) and the solvent removed. The crude product was purified using flash 
column chromatography (silica, gradient elution 10:1 to 1:1 hexanes/EtOAc) returning 
starting material (477 mg) and yielding a colourless oil (5.01 g, 96% recovered). Rf  = 
0.42.  1H NMR (300 MHz, CDCl3) δ 4.65 (d, J = 2.7 Hz, 1H), 3.78 (d, J = 11.1 Hz, 1H), 
3.66 (dd, J = 11.5, 3.2 Hz, 1H), 3.61 – 3.46 (m, 2H), 3.34 (s, 3H), 1.99 (s, 1H), 1.95 – 
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1.48 (m, 4H), 0.86 (s, 9H), 0.06 (s, 6H). Spectral data matched those reported in the 
literature.92 
 
Methyl 4-O-(tert-butyldimethylsilyl)-2,3-deoxy-α-D-
hexodialdo-1,5-pyranoside (177) 
To a solution of the alcohol 176 (34 mg, 0.123 mmol) in 
CH2Cl2 (1 mL) at 0 °C was added TEMPO (2.0 mg, 12.3 μmol) and BAIB (46 mg, 
0.142 mmol). The reaction was left to warm to rt and stirred for 12 h. The reaction was 
quenched with the addition of sat. Na2S2O3 (aq) (2.5 mL) and extracted with CH2Cl2 (3 x 
2.5 mL). The combined organic fractions were washed with NaHCO3 (aq) (10 mL), dried 
over MgSO4, filtered and reduced to give a pale orange oil (31 mg). The 1H NMR of the 
crude product indicated there was a 1:1 ratio of starting material to product (15.5 mg, 
46%).  
 
Methyl 4-O-(tert-butyldimethylsilyl)-2,3-deoxy-α-D-
hexodialdo-1,5-pyranoside (177)92  
To a solution of oxalyl chloride (0.47 mL, 5.4 mmol) in 
CH2Cl2 (7.5 mL) was added DMSO (0.52 mL, 7.3 mmol) at -78 ˚C under an argon 
atmosphere. After stirring for 15 min, a solution of alcohol 176 (1.00 g, 3.62 mmol) in 
CH2Cl2 (2 mL) was added at -78 ˚C and the mixture stirred for 1 h. After this time Et3N 
(2.5 mL, 18 mmol) was added at -78 ˚C and the mixture was stirred at rt for 1 h. The 
reaction was quenched with NaHSO3 (aq) (20 mL) and washed with NaHCO3 (aq) (2 x 20 
mL). The organics were dried over MgSO4, filtered and reduced to give an orange oil. 
The oil was purified by flash column chromatography (silica, 5:1 hexanes/EtOAc) give 
a colourless oil (685 mg, 68%). 1H NMR (500 MHz, CDCl3) δ 9.82 (s, 1H), 5.30 (s, 
1H), 4.76 (d, J = 2.3 Hz, 1H), 4.11 (d, J = 9.7 Hz, 1H), 3.75 (ddd, J = 10.5, 9.8, 4.8 Hz, 
1H), 3.35 (s, 3H), 1.93 (m, 1H), 1.87 – 1.80 (m, 2H),  1.72 (tdd, J = 13.7, 4.6, 3.5 Hz, 
1H), 0.88 (s, 9H), 0.08 (s, 3H), 0.05 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 199.7, 97.5, 
77.3, 67.8, 55.0, 28.4, 28.4, 25.6, 17.9, -4.0, -5.0. 
 
Methyl 4-O-(tert-butyldimethylsilyl)-2,3-deoxy-α-D-erythro-
hept-6-enose (178)93 
To a suspension of the Ph3P+CH3Br- (820 mg, 2.23 mmol) in 
THF (10 mL) at -78 ˚C was added dropwise a 1.6M solution of n-BuLi in hexanes (1.44 
mL, 2.23 mmol). To the resulting yellow solution was added aldehyde 177 (574 mg, 
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2.09 mmol) dissolved in THF (10 mL). The reaction was allowed to warm to rt slowly 
whilst stirring for 2 h. The reaction was quenched with NH4Cl (aq) (20 mL) and extracted 
with EtOAc (3 x 20 mL). The crude product was purified via flash column 
chromatography (silica, gradient elution 10:1 to 5:1 hexanes/EtOAc), yielding a 
colourless oil (405 mg, 72%). Rf  = 0.67.  1H NMR (500 MHz, CDCl3) δ 5.88 (ddd, J = 
17.3, 10.6, 6.3 Hz, 1H), 5.33 (ddd, J = 17.3, 2.0, 1.4 Hz, 1H), 5.19 (ddd, J = 10.5, 2.0, 
1.4 Hz, 1H), 4.68 (d, J = 3.1 Hz, 1H), 3.91 (dd, J = 9.1, 6.3 Hz, 1H), 3.35 (m, 1H), 3.34 
(s, 3H), 1.89 – 1.71 (m, 4H), 0.86 (s, 9H), 0.04 (s, 3H), 0.02 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ 136.7, 116.8, 97.3, 74.1, 70.9, 54.4, 29.2, 28.2, 25.8, 18.0, -4.2, -4.6. 
Spectral data matched those reported in the literature.235 
 
Attempted synthesis of 4-O-(tert-Butyldimethylsilyl)-2,3-
deoxy-D-erythro-hept-6-enose (179) 
 
A. A solution of methyl glycoside 178 (103 mg, 0.38 mmol) in THF (5 mL) and 6% 
HCl (aq) (1.25 mL) was stirred for 18 h. The reaction mixture was extracted with EtOAc 
(3 x 10 mL). The combined organic fraction were dried over MgSO4, filtered and 
reduced. The crude residue contained a complex mixture of products as visualised by 
TLC and 1H NMR spectroscopy. 
 
B. To a solution of methyl glycoside 178 (118 mg, 0.432 mmol) in 1,4-dioxane (3 mL) 
was added 10% HCl (1 mL). The reaction was stirred at rt for 30 min before refluxing 
for 2 h. The cooled reaction was extracted with EtOAc (3 x 10 mL). The combined 
organic fraction were dried over MgSO4, filtered and reduced. The purification of the 
crude product was attempted by flash column chromatography (silica, eluent gradient 
3:1 to 1:2 hexanes/EtOAc). No compounds from the reaction were isolated in suitable 
quantity and purity to be characterised by standard NMR techniques. 
 
C. To a solution of methyl glycoside 178 (103 mg, 0.38 mmol) in 1,4-dioxane (3 mL) 
was added 50% AcOH (2 mL). The reaction was heated to 50 °C for 2h. The cooled 
reaction was extracted with EtOAc (3 x 10 mL). The combined organic fraction were 
dried over MgSO4, filtered and reduced. The crude residue contained a complex mixture 
of products as visualised by TLC and 1H NMR spectroscopy. 
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D. To a solution of methyl glycoside 178 (127 mg, 0.468 mmol) in 1,4-dioxane (3 mL) 
was added 10% HCl (1 mL). The reaction was heated to 50 °C for 2h. The cooled 
reaction was extracted with EtOAc (3 x 10 mL). The combined organic fraction were 
dried over MgSO4, filtered and reduced. The crude residue contained a complex mixture 
of products as visualised by TLC and 1H NMR spectroscopy. 
 
Reduction of the crude residue from hydrolysis attempt C (above). 
To a solution of the crude product 179 (attempt C) (44 mg, 
~0.306 mmol) in MeOH (1 mL) at 0 °C was added NaBH4 (23 
mg, 0.612 mmol). Stirred at rt for 12 h. The reaction was 
quenched with the addition of water (5 mL) and extracted with EtOAc (3 x 5 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced. The crude 
residue contained a complex mixture of products as visualised by TLC and 1H NMR 
spectroscopy. 
 
Methyl 2,3-O-(1-methylethylidene)-β-D-ribofuranoside (182)98 
A solution of D-ribose (85) (25 g, 167 mmol) in Me2CO (95 mL), 
MeOH (95 mL) and conc. HCl (2.5 mL) was heated under reflux 
for 8 h. The reaction was poured into 200 mL of water and the 
organic solvents were removed under reduced pressure. The aqueous layer was 
extracted with Et2O (3 x 100 mL). The combined organics were dried over MgSO4, 
filtered and reduced, giving the title compound as a colourless oil (18.7 g, 55%), which 
was immediately reacted on without further purification. Rf = 0.29.  1H NMR (500 
MHz, CDCl3) δ 4.97 (s, 1H), 4.84 (d, J = 5.9 Hz, 1H), 4.59 (d, J = 5.9 Hz, 1H), 4.44 (t, 
J = 2.6 Hz, 1H), 3.70 (dt, J = 12.6, 2.4 Hz, 1H), 3.62 (ddd, J = 12.6, 10.7, 3.4 Hz, 1H), 
3.44 (s, 3H), 3.23 (dd, J = 10.7, 2.6 Hz, 1H), 1.49 (s, 3H), 1.32 (s, 3H). Spectral data 
matched those reported in the literature.236 
 
The aqueous layer was reduced to half its volume and extracted again with Et2O (3 x 50 
mL). The organic layer was dried over MgSO4, filtered and reduced giving methyl-β-D-
ribofuranoside as a pale brown oil (1.88 g, 7%). The aqueous layer was finally reduced 
to dryness returning the unreacted D-ribose (8.1 g, 32%). 
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Methyl 5-(4-methylbenzenesulfonate)-2,3-O-(1-
methylethylidene)-β-D-ribofuranoside (183)98 
Crude methyl 2,3-O-(1-methylethylidene)-β-D-ribofuranoside 
(18.7 g, 97 mmol) was dissolved in dry pyridine (40 mL) and cooled to 0 °C. To this 
was added tosyl chloride (23.2 g, 122 mmol) and the reaction was allowed to warm to rt 
as it stirred for 15 h. The reaction mixture was cooled to 0 °C and was quenched by the 
addition of H2O (100 mL), then extracted with Et2O (2 x 100 mL). The organic layer 
was washed with 5% H2SO4 (2 x 50 mL), 0.2 M KOH (3 x 50 mL) and H2O (100 mL). 
The organic layer was dried over MgSO4, filtered and solvent removed under reduced 
pressure. The crude solid was recrystallised from EtOH, yielding a white solid, 
collected over three crops (29.2 g, 84%). mp 80 – 81 °C (lit.237 mp 80 – 84). Rf = 0.67. 
1H NMR (300 MHz, CDCl3) δ 7.80 (d, J = 8.3 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 4.93 
(s, 1H), 4.60 (d, J = 5.9 Hz, 1H), 4.53 (d, J = 5.9 Hz, 1H), 4.31 (t, J = 7.5 Hz, 1H), 4.01 
(dd, J = 7.2, 1.5 Hz, 2H), 3.23 (s, 3H), 2.45 (s, 3H), 1.44 (s, 3H), 1.28 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 145.1, 132.7, 129.9, 128.0, 112.7, 109.4, 84.8, 83.5, 81.3, 69.1, 
55.0, 26.3, 24.8, 21.6. Spectral data matched those reported in the literature.238 
 
Methyl 5-deoxy-5-iodo-2,3-O-(1-methylethylidene)-β-D-
ribofuranoside (184)98 
To a solution of tosylate 183 (21.9 g, 61.2 mmol) in methyl ethyl 
ketone (200 mL) was added NaI (18.4 g, 122 mmol). The reaction 
was refluxed for 24 h before it was cooled to rt and the solvent removed. The crude 
yellow oil was dissolved in EtOAc and washed with H2O (2 x 50 mL) and brine (50 
mL). The organic layer was dried over MgSO4, filtered and reduced to give the iodide 
as a yellow oil (19.0 g, 99%). Rf  = 0.67. The 1H NMR spectrum of the crude product 
confirmed its purity and it was used without further purification. [α]D22 = -68.3 (c 1.00, 
CHCl3) [lit.98 -69.7 (c 2.55, CHCl3)]. 1H NMR (500 MHz, CDCl3) δ 5.05 (s, 1H), 4.77 
(d, J = 5.8 Hz, 1H), 4.63 (d, J = 5.9 Hz, 1H), 4.44 (dd, J = 10.1, 6.0 Hz, 1H), 3.37 (s, 
3H), 3.29 (dd, J = 9.9, 6.0 Hz, 1H), 3.16 (t, J = 10.0 Hz, 1H), 1.49 (s, 3H), 1.33 (s, 3H). 
Spectral data matched those reported in the literature.239 
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Methyl (2Z,4S,5R)-4,5-O-(1-methylethylidene)-hepta-2,6-
dienoate [(Z)-186] and Methyl (2E,4S,5R)-4,5-O-(1-
methylethylidene)-hepta-2,6-dienoate [(E)-186] 
To iodide 184 (2.05 g, 6.52 mmol) in MeOH (30 mL) was added activated zinc (3.00 g, 
45.9 mmol) and AcOH (100 μL) before the mixture was refluxed for 4 h. After this time 
another portion of zinc (1.50 g, 23.0 mmol) was added and the reaction refluxed for a 
further 4 h. Once TLC had confirmed the consumption of starting material, the reaction 
mixture was cooled and filtered through a wad of silica to remove the excess zinc and 
zinc salts.  
 
The filtrate was cooled to 0 °C and methyl (triphenylphosphoranylidene)acetate (2.62 g, 
7.83 mmol) was added to the solution. The reaction was left to warm up over 12 h. The 
solvent was removed and the crude product partitioned between EtOAc (100 mL) and 
NH4Cl (aq) (100 mL). The aqueous layer was extracted a further with EtOAc (2 x 50 
mL). The combined organic fractions where dried over MgSO4, filtered and 
concentrated under reduced pressure. The resulting pale yellow oil was purified using 
flash column chromatography (silica,10:1 hexanes/EtOAc), yielding the α,β-unsaturated 
ester 186 as a colourless oil [1.06 g, 74% (E/Z = 1:4.7)]. Rf (E/Z) = 0.59/0.51. A portion 
was subjected to careful flash column chromatography for the purposes of 
characterization to yield separated samples of (Z)-186 and (E)- 186. [(Z)-186]: [α]D22 = 
+216.8 (c 1.00, CHCl3). Rf  = 0.59.  1H NMR (500 MHz, CDCl3) δ 6.20 (dd, J = 11.6, 
7.5 Hz, 1H), 5.90 (dd, J = 11.6, 1.6 Hz, 1H), 5.68 (td, J = 7.3, 1.5 Hz, 1H), 5.66 (ddd, J 
= 17.4, 10.2, 7.2 Hz, 1H), 5.28 (ddd, J = 17.1, 1.7, 1.3 Hz, 1H), 5.15 (ddd, J = 10.3, 7.2, 
1.1 Hz, 1H), 4.87 (tt, J = 7.1, 0.9 Hz, 1H), 3.72 (s, 3H), 1.55 (s, 3H), 1.42 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 166.1, 146.8, 134.0, 121.0, 117.9, 109.2, 79.7, 75.6, 51.5, 
27.7, 25.1. IR (KBr): 2985, 2945, 1722, 1648, 1439, 1406, 1381, 1224, 1198, 1179, 
1046, 1001, 927, 876, 825 cm-1. HRMS (ESI) calcd. for C11H16O4Na+ [M + Na]+ 
235.0946, found 235.0942.  [(E)-186]: Rf = 0.51. 1H NMR (500 MHz, CDCl3) δ 6.79 
(dd, J = 15.6 5.5 Hz, 1H), 6.08 (dd, J = 15.6, 1.6 Hz, 1H), 5.69 (ddd, J = 17.1, 10.3, 7.6 
Hz, 1H), 5.37 (dd, J = 17.1, 1.5 Hz, 1H), 5.27 (ddd, J = 10.3, 1.5, 0.9 Hz, 1H), 4.78 
(ddd, J = 7.0, 5.6, 1.6 Hz, 1H), 4.71 (tt, J = 7.0, 0.9 Hz, 1H), 3.75 (s, 3H), 1.56 (s, 3H), 
1.42 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 166.4, 143.9, 133.4, 122.2, 119.3, 109.6, 
79.8, 77.5, 51.7, 27.7, 25.4. 
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Ethyl (2Z)-3-[(4S,5R)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-
yl]acrylate (266) 
To iodide 184 (1.05 g, 3.34 mmol) in EtOH (15 mL) was added 
activated zinc (1.60 g, 24.4 mmol) and the mixture was refluxed for 4 h. After this time 
another portion of Zinc (0.80 g, 12.2 mmol) was added and the reaction refluxed for a 
further 4 h. Once TLC had confirmed the consumption of starting material, the reaction 
mixture was cooled and filtered through a wad of silica to remove the excess zinc and 
zinc salts.  
 
To the cooled filtrate (0 °C) was added phosphonate (803 μL, 4.01 mmol) and a solution 
of freshly prepared NaOEt (547 mg, 8.02 mmol) in EtOH (2 mL). The reaction was left 
warm to rt while stirring for 12 h. The organic solvent was removed and the crude 
residue partitioned between EtOAc (50 mL) and sat. NH4Cl (aq) (50 mL). The aqueous 
layer was extracted a further with EtOAc (2 x 25 mL). The pale orange oil was purified 
using flash column chromatography (silica, 10:1 hexanes/EtOAc) yielding the α,β-
unsaturated ester as a colourless oil (462 mg, 65% (E/Z = 10:1)). (E): Rf  = 0.63. 1H 
NMR (500 MHz, CDCl3) δ 6.18 (dd, J = 11.6, 7.5 Hz, 1H), 5.89 (dd, J = 11.6, 1.6 Hz, 
1H), 5.69 (td, J = 7.3, 1.6 Hz, 1H), 5.66 (dd, J = 16.8, 10.4, 7.1 Hz, 1H), 5.28 (ddd, J = 
17.0, 1.7, 1.2 Hz, 1H), 5.16 (ddd, J = 10.3, 1.7, 1.1 Hz, 1H), 4.87 (tt, J = 7.1, 1.0 Hz, 
1H), 4.17 (q, J = 7.1 Hz, 2H), 1.55 (s, 3H), 1.42 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H). (Z): 1H 
NMR (500 MHz, CDCl3) δ 6.86 (dd, J = 15.6, 5.4 Hz, 1H), 6.12 (dd, J = 15.6, 1.5 Hz, 
1H), 5.83 (ddd, J = 17.2, 10.4, 7.2 Hz, 1H), 5.41 (dt, J = 17.1, 1.1 Hz, 1H),  5.32 (ddd, J 
= 10.3, 1.3, 0.9 Hz, 1H), 4.25 (ddd, J = 7.8, 5.0, 1.0 Hz, 1H) 4.21 (q, J = 7.1 Hz, 2H), 
4.14 (m, 1H), 1.48 (s, 3H), 1.46 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H). 
 
Methyl (4S,5R)-4,5-O-(1-methylethylidene)-hept-6-enoate 
(267) 
To a solution of α,β-unsaturated ester 186 (519 mg, 2.45 mmol), 
CuCl (186 mg, 1.88 mmol) and cyclohexene (960 μL, 9.43 mmol) in MeOH (40 mL) at 
-78 °C was added NaBH4 (446 mg, 11.8 mmol). The reaction was left at -78 °C for 1 h, 
during which time it turned from green to brown. While still cold, the solvent was 
removed on the rotavap. The products were partitioned between sat. NH4Cl (aq) (50 mL) 
and Et2O (50 mL). The organic phase was separated and the aqueous layer was 
extracted with more Et2O (4 x 20 mL). The organic layers were combined, dried with 
MgSO4, filtered and reduced to give a colourless oil (520 mg, 96%). The product was 
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deemed sufficiently pure by 1H NMR for use without further purification. Rf = 0.46. 
[α]D22 = -31.0 (c 1.00, CHCl3). 1H NMR (500 MHz, CDCl3) δ 5.82 (ddd, J = 17.2, 10.3, 
7.6 Hz, 1H), 5.34 (ddd, J = 17.1, 1.7, 1.1 Hz, 1H), 5.26 (ddd, J = 10.3, 1.6, 0.9 Hz, 1H), 
4.54 (dd, J = 7.5, 6.4 Hz, 1H), 4.16 (ddd, J = 8.8, 6.2, 5.4 Hz, 1H), 3.67 (s, 3H), 2.49 
(ddd, J = 16.3, 8.3, 6.4 Hz, 1H), 2.40 (ddd, J = 16.4, 8.5, 7.4 Hz, 1H), 1.81 – 1.70 (m, 
2H), 1.47 (s, 3H), 1.36 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 173.6, 133.7, 118.6, 
108.4, 79.5, 77.2, 51.7, 30.7, 28.2, 26.2, 25.7. IR (KBr): 2987, 2935, 1736, 1645, 1440, 
1371, 1255, 1217, 1162, 1067, 1011, 931, 871 cm-1. HRMS (ESI) calcd. for 
C11H18O4Na+ [M + Na]+ 237.1103, found 237.1100. 
 
Attempted reduction of the α,β-unsaturated ester 186 with 
Mg/MeOH yielding methyl (3E,5R)-5-hydroxyhepta-3,6-
dienoate (269)105 
To a solution of α,β-unsaturated ester 186 (44 mg, 0.206 mmol) in MeOH (8 mL) was 
added Mg turnings (50 mg, 2.06 mmol). After ~15 min of stirring the reaction mixture 
began to evolve gas and over 4 h a white emulsion formed. The reaction was quenched 
with the addition of water (10 mL). The organics were extracted with Et2O (3 x 10 mL). 
The combined organic fractions were dried over MgSO4, filtered and reduced to give a 
colourless oil. The crude oil was purified by flash column chromatography (silica, 3:1 
hexanes/EtOAc) to give heptadienoate 269 as a colourless oil (18 mg, 56%). Rf  = 0.26.  
1H NMR (500 MHz, CDCl3) δ  6.97 (dt, J = 15.7, 7.4 Hz, 1H), 5.93 (dt, J = 15.7, 1.4 
Hz, 1H), 5.89 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H), 5.29 (dt, J = 17.2, 1.2 Hz, 1H), 5.18 (dt, 
J = 10.4, 1.0 Hz, 1H), 4.29 (dd, J = 12.1, 6.2 Hz, 1H), 3.74 (s, 3H), 2.52 – 2.42 (m, 2H). 
13C NMR (125 MHz, CDCl3) δ 166.5, 144.5, 139.6, 123.6, 115.6, 71.6, 51.6, 39.8. 
 
Attempted reduction of the α,β-unsaturated ester 186 with LAH 
To a suspension of LAH (27 mg, 0.701 mmol) in Et2O (5 mL) cooled to -78 °C was 
added α,β-unsaturated 186 (50 mg, 0.234 mmol) in Et2O (2 mL). The reaction was 
stirred at -78 °C for 1.5 h before slowly warming to rt over 1.5 h. The reaction was 
quenched with wet Na2SO4. The aluminium salts were filtered through Celite®, washing 
the solid with Et2O. The filtrate was reduced to give a colourless oil which was purified 
by flash column chromatography (silica, 5:1 hexanes:EtOAc) yielding saturated ester 
267 (7 mg, 14%) and an inseparable mixture of alcohols 270 (major) and 187 (minor) 
(~4.5:1, 28 mg, 63%). 267: Rf = 0.56. 1H NMR (300 MHz, CDCl3) δ 5.82 (ddd, J = 
17.1, 10.2, 7.7 Hz, 1H), 5.34 (dd, J = 17.2, 2.7 Hz, 1H), 5.27 (dd, J = 10.3, 2.5 Hz, 1H), 
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4.54 (t, J = 7.3 Hz, 1H), 4.15 (dd, J = 13.7, 7.5 Hz, 1H), 3.68 (s, 3H), 2.58 – 2.24 (m, 
2H), 1.74 (dd, J = 14.5, 8.1 Hz, 2H), 1.47 (s, 3H), 1.36 (s, 3H). 270: Rf = 0.21.  1H NMR 
(300 MHz, CDCl3) δ 5.92 – 5.80 (m, 3H), 5.30 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 10.3 
Hz, 1H), 4.63 (m, 2H), 4.17 (d, J = 5.1 Hz, 1H), 1.52 (s, 3H), 1.40 (s, 3H). 
 
Attempted reduction of the α,β-unsaturated ester 186 with NaBH4  
To a solution of α,β-unsaturated ester 186 (20 mg, 93 μmol) in MeOH (1 mL) at 0 °C 
was added NaBH4 (18 mg, 0.467 mmol). The reaction was left to warm to rt with 
stirring over 3 h. The reaction was quenched with the addition of sat. NH4Cl (aq) (10 mL) 
and extracted with CH2Cl2 (4 x 5 mL). The combined organic layers were dried over 
MgSO4, filtered and reduced to give a colourless oil (19 mg). 1H NMR spectroscopy 
confirmed that starting material was recovered.  
 
Attempted reduction of the α,β-unsaturated ester 186 with 
NiCl2/NaBH4 that yielded methyl 3-[(4S,5R)-5-ethyl-2,2-
dimethyl-1,3-dioxolan-4-yl]propanoate (271)106 
A solution of α,β-unsaturated ester 186 (55 mg, 0.257 mmol) and NiCl2.6H2O (30.5 mg, 
0.129) in MeOH (4 mL) was cooled down to -40 °C. To this solution was added NaBH4 
(49 mg, 1.29 mmol) in portions over 10 min. The solution slowly turned black. The 
reaction was stirred at -40 °C for a further 30 min before filtering the cold solution 
through Celite®. The filtrate was reduced to dryness before redissolving in CH2Cl2 (10 
mL) and washing with sat. NaHCO3(aq) (20 mL). The aqueous layer was further 
extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were dried over 
MgSO4, filtered and reduced to give propanoate 271 a colourless oil (46 mg, 84%). 1H 
NMR (500 MHz, CDCl3) δ 4.01 (m, 2H), 3.67 (s, 3H), 2.54 (ddd, J = 16.4, 8.5, 7.0 Hz, 
1H), 2.40 (ddd, J = 16.6, 8.4, 7.4 Hz, 1H), 1.73 (dd, J = 13.9, 7.4 Hz, 2H), 1.58 (dt, J = 
13.7, 7.2 Hz, 1H), 1.48 (m, 1H), 1.42 (s, 3H), 1.33 (s, 3H), 0.99 (t, J = 7.3 Hz, 3H). 13C 
NMR (125 MHz, CDCl3) δ 173.8, 107.6, 79.3, 76.8, 51.6, 30.6, 28.6, 26.0, 25.3, 22.5, 
10.8. HRMS (ESI) calcd. for C11H20O4Na+ [M + Na]+ 239.1259, found 239.1260.  
 
Attempted reduction of the α,β-unsaturated ester 186 with 
CoCl2/NaBH4 yielding methyl 3-[(4S,5R)-5-ethyl-2,2-
dimethyl-1,3-dioxolan-4-yl]propanoate (271)190  
A solution of α,β-unsaturated ester 186 (55 mg, 0.257 mmol) and CoCl2.6H2O (12 mg, 
51 μmol) in MeOH (4 mL) was stirred at rt for 15 min. To this solution was added 
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NaBH4 (39 mg, 1.03 mmol). The reaction was stirred at rt for 30 min before quenching 
with water (5 mL) and extraction with CH2Cl2 (3 x 5 mL). The combined organic layers 
were dried over MgSO4, filtered and reduced. The crude residue was purified by flash 
column chromatography (silica, gradient elution 10:1 to 3:1 hexanes/EtOAc) to give a 
colourless oil (37 mg, 67%). H NMR (500 MHz, CDCl3) δ 4.01 (m, 2H), 3.67 (s, 3H), 
2.53 (ddd, J = 16.6, 8.6, 7.5 Hz, 1H), 2.40 (ddd, J = 16.6, 8.4, 7.2 Hz, 1H), 1.73 (dd, J = 
14.7, 7.8 Hz, 2H), 1.58 (m, 1H), 1.47 (m, 1H), 1.42 (s, 3H), 1.33 (s, 3H), 0.99 (t, J = 7.4 
Hz, 3H). The 1H NMR data was a close match with that of the NiCl2 reduction and the 
product was taken as being 271. 
 
Attempted reductions of the α,β-unsaturated ester 186 with CuCl2/NaBH4108 
A. To a solution of α,β-unsaturated ester 186 (50 mg, 0.234 mmol) in MeOH (4 mL) at 
0 °C was added CuCl2 (24 mg, 0.175 mmol). At this point, NaBH4 (44 mg, 1.17 mmol) 
was added in portions over 5 min and the reaction allowed to warm to rt and stir 12 h. 
The reaction was quenched with the addition of sat. NH4Cl (aq) (10 mL) and extracted 
with CH2Cl2 (4 x 5 mL). The combined organic layers were dried over MgSO4, filtered 
and reduced to give a colourless oil. The crude product was purified using flash column 
chromatography (silica, 10:1 hexanes/EtOAc) returning 186 (9 mg, 38%) and affording 
an inseparable mixture of desire product 267 and compound 271 as a colourless oil 
(~2:1, 23 mg, 56%). Rf = 0.54. 1H NMR (500 MHz, CDCl3) δ 5.81 (ddd, J = 17.1, 10.3, 
7.6 Hz, 1H), 5.34 (ddd, J = 17.1, 1.6, 1.1 Hz, 1H), 5.26 (ddd, J = 10.3,1.6, 0.9 Hz, 1H), 
4.54 (dd, J = 7.4, 6.4 Hz, 1H), 4.15 (ddd, J = 8.8, 6.2, 5.5 Hz, 1H), 4.02 (ddt, J = 10.6, 
8.5, 5.6 Hz, 1H, minor), 3.67 (s, 3H), 2.58 – 2.45 (m, 1H), 2.40 (dtd, J = 14.1, 7.9, 6.3 
Hz, 1H), 1.78 – 1.71 (m, 2H), 1.62 – 1.54 (m, 0.5H, minor), 1.54 – 1.46 (m, 0.5H, 
minor), 1.47 (s, 3H), 1.43 (s, 1.5H, minor), 1.36 (s, 3H), 1.33 (s, 1.5H, minor), 1.00 (t, J 
= 7.4 Hz, 1.5H, minor). 13C NMR (125 MHz, CDCl3) δ 173.8 (minor), 173.6, 133.7, 
118.6, 108.4, 107.6, (minor) 79.5, 79.4 (minor), 77.2, 76.9 (minor), 51.6, 51.6 (minor), 
30.7, 30.6 (minor), 28.6 (minor), 28.2, 26.2, 26.0 (minor), 25.7, 25.4 (minor), 22.6 
(minor), 10.8 (minor).  
γ-trans-1-Propenyl-γ-butyrolactone (272): Lactone 272 was also 
isolated (5 mg, 17%). Rf = 0.30. 1H NMR (300 MHz, CDCl3) δ 5.83 
(dq, J = 15.2, 6.5 Hz, 1H), 5.52 (dddd, J = 15.3, 7.0, 3.1, 1.5 Hz, 1H), 
4.89 (q, J = 7.2 Hz, 1H), 2.54 (m, 2H), 2.36 (dt, J = 13.6, 6.5 Hz, 1H), 1.98 (m, 1H), 
1.78 – 1.72 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 176.5, 130.1, 128.2, 80.7, 28.4, 
28.4, 17.4. Spectral data matched those reported in the literature.240 
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B. To a solution of α,β-unsaturated ester 186 (88.5 mg, 0.411 mmol) in MeOH (5 mL) 
was added NaBH4 (78 mg, 2.06 mmol) in portions over 5 min at 0 °C. To this was 
added CuCl2 (41.5 mg, 0.308 mmol) slowly over 5 min. The reaction was warmed to rt 
and stirred for 1 h. The solvent was removed and the residue partitioned between NH4Cl 
(aq) (10 mL) and CH2Cl2 (10 mL). The aqueous layer was further extracted with 
CH2Cl2 (3 x 10 mL). The combined organic fractions were combined dried over 
MgSO4, filtered and reduced to give a colourless oil which was purified using flash 
column chromatography (silica, gradient elution 10:1 to 3:1 hexanes/EtOAc) returning 
186 (21 mg, 24%), a mixture of compounds 267 and 271 (~5.6:1, 47 mg, 53%), lactone 
272 (5 mg, 10%) and alcohol 273 (2 mg, 3%).   
Methyl (4S,5E)-4-hydroxyhept-5-enoate (273): Rf = 0.28. 1H 
NMR (500 MHz, CDCl3) δ 5.69 (dq, J = 15.2, 6.5 Hz, 1H), 
5.48 (dd, J = 15.3, 7.0 Hz, 1H), 4.10 (q, J = 6.3 Hz, 1H), 3.68 
(s, 3H), 2.42 (t, J = 7.4 Hz, 2H), 1.85 (dd, J = 13.5 , 7.2 Hz, 2H), 1.71 (d, J = 6.5 Hz, 
3H). 13C NMR (125 MHz, CDCl3) δ 176.91, 130.52, 128.61, 81.10, 28.84, 28.82, 17.77. 
 
C. To a solution of α,β-unsaturated ester 186 (60 mg, 0.280 mmol) in 3:1 MeOH/THF 
(4 mL) at 0 °C was added CuCl2 (28 mg, 0.210 mmol). At this point, NaBH4 (53 mg, 
1.40 mmol) was added in portions over 5 min and the reaction allowed to warm to rt 
and stirred for 12 h. The reaction was quenched with the addition of sat. NH4Cl (aq) (10 
mL) and extracted with CH2Cl2 (4 x 5 mL). The combined organic layers were dried 
over MgSO4, filtered and reduced to give a colourless oil. The crude product was 
purified using flash column chromatography (silica, gradient elution 10:1 to 3:1 
hexanes/EtOAc) returning 186 (22 mg, 37%) and a mixture of compounds 267 and 271 
(~5.2:1, 34 mg, 56%). 
 
D. To a solution of α,β-unsaturated ester 186 (65.5 mg, 0.306) and CuCl2 (41 mg, 0.306 
mmol) in MeOH (5 mL) at -78 °C was added NaBH4 (58 mg, 1.53 mmol) in portions 
over 10 min. The solution turned from pale green to brown and a black precipitate (ppt) 
began to form. The reaction was left at -78 °C for 15 min before warming to rt for 45 
min. The reaction was quenched with sat. NH4Cl (aq) (15 mL) and extracted with EtOAc 
(3 x 15 mL). The combined organic fractions were dried over MgSO4, filtered and 
reduced to give a colourless oil which was purified using flash column chromatography 
(silica, gradient elution 10:1 to 2:1 hexanes/EtOAc) returning 186 (16 mg, 24%), a 
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mixture of compounds 267 and 271 (~4.8:1, 19 mg, 29%) lactone 272 (4 mg, 10%) and 
alcohol 273 (5 mg, 10%).   
 
Attempted reduction of the α,β-unsaturated ester 186 with CuCl/NaBH4108 
A. To a solution of α,β-unsaturated ester 186 (58 mg, 0.271 mmol) and CuCl (20 mg, 
0.203 mmol) in MeOH (4 mL) at 0 °C was added NaBH4 (51 mg, 1.35 mmol) over 10 
min. A black ppt slowly formed over the course of the reaction. The reaction was 
warmed to rt and stirred for 4 h. The solvent was removed and the residue partitioned 
between NH4Cl (aq) (10 mL) and CH2Cl2 (10 mL). The aqueous layer was further 
extracted with CH2Cl2 (3 x 10 mL). The combined organic fractions were combined 
dried over MgSO4, filtered and reduced to give a colourless oil which was purified 
using flash column chromatography (silica, gradient elution 10:1 to 2:1 hexanes/EtOAc) 
returning 186 (27 mg, 47%) and affording a mixture of compounds 267 and 271 
(~6.6:1, 22 mg, 38%). 
 
B. To the α,β-unsaturated ester 186 (70 mg, 0.330 mmol), CuCl (24.5 mg, 0.248 mmol), 
cyclohexene (124 μL, 1.32 mmol) in MeOH (5 mL) was added NaOMe (13 mg, 0.25 
mmol). The solution went from green to brown. TLC showed new products forming. 
The reaction mixture was cooled down to -78 °C and NaBH4 (62.4 mg, 1.65 mmol) and 
left to slowly warm to rt. The solvent was removed and the residue partitioned between 
sat. NH4Cl (aq) (10 mL) and CH2Cl2 (10 mL). The aqueous layer was further extracted 
with CH2Cl2 (3 x 10 mL). The combined organic fractions were combined dried over 
MgSO4, filtered and reduced to give a colourless oil which was purified using flash 
column chromatography (silica, gradient elution 10:1 to 2:1 hexanes/EtOAc) returning 
186 (9 mg, 13%) and affording a mixture of compounds 267 and 271 (~11.8:1, 54 mg, 
38%). 
 
 (4S,5R)-4,5-O-(1-Methylethylidene)-hept-6-en-1-ol (187) 
To suspension of LAH (115 mg, 3.03 mmol) in Et2O (30 mL) at 
-10 °C was added methyl ester 267 (540 mg, 2.52 mmol) in Et2O 
(15 mL). After 10 min, TLC analysis confirmed that all the starting material had been 
consumed. The reaction was quenched with wet Na2SO4, filtered through Celite® and 
reduced to dryness to yield alcohol 187 as a colourless oil (458 mg, 97%). Rf = 0.20. 
[α]D22 = -6.1 (c 1.00, CHCl3) 1H NMR (500 MHz, CDCl3) δ 5.82 (ddd, J = 17.1, 10.3, 
7.8 Hz, 1H), 5.31 (ddd, J = 17.1, 1.6, 1.1 Hz, 1H), 5.24 (ddd, J = 10.3, 1.6, 0.9 Hz, 1H), 
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4.52 (dd, J = 7.4, 6.7 Hz, 1H), 4.18 (ddd, J = 8.5, 6.2, 5.0 Hz, 1H), 3.68 (t, J = 5.8 Hz, 
2H), 1.91 (s, 1H), 1.75 – 1.65 (complex m, 2H), 1.55 (ddd, J = 16.1, 8.6, 4.5 Hz, 2H), 
1.50 (s, 3H), 1.38 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 134.2, 118.4, 108.3, 79.9, 
78.2, 62.7, 29.8, 28.3, 27.5, 25.7. IR (KBr): 3435, 2934, 2874, 1644, 1429, 1380, 1248, 
1217, 1165, 1047, 1018, 926, 872 cm-1. HRMS (ESI) calcd. for C10H18O3Na+ [M + Na]+ 
209.1154, found 209.1152. 
 
(4S,5R)-4,5-O-(1-Methylethylidene)-hept-6-en-1-
methanesulfonate (188) 
To solution of alcohol 187 (213 mg, 1.15 mmol) in CH2Cl2 
(10 mL) at 0 °C was added NEt3 (320 μL, 2.30 mmol), DMAP (14 mg, 0.115 mmol), 
and MsCl (134 μL, 1.70 mmol). The reaction was left to warm to rt and stir for 12 h. 
After this time, the reaction was deemed complete by TLC (colour change from purple 
to black with anisaldyde dip). The solvent was removed and the crude product dissolved 
in EtOAc (20 mL), before being washed with water (10 mL) and sat. NaHCO3 (10 mL). 
The organic layer was dried with MgSO4, filtered and reduced to give a crude oil which 
was purified using flash column chromatography (silica, gradient elution 3:1 to 1:1 
hexanes/EtOAc) yielding the title compound as a colourless oil (294 mg, 97%). Rf  = 
0.26. [α]D22 = -14.3 (c 1.09, CHCl3). 1H NMR (500 MHz, CDCl3) δ 5.84 (ddd, J = 17.1, 
10.3, 7.7 Hz, 1H), 5.33 (ddd, J = 17.1, 1.6, 1.1 Hz, 1H), 5.30 (ddd, J = 10.3, 1.6, 0.9 Hz, 
1H), 4.57 (dd, J = 7.5, 6.4 Hz, 1H), 4.30 (dt, J = 9.9, 6.3 Hz, 1H ), 4.25 (ddd, J = 9.8, 
7.0, 6.0 Hz, 1H), 4.19 (ddd, J = 9.0, 6.2, 4.7 Hz, 1H), 3.05 (s, 3H), 1.99 (tdd, J = 12.3, 
9.2, 6.2 Hz, 1H), 1.91 – 1.82 (m, 1H), 1.62 – 1.54 (complex m, 2H), 1.52 (s, 3H), 1.41 
(s, 3H). 13C NMR (125 MHz, CDCl3) δ 134.2, 118.5, 108.3, 79.7, 77.7, 30.6, 29.6, 28.9, 
28.2, 26.3, 25.6. IR (film): 2994, 2939, 1353, 1248, 1212, 1174, 926, 908, 733 cm-1.  
  
(4S,5R)-4,5-O-(1-Methylethylidene)-hept-6-en-1-thio acetate 
(189) 
To a solution of the mesylate (1.59 g, 6.02 mmol) in DMF (50 
mL) at 0° C was added KSAc (824 mg, 7.23 mmol). The reaction was left to warm and 
stir at rt for 12 h. The reaction was diluted with Et2O (100 mL) and H2O (100 mL). The 
organic layer was further washed with sat. NaHCO3 (3 x 50 mL) before drying with 
MgSO4, filtering and reducing to give a crude oil which was purified using flash column 
chromatography (silica, gradient elution 20:1 to 10:1 hexanes/EtOAc) yielding 
thioacetate 189 as a colourless oil (1.32 g, 90%). Rf = 0.56. [α]D22 = -9.5 (c 1.05, 
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CHCl3). 1H NMR (500 MHz, CDCl3) δ 5.79 (ddd, J = 17.1, 9.7, 7.8 Hz, 1H), 5.30 (d, J 
= 17.1 Hz, 1H), 5.24 (d, J = 10.3 Hz, 1H), 4.49 (t, J = 6.9 Hz, 1H), 4.13 (dt, J = 8.6, 5.5 
Hz, 1H), 2.95 – 2.83 (m, 2H), 2.32 (s, 3H), 1.80 – 1.68 (m, 1H), 1.66 – 1.50 (m, 2H), 
1.49 – 1.41 (m, 1H), 1.47 (s, 3H), 1.36 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 195.8, 
134.2, 118.5, 108.3, 79.7, 77.7, 30.6, 29.6, 28.9, 28.2, 26.3, 25.6. IR (film): 2986, 2916, 
1692, 1455, 1428, 1379, 1369, 1244, 1216, 1134, 1134, 1048, 1012, 929, 871, 625 cm-1. 
HRMS (ESI) calcd. for C12H20O3SNa+ [M + Na]+ 267.1031, found 267.1028. 
 
Attempted synthesis of 3-[(4S,5R)-2,2-dimethyl-5-vinyl-1,3-
dioxolan-4-yl]propane-1-thiol (169) 
A. To a solution of thioactetate 189 (64 mg, 0.26 mmol) in 
MeOH (2.5 mL) was added MeONa (14 mg, 0.26 mmol). The reaction was stirred at rt 
for 12 h. Solvent was removed and the residue partitioned between 10% HCl (10 mL) 
and Et2O (10 mL). The aqueous layer was further extracted with Et2O (2 x 10 mL). The 
combined organics were dried over MgSO4, filtered and reduced to give a colourless oil 
(46 mg, 87%). The colourless oil was determined to be disulfide 190 by mass 
spectrometric analysis. 
190: [α]D22 = +5.2 (c 1.00, CHCl3). Rf = 0.59. 
1H NMR (500 MHz, CDCl3) δ 5.80 (ddd, J = 
17.1, 10.3, 7.8 Hz, 1H), 5.31 (ddd, J = 17.1, 
1.6, 1.0 Hz, 1H), 5.24 (ddd, J = 10.3, 1.6, 0.9 Hz, 1H), 4.50 (dd, J = 7.7, 6.3 Hz, 1H), 
4.14 (ddd, J = 9.0, 6.2, 4.6 Hz, 1H), 2.70 (m, 2H), 1.86 (m, 1H), 1.72 (m, 1H), 1.60 – 
1.49 (m, 2H), 1.48 (s, 3H), 1.36 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 134.2, 118.4, 
108.2, 79.7, 77.8, 38.7, 29.2, 28.2, 25.8, 25.6. IR(neat): 2986, 2937, 1379, 1370, 1244, 
1216, 1047, 914, 733 cm-1. HRMS (ESI) calcd. for C20H34O4S2Na+ [M + Na]+ 425.1796, 
found 425.1790.  
 
B. To a solution of thioactetate 189 (38 mg, 0.16 mmol) in THF (2 mL) was added 0.2 
M NaOH (4 mL, 0.80 mmol). The reaction was stirred at rt for 12 h. The reaction was 
acidified to pH 1 with 10% HCl and extracted with EtOAc (3 x 10 mL). The combined 
organics were dried over MgSO4, filtered and reduced to give a colourless oil (28 mg, 
89%). The 1H NMR spectrum was identical to that of attempt A. 
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8.4 Experimental for Chapter Four 
 
8.4.1  The HWE route 
 
4-(Diethylamino)butan-2-one (143)80 
A solution of acetone (12.7 mL, 174 mmol), paraformaldehyde (3.90 g, 
130 mmol) and diethylamine hydrochloride (8.00 g, 74 mmol) was refluxed in 
isopropanol (20 mL) for 6 h. The mixture was cooled to rt and reduced in volume before 
a solution of 50% KOH (aq) was added to adjust the pH to 14. The organics were 
extracted with Et2O (3 x 20 mL). The combined organic layers were washed with brine 
(20 mL) and dried with MgSO4 before filtering and reducing to give a dark orange oil. 
The crude product was purified by distillation (73 ˚C, 20 mmHg) yielding a pale orange 
liquid (4.78 g, 45%). 1H NMR (300 MHz, CDCl3) δ 2.75 (t, J = 7.1 Hz, 2H), 2.54 (t, J = 
7.1 Hz, 2H), 2.51 (q, J = 7.1 Hz, 4H), 2.17 (s, 3H), 1.02 (t, J = 7.1 Hz, 6H).  
 
Diethyl 3-oxobutylphosphonate (144)82 
To amine 143 (4.25 g, 30.0 mmol) was added methyl iodide (2.00 mL, 
32.1 mmol) and the mixture stirred for 10 min at rt. After this time 
triethyl phosphite (28.3 mL, 162 mmol) was added and the reaction mixture heated to 
130 ˚C for 1 h. The reaction mixture was cooled to rt and the white precipitate was 
filtered. The solid was washed with Et2O. The filtrate was concentrated under reduced 
pressure to yield a yellow liquid. The yellow phosphonate was purified by distillation 
(96–98 ˚C, 0.2 mmHg) followed by flash column chromatography (silica, 10% 
MeOH/CH2Cl2) to give a pale yellow oil (4.90 g, 79%). 1H NMR (300 MHz, CDCl3) δ 
4.12 (m, 4H), 2.69 (m, 2H), 2.21 (s, 3H), 2.02 (m, 2H), 1.34 (t, J = 7.1 Hz, 6H). IR 
(neat): 2985, 2909, 1719, 1416, 1366, 1228, 1027, 964, 802, 787, 732 cm-1. Spectral 
data matched those reported in the literature.241  
 
Diethyl 3-hydroxybutanephosphonate [(±)-118] 
To a solution of phosphonate 144 (130 mg, 0.625 mmol) in EtOH (1 
mL) at -10 °C was slowly added NaBH4 (28 mg, 0.740 mmol) in 
portions to the reaction solution. The reaction was left to warm to rt and stirred for 
another 12 h. The reaction was quenched with H2O (1 mL) and extracted with EtOAc (3 
x 5 mL). The organic fractions were dried with MgSO4, filtered and reduced to dryness 
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giving pale yellow oil. The crude oil was purified using flash column chromatography 
(silica, EtOAc) yielding a colourless oil (81 mg, 62%). 1H NMR (300 MHz, CDCl3) δ 
4.07 (m, 4H), 3.81 (m, 1H), 2.01-1.61 (m, 4H), 1.30 (t, J = 7.1 Hz, 6H), 1.15 (d, J = 6.1 
Hz, 3H). Spectral data matched those reported in the literature.83 
 
Diethyl (3S)-3-hydroxybutylphosphonate (118) 
A solution of phosphonate 144 (97 mg, 0.47 mmol) in THF (1.6 mL) 
was added dropwise to a 1M THF solution of (R)-Me-CBS (100 μL, 
0.100 mmol) and BH3.SMe2 (54 μL, 0.56 mmol) at 0 ˚C. The reaction mixture was 
stirred for 40 min at 0 ˚C before being quenched by the slow addition of MeOH (2 mL). 
The mixture was stirred for a further 20 min at rt and concentrated. The crude product 
was purified using flash column chromatography (silica, EtOAc) yielding a pale yellow 
oil (59 mg, 60%). 1H NMR (500 MHz, CDCl3) δ 4.07 (m, 4H), 3.82 (m, 1H), 1.92 – 
1.53 (m, 5H), 1.29 (td, J = 0.9, 7.1 Hz, 6H), 1.17 (d, J = 6.2 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 67.4 (d, J = 14.3 Hz), 61.7 (t, J = 6.2 Hz), 31.6 (d, J = 4.9 Hz), 23.2, 
22.5, 21.4, 16.4 (d, J = 6.2 Hz). Spectral data matched those reported in the literature.83 
 
(S)-Mosher’s ester of diethyl (3S)-3-
hydroxybutylphosphonate [(S)-Mosher-118]242 
To a solution of DMAP (6.5 mg, 53 μmol) and phosphonate 
118 (5.6 mg, 27 μmol) in CH2Cl2 (0.5 mL) was added (R)-
MTPA-Cl (6.5 μL, 35 μmol). This was stirred at rt for 1 h before being quenched with 
Et2O (1 mL) and H2O (3 mL). This was then washed with 1 M HCl (5 mL), 1M NaOH 
(5 mL) and brine (5 mL) before drying with MgSO4, filtering and reducing to give a 
colourless oil (6.4 mg, 56%). 1H NMR analysis was undertaken without any further 
purification. 1H NMR (300 MHz, CDCl3) δ 7.56 – 7.46 (m, 2H), 7.44 – 7.38 (m, 3H), 
5.17 (qd, J = 6.1, 12.4 Hz, 1H), 4.15 – 4.00 (m, 4H), 3.56 (app.quin, J = 1.2 Hz, 0.8H), 
3.53 (q, J = 1.2 Hz, 2.2H), 1.99 – 1.84 (m, 2H), 1.83 – 1.66 (m, 2H), 1.31 (t, J = 7.1 Hz, 
6H), 1.28 (d, J = 6.3 Hz, 3H). 
 
(R)-Mosher’s ester of diethyl (3S)-3-
hydroxybutylphosphonate [(R)-Mosher-118]242 
To a solution of DMAP (9.3 mg, 76 μL) and phosphonate 118 
(8.0 mg, 38 μmol) in CH2Cl2 (0.5 mL) was added (S)-MTPA-Cl 
(9.3 μL, 50 μmol). This was stirred at rt for an hour before being quenched with Et2O 
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(1 mL) and H2O (3 mL). This was then washed with 1 M HCl (5 mL), 1M NaOH 
(5 mL) and brine (5 mL) before drying with MgSO4, filtering and reducing to give a 
colourless oil (6.8 mg, 42%). 1H NMR analysis was undertaken without any further 
purification. 1H NMR (300 MHz, CDCl3) δ 7.56 – 7.47 (m, 2H), 7.46 – 7.36 (m, 3H), 
5.17 (qd, J = 6.2, 12.4 Hz, 1H), 4.09 – 3.96 (m, 4H), 3.56 (q, J = 1.2 Hz, 2.6H), 3.53 (q, 
J = 1.2 Hz, 0.4H), 1.95 – 1.79 (m, 2H), 1.68 – 1.52 (m, 2H), 1.36 (d, J = 6.3 Hz, 3H), 
1.29 (td, J = 2.6, 7.1 Hz, 6H). 
 
 
8.4.2  The RB route 
 
Attempted syntheses of (R)-4-penten-2-ol (22)242 
To a cooled (0 °C) solution of (+)-α-pinene (10 mL, 62.9 mmol) in 
anhydrous THF (8 mL) was added BH3.SMe2 (2.5 mL, 26.2 mmol) 
dropwise. After stirring for 15 min at 0 °C, the resulting mixture was 
cooled to -17 °C for 72 h, during which time a white precipitate formed. The suspension 
was warmed to rt and the supernatant removed using a syringe whilst maintaining an 
argon atmosphere. The white solid was washed with anhydrous Et2O (3 x 20 mL) and 
the remaining solvent was removed under reduced pressure (0.2 mm Hg, 2 h) giving 
(-)-(IPC)2BH as a white solid (8.06 g, 90%). The white solid was resuspended in 
anhydrous Et2O (22 mL) and cooled to 0 °C. Ice-cold MeOH (2.25 mL, 56.3 mmol) was 
slowly added to the reaction mixture over a period of 30 min. The reaction was warmed 
to rt and stirred for 1 h until no solid remained. The solvent was removed under reduced 
pressure (0.2 mmHg, 2 h) to give a colourless oil (7.11 g, 80%). The oil was redissolved 
in anhydrous Et2O (18 ml) and cooled to -78 °C. To the cooled solution was added 
dropwise a 1.0M Et2O solution of allylmagnesium bromide (22.5 mL, 22.5 mmol). 
After stirring for 1 h at -78 °C, the reaction was warmed to rt for 1 h. Over this time, 
white magnesium salts precipitated out of solution.  
 
The reaction mixture was once more cooled to -78 °C and acetaldehyde (1.26 mL, 22.5 
mmol) was added dropwise. The reaction was stirred at -78 °C for 1 h before warming 
to rt for 1 h. The reaction was quenched by a variety of reagents: addition of 1 M NaOH 
(15 mL) and 30% H2O2 (15 mL), H2O (20 mL) or silica gel (20 g). Attempts to purify 
the title compound by distillation and/or column chromatography (silica, eluent gradient 
petane to 4:1 petane/Et2O) failed to provide the pure alcohol.  
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8.5 Experimental for Chapter Five 
 
8.5.1  The HWE route 
 
HWE reactions of phosphonates 210, 211, and 294 with octanal or butanal: 
A. To a solution of phosphonate 210 (72 mg, 0.25 mmol) in THF (1 mL) at 0 °C was 
added a 1M solution of LiHMDS in THF (250 μL, 0.25 mmol) dropwise. Deprotonation 
was observed with the rapid formation of a bright orange solution. To this orange 
solution was added octanal (43 μL, 0.28 mmol). The reaction was allowed to warm to rt 
whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (10 mL) and 
extracted with EtOAc (3 x 10 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced. The crude residue was purified by flash column 
chromatography (silica, gradient elution 20:1 hexanes/Et2O to EtOAc) giving the alkene 
291a as a colourless oil (20 mg, 30%), phosphonate 210 (11 mg, 15%) and 
enephosphonate 293 (28 mg, 28%).  
 291a: 1H NMR (500 MHz, CDCl3) δ 7.83 (dd, J = 7.8, 
1.4 Hz, 1H), 7.54 (d, J = 7.8 Hz, 1H), 7.43 (td, J = 7.6, 
1.4 Hz, 1H), 7.25 (dt, J = 7.6, 1.5 Hz, 1H), 7.12 (d, J = 
15.7 Hz, 1H), 6.14 (dt, J = 15.7, 6.9 Hz, 1H), 3.90 (s, 3H), 2.25 (ddd, J = 14.8, 7.2, 1.5 
Hz, 2H), 1.53 – 1.44 (m, 2H), 1.40 – 1.24 (m, 9H), 0.89 (t, J = 7.0 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) δ 168.1, 139.7, 134.2, 131.9, 130.2, 128.3, 128.1, 127.2, 126.4, 52.0, 
33.2, 31.9, 29.3, 29.2, 29.2, 22.7, 14.1. IR (neat): 2928, 2850, 1723, 1434, 1254, 1121, 
1078, 729 cm-1. 
293: 1H NMR (300 MHz, CDCl3) δ 9.26 (s, 1H), 7.95 (d, 
J = 7.7 Hz, 1H), 7.48 (tdd, J = 7.5, 1.5, 0.7 Hz, 1H), 7.39 
(tt, J = 7.5, 1.5 Hz, 1H), 7.12 (dt, J = 7.5, 1.5 Hz, 1H), 
6.72 (dt, J = 23.1, 7.3 Hz, 1H), 4.14 (p, J = 7.3 Hz, 2H), 
4.09 – 3.97 (m, 2H), 1.99 – 1.82 (m, 2H), 1.43 – 1.26 
(m, 2H), 1.30 (t, J = 7.3 Hz, 3H), 1.21 (t, J = 7.4 Hz, 3H), 1.23 – 1.17 (m, 8H), 0.82 (t, J 
= 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 169.9, 148.5 (d, J = 8.1 Hz), 134.9 (d, J = 
10.4 Hz), 132.1 (d, J = 4.6 Hz), 131.2 (d, J = 49.2 Hz), 131.3, 130.6 (d, J = 4.6 Hz), 
128.8 (d, J = 2.3 Hz), 127.9, 62.7 (d, J = 6.3 Hz), 62.5 (d, J = 6.0), 31.6, 29.9 (d, J = 
17.7 Hz), 29.2, 28.9, 28.2 (d, J = 1.4 Hz), 22.5, 16.2 (d, J = 4.4 Hz), 16.1 (d, J = 4.3 
Hz), 14.0. 
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B. To a solution of phosphonate 210 (103 mg, 0.360 mmol) in Et2O (2 mL) at -78 °C 
was added a 1M solution of LiHMDS in THF (360 μL, 0.36 mmol) dropwise. To this 
orange solution was added octanal (62 μL, 0.396 mmol). The reaction was allowed to 
warm to rt whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (10 
mL) and extracted with EtOAC (3 x 10 mL). The combined organic fractions were dried 
over MgSO4, filtered and reduced. The crude residue was purified by flash column 
chromatography (silica, gradient elution 20:1 hexanes/Et2O to EtOAc) giving the alkene 
291a as a colourless oil (6 mg, 7%) and enephosphonate 293 (78 mg, 55%). 
 
C. To a solution of phosphonate 210 (105 mg, 0.367 mmol) in THF (2 mL) at -78 °C 
was added a 1M solution of LiHMDS in THF (370 μL, 0.37 mmol) dropwise. To this 
orange solution was added octanal (63 μL, 0.404 mmol). The reaction was allowed to 
warm to rt whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (10 
mL) and extracted with EtOAC (3 x 10 mL). The combined organic fractions were dried 
over MgSO4, filtered and reduced. The crude residue was purified by flash column 
chromatography (silica, gradient elution 20:1 hexanes/Et2O to EtOAc) affording 
enephosphonate 293 as pale yellow solid (100 mg, 69%). 
 
D. To a solution of phosphonate 210 (103 mg, 0.360 mmol) in toluene (2 mL) at -78 °C 
was added a 1M solution of LiHMDS in THF (360 μL, 0.36 mmol) dropwise. To this 
orange solution was added octanal (62 μL, 0.396 mmol). The reaction was allowed to 
warm to rt whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (10 
mL) and extracted with EtOAC (3 x 10 mL). The combined organic fractions were dried 
over MgSO4, filtered and reduced. The crude residue was purified by flash column 
chromatography (silica, gradient elution 20:1 hexanes/Et2O to EtOAc) providing alkene 
291a as a colourless oil (8.4 mg, 9%), phosphonate 210 (23 mg, 22%) and 
enephosphonate 293 (47 mg, 33%). 
 
E. To a solution of phosphonate 210 (40 mg, 0.14 mmol) and octanal (22 μL, 0.14 
mmol) in THF (3 mL) was added K2CO3 (44 mg, 0.28 mmol). The reaction was stirred 
at rt for 12 h before being heated to reflux for 12 h. The cooled reaction mixture was 
quenched with the H2O (10 mL) and extracted with EtOAc (3 x 10 mL). The combined 
organic fractions were dried over MgSO4, filtered and reduced. The residue was 
confirmed to be phosphonate 210 by 1H NMR spectroscopy. 
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F. To a solution of phosphonate 210 (55 mg, 0.192 mmol) in Et2O (0.5 mL) at -78 °C 
was added a 1M solution of LiHMDS in THF (212 μL, 0.212 mmol) dropwise. To this 
orange solution was added butanal (19 μL, 0.212 mmol). The reaction was allowed to 
warm to rt whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 
mL) and extracted with EtOAC (3 x 5 mL). The combined organic fractions were dried 
over MgSO4, filtered and reduced. The crude residue was purified by flash column 
chromatography (silica, gradient elution 20:1 hexanes/Et2O to EtOAc) giving 
phosphonate 290a (8 mg, 14%) and enephosphonate 292 (19 mg, 29%). 
290a: 1H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 7.8 Hz, 1H), 
7.52 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.6 Hz, 1H), 7.25 (t, J = 7.5 
Hz, 1H), 7.13 (d, J = 15.7 Hz, 1H), 6.14 (dt, J = 15.6, 6.9 Hz, 
1H), 3.89 (s, 3H), 2.23 (q, J = 7.4 Hz, 2H), 1.52 (q, J = 7.3 Hz, 2H), 0.97 (t, J = 7.3 Hz, 
3H). 
292: 1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 7.7 Hz, 1H), 7.49 
(t, J = 7.4 Hz, 1H), 7.41 (t, J = 7.6 Hz, 1H), 7.12 (d, J = 7.6 Hz, 
1H), 6.70 (dt, J = 23.1, 7.3 Hz, 1H), 4.16 (m, 2H), 4.09 – 3.97 (m, 
2H), 2.00 – 1.82 (m, 2H), 1.39 (m, 1H), 1.34 (t, J = 7.1 Hz, 3H), 
1.24 (m, 1H), 1.20 (t, J = 6.9 Hz, 3H), 0.83 (t, J = 7.4 Hz, 3H). 13C 
NMR (125 MHz, CDCl3) δ 169.9, 148.3 (d, J = 8.1 Hz), 134.4 (d, J = 9.5 Hz), 132.5 (d, 
J = 5.0 Hz), 131.2 (d, J = 81.2 Hz), 130.8 (d, J = 2.0 Hz), 130.6 (d, J = 4.6 Hz), 129.3, 
128.0 (d, J = 2.3 Hz), 62.9 (appt, J = 6.2 Hz), 31.9 (d, J = 17.5 Hz) 21.5 (d, J = 1.7 Hz), 
16.3 (d, J = 6.4 Hz), 16.2 (d, J = 6.4 Hz), 13.8. IR (neat): 3418, 2960, 2932, 2872, 1717, 
1209, 1138, 1052, 1024, 978. HRMS (ESI) calcd. for C16H23O5PNa+ [M + Na]+ 
349.1181, found 349.1184 
 
G. To a solution of phosphonate 210 (34 mg, 0.118 mmol) in toluene (0.5 mL) at -78 °C 
was added a 1M solution of LiHMDS in THF (142 μL, 0.142 mmol) dropwise. To this 
orange solution was added butanal (10 μL, 0.142  mmol). The reaction was allowed to 
warm to rt whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 
mL) and extracted with EtOAC (3 x 5 mL). The combined organic fractions were dried 
over MgSO4, filtered and reduced. The crude residue was purified by flash column 
chromatography (silica, gradient elution 20:1 hexanes/Et2O to EtOAc) providing alkene 
290a as a colourless oil (5 mg, 20%), phosphonate 210 (6 mg, 18%) and 
enephosphonate 292 (8 mg, 21%). 
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H. To a solution of phosphonate 294 (50 mg, 0.184 mmol) in THF (0.5 mL) at -78 °C 
was added a 1M solution of LiHMDS in THF (404 μL, 0.404 mmol) dropwise. To this 
orange solution was added butanal (18 μL, 0.202 mmol). The reaction was allowed to 
warm to rt whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 
mL) and extracted with EtOAC (3 x 5 mL). The combined organic fractions were dried 
over MgSO4, filtered and reduced. The residue was confirmed to be phosphonate 294 by 
1H NMR spectroscopy. 
 
I. To a solution of phosphonate 211 (57 mg, 0.190 mmol) in THF (1.0 mL) at -78 °C 
was added 60% dispersion of NaH in paraffin oil (7.6 mg, 0.190 mmol). To this orange 
solution was added butanal (10 μL, 0.142  mmol). The reaction was allowed to warm to 
rt whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 mL) and 
extracted with EtOAC (3 x 5 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced. The crude residue was purified through flash column 
chromatography (silica, gradient elution 20:1 hexanes/Et2O to EtOAc) giving providing 
alkene 290b as a colourless oil (8 mg, 20%). 
ethyl 2-[(1E)-pent-1-enyl]benzoate (290b) 
1H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 7.9 Hz, 1H), 7.53 (d, J 
= 7.9 Hz, 1H), 7.43 (t, J = 7.2 Hz, 1H), 7.25 (t, J = 7.6 Hz, 1H), 
7.13 (d, J = 15.7 Hz, 1H), 6.14 (dt, J = 15.6, 6.9 Hz, 1H), 4.36 (q, J = 7.2 Hz, 2H), 2.23 
(q, J = 7.1 Hz, 2H), 1.52 (q, J = 7.3 Hz, 2H), 1.39 (t, J = 7.2 Hz, 3H), 0.97 (t, J = 7.3 
Hz, 3H). 
 
J. To phosphonate 211 (191 mg, 0.637 mmol) was added NaOMe (69 mg, 1.27 mmol). 
To the orange suspension was added butanal (55 μL, 0.764  mmol). The reaction was 
stirred at rt for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 mL) and 
extracted with EtOAC (3 x 5 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced. The residue was confirmed to be phosphonate 211 by 1H 
NMR spectroscopy. 
 
Methyl 2-[(1E)-3,3-dimethylbut-1-enyl]benzoate (297) 
To a solution of phosphonate 210 (83 mg, 0.290 mmol) in THF (0.5 
mL) at -78 ˚C was added a 1M solution of LiHMDS in THF (320 μL, 
0.320 mmol). The solution immediately turned bright yellow. After 2 
min, pivaldehyde (38 μL, 0.348 mmol) was added to the reaction 
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mixture. The reaction was stirred at -78 °C for 1.5 h before warming up to rt for a 
further 12 h. The reaction was quenched with the addition of sat NH4Cl(aq) (5 mL) and 
extracted with EtOAc (3 x 5 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced to give a colourless oil. The oil was purified using flash 
column chromatography (silica, 20:1 hexanes/EtOAc), yielding the title compound as a 
colourless oil (56 mg, 88%). 1H NMR (300 MHz, CDCl3) δ 7.85 (dd, J = 7.8, 1.3 Hz, 
1H), 7.54 (d, J = 7.8 Hz, 1H), 7.44 (td, J = 7.9, 1.3 Hz, 1H), 7.25 (td, J = 7.9, 1.3 Hz, 
1H), 7.09 (d, J = 16.1 Hz, 1H), 6.13 (d, J = 16.1 Hz, 1H), 3.90 (s, 3H), 1.14 (s, 9H). 
NMR (125 MHz, CDCl3) δ 168.1, 144.5, 140.0, 131.9, 130.3, 128.3, 127.2, 126.4, 
123.7, 52.0, 33.7, 29.6. IR: 2954, 2866, 1720, 1476, 1434, 1246, 1130, 1078, 735 cm-1. 
HRMS (ESI) calcd. for C14H18O2Na+ [M + Na]+ 241.1204, found 241.1203. 
 
Attempted synthesis of methyl 2-[(E)-2-phenylvinyl]benzoate 
To a solution of phosphonate (100 mg, 0.350 mmol) in DMF (1 
mL) at 0 °C was added NaOMe (38 mg, 0.700 mmol). The solution 
immediately turned orange indicating deprotonation. To this 
orange solution was benzaldehyde (35 μL, 0.350 mmol) before heating to 80 °C for 30 
min. The cooled solution was quenched with sat. NH4Cl(aq) (5 mL) and extracted with 
EtOAC (3 x 5 mL). The combined organic fractions were dried over MgSO4, filtered 
and reduced. 1H NMR spectroscopy showed that both starting materials were returned 
unreacted.  
 
Attempted HWE reactions between phosphonate 210 and hemiacetal 122: 
A. To a suspension of t-BuOK (60 mg, 0.54 mmol) in THF (2 mL) was added a solution 
of phosphonate 210 (129 mh, 0.45 mmol) in THF (2 mL) dropwise at 0 °C. After 
stirring for 10 min the colour changed to orange. To the orange solution was added a 
solution of hemiacetal 122 (93 mg, 0.45 mmol) in THF (2 mL). The reaction was 
allowed to warm to rt stirring for 12 h. The reaction was quenched with 10% HCl (5 
mL) and extracted with EtOAc (3 x 10 mL). The combined organic fractions were dried 
over MgSO4, filtered and reduced. The residue was confirmed to be phosphonate 210 by 
1H NMR spectroscopy. 
 
B. To a suspension of t-BuOK (25 mg, 0.220 mmol) and 18-crown-6 (59 mg, 0.220 
mmol) in THF (2 mL) was added a THF (1 mL) solution of phosphonate 210 (53 mg, 
0.185 mmol) at 0 °C. To the resultant orange solution was added a THF (1 mL) solution 
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of hemiacetal 122 (37 mg, 0.185 mmol) dropwise at 0 °C. The reaction was allowed to 
warm to rt and stirred for 16 h. The reaction was quenched with 10% HCl (5 mL) and 
extracted with EtOAc (3 x 10 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced. The residue was confirmed to be phosphonate 210 by 1H 
NMR spectroscopy. 
 
C. To a suspension of a 60% dispersion of NaH in paraffin oil (10 mg, 0.250 mmol) in 
THF (2 mL) at 0 °C was added a THF solution (1 mL) of phosphonate 210 (41.5 mg, 
0.145 mmol) and hemiacetal 122 (30 mg, 0.129 mmol). The reaction was allowed to 
warm to rt whilst stirring for 12 h.  The reaction was quenched with AcOH (4 drops) 
and reduced to dryness. The 1H NMR spectrum of the crude mixture exhibited the 
presence of the phosphonate 210 and hemiacetal 122.  
 
D. To a solution of the phosphonate 210 (67 mg, 0.234 mmol) in THF (2 mL) at 0 °C 
was added a 1M solution of LiHMDS in THF (210 μL, 0.210 mmol). To the bright 
orange solution was added a solution of the hemiacetal 122 (63 mg, 0.271 mmol) in 
THF (1 mL). The reaction was allowed to warm to rt overnight. The mixture was 
filtered through a silica gel pad and concentrated under reduced pressure. The 1H NMR 
spectrum confirmed that no reaction had occurred.  
 
Attempted HWE reactions between phosphonate 142 and butanal: 
To a solution of phosphonate 142 (48 mg, 0.119 mmol) in THF (1 mL) at -78 °C were 
added a 1M solution of LiHMDS in THF (131 μL, 0.131 mmol) followed by butanal 
(12 μL, 0.131 mmol). The reaction mixture was left to warm to rt for 12 h. The reaction 
was quenched with sat. NH4Cl(aq) (5 mL) and extracted with EtOAc (3 x 5 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced. The crude 
products were purified using flash column chromatography (silica, gradient elution 10:1 
hexanes/EtOAc to EtOAc) to give alkene 302 (4 mg, 14%), alkene 304 (8 mg, 24%), 
and phosphonate 303 (3 mg, 7%) phosphonate 121 (15 mg, 40%) as colourless oils.   
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302: 1H NMR (300 MHz, CDCl3) δ 11.59 (s, 1H), 6.90 (d, J = 15.4 Hz, 2H), 6.41 (d, J = 
2.5 Hz, 2H), 6.32 (d, J = 2.6 Hz, 2H), 5.91 (dt, J = 15.4, 6.9 Hz, 3H), 5.32 (s, 1H), 3.91 
(s, 3H), 2.18 (q, J = 7.2 Hz, 2H), 1.50 (q, J = 7.3 Hz, 2H), 0.96 (t, J = 7.2 Hz, 3H). 
303: 1H NMR (300 MHz, CDCl3) δ 6.97 (t, J = 2.5 Hz, 1H), 6.47 (t, J = 2.5 Hz, 1H), 
4.04 – 3.94 (m, 4H), 3.84 (s, 3H), 3.55 (d, J = 23.1 Hz, 2H), 2.26 (s, 3H), 1.21 (t, J = 7.0 
Hz, 6H) 
304: 1H NMR (300 MHz, CDCl3) δ 6.84 (d, J = 2.4 Hz, 1H), 6.53 (d, J = 15.6 Hz, 1H), 
6.47 (d, J = 2.4 Hz, 1H), 6.12 (dt, J = 15.6  7.0 Hz, 1H), 5.32 (s, 1H), 3.86 (s, 3H), 2.26 
(s, 3H), 2.17 (q, J = 7.3 Hz, 2H), 1.47 (q, J = 7.3 Hz, 2H), 0.94 (t, J = 7.4 Hz, 3H). 
 
Attempted HWE reactions between phosphonate 142 and hemiactels 122 or 152: 
A. To solution of phosphonate 142 (50 mg, 0.124 mmol) in THF (0.5 mL) at 0 °C was 
added a 1M solution of LiHMDS in THF (190 μL, 0.190 mmol). To this orange solution 
was added a THF solution (0.5 mL) of hemiacetal 122 (32 mg, 0.133 mmol). The 
reaction was left to warm to rt for 12 h. The reaction was quenched with sat. NH4Cl(aq) 
(5 mL) and extracted with EtOAc (3 x 5 mL). The combined organic fractions were 
dried over MgSO4, filtered and reduced. The 1H NMR spectrum of the residue indicated 
that no reaction had occurred.  
 
B. To a solution of phosphonate 142 (173 mg, 0.430 mmol) in MeOH (1 mL) was added 
NaOMe (70 mg, 1.29 mmol) at rt. To the reaction was added a THF solution (0.5 mL) 
of acetonide 152 (37 mg, 197 mmol). The reaction stirred at rt for 12 h. The reaction 
was quenched with sat. NH4Cl(aq) (5 mL) and extracted with EtOAc (3 x 5 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced. The 1H NMR 
spectrum of the residue indicated that no reaction had occurred.  
 
C. To a solution of phosphonate 142 (10 mg, 25 μmol) in THF (0.5 mL) was added t-
BuOK (5.5 mg, 49 μmol) at 0 °C. To the reaction was added a THF solution (0.2 mL) of 
hemiacetal 152 (5.5 mg, 29 mmol). The reaction was allowed to warm to rt whilst 
stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 mL) and extracted 
with EtOAc (3 x 5 mL). The combined organic fractions were dried over MgSO4, 
filtered and reduced. The 1H NMR spectrum of the residue indicated that no reaction 
had occurred.  
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D. To a solution of phosphonate 142 (27 mg, 67 μmol) and hemiacetal 152 (13.5 mg, 67 
μmol) in DMF (0.5 mL) was added NaOMe (11 mg, 0.204 mmol) at 0 °C. The reaction 
was then heated to 80 °C for 30 min. The cooled reaction mixture was quenched with 
sat. NH4Cl(aq) (5 mL) and extracted with EtOAc (3 x 5 mL). The combined organic 
fractions were washed with sat. NaHCO3(aq), dried over MgSO4, filtered and reduced. 
The 1H NMR spectrum of the residue confirmed that no reaction had occurred. The 
main component of the reaction was deprotected phosphonate 142.  
 
E. To a solution of phosphonate 142 (14 mg, 26 μmol) in THF (0.5 mL) was added 
LDA (26 μL, 4 μL) at -78 °C. To the reaction mixture was then added a THF solution 
(0.25 mL) of hemiacetal 152 (4 mg, 21 mmol). The reaction was allowed to warm to rt 
whilst stirring for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 mL) and 
extracted with EtOAc (3 x 5 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced. The 1H NMR spectrum of the residue indicated that no 
reaction had occurred.  
 
F. To a solution of phosphonate 142 (14 mg, 26 μmol) in toluene (0.5 mL) was added 
NaOMe (5 mg, 93 μmol) at rt. To the reaction was added a THF solution (0.25 mL) of 
hemiacetal 152 (5 mg, 27 mmol). The reaction was stirred at rt for 12 h. The reaction 
was quenched with sat. NH4Cl(aq) (5 mL) and extracted with EtOAc (3 x 5 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced. The 1H NMR 
spectrum of the residue indicated that no reaction had occurred.  
 
G. To a solution of phosphonate 142 (24 mg, 44 μmol) in THF (0.5 mL) was added 
Et3N (7 μL, 51 μmol) and LiBr (4.5 mg, 52 μmol) at rt. To the reaction was added a 
THF solution (0.25 mL) of hemiacetal 152 (8 mg, 43 μmol). The reaction was stirred at 
rt for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 mL) and extracted with 
EtOAc (3 x 5 mL). The combined organic fractions were dried over MgSO4, filtered and 
reduced. The 1H NMR spectrum of the residue confirmed that no reaction had occurred.  
 
H. To a solution of phosphonate 142 (33 mg, 60 μmol) in DMF (200 μL) was added 
NaOMe (6.5 mg, 0.120 mmol) at 0 °C. The reaction mixture was left to warm to rt for 5 
min. To this reaction mixture was added the hemiacetal 152 (11 mg, 57 μmol). 
Additional DMF (100 μL) was used to wash down the sides of the flask. The reaction 
was stirred at rt for 12 h. The reaction was quenched with sat. NH4Cl(aq) (5 mL) and 
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extracted with EtOAc (3 x 5 mL). The combined organic fractions were washed with 
sat. NaHCO3(aq), dried over MgSO4, filtered and reduced. The 1H NMR spectrum of the 
crude residue showed evidence of the starting materials and the deprotected 
phosphonate 142.  
 
2,4,5-deoxy-6,8-O-(1-methylethylidene)-D-glycero-D-
gulo-octonic methyl ester (307) 
To a solution of sugar 122 (30 mg, 0.16 mmol) and triethyl 
phosphonoacetate (35 μL, 0.176 mmol) in MeOH (1.0 mL) at 0 °C was added MeONa 
(17 mg, 0.319 mmol). The reaction was stirred as it warmed to rt for 12 h. The solvent 
was removed and the crude residue was re-dissolved in EtOAc (10 mL) and washed 
with H2O (10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered 
and reduced. The crude product was purified by flash column chromatography (silica, 
gradient elution 3:1 to 1:1 hexanes/EtOAc) yielding a colourless oil (26 mg, 67%). 1H 
NMR (500 MHz, CDCl3) δ 3.89  (m, 1H), 3.83 (dd, J = 10.7, 5.2 Hz, 1H), 3.69 (s, 3H), 
3.68 (m, 1H), 3.56 (dt, J = 10.5, 4.6 Hz, 1H), 3.24 (dt, J = 9.2, 5.3 Hz, 1H)  2.54 (dd, J 
= 15.4, 7.5 Hz, 1H), 2.40 (dd, J = 15.4, 5.6 Hz, 1H), 1.94 (m, 1H), 1.86 (m, 1H)  1.62 – 
1.44 (m, 2H), 1.49 (s, 3H), 1.39 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 171.3, 99.3, 
74.2, 70.0, 51.6, 40.5, 30.7, 29.3, 29.2, 28.9, 19.2, 19.0. 
 
 
8.5.2  The RB route 
 
Methyl (6′S,7′R)-6-(6′,7′-O-(1′′-methylethylidene)-2′-thianon-8′-enyl)-2,4-
dihydroxybenzoate (191)  
A solution of thioacetate 189 (340 mg, 1.39 mmol) 
and bromide 135 (485 mg, 1.41 mmol) in dry MeOH 
(25 mL) was degassed by bubbling dry argon through 
the solution for 10 min. After this time, K2CO3 (466 
mg, 3.37 mmol) was added and the reaction was 
stirred at rt for 12 h. After TLC analysis confirmed the consumption of bromide 135, the 
solvent was removed to dryness. The residue was dissolved in EtOAc (50 mL) and sat. 
NH4Cl(aq) (50 mL). The organic layer was separated and the aqueous layer was extracted 
with EtOAc (2 x 25 mL). The organic layers were combined, washed with brine (50 
mL), dried with MgSO4, filtered and reduced to dryness. The crude residue was purified 
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using column chromatography (silica, gradient column, 5:1 to 3:1 hexanes/EtOAc) to 
yield coupled product 191 as a colourless oil (447 mg, 86%). Rf = 0.33. [α]D18 = -21.5 (c 
1.06, CHCl3). 1H NMR (500 MHz, CDCl3) δ 11.67 (s, 1H), 6.34 (d, J = 2.5 Hz, 1H), 
6.31 (s, 1H), 6.28 (d, J = 2.5 Hz, 1H), 5.79 (ddd, J = 17.2, 10.3, 7.8 Hz, 1H), 5.31 (ddd, 
J = 17.1, 1.7, 1.1 Hz, 1H), 5.25 (ddd, J = 10.3, 1.5, 0.9 Hz, 1H), 4.50 (dd, J = 6.4, 7.7 
Hz, 1H), 4.10 (ddd, J = 4.3, 6.1, 9.1 Hz, 1H), 3.93 (d, J = 13.6 Hz, 1H), 3.93 (s, 3H), 
3.87 (d, J = 13.6 Hz, 1H), 2.43 (t, J = 7.4 Hz, 2H), 1.76 – 1.66 (m, 1H), 1.65 – 1.50 (m, 
2H), 1.49 (s, 3H), 1.50 – 1.40 (m, 1H), 1.38 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
171.3, 165.7, 160.2, 143.9, 133.8, 118.7, 111.1, 108.4, 104.4, 102.5, 79.8, 77.7, 52.2, 
37.0, 31.1, 29.5, 28.2, 25.8, 25.7. IR (KBr): 3272, 2988, 2951, 1655, 1621, 1588, 1441, 
1381, 1326, 1259, 1210, 1162, 1109, 1031, 1003, 951, 851 cm-1. HRMS (ESI) calcd. for 
C19H26O6SNa+ [M + Na]+ 405.1348, found 405.1345.  
Disulfide 190 was isolated as a minor by-
product. Rf = 0.59. 1H NMR (500 MHz, 
CDCl3) δ 5.81 (dddd, J = 17.2, 10.6, 7.8, 
3.0 Hz, 2H), 5.31 (d, J = 17.1 Hz, 2H), 5.24 (dd, J = 10.3, 0.8 Hz, 2H), 4.50 (dd, J = 
6.9, 7.8 Hz, 2H), 4.14 (ddt, J = 8.7, 6.1, 4.3 Hz, 2H), 2.70 (m, 2H), 2.56 (ddd, J = 14.4, 
7.5, 3.7 Hz, 2H), 1.92 – 1.49 (m, 8H), 1.49 (s, 6H), 1.36 (s, 6H). HRMS (ESI) calcd. for 
C20H34O4S2Na+ [M + Na]+ 425.1796, found 425.1792.  
 
 
Methyl (6′S,7′R)-6-(6′,7′-O-(1′′-methylethylidene)-
2′-thianon-8′-enyl)-2,4-dihydroxybenzoate 2′,2′-
dioxide (309) 
To a solution of thioether 191 (38 mg, 99 μmol) in 
CH2Cl2 (2.5 mL) was added 75% m-CPBA (55 mg, 
0.224 mmol) at 0 °C. The solution was left to warm to rt stirring for 18 h. The solvent 
was removed and the crude product was purified using flash column chromatography 
(silica, 1:1 hexanes/EtOAc) to give a white solid (36 mg, 87%). [α]D22 = -21.5 (c 0.50, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 11.38 (s, 1H), 6.46 (d, J = 2.5 Hz, 1H), 6.42 (d, 
J = 2.5 Hz, 1H), 5.76 (ddd, J = 17.2, 10.3, 7.6 Hz, 1H), 5.33 (ddd, J = 17.1, 1.7, 1.2 Hz, 
1H), 5.25 (ddd, J = 10.3, 1.6, 0.9 Hz, 1H), 4.77 (d, J = 13.9 Hz, 1H), 4.70 (d, J = 13.9 
Hz, 1H), 4.53 (dd, J = 7.4, 6.5 Hz, 1H), 4.11 (ddd, J = 9.8, 6.8, 3.7 Hz, 1H), 3.97 (s, 
3H), 2.93 (qdd, J = 13.9, 10.2, 5.8 Hz, 2H), 2.05 – 1.85 (m, 2H), 1.61 – 1.49 (m, 2H), 
1.48 (s, 3H), 1.36 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 170.5, 165.2, 160.6, 141.1, 
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133.5, 118.9, 113.4, 108.7, 105.0, 104.7, 79.5, 77.5, 58.5, 52.4, 51.4, 29.2, 28.2, 25.6, 
19.0. IR: 3352, 2990, 2955, 1661, 1621, 1591, 1440, 1381, 1328, 1262, 1213, 1165, 
1118, 750 cm-1. HRMS (ESI) calcd. for C19H26O8SNa+ [M + Na]+ 437.1246, found 
437.1241. 
 
Attempted saponification of sulfone 309: 
A solution of sulfone 309 (23 mg, 57 μmol) and LiOH (7 mg, 1.56 mmol) in 3:1 
MeOH/H2O (900 μL) was heated to 50 °C for 12 h. The cooled solution was acidified to 
pH 1 with 10% HCl and extracted with Et2O (3 x 10 mL). The combined organics were 
dried over MgSO4, filtered and reduced to dryness. The 1H NMR spectrum of the crude 
residue indicated that the compound had decomposed.  
 
Saponification of ester 191 leading to 5-[({3-[(4S,5R)-2,2-dimethyl-5-vinyl-1,3-
dioxolan-4-yl]propyl}thio)methyl]benzene-1,3-diol (311) 
A solution of thioether 191 (101 mg, 0.264 mmol) 
and LiOH (46 mg, 1.09 mmol) in 1:1 THF/H2O (4 
mL) was heated to 50 °C for 12 h. The cooled 
solution was extracted with Et2O (2 x 10 mL) and the 
organic fractions discarded. The aqueous layer was 
acidified to pH 1 with 10% HCl and further extracted with Et2O (3 x 10 mL). The 
combined organics were dried over MgSO4, filtered and reduced to dryness. The crude 
residue was purified by flash column chromatography (silica, gradient chromatography, 
10:1 to 1:1 hexanes/EtOAc), returning thioether 191 (5 mg, 5%) and affording diol 311 
a colourless oil (22 mg, 26%). 311: [α]D22 = -22.8 (c 0.50, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 6.37 (d, J = 2.2 Hz, 2H), 6.23 (t, J = 2.2 Hz, 1H), 5.79 (ddd, J = 17.2, 10.3, 
7.8 Hz, 1H), 5.33 (s, 1H), 5.31 (ddd,  J = 17.2, 1.7, 1.2 Hz, 1H), 5.24 (ddd, J = 10.3, 1.5, 
0.9 Hz, 1H), 4.49 (dd, J = 7.6, 6.4 Hz, 1H), 4.10 (ddd, J = 8.7, 6.1, 4.5 Hz, 1H), 3.56 (s, 
2H), 2.43 (t, J = 7.1 Hz, 2H), 1.78 – 1.65 (m, 1H), 1.64-1.50 (m, 2H), 1.49 (s, 3H), 1.48 
– 1.42 (m, 1H), 1.37 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 156.8, 141.4, 134.0, 118.7, 
108.4, 108.4, 101.5, 79.8, 77.8, 35.8, 31.0, 29.5, 28.2, 25.7, 25.7. IR: 3339, 2987, 2930, 
1603, 1454, 1373, 1340, 1218, 1156, 1003, 735 cm-1. HRMS (ESI) calcd. for 
C17H24O4SNa+ [M + Na]+ 347.1293, found 347.1288. 
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Attempted hydrolyses of methyl ester 191: 
A. A solution of thioether 191 (23 mg, 60.2 mmol) and LiOH (10 mg, 0.24 mmol) in 
2:1 MeOH/H2O (1.5 mL) was stirred at rt for 1 h. The reaction mixture was then heated 
at 50 °C for 8 h. The cooled solution reduced to dryness. The residue was partitioned 
between 10% HCl (10 mL) and EtOAc (10 mL). The aqueous layer extracted with 
EtOAc (2 x 10 mL). The combined organic fractions were dried over MgSO4, filtered 
and reduced to dryness. The 1H NMR spectrum of the residue indicated the presence of 
a ~1.78:1 ratio of ester 191 to diol 311. 
 
B. A solution of thioether 191 (23 mg, 60.2 mmol) and NaOH (13.5 mg, 0.24 mmol) in 
2:1 MeOH/H2O (1.5 mL) was stirred at rt for 1 h. The reaction mixture was then heated 
at 50 °C for 8 h. The cooled solution reduced to dryness. The residue was partitioned 
between 10% HCl (10 mL) and EtOAc (10 mL). The aqueous layer extracted with 
EtOAc (2 x 10 mL). The combined organic fractions were dried over MgSO4, filtered 
and reduced to dryness. The 1H NMR spectrum of the residue indicated the presence of 
a ~1:1.70 ratio of ester 191 to diol 311. 
 
C. To a solution of thioether 191 (41 mg, 0.11 mmol) in EtOH (3.5 mL) was added 
Ba(OH)2 (105 mg, 0.33 mmol) and the reaction mixture stirred at rt for 18 h. The 
solution turned a deep red colour. The reaction mixture was diluted with Et2O (15 mL) 
and acidified with 10% HCl (15 mL). The organic phase was separated and the aqueous 
further extracted with Et2O (10 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced to dryness. The 1H NMR spectrum of the residue indicated 
that the material had degraded.  
 
D. To a solution of ethanethiol (49 μL, 0.65 mmol) in THF (2 mL) was added n-BuLi 
(370μL, 0.59 mmol) at -10 °C. The solution instantly went cloudy. The solution was 
warmed to rt for 5 min. The reaction mixture was cooled to -10 °C and a THF solution 
(2 mL) of methyl ester 191 (57 mg, 0.15 mmol) was added dropwise. After stirring at 
-10 °C for 30 min, the reaction mixture was warmed to rt for 2 h. The reaction was 
quenched with sat. NH4Cl(aq) (10 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced to dryness. 
The 1H NMR spectrum of the residue indicated that starting material had been 
recovered.  
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E. To a solution of ethanethiol (56 μL, 0.75 mmol) in DMF (2 mL) was added a 60% 
dispersion of NaH in mineral oil (27 mg, 0.67 mmol) at -10 °C. The solution was 
warmed to rt for 5 min. The reaction mixture was cooled to -10 °C and a DMF solution 
(2 mL) of methyl ester 191 (57 mg, 0.15 mmol) was added dropwise. After stirring at -
10 °C for 30 min, the reaction mixture was warmed to rt for 12 h. The reaction was 
quenched with sat. NH4Cl(aq) (10 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced to dryness. 
The 1H NMR spectrum of the residue indicated the presence of a ~1:4 ratio of ester 191 
to diol 311. 
 
Attempted hydrolyses of orsellinate 74:  
A. To a solution of orsellinate 74 (305 mg, 1.68 mmol) in 1:1 MeOH/H2O (10 mL) was 
added KOH (506 mg, 9.02 mmol) and the reaction heated to reflux for 18 h. The cooled 
solution was acidified to pH 1 with conc. HCl and extracted with 
EtOAc (3 x 15 mL). The combined organic fractions were dried over 
MgSO4, filtered and reduced to dryness. The crude residue was 
recystallised from EtOAc to give a white solid (236 mg, 82%). The 
product was identified as 5-methylbenzene-1,3-diol (orcinol, 312): 1H NMR (500 
MHz, CDCl3) δ 6.24 (d, J = 2.3 Hz, 2H), 6.16 (t, J = 2.3 Hz, 1H), 2.24 (s, 3H). Spectral 
data matched those reported in the literature.243 
 
B. To a solution of orsellinate 74 (125 mg, 0.69 mmol) in 2:1 MeOH/H2O (4.5 mL) was 
added KOH (415 mg, 7.48 mmol) and the reaction stirred at rt for 4 days. The reaction 
mixture was reduced to dryness, resuspended in EtOAc (15 mL), acidified to pH 1 with 
conc. HCl and extracted with EtOAc (3 x 15 mL). The combined organic fractions were 
dried over MgSO4, filtered and reduced to dryness. The 1H NMR spectrum of the 
residue indicated the presence of a ~2.13:1 ratio of ester 74 to diol 312. 
 
C. To a solution of orsellinate 74 (100 mg, 0.55 mmol) in 3:1 DMSO/H2O (4 mL) was 
added KOH (220 mg, 3.78 mmol) and the reaction heated at 80 °C for 12 h. The 
reaction mixture was diluted with H2O (2 mL) and extracted with Et2O (5 mL). The 
aqueous phase was acidified to pH 2 with conc. HCl and extracted with CH2Cl2 (3 x 10 
mL). The combined organic fractions were washed with H2O (2 x 15 mL), brine (15 
mL), dried over MgSO4, filtered and reduced to dryness. The 1H NMR spectrum of the 
residue indicated that the material had degraded. 
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D. To a solution of orsellinate 74 (100 mg, 0.55 mmol) in 1:1 1,4-dioxane/H2O (16 mL) 
was added NaOH (79 mg, 3.30 mmol) and the reaction stirred at rt for 12 h. The 
reaction mixture was reduced to dryness, resuspended in EtOAc (15 mL) and acidified 
to pH 1 with conc. HCl and extracted with EtOAc (3 x 15 mL). The combined organic 
fractions were dried over MgSO4, filtered and reduced to dryness. The 1H NMR 
spectrum of the residue indicated that starting material had been recovered.  
 
E. To a solution of orsellinate 74 (100 mg, 0.55 mmol) in THF (10 mL) was added 
t-BuOK (370 mg, 3.30 mmol) and the reaction stirred at rt for 6 days. The reaction 
mixture was reduced to dryness, resuspended in Et2O (15 mL) and acidified to pH 1 
with conc. HCl and separated. The aqueous phase was further extracted with Et2O (3 x 
15 mL). The combined organic fractions were dried over MgSO4, filtered and reduced 
to dryness. The 1H NMR spectrum of the residue indicated the presence of a ~2.85:1 
ratio of ester 74 to diol 312. 
 
F. A solution of orsellinate 74 (102 mg, 0.56 mmol) in pyridine (2 mL) was refluxed 18 
h. The reaction mixture was diluted with EtOAc (20 mL) and washed with 10% HCl (4 
x 10 mL). The organic phase was dried over MgSO4, filtered and reduced to dryness. 
The 1H NMR spectrum of the residue indicated the presence of a ~2.13:1 ratio of ester 
74 to diol 312. 
 
G. A solution of orsellinate 74 (182 mg, 1.0 mmol) and pyridine hydrochloride (116 
mg, 1.0 mmol) in pyridine (3 mL) was heated to reflux for 12 h. The reaction mixture 
was diluted with EtOAc (20 mL) and washed with 10% HCl (4 x 10 mL). The organic 
phase was dried over MgSO4, filtered and reduced to dryness. The 1H NMR spectrum of 
the residue indicated the presence of a ~1:1.33 ratio of ester 74 to diol 312. 
 
H. A solution of orsellinate 74 (169 mg, 0.93 mmol) in 5:1 THF/10% H2SO4(aq) (6 mL) 
was heated to 50 °C for 4h. The cooled solution was extracted with Et2O (3 x 10 mL). 
The combined organic fractions was dried over MgSO4, filtered and reduced to dryness. 
The 1H NMR spectrum of the residue indicated that starting material had been 
recovered. 
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Methyl (6′S,7′R)-6-(6,7-O-(1-methylethylidene)-2-thianon-8-enyl)-2-hydroxy,4-
methoxymethoxybenzoate 
To a solution of compound 191 (50 mg, 0.131 
mmol) in THF (5 mL) at 0°C was added a 60% 
dispersion of NaH in mineral oil (11 mg, 0.275 
mmol). The NaH was allowed to react for 10 min at 
0 °C and 20 min at rt. The reaction mixture was then cooled to 0 °C before the addition 
of MOMCl (30 μL, 0.393 mmol). The reaction was stirred for 12 h, warming to rt. The 
reaction was quenched with H2O (10 mL) and extracted with Et2O (3 x 10 mL). The 
combined organic fractions were combined, dried over MgSO4 and reduced to dryness 
to give a colourless oil. The crude oil was purified using flash column chromatography 
(silica, 20:1 to 10:1 hexanes/EtOAc) giving the mono-protected derivative of 191 (18 
mg, 32%) and bis-MOM 192 (22 mg, 36%). mono-MOM: 1H NMR (500 MHz, CDCl3) 
δ 11.54 (s, 1H), 6.55 (d, J = 2.5 Hz, 1H), 6.39 (d, J = 2.5 Hz, 1H), 5.79 (ddd, J = 17.1, 
10.3, 7.8 Hz, 1H), 5.30 (ddd, J = 17.1, 1.6, 1.1 Hz, 1H), 5.23 (ddd, J = 10.3, 1.6, 0.8 Hz, 
1H), 5.18 (s, 2H), 4.47 (dd, J = 7.6, 6.4 Hz, 1H), 4.09 (ddd, J = 8.7, 6.1, 4.6 Hz, 1H), 
3.94 (s, 3H), 3.91 (d, J = 1.4, 2H), 3.46 (s, 3H), 2.49 – 2.40 (m, 2H), 1.79 – 1.69 (m, 
1H), 1.61 – 1.48 (m, 2H), 1.47 (s, 3H), 1.48 – 1.39 (m, 1H), 1.35 (s, 3H).  
 
Methyl (6′S,7′R)-6-(6,7-O-(1-methylethylidene)-2-thianon-8-enyl)-2,4-
bis(methoxymethoxy)benzoate (192) 
To a solution of compound 191 (621 mg, 1.62 
mmol) in DMF (6 mL) at 0 °C was added a 60% 
dispersion of NaH in mineral oil (163 mg, 4.06 
mmol). The reaction was stirred at 0 °C for 20 min 
before the addition of MOMCl (370 μL, 4.89 
mmol). The reaction mixture was left to warm to rt stirring for 2 h. The reaction mixture 
was diluted with Et2O (30 mL) and washed with saturated aqueous NH4Cl solution (20 
mL). The organic layer was separated and the aqueous layer further extracted with Et2O 
(2 x 15 mL). The combined organic fractions were washed with brine (20 mL), dried 
over MgSO4, filtered and reduced to give a colourless oil. The crude oil was purified 
using flash column chromatography (silica, gradient chromatography, 10:1 to 5:1 
hexanes/EtOAc) affording the desired bis-MOM ether as a colourless oil (562 mg, 
74%). Rf = 0.30. [α]D18 = -30.3 (c 0.08, CHCl3). 1H NMR (500 MHz, CDCl3) δ 6.74 (d, J 
= 2.2 Hz, 1H), 6.68 (d, J = 2.2 Hz, 1H), 5.79 (ddd, J = 17.1, 10.3, 7.8 Hz, 1H), 5.29 
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(ddd, J = 17.1, 1.6, 1.1 Hz, 1H), 5.22 (ddd, J = 10.3, 1.6, 0.9 Hz, 1H), 5.16 (s, 2H), 5.16 
(s, 2H), 4.47 (dd, J = 7.6, 6.4 Hz, 1H), 4.09 (ddd, J = 8.6, 4.7, 6.1 Hz, 1H), 3.88 (s, 3H), 
3.71 (s, 2H), 3.47 (s, 3H), 3.46 (s, 3H), 2.48 – 2.40 (m, 2H), 1.77 – 1.67 (m, 1H), 1.60 – 
1.43 (m, 3H), 1.47 (s, 3H), 1.35 (s, H). 13C NMR (125 MHz, CDCl3) δ 167.9, 158.8, 
156.0, 139.4, 134.3, 118.3, 110.6, 108.2, 102.5, 95.0, 94.3, 79.7, 77.8, 77.2 56.3, 56.2, 
52.2, 34.0, 31.4, 29.5, 28.2, 25.8, 25.6. IR (neat): 2949, 2906, 1727, 1605, 1434, 1277, 
1215, 1144, 1038, 1017, 928, 870 cm-1.  HRMS (ESI) calcd. for C23H34O8SNa+ [M + 
Na]+ 493.1872, found 493.1867. 
 
(6′S,7′R)-6-(6,7-O-(1-methylethylidene)-2-thianon-8-enyl)-2,4-
(bismethoxymethoxy)benzoic acid (193) 
To a solution of ester 192 (455 mg, 0.968 mmol) 
in 2:1 MeOH/H2O (15 mL) was added KOH (271 
mg, 4.84 mmol) and the reaction mixture heated to 
90 °C for 48 h. After cooling to rt, the mixture was 
extracted with Et2O (20 ml) and the organic layer 
discarded. The aqueous layer was acidified to pH 6 with an aqueous acetic acid solution 
(50%; v/v, 0.78 mL, 6.8 mmol) and extracted with Et2O (3 x 15 mL). The combined 
organic phases were washed with H2O (4 x 20 mL), dried over MgSO4, filtered and 
evaporated under reduced pressure to afford the acid as a colourless oil (434 mg, 98%).  
[α]D20 = -32.1 (c 0.2, CHCl3). 1H NMR (300 MHz, CDCl3) δ 6.77 (d, J = 2.3 Hz, 1H), 
6.73 (d, J = 2.2 Hz, 1H), 5.79 (ddd, J = 17.2, 10.2, 7.8 Hz, 1H), 5.28 (ddd, J = 17.1, 1.6, 
1.0 Hz, 1H), 5.22 (s, 2H), 5.22 (dd, J = 10.3, 1.6, 0.8 Hz, 1H), 5.18 (s, 2H), 4.47 (dd, J = 
7.6, 6.4 Hz, 1H), 4.12 (ddd, J =  8.4, 6.1, 4.6 Hz, 1H), 3.90 (d, J = 2.0 Hz, 2H), 3.50 (s, 
3H), 3.47 (s, 3H), 2.48 (t, J = 7.0 Hz, 2H), 1.74 (m, 1H), 1.64 – 1.38 (m, 3H), 1.47 (s, 
3H), 1.35 (s, 3H). IR (neat): 2908, 2845, 1604, 1586, 1462, 1377, 1277, 1216, 1151, 
1028, 1020, 927, 744 cm-1. HRMS (ESI) calcd. for C22H32O8SNa+ [M + Na]+ 479.1716, 
found 479.1720. 
 
(4S,6′S,7′R)-Pent-1-en-4-yl 6-(6,7-O-(1-methylethylidene)-2-thianon-8-enyl)-2,4-
(bismethoxymethoxy)benzoate (167) 
To a solution of alcohol 22 (147 μL, 1.43 mmol) 
and PPh3 (624 mg, 2.38 mmol) in THF (20 mL) at 
0 °C was added DIAD (463 μL, 2.38 mmol). The 
solution was stirred at 0 °C for 20 min during 
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which time a white precipitate formed. After this time a solution of the acid 194 (434 
mg, 0.952 mmol) in THF (15 mL) was added dropwise and the reaction was left to stir 
at rt for 2 days. To the crude reaction mixture was added a small amount of silica gel 
before removal of solvent. The silica gel was dry loaded onto a column and eluted 
(gradient elution 20:1 to 5:1 hexanes/EtOAc) to yield title compound 167 as a 
colourless oil (468 mg, 94%). Rf = 0.60. [α]D18 = -34.9 (c 0.18, CHCl3). 1H NMR (500 
MHz, CDCl3) δ 6.72 (d, J = 2.2 Hz, 1H), 6.69 (d, J = 2.1 Hz, 1H), 5.85 (ddt, J = 17.2, 
10.2, 7.0 Hz, 1H), 5.78 (ddd, J = 17.9, 10.3, 7.8 Hz, 1H), 5.28 (d, J = 17.1 Hz, 1H), 5.25 
– 5.20 (m, 2H), 5.15 (s, 2H), 5.14 (d, J = 1.7 Hz, 2H), 5.13 – 5.07 (m, 2H), 4.46 (dd, J = 
7.3, 6.6 Hz, 1H), 4.09 (ddd, J = 8.5, 6.0, 4.8 Hz, 1H), 3.71 (q, J = 13.7 Hz, 2H), 3.46 (s, 
3H), 3.45 (s, 3H), 2.46 (qt, J = 12.9, 6.6 Hz, 3H), 2.40 – 2.33 (m, 1H), 1.72 (m, 1H), 
1.60 – 1.40 (m, 3H), 1.46 (s, 3H), 1.34 (s, 3H), 1.34 (d, J = 6.2 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 166.9, 158.6, 155.8, 139.0, 134.3, 133.8, 118.4, 118.3, 117.7, 110.4, 
108.2, 102.3, 94.7, 94.3, 79.7, 77.8, 71.2, 56.2, 56.1, 40.2, 33.8, 31.6, 29.5, 28.2, 25.8, 
25.6, 19.4. IR (neat): 2984, 2906, 2845, 1715, 1604, 1584, 1434, 1380, 1272, 1216, 
1149, 1039, 1019, 926 cm-1. HRMS (ESI) calcd. for C27H40O8SNa+ [M + Na]+ 
547.2342, found 547.2342. 
 
(4S,6′S,7′R)-Pent-1-en-4-yl 6-(6′,7′-O-(1′′-methylethylidene)-2′-thianon-8′-enyl)-
2,4-(bismethoxymethoxy)benzoate 2′,2′-dioxide (195) 
To a solution of thioether 167 (122 mg, 0.230 
mmol) in CH2Cl2 (5 mL) at 0 °C was added 75% 
m-CPBA (115 mg, 0.501 mmol). The reaction was 
left to warm to rt whilst stirring for 2 h. The 
reaction was quenched with the addition of 20% 
aqueous Na2SO3 solution (10 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
combined organic phases were washed with sat. NaHCO3(aq) (20 mL), dried over 
MgSO4, filtered and reduced in vacuo to give a colourless oil. The product was purified 
by flash column chromatography (silica, gradient elution 3:1 to 2:1 hexanes/EtOAc) 
yielding the title compound as a colourless oil (109 mg, 84%). Rf = 0.31. [α]D22 = -11.0 
(c 1.05, CHCl3). 1H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 2.2 Hz, 1H), 6.86 (d, J = 2.2 
Hz, 1H), 5.85 (ddt, J = 17.2, 10.2, 7.0 Hz, 1H), 5.75 (ddd, J = 17.1, 10.3, 7.7 Hz, 1H), 
5.29 (ddd, J = 17.1, 1.5, 1.1 Hz, 1H), 5.25 – 5.20 (m, 2H), 5.18 (s, 2H), 5.17 – 5.14 (m, 
3H), 5.11 (ddt, J = 9.0, 2.0, 1.1 Hz, 1H), 4.48 (dd, J = 7.5, 6.5 Hz, 1H), 4.38 (d, J = 14.1 
Hz, 1H), 4.28 (d, J = 14.1 Hz, 1H), 4.12 – 4.07 (m, 1H), 3.47 (s, 3H), 3.46 (s, 3H), 3.02 
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(ddd, J = 13.9, 10.2, 5.7 Hz, 1H), 2.94 (ddd, J = 13.9, 10.1, 5.7 Hz, 1H), 2.51 – 2.44 (m, 
1H), 2.42 – 2.35 (m, 1H), 2.02 – 1.91 (m, 1H), 1.89 – 1.80 (m, 1H), 1.52 (tdd, J =  11.2, 
7.0, 3.9 Hz, 2H), 1.45 (s, 3H), 1.34 (d, J = 6.3 Hz, 3H), 1.33 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ 166.6, 159.0, 156.4, 134.0, 133.7, 128.5, 119.3, 118.6, 117.9, 112.2, 
108.4, 104.2, 94.8, 94.3, 79.6, 77.6, 71.7, 56.7, 56.4, 56.3, 51.5, 40.2, 29.3, 28.1, 25.5, 
19.5, 18.7. IR (neat): 1708, 1605, 1586, 1285, 1214, 1150, 1122, 1039, 1018, 914, 734. 
HRMS (ESI) calcd. for C27H40O10SNa+ [M + Na]+ 579.2246, found 579.2240. 
 
(5S,7E,9R,10S)-1,2-(3′,5′-Di-O-methoxymethyl)benzo-4-oxa-14-thia-3-oxo-5-
methyl-9,10-O-(1-methylethylidene)-pentadec-7-ene 14,14-dioxide (196)  
To a solution of the diene 195 (55 mg, 99 μmol) in 
CH2Cl2 (20 mL) in a 100 mL MW Teflon™ 
reactor vessel was added a catalytic amount of 
Grubbs’ second generation catalyst 28 (8.4 mg, 9.9 
μmol). The vessel was flushed with argon before 
sealing with the cap. The vessel was placed in the MW carousel and the 
temperature/pressure probe inserted into the reaction vessel. The vessel was irradiated 
for 30 min and heated to 75 °C. Once the reaction vessel had cooled to rt the cap was 
removed and the solution transferred to a round-bottom flask. The solvent was removed 
to yield a brown oil. The crude product was purified on a silica column (gradient 
chromatography, 5:1 to 2:1 hexanes/EtOAc) yielding compound 196 as a colourless oil 
(45 mg, 86%). Rf = 0.14. [α]D22 = -28.5 (c 0.50, CHCl3).  1H NMR (500 MHz, CDCl3) δ 
7.16 (d, J = 2.2 Hz, 1H), 6.85 (d, J = 2.2 Hz, 1H), 5.71 (ddd, J = 15.2, 9.3, 4.3 Hz, 1H), 
5.55 (ddd, J = 15.4, 9.4, 1.4 Hz, 1H), 5.29 (m, 1H), 5.21 (d, J = 6.8 Hz, 1H), 5.16 (t, J = 
3.4 Hz, 1H), 5.16 (s, 2H), 4.47 (d, J = 15.3 Hz, 1H), 4.43 (dd, J = 9.3, 5.8 Hz, 1H), 4.13 
(d, J = 15.1 Hz, 1H), 4.11 (m, 1H), 3.47 (s, 3H), 3.47 (s, 3H), 2.83 (ddd, J = 14.6, 11.1, 
5.3 Hz, 1H), 2.65 (m, 1H), .47 (m, 1H), 2.41 (dd, J = 15.5, 9.8 Hz, 1H), 1.75 (m, 1H), 
1.67 (m, 1H), 1.62 – 1.53 (m, 2H), 1.43 (s, 3H), 1.40 (d, J = 6.2 Hz, 3H), 1.32 (s, 3H). 
13C NMR (500 MHz, CDCl3) δ 167.1, 159.3, 156.6, 132.4, 129.0 (2), 118.6, 110.9, 
107.9, 103.6, 94.6, 94.4, 76.3, 77.6, 72.3, 56.4, 56.4, 55.4, 51.1, 39.5, 28.3, 27.6, 25.5, 
20.8, 18.5. IR (neat): 2982, 2903, 2829, 1708, 1604, 1585, 1277, 1215, 1149, 1122, 
1017, 926, 737 cm-1. HRMS (ESI) calcd. for C25H36O10SNa+ [M + Na]+ 551.1928, found 
551.1927. 
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Benzyl pentyl sulfide (315) 
To a solution of mercaptan benzyl (0.97 ml, 8.06 mmol) and 
1-bromopentane (1.0 mL, 8.06 mmol) in MeOH (40 mL) was 
added K2CO3 (2.23 g, 16.1 mmol). The reaction was stirred overnight at rt. The solvent 
was removed and the residue dissolved in Et2O (100 mL), washed with H2O (2 x 50 
mL) and brine (50 mL), dried over MgSO4, filtered and reduced to give a yellow oil. 
The thioether was deemed to be pure by 1H NMR and was carried forward without 
further purification (1.54 g, 98%). 1H NMR (300 MHz, CDCl3) δ 7.38 – 7.24 (m, 5H), 
3.73 (s, 2H), 2.45 (t, J = 7.5 Hz, 2H), 1.60 – 1.50 (m, 2H), 1.38 – 1.24 (m, 4H), 0.90 (t, 
J = 6.9 Hz, 3H). Spectral data matched those reported in the literature.244 
 
Benzyl pentyl sulfone (316)117 
To a solution of thioether 315 (1.32g, 6.80 mmol) in AcOH 
(40 mL) was added NaBO3.4H2O (3.35 g, 21.8 mmol) in 
portions over 30 min. The reaction mixture was stirred at rt for 12 h. The solvent was 
removed under reduced pressure and the crude white solid partitioned between EtOAc 
(50 mL) and H2O (50 mL) and separated. The aqueous layer was extracted with EtOAc 
(3 x 30 mL). The combined organic factions were washed with sat. NaHCO3 aq (3 x 30 
mL) and brine (30 mL) before drying over MgSO4, filtering and reducing to give a 
white solid (1.95 g, 97%). The sulfone was deemed to be pure by 1H NMR 
spectroscopy. 1H NMR (500 MHz, CDCl3) δ 7.40 (s, 5H), 4.21 (s, 2H), 2.80 (m, 2H), 
1.84 – 1.78 (m, 2H), 1.40 – 1.30 (m, 4H), 0.89 (t, J = 7.2 Hz, 3H). 
 
Preparation of alumina-loaded KOH (KOH–Al2O3)124 
Alumina (30 g) was suspended in a methanolic solution of KOH (10 g, 50 mL) in a 250 
mL round bottom flask. The solvent was removed under reduced pressure at 50 °C until 
the powder was free flowing with a constant weight. When stored in a sealed container, 
the KOH–Al2O3 has a shelf-life of several months.   
 
Attempted synthesis of benzyl 1-chloropentyl sulfone (317a) 
A solution of sulfone 316 (52 mg, 0.24 mmol) and NCS (34 mg, 0.25 mmol) in CCl4 (2 
mL) was stirred at rt for 15 h. The reaction mixture was reduced to dryness. The 1H 
NMR spectrum of the residue indicated that no reaction had occurred.  
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Attempted synthesis of benzyl 1-bromopentyl sulfone (317b) 
A solution of sulfone 316 (98 mg, 0.45 mmol) and NBS (95 mg, 0.54 mmol) in CCl4 (5 
mL) was refluxed under a heat lamp (200 W) for 15 min. The cooled reaction mixture 
was reduced to dryness. The 1H NMR spectrum of the residue indicated that no reaction 
had occurred.  
 
Attempted Ramberg-Backlund reactions with sulfone 316 
A. To a solution of sulfone 316 (100 mg, 0.45 mmol) in t-BuOH (1.8 mL) and CCl4 (1.8 
mL) was added KOH–Al2O3 (900 mg). The reaction mixture was stirred at rt for 2 h 
before filtering and reducing to dryness. The 1H NMR spectrum of the residue indicated 
the presence of sulfone 316 (49%), alkene 318 (20%) and complex mixture of other 
products (31%). 
 
B. To a solution of sulfone 316 (64 mg, 0.29 mmol) in t-BuOH (1.15 mL) and CCl4 
(1.15 mL) was added KOH–Al2O3 (580 mg). The reaction mixture was heated to 40 °C 
for 2 h. The cooled solution was filtered and reduced to dryness. The 1H NMR spectrum 
of the residue indicated the presence of sulfone 316 (49%), alkene 318 (31%) and 
complex mixture of other products (20%). 
 
C. To a solution of sulfone 316 (32 mg, 0.15 mmol) and NBS (31 mg, 0.18 mmol) in t-
BuOH (0.75 mL) and CH2Cl2 (1 mL) was added KOH–Al2O3 (400 mg). The reaction 
mixture was stirred at rt for 2 h, before filtering and reducing to dryness. The 1H NMR 
spectrum of the residue indicated the presence of sulfone 316 (78%), alkene 318 (16%) 
and complex mixture of other products (6%). 
 
D. To a solution of sulfone 316 (95 mg, 0.43 mmol) and NBS (77 mg, 0.43 mmol) in 
DMF (1 mL) was added DBU (129 μL, 0.86 mmol). The reaction mixture was stirred at 
rt for 2 h. The reaction mixture was diluted with EtOAc (10 ml) and washed with sat. 
NaHCO3(aq) (10 mL) and brine (10 mL). The organic phase was dried over MgSO4, 
filtered and reduced to dryness. The 1H NMR spectrum of the residue indicated that 
sulfone 316 was recovered. 
 
E. To a solution of sulfone 316 (53 mg, 0.24 mmol) in t-BuOH (1 mL), CCl4 (1 mL), 
CH2Cl2 (500 μL) and H2O (50 μL) was added powdered KOH (270 mg, 4.81 mmol). 
After the reaction mixture was stirred at rt for 2 h, the solvent was removed to dryness 
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and the residue partitioned between sat. NH4Cl(aq) (5 mL) and EtOAc (5 mL). The 
aqueous layer was further extracted with EtOAc (2 x 5 mL). The combined organic 
phases were dried over MgSO4, filtered and reduced to dryness. The 1H NMR spectrum 
of the residue indicated the presence of sulfone 316 (25%), alkene 318 (45%) and 
complex mixture of other products (30%). 
 
(5′S,6′R,10′S)-2,4-Di-O-(methoxymethyl)-5′,6′-O-(1-
methylethylidene)-aigialomycin D (35) 
To a solution of sulfone 196 (34 mg, 64.4 μmol) in 
tBuOH (250 μl) and CH2Cl2 (100 μL) was added 
powdered KOH (72 mg, 1.29 mmol) at rt. To the 
resulting suspension was added CCl4 (250 μmol) 
dropwise over 2 min. The reaction was then heated to 35 °C for 30 min. After cooling to 
rt the solvent was removed to dryness and the residue partitioned between sat. NH4Cl 
(aq) (5 mL) and EtOAc (5 mL). The aqueous layer was further extracted with EtOAc (2 x 
5 mL). The combined organic phases were dried over MgSO4, filtered and reduced. The 
crude product was purified by flash column chromatography (silica, gradient elution 
20:1 to 5:1 hexanes/EtOAc) to give the title compound 35 as a white solid (25 mg, 
84%). Rf = 0.40. [α]D19 = -118.6 (c 0.15, CHCl3) [lit.35 -116.5 (c 0.13, CHCl3) and lit.32 -
120 (c 0.08, CHCl3)] 1H NMR (500 MHz, CDCl3) δ 6.81 (d, J = 2.1 Hz, 1H), 6.69 (d, J 
= 2.1 Hz, 1H), 6.24 (d, J = 15.8 Hz, 1H), 6.14 (ddd, J = 15.3, 9.6, 4.2 Hz, 1H), 5.74 
(ddd, J = 15.3, 9.4, 3.5 Hz, 1H), 5.60 (ddd, J = 15.4, 9.7, 1.7 Hz, 1H), 5.34 (m, 1H), 
5.20 (d, J = 6.7 Hz, 1H), 5.16 (s, 2H), 5.12 (d, J = 6.8 Hz, 1H), 4.57 (dd, J = 9.6, 5.4 Hz, 
1H), 4.19 (ddd, J = 11.6, 5.4, 3.1 Hz, 1H), 3.46 (s, 3H), 3.46 (s, 3H), 2.58 – 2.44 (m, 
2H), 2.31 (m, 1H), 2.11 (m, 1H), 1.80 (m, 1H), 1.49 (m, 1H), 1.47 (s, 3H), 1.37 (d, J = 
6.3 Hz, 3H), 1.36 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 167.4, 158.9, 155.1, 136.8, 
132.3, 131.9, 129.3, 128.4, 117.9, 108.3, 104.8, 102.5, 94.5, 94.3, 80.1, 77.2, 71.6, 56.2, 
56.1, 39.5, 29.0, 28.7, 28.6, 25.8, 21.1. IR (neat): 2984, 2897, 1722, 1601, 1579, 1263, 
1218, 1148, 1052, 1018, 925 cm-1. HRMS (ESI) calcd. for C25H34O8Na+ [M + Na]+ 
485.2151, found 485.2147. 
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Aigialomycin D (1) 
A solution of compound 15 (45 mg, 97.3 μmol) in 1:1 
MeOH/1M HCl (10 mL) was stirred at rt for 3 days. The 
reaction mixture was extracted with EtOAc (3 x 10 mL), 
washed with brine (5 ml), dried over MgSO4, filtered and 
reduced to give aigialomycin D as a white solid (28 mg, 
86%). Rf (5% MeOH/CH2Cl2) = 0.21. [α]D19 = -25.1 (c 0.78, MeOH) [lit.35 -21.9 (c 0.35, 
MeOH)]. 1H NMR (500 MHz, d6-acetone) δ 11.66 (s, 1H), 9.25 (brs, 1H), 7.15 (d, J = 
15.9 Hz, 1H), 6.53 (d, J = 2.0 Hz, 1H), 6.28 (d, J = 2.0 Hz, 1H), 6.09 (ddd, J = 15.9, 
5.7, 5.5 Hz, 1H), 5.88 (ddd, J = 15.6, 7.4, 1.6 Hz, 1H), 5.69 (ddd, J = 15.6, 5.2, 1.2 Hz, 
1H), 5.44 (m, 1H), 4.35 (brd, J = 4.1 Hz, 1H), 3.82 (brs, 1H), 3.63 (m, 1H), 3.20 (brs, 
1H), 2.57 (ddd, J = 14.6, 7.4, 3.1 Hz, 1H), 2.43 (m, 1H), 2.36 – 2.32 (m, 2H), 2.14 (m, 
1H), 1.59 (m, 1H), 1.37 (d, J = 6.4 Hz, 3H). 13C NMR (125 MHz, d6-acetone) δ 172.2, 
165.8, 163.1, 144.3, 135.7, 133.6, 130.6, 125.4, 107.8, 104.4, 102.5, 76.5, 73.0, 73.0, 
37.9, 28.5, 28.0, 19.1. IR (neat): 3338, 2979, 1644, 1608, 1448, 1312, 1259, 1167, 1110, 
1018, 972 cm-1. HRMS (ESI) calcd. for C18H22O6Na+ [M + Na]+ 357.1308, found 
357.1314. 
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8.6 Experimental for Chapter Six 
 
(5′S,6′R,10′S)-2,4-Di-O-(methoxymethyl)-5′,6′-O-(1-methylethylidene)-tetrahydro-
aigialomycin D (15) (324) 
To a solution of unsaturated 35 (16 mg, 34.5 μmol) in 
EtOH (1 mL) was added 10% Pd/C (1.5 mg). The 
flask was briefly evacuated before creation of a H2(g) 
atmosphere with the installation of a H2(g) balloon. The 
reaction was left stirring under the H2(g) atmosphere 
for 2 h. The mixture was filtered through Celite® and reduced, giving a colourless oil 
(14 mg, 88%). The crude product was carried forward without further purification. 1H 
NMR (500 MHz, CDCl3) δ 6.66 (d, J = 2.2 Hz, 1H), 6.55 (d, J = 2.1 Hz, 1H), 5.25 (m, 
1H), 5.18 – 5.10 (m, 4H), 4.11 – 4.06 (m, 2H), 3.45 (s, 6H), 2.63 (ddd, J = 13.6, 11.0, 
5.8 Hz, 1H), 2.49 (ddd, J = 13.7, 10.6, 5.2 Hz, 1H), 1.88 – 1.66 (m, 4H), 1.66 – 1.50 (m, 
4H), 1.40 (s, 3H), 1.50 – 1.30 (m, 2H), 1.34 (d, J = 6.3 Hz, 3H), 1.31 (s, 3H), 1.30 – 
1.19 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 168.3, 158.6, 155.1, 141.5, 119.1, 109.2, 
107.1, 101.0, 94.6, 94.3, 77.7, 77.0, 72.4, 56.2, 56.1, 36.5, 33.2, 31.3, 31.3, 28.4, 27.6, 
25.9, 24.7, 23.0, 21.0.  
 
Tetrahydro-aigialomycin D (209) 
To a solution of protected 324 (14 mg, 29.9 μmol) 
in MeOH (1.5 mL) was added 10% HCl (1.5 mL) 
and the mixture was stirred at rt for 3 days. The 
reaction was extracted with EtOAc (3 x 10 mL). 
The combined organic fractions were washed with 
H2O (4 x 10 mL) until the aqueous layer was pH 7, 
dried over MgSO4, filtered and reduced to dryness. The crude oil was purified by flash 
column chromatography (silica, gradient elution 1:1 hexanes/EtOAc to EtOAc) to give 
a colourless oil (6.5 mg, 89% over two steps). [α]D19 = -8.2 (c 0.11, MeOH). 1H NMR 
(500 MHz, d6-acetone) δ 11.77 (s, 1H), 9.09 (s, 1H), 6.34 (d, J = 2.5 Hz, 1H), 6.24 (d, J 
= 2.5 Hz, 1H), 5.10 (m, 1H), 3.83 – 3.76 (m, 2H), 3.53 (td, J = 12.3, 4.0 Hz, 1H), 2.36 
(td, J = 12.1, 4.6 Hz, 1H), 2.21 (m, 1H), 1.92 – 1.79 (m, 4H), 1.77 – 1.67 (m, 2H), 1.61 
(m, 1H), 1.55 – 1.35 (m, 4H), 1.33 (d, J = 6.1 Hz, 3H). 13C NMR (125 MHz, d6-
acetone) δ 172.7, 166.2, 163.1, 149.4, 111.8, 105.2, 101.8, 74.6, 73.9, 69.3, 37.2, 36.5, 
34.6, 32.9, 28.3, 26.6, 21.6, 21.0. IR (neat): 3410, 3063, 2943 2869, 1643, 1607, 1489, 
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1443, 1312, 1258, 1161, 1009, 759, 698, 638 cm-1. HRMS (ESI) calcd. for 
C18H26O6Na+ [M + Na]+ 361.1627, found 361.1627. 
 
Attempted synthesis of (5′S,6′R,10′S)-2,4-Di-O-(methoxymethyl)-5-chloro-5′,6′-O-
(1-methylethylidene)-aigialomycin D30 
Calcium hypochlorite (6 mg, 41 μmol, 30% in Cl) 
dissolved in 10% AcOH/H2O (1 mL) was slowly 
added to a solution of bisMOM 35 (8 mg, 17 μmol) in 
acetone (1 mL) at rt. After stirring for 2 h at rt, 
additional calcium hypochlorite (2.5 mg, 17 μmol) was 
added and the mixture stirred for a further 2.5 h. H2O 
(2 mL) and EtOAc (5 mL) were added to the mixture and the aqueous layer removed. 
The organic layer was washed with H2O (2 x 2 mL) and saturated aqueous NaCl (5 
mL), dried over MgSO4, filtered and concentrated. The 1H NMR of the crude residue 
indicated that no reaction had taken place. 
 
(5S,7E,9R,10S)-1,2-(3′,5′-Di-O-hydroxy)benzo-4-oxa-14-thia-3-oxo-5-methyl-9,10-
dihydroxypentadec-7-ene 14,14-dioxide (325) 
 To a solution of protected 35 in MeOH (2 mL) was 
added 1M HCl (2 mL). The reaction was left stirring at 
rt for three days. The reaction mixture was extracted 
with EtOAc (3 x 10 mL), washed with brine (5 ml), 
dried over MgSO4, filtered and reduced to give a 
colourless oil (6.4 mg, 89%). [α]D19 = -7.2 (c 0.69, MeOH). 1H NMR (500 MHz, d6-
acetone) δ 11.28 (s, 1H), 6.63 (s, 1H), 6.41 (s, 1H), 5.79 (ddd, J = 15.9, 8.5, 4.7 Hz, 
1H), 5.72 (dd, J = 15.9, 6.7 Hz, 1H), 5.46 (m, 1H), 4.88 (d, J = 13.3 Hz, 1H), 4.76 (d, J 
= 13.4 Hz, 1H), 4.20 (d, J = 6.6 Hz, 1H), 3.94 (s, 1H), 3.74 (s, 1H), 3.66 (brs, 1H), 3.16 
(dt, J = 14.5, 6.9 Hz, 1H), 2.87 (m, 1H), 2.67 (td, J = 15.0, 3.4 Hz, 1H), 2.41 (ddd, J =  
15.0, 7.6, 7.1 Hz, 1H), 2.12 – 2.02 (m, 2H), 1.92 – 1.79 (m, 2H), 1.57 (m, 1H), 1.43 (d, 
J = 6.4 Hz, 3H). 13C NMR (125 MHz, d6-acetone) δ 171.0, 170.9, 165.7, 165.4, 162.8, 
135.3, 132.8, 127.4, 114.9, 106.8, 104.3, 104.3, 74.0, 57.8, 53.8, 38.3, 31.8, 19.8, 19.1. 
IR(neat): 3396, 2927, 1711, 1650, 1620, 1597, 1453, 1357, 1304, 1299, 1264, 1173, 
1115 cm-1. HRMS (ESI) calcd. for C18H24O8SNa+ [M + Na]+ 423.1090, found 423.1082. 
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(4R,6′S,7′R)-Pent-1-en-4-yl 6-(6,7-O-(1-methylethylidene)-2-thianon-8-enyl)-2,4-
(bismethoxymethoxy)benzoate (10′-epi-167) 
To solution of acid 193 (102 mg, 0.22 mmol) and 
alcohol 22 (34 μL, 0.33 mmol) in CH2Cl2 (2 mL) 
were added DMAP (27 mg, 0.22 mmol) and DCC 
(46 mg, 0.22 mmol). The reaction was stirred at rt 
for 12 h. The reaction was quenched with H2O (10 
mL) and extracted with CH2Cl2 (3 x 10 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced to give a 
colourless oil. The crude oil was dissolved in CH2Cl2, absorbed on silica gel, dry-loaded 
on a silica gel column and eluted (gradient elution 20:1 to 10:1 hexanes/EtOAc) to 
afford a colourless oil (37 mg, 32%). 1H NMR (500 MHz, CDCl3) δ 6.72 (d, J = 2.2 Hz, 
1H), 6.69 (d, J = 2.2 Hz, 1H), 5.85 (ddt, J = 17.2, 10.2, 7.0 Hz, 1H), 5.78 (ddd, J = 17.9, 
10.3, 7.8 Hz, 1H), 5.28 (d, J = 17.1 Hz, 1H), 5.25 – 5.20 (m, 2H), 5.15 (s, 2H), 5.14 (d, 
J = 1.7 Hz, 2H), 5.13 – 5.07 (m, 2H), 4.46 (dd, J = 7.3, 6.6 Hz, 1H), 4.09 (ddd, J = 8.5, 
6.0, 4.8 Hz, 1H), 3.73 (d, J = 13.7 Hz, 1H), 3.69 (d, J = 13.7 Hz, 1H), 3.46 (s, 3H), 3.45 
(s, 3H), 2.51 – 2.43 (m, 2H), 2.37 (m, 1H), 1.72 (m, 1H), 1.60 – 1.40 (m, 4H), 1.46 (s, 
3H), 1.34 (s, 3H), 1.34 (d, J = 6.2 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 166.9, 158.6, 
155.8, 139.0, 134.3, 133.8, 118.4, 118.3, 117.7, 110.4, 108.2, 102.3, 94.7, 94.3, 79.7, 
77.8, 71.2, 56.2, 56.1, 40.2, 33.8, 31.6, 29.5, 28.2, 25.8, 25.6, 19.4. 
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(4R,6′S,7′R)-Pent-1-en-4-yl 6-(6′,7′-O-(1′′-methylethylidene)-2′-thianon-8′-enyl)-
2,4-(bismethoxymethoxy)benzoate 2′,2′-dioxide 
(10′-epi-195) 
To a solution of thioether 10′-epi-167 (27 mg, 52 
μmol) in CH2Cl2 (1.5 mL) at 0 °C was added 75% 
m-CPBA (26 mg, 0.112 mmol). The reaction was 
left to warm to rt whilst stirring for 2 h. The reaction was quenched with the addition of 
20% aqueous Na2SO3 solution (5 mL) and extracted with CH2Cl2 (3 x 5 mL). The 
combined organic phases were washed with sat. NaHCO3(aq) solution (20 mL), dried 
over MgSO4, filtered and reduced in vacuo to give a colourless oil. The product was 
purified by flash column chromatography (silica, gradient elution 3:1 to 2:1 
hexanes/EtOAc) yielding the title compound as a colourless oil (23 mg, 80%). 1H NMR 
(500 MHz, CDCl3) δ 6.87 (d, J = 2.2 Hz, 1H), 6.85 (d, J = 2.2 Hz, 1H), 5.85 (ddt, J = 
17.2, 10.2, 7.0 Hz, 1H), 5.75 (ddd, J = 17.1, 10.3, 7.7 Hz, 1H), 5.29 (ddd, J = 17.1, 1.5, 
1.1 Hz, 1H), 5.25 – 5.20 (m, 2H), 5.18 (s, 2H), 5.17 – 5.14 (m, 3H), 5.11 (ddt, J = 9.0, 
2.0, 1.1 Hz, 1H), 4.48 (dd, J = 7.5, 6.5 Hz, 1H), 4.38 (d, J = 14.1 Hz, 1H), 4.28 (d, J = 
14.1 Hz, 1H), 4.12 – 4.07 (m, 1H), 3.47 (s, 3H), 3.46 (s, 3H), 3.02 (ddd, J = 13.9, 10.2, 
5.7 Hz, 1H), 2.94 (ddd, J = 13.9, 10.1, 5.7 Hz, 1H), 2.47 (m, 1H), 2.40 (m, 1H), 1.96 
(m, 1H), 1.84 (m, 1H), 1.52 (m, 1H), 1.45 (s, 3H), 1.34 (d, J = 6.3 Hz, 3H), 1.33 (s, 3H). 
 
(5R,7E,9R,10S)-1,2-(3′,5′-Di-O-methoxymethyl)benzo-4-oxa-14-thia-3-oxo-5-
methyl-9,10-O-(1-methylethylidene)-pentadec-7-ene 14,14-dioxide (10′-epi-196)  
To a solution of the diene 10′-epi-195 (23 mg, 41 
μmol) in CH2Cl2 (8.5 mL) in a 100 mL MW 
Teflon™ reactor vessel was added a catalytic 
amount of Grubbs’ second generation catalyst (3.5 
mg, 4.1 μmol). The vessel was flushed with argon 
before sealing with the cap. The vessel was placed 
in the MW carousel and the probe inserted into the reaction vessel. The vessel was 
irradiated for 30 min and heated to 75 °C. Once the reaction vessel had cooled to rt the 
cap was removed and the solution transferred to a round-bottom flask. The solvent was 
removed to yield a brown oil. The crude product was purified on a silica column 
(gradient chromatography, 5:1 to 2:1 hexanes/EtOAc) returning diene 10′-epi-195 (2.5 
mg) and yielding compound 10′-epi-196 as a colourless oil (18.5 mg, 85%). 1H NMR 
(500 MHz, CDCl3) δ 6.98 (d, J = 2.2 Hz, 1H), 6.86 (d, J = 2.2 Hz, 1H), 5.86 (ddd, J =  
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15.7, 7.4, 6.2 Hz, 1H), 5.68 (dd, J = 15.7, 8.5 Hz, 1H), 5.40 (m, 1H), 5.19 (m, 1H), 5.19 
(d, J = 5.3 Hz, 1H), 5.18 (s, 2H), 5.16 (d, J = 6.9 Hz, 1H), 4.53 (dd, J = 8.4, 6.2 Hz, 
1H), 4.42 (d, J = 14.5 Hz, 1H), 4.15 (m, 1H), 4.14 (d, J = 14.4 Hz, 1H), 3.48 (s, 3H), 
3.47 (s, 3H), 3.08 (ddd, J = 14.7, 9.8, 6.1 Hz, 1H), 2.85 (ddd, J = 14.7, 8.5, 5.0 Hz, 1H), 
2.50 – 2.39 (m, 2H), 1.81 (m, 1H), 1.76 – 1.62 (m, 3H), 1.47 (s, 3H), 1.42 (d, J = 6.3 
Hz, 3H), 1.34 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 166.7, 159.1, 156.2, 130.2, 129.4, 
128.0, 119.0, 111.7, 108.2, 104.0, 94.7, 94.4, 79.2, 77.0, 72.5, 56.4, 56.4, 56.1, 51.9, 
37.7, 28.1, 27.7, 25.4, 20.1, 18.5. HRMS (ESI) calcd. for C25H36O10SNa+ [M + Na]+ 
551.1927, found 551.1923. 
 
(5′S,6′R,10′R)-2,4-Di-O-(methoxymethyl)-5′,6′-O-(1-
methylethylidene)-aigialomycin D (10′-epi-35) 
To a solution of sulfone 10′-epi-196 (12 mg, 23 μmol) 
in t-BuOH (250 μl) and CH2Cl2 (100 μL) was added 
powdered KOH (25 mg, 0.46 mmol) at rt. To the 
resulting suspension was added CCl4 (250 μmol) dropwise over 2 min. The reaction was 
then heated to 35 °C for 30 min. After cooling to rt the solvent was removed to dryness 
and the residue partitioned between sat. NH4Cl (aq) (5 mL) and EtOAc (5 mL). The 
aqueous layer was further extracted with EtOAc (2 x 5 mL). The combined organic 
phases were dried over MgSO4, filtered and reduced to dryness. Purification was 
attempted by flash column chromatography (silica, gradient elution 10:1 to 5:1 
hexanes/EtOAc). 1H NMR (500 MHz, CDCl3) δ 6.71 (d, J = 2.2 Hz, 1H), 6.69 (d, J = 
2.1 Hz, 1H), 6.43 (d, J = 15.8 Hz, 1H), 6.09 (dt, J = 15.8, 6.4 Hz, 1H), 5.86 (ddd, J = 
15.6, 7.6, 6.0 Hz, 1H), 5.67 (dd, J = 15.6, 8.0 Hz, 1H), 5.18 (d, J = 6.7 Hz, 1H), 5.17 
(m, 1H), 5.16 (s, 2H), 5.14 (d, J = 6.8 Hz, 1H), 4.57 (dd, J = 7.8, 6.0, Hz, 1H), 4.16 (m, 
1H), 3.47 (s, 3H), 3.46 (s, 3H), 2.64 (ddd, J = 10.7, 8.1, 3.3 Hz, 1H), 2.43 (m, 1H), 2.34 
(m, 1H), 2.11 – 2.01 (m, 1H), 1.88 – 1.80 (m, 2H), 1.49 (s, 3H), 1.41 (d, J = 6.4 Hz, 
3H), 1.35 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 167.2, 158.8, 155.4, 137.6, 132.8, 
130.3, 128.8, 128.2, 107.8, 106.4, 102.5, 94.8, 94.3, 79.6, 78.1, 72.2, 56.2, 56.1, 37.5, 
28.3, 28.2, 28.1, 25.6, 20.2. 
 
Methyl (6′S,7′R)-6-(6,7-O-(1-methylethylidene)-2-
thianon-8-enyl)benzoate (326) 
To solution of bromide 210 (531 mg, 2.32 mmol) and 
thioactate 189 (566 mg, 2.32 mmol) in MeOH (10 mL) was 
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degassed with bubbling argon for 10 min. To this solution was added K2CO3  (641 mg, 
4.64 mmol) and the reaction stirred for 18 h at rt. The solvent was removed and the 
crude residue partitioned between EtOAc (20 mL) and H2O (20 mL). The aqueous layer 
was further extracted with EtOAc (3 x 10 mL). The combined organics fractions were 
washed with sat. NH4Cl (aq) (10 mL), dried over MgSO4, filtered and reduced to give a 
colourless oil. The product was purified using flash column chromatography (silica, 
gradient elution 20:1 to 5:1 hexanes/EtOAc) affording the title compound as a 
colourless oil (683 mg, 84%). [α]D22 = -14.6 (c 0.55, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.90 (dd, J = 7.7, 1.1 Hz, 1H), 7.43 (td, J = 7.6, 1.4 Hz, 1H), 7.33 – 7.28 (m, 
2H), 5.78 (ddd, J = 17.3, 10.3, 7.8 Hz, 1H), 5.29 (d, J = 17.1 Hz, 1H), 5.22 (d, J = 10.3 
Hz, 1H), 4.46 (dd, J = 7.9, 6.9 Hz, 1H), 4.12 – 4.05 (m, 3H), 3.90 (s, 3H), 2.45 (t, J = 
5.9 Hz, 2H), 1.79 – 1.67 (m, 2H), 1.58 – 1.45 (m, 2H), 1.46 (s, 3H), 1.34 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 167.8, 140.6, 134.3, 131.7, 131.1, 130.9, 129.5, 127.0, 
118.3, 108.2, 79.7, 77.8, 52.1, 34.5, 31.6, 29.5, 28.2, 25.9, 25.6. IR (KBr): 2986, 2938, 
1723, 1434, 1379, 1262, 1216, 1123, 1077, 1046, 1011, 928, 872, 769, 716. HRMS 
(ESI) calcd. for C19H26O4SNa+ [M + Na]+ 373.1450, found 373.1444; C19H26O4SK+ [M 
+ K+] 389.1189, found 389.1189. 
 
(6′S,7′R)-6-(6,7-O-(1-methylethylidene)-2-thianon-8-
enyl)benzoic acid (327) 
To a solution of solution of ester 326 (252 mg, 0.72 mmol) 
in MeOH (5 mL) was added a solution of KOH (202 mg, 
3.61 mmol) in H2O (5 mL). The reaction was warmed to 80 
°C for 4 h. The reaction was cooled to rt and extracted with Et2O (2 x 15 mL). The 
combined organic fractions were dried over MgSO4, filtered and reduced to give a 
colourless oil. The residue was identified as disulfide 190. The aqueous layer was 
acidified to pH 1 with 10% HCl and extracted with Et2O (3 x 10 mL). The second 
organic layer was dried over MgSO4, filtered and reduced to give the acid as a 
colourless oil (212 mg, 92%). The product was deemed pure by 1H NMR and was not 
purified further. [α]D20 = -26.5 (c 0.12, CHCl3). 1H NMR (500 MHz, CDCl3) δ 8.05 (dd, 
J = 7.8, 1.4 Hz, 1H), 7.49 (td, J = 7.5, 1.4 Hz, 1H), 7.38 – 7.32 (m, 2H), 5.79 (ddd, J = 
17.2, 10.3, 7.8 Hz, 1H), 5.28 (ddd, J = 17.1, 1.7, 1.3 Hz, 1H), 5.22 (ddd, J =  10.3, 1.5, 
0.8 Hz, 1H), 4.47 (dd, 7.9, 6.9 Hz, 1H), 4.18 (d, J = 13.3 Hz, 1H), 4.14 (d, J = 14.1 Hz, 
1H), 4.10 (ddd, J = 8.9, 6.2, 4.5 Hz, 1H), 2.48 (t, J = 7.1 Hz, 2H), 1.75 (m, 1H), 1.66 – 
1.49 (m, 2H), 1.47 (s, 3H), 1.45 (m, 1H), 1.35 (s, 3H). IR (neat): 1692, 1372, 1298, 
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1267, 1242, 1218, 1046, 913, 873, 733 cm-1.HRMS (ESI) calcd. for C18H24O4SNa+ [M + 
Na]+ 359.1293, found 359.1288. 
 
(4S,6′S,7′R)-Pent-1-en-4-yl 6-(6,7-O-(1-
methylethylidene)-2-thianon-8-enyl)benzoate (328)  
To a solution of alcohol 22 (46 μL, 0.446 mmol) and PPh3 
(195 mg, 0.744 mmol) in THF (5 mL) at 0 ˚C was added 
DIAD (145 μL, 0.744 mmol). The solution was stirred at 0 
˚C for 20 min during which time a white precipitate formed. After this time a solution of 
the acid 327 (100 mg, 0.298 mmol) in THF (2 mL) was added dropwise and the reaction 
mixture was left to stir at rt for 16 h. To the crude reaction mixture was added silica gel 
before removal of solvent. The silica gel was dry loaded onto a silica column and eluted 
(20:1 hexanes/EtOAc) yielding a colourless oil (103 mg, 85%). [α]D22 = -21.9 (c 0.75, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.9 Hz, 1H), 7.41 (td, J = 7.6, 1.3 
Hz, 1H), 7.32 – 7.27 (m, 2H), 5.85 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 5.78 (ddd, J = 17.1, 
9.8, 7.8 Hz, 1H), 5.29 (d, J = 17.1, 1H), 5.22 (d, J = 12.1, 1H), 5.21 (m, 1H), 5.15 (dd, J 
= 17.1, 1.5 Hz, 1H), 5.11 (dd, J = 10.2, 0.9 Hz, 1H ), 4.46 (dd, J = 7.8, 6.8 Hz, 1H), 4.14 
– 4.04 (m, 3H), 2.55 – 2.38 (m, 4H), 1.72 (m, 1H), 1.61 – 1.41 (m, 3H), 1.46 (s 3H), 
1.36 (d, J = 6.3 Hz, 3H), 1.34 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 167.0, 140.4, 
134.3, 133.7, 131.5, 130.9, 130.8, 130.3, 126.9, 118.4, 117.9, 108.2, 79.7, 77.8, 70.9, 
40.3, 34.4, 31.6, 29.5, 28.2, 25.9, 25.6, 19.5. IR(neat): 2983, 2934, 1713, 1379, 1260, 
1216, 1118, 1072, 1047, 994, 922 cm-1. HRMS (ESI) calcd. for C23H32O4SNa+ [M + 
Na]+ 427.1919, found 427.1914. 
 
 (4S,6′S,7′R)-Pent-1-en-4-yl 6-(6′,7′-O-(1′′-
methylethylidene)-2′-thianon-8′-enyl)benzoate 2′,2′-
dioxide (329) 
To a solution of thioether 328 (125 mg, 0.309 mmol) in 
CH2Cl2 (7 mL) at 0˚C was added ~75% m-CPBA (157 mg, 
0.681 mmol). The solution was strirred at rt for 2 h. The reaction was quenched with 
addition of 20% Na2SO3 (10 mL). The solution was stirred for 20 min before the 
organic layer was separated. The aqueous layer was further extracted with CH2Cl2 (3 x 
10 mL). The combined organic fractions were washed with sat. NaHCO3(aq) (10 mL), 
dried over MgSO4 and filtered. The crude product was purified using flash column 
chromatography (silica, gradient elution 3:1 to 1:1 hexanes/EtOAc) affording the title 
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compound as a colourless oil (124 mg, 92%). 1H NMR (300 MHz, CDCl3) δ 7.98 (d, J = 
7.4 Hz, 1H), 7.59 – 7.49 (m, 2H), 7.49 – 7.41 (m, 1H), 5.84 (ddt, J = 17.2, 10.2, 7.0 Hz, 
1H), 5.78 (m, 1H), 5.78 (ddd, J = 7.7, 9.8, 17.2 Hz, 1H), 5.29 (d, J = 17.1 Hz, 1H), 5.22 
(d, J = 8.9 Hz, 1H), 5.18 (dd, J = 2.1, 3.8 Hz, 1H), 5.11 (d, J = 8.3 Hz, 1H), 4.94 (d, J = 
13.5 Hz, 1H), 4.84 (d, J = 13.5 Hz, 1H), 4.49 (dd, J = 6.8, 7.8 Hz, 1H), 4.09 (dd, J = 
6.5, 13.2, 1H), 3.09 – 2.85 (m, 2H), 2.57 – 2.35 (m, 2H), 2.07 – 1.79 (m, 2H), 1.56 – 
1.51 (m, 2H), 1.44 (s, 3H), 1.37 (d, J = 6.3 Hz, 3H), 1.33 (s, 3H). IR(neat): 2980, 2928, 
1711, 1299, 1268, 1116, 1076, 911, 733 cm-1. HRMS (ESI) calcd. for C23H32O6SNa+ [M 
+ Na]+ 459.1817, found 459.1817.  
 
(5S,7E,9R,10S)-1,2-benzo-4-oxa-14-thia-3-oxo-5-methyl-
9,10-O-(1-methylethylidene)-pentadec-7-ene 14,14-dioxide 
(330)  
To a solution of diene 329 (120 mg, 28 μmol) in CH2Cl2 (55 
mL) in a 50 mL MW Teflon™ reactor vessel was added a 
catalytic amount of Grubbs’ 2nd generation catalyst (23 mg, 28 μmol). The vessel was 
flushed with argon before sealing with the cap. The vessel was placed in the MW 
carousel and probe inserted into the reaction vessel. The vessel was irradiated for 30 
min and heated to 75 ˚C. Once the reaction vessel had cooled to rt the cap was removed 
and the solution transferred to a round bottom flask. The solvent was removed to yield a 
brown oil. The crude oil was dissolved up in CH2Cl2 and silica added to form a slurry. 
The solvent was removed to form a free flowing powder. The silica was loaded onto a 
silica column and eluted (10:1 hexanes/EtOAc) to give the macrocyle as a white solid 
(97 mg, 86%). mp 180 – 181 °C. [α]D22 = -11.3 (c 0.54, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 8.03 (dd, J = 7.9, 1.4 Hz, 1H), 7.84 (d, J = 7.8 Hz, 1H), 7.58 (td, J = 7.6, 1.5 
Hz, 1H), 7.45 (td, J = 7.7, 1.3 Hz, 1H), 5.94 (d, J = 14.8 Hz, 1H), 5.83 (ddd, J = 15.1, 
10.2, 3.6 Hz, 1H), 5.49 (ddd, J = 15.3, 9.6, 1.8 Hz, 1H), 5.40 (m, 1H), 4.42 (dd, J = 9.6, 
5.7 Hz, 1H), 4.07 (ddd, J = 9.8, 5.6, 3.6 Hz, 1H), 2.57 – 2.49 (m, 3H), 2.42 (dt, J = 15.6, 
10.4 Hz, 1H), 1.72 – 1.64 (m, 2H), 1.60 – 1.49 (m, 2H), 1.42 (m, 1H), 1.41 (d, J = 6.4 
Hz, 3H), 1.41 (s, 3H), 1.31 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 166.3, 133.2, 132.9, 
132.8, 131.6, 130.6, 129.4, 128.9, 127.7, 107.8, 79.6, 77.3, 71.2, 54.4, 50.9, 40.6, 28.3, 
27.9, 25.6, 21.4, 19.0. IR (neat): 2932, 2879, 1706, 1448, 1295, 1244, 1223, 1109, 1072, 
1033, 973, 915, 731 cm-1. HRMS (ESI) calcd. for C21H28O6SNa+ [M + Na]+ 431.1504, 
found 431.1502. 
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(5′S,6′R,10′S)-2,4-Dideoxy-5′,6′-O-(1-methylethylidene)-
aigialomycin D (331) 
To a solution of sulfone 330 (70 mg, 0.172 mmol) in 
tBuOH/CH2Cl2 (750 μL/300 μL) was added powdered KOH 
(214 mg, 3.82 mmol) at rt. To the resulting suspension was 
added CCl4 (750 μL) dropwise over 2 min. The reaction was then heated to 35 ˚C for 30 
min. After cooling to rt the solvent was removed to dryness and the residue partitioned 
between sat. NH4Cl(aq) (10 mL) and EtOAc (10 mL). The aqueous layer was further 
extracted with EtOAc (2 x 10 mL). The combined organic phases were dried over 
MgSO4, filtered and reduced to give a white solid. The product was purified using silica 
column chromatography (silica, 10:1 hexanes/EtOAc) yielding a white solid (47 mg, 
80%). [α]D22 = -34.8 (c 0.59, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.62 (dd, J = 7.7, 
1.1 Hz, 1H), 7.47 (d, J = 7.9 Hz, 1H), 7.39 (td, J = 7.4, 1.0 Hz, 1H), 7.25 (td, J = 7.5, 
1.2 Hz, 1H), 6.67 (d, J = 15.5 Hz, 1H), 6.12 (ddd, J = 15.3, 9.3, 5.2 Hz, 1H), 5.80 (m, 
1H), 5.66 (ddt, J = 15.3, 8.9, 1.4 Hz, 1H), 5.24 (dq, J = 12.2, 6.1 Hz, 1H), 4.60 (dd, J = 
8.9, 5.5 Hz, 1H), 4.19 (ddd, J = 11.5, 5.5, 2.9 Hz, 1H), 2.55 (dd, J = 7.3, 5.9 Hz, 2H), 
2.31 (m, 1H), 2.04 (m, 1H), 1.91 (m, 1H), 1.64 (m, 1H), 1.48 (s, 3H), 1.40 (d, J = 6.1 
Hz, 3H), 1.36 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 169.6, 136.2, 131.3, 131.1, 130.9, 
130.4, 130.1, 129.6, 129.1, 126.9, 125.8, 108.2, 79.7, 77.3, 72.4, 39.5, 29.2, 29.1, 28.5, 
25.8, 20.3. IR(neat): 2984, 2936, 1703, 1450, 1379, 1291, 1257, 1216, 1121, 1043, 971 
cm-1. HRMS (ESI) calcd. for C21H26O4Na+ [M + Na]+ 365.1729, found 365.1722. 
 
2,4-Dideoxy-aigialomycin D (204) 
To a solution of macrolide 331 (34 mg, 99 μmol) in MeOH 
(1.5 mL) was added 1M HCl (1.5 mL). The reaction was 
stirred for 2 days at rt. The reaction mixture was extracted with 
EtOAc (3 x 10 mL). The combined organic phases were dried 
over MgSO4, filtered and reduced to dryness. The crude was purified by flash column 
chromatography (diol silica, gradient elution CH2Cl2 to 5% MeOH/CH2Cl2) yielding a 
white solid (26 mg, 80%). [α]D23 = -117.0 (c 0.02, CHCl3). 1H NMR (500 MHz, CDCl3) 
δ 7.75 (d, J = 7.8 Hz, 1H), 7.51 (d, J = 7.9 Hz, 1H), 7.41 (t, J = 7.6 Hz, 1H), 7.27 (m, 
1H), 6.97 (d, J = 16.2 Hz, 1H), 6.23 (dt, J = 16.1, 5.4 Hz, 1H), 5.88 (m, 1H), 5.67 (dd, J 
= 15.7, 6.0 Hz, 1H), 5.35 (m, 1H), 4.41 (d, J = 5.5 Hz, 1H), 3.75 (brs, 1H), 2.60 (m, 
1H), 2.44 (dd, J = 15.3, 7.6 Hz, 1H), 2.38 (dd, J = 11.8, 6.1 Hz, 2H), 2.18 (brs, 1H), 
2.09 (m, 1H), 2.04 (s, 1H), 1.65 (m, 1H), 1.39 (d, J = 6.4 Hz, 3H). 13C NMR (125 MHz, 
O
O
O
O
O
O
OH
OH
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CDCl3) δ 169.0, 137.3, 132.5, 132.0, 131.5, 130.5, 130.2, 127.9, 127.8, 126.7, 126.2, 
76.0, 73.0, 71.8, 38.0, 27.4, 26.9, 19.7. IR (neat): 3435, 2976, 2932, 1710, 1448, 1357, 
1263, 1123, 1076, 977, 756 cm-1. HRMS (ESI) calcd. for C18H22O4Na+ [M + Na]+ 
325.1416, found 325.1412. 
 202
Appendix 
 
Selected 1H NMR and 13C NMR spectra of key compounds 
 
 
Figure A–1. 1H NMR spectrum of arylmethyl 134 (300 MHz, CDCl3). 
 203
 
 
Figure A–2. 1H NMR spectrum of bromide 135 (300 MHz, CDCl3). 
 204
 
 
Figure A–3. 1H NMR spectrum of α,β-unsaturated ester (Z)-186 (500 MHz, CDCl3). 
 205
 
 
Figure A–4. 1H NMR spectrum of methyl ester 267 (500 MHz, CDCl3). 
 206
 
 
Figure A–5. 1H NMR spectrum of alcohol 187 (500 MHz, CDCl3). 
 207
 
 
Figure A–6. 1H NMR spectrum of mesylate 188 (500 MHz, CDCl3). 
 208
 
 
Figure A–7. 1H NMR spectrum of thioacetate 189 (500 MHz, CDCl3). 
 209
 
 
Figure A–8. 1H NMR spectrum of conjugate 191 (500 MHz, CDCl3). 
 210
 
 
Figure A–9. 1H NMR spectrum of bis-MOM protected 192 (500 MHz, CDCl3). 
 211
 
 
Figure A–10. 1H NMR spectrum of benzoic acid derivative 193 (500 MHz, CDCl3). 
 212
 
 
Figure A–11. 1H NMR spectrum of ester 167 (500 MHz, CDCl3). 
 213
 
 
Figure A–12. 1H NMR spectrum of sulfone 195 (500 MHz, CDCl3). 
 214
 
 
Figure A–13. 1H NMR spectrum of RB precursor 196 (500 MHz, CDCl3). 
 
 
 
 215
 
 
Figure A–14. 1H NMR spectrum of protected Am D 35 (500 MHz, CDCl3). 
 216
 
 
Figure A–15. 1H NMR spectrum of aigialomycin D, 1 (500 MHz, acetone-d6). 
 
 217
 
 
Figure A–16. 1H NMR spectrum of aigialomycin D, 1 (500 MHz, acetone-d6). 
 
 
 218
 
Figure A–17. 13C NMR spectrum of aigialomycin D, 1 (500 MHz, acetone-d6). 
 
 219
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